<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Physiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Physiol</journal-id>
<journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Physiology</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-042X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32116773</article-id>
<article-id pub-id-type="pmc">7016185</article-id>
<article-id pub-id-type="doi">10.3389/fphys.2020.00063</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Physiology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Carrera-Juliá</surname>
<given-names>Sandra</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moreno</surname>
<given-names>Mari Luz</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/505340/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barrios</surname>
<given-names>Carlos</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>de la Rubia Ortí</surname>
<given-names>Jose Enrique</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/782126/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Drehmer</surname>
<given-names>Eraci</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/778122/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Doctoral Degree’s School, Catholic University of Valencia “San Vicente Mártir”</institution>, <addr-line>Valencia</addr-line>, <country>Spain</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Nutrition and Dietetics, Catholic University of Valencia “San Vicente Mártir”</institution>, <addr-line>Valencia</addr-line>, <country>Spain</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Basic Sciences, Catholic University of Valencia “San Vicente Mártir”</institution>, <addr-line>Valencia</addr-line>, <country>Spain</country></aff>
<aff id="aff4"><sup>4</sup><institution>Institute for Research on Musculoskeletal Disorders, Catholic University of Valencia “San Vicente Mártir”</institution>, <addr-line>Valencia</addr-line>, <country>Spain</country></aff>
<aff id="aff5"><sup>5</sup><institution>Department of Basic Medical Sciences, Catholic University of Valencia “San Vicente Mártir”</institution>, <addr-line>Valencia</addr-line>, <country>Spain</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Murugesan Velayutham, West Virginia University, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Houzao Chen, Chinese Academy of Medical Sciences, China; Marcos Lopez, University of Puerto Rico, Puerto Rico</p>
</fn>
<corresp id="c001">*Correspondence: Eraci Drehmer, <email>eraci.drehmer@ucv.es</email></corresp>
<fn fn-type="other" id="fn004">
<p>This article was submitted to Oxidant Physiology, a section of the journal Frontiers in Physiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>06</day>
<month>2</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>11</volume>
<elocation-id>63</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>7</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>1</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2020 Carrera-Juliá, Moreno, Barrios, de la Rubia Ortí and Drehmer.</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Carrera-Juliá, Moreno, Barrios, de la Rubia Ortí and Drehmer</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that produces a selective loss of the motor neurons of the spinal cord, brain stem and motor cortex. Oxidative stress (OS) associated with mitochondrial dysfunction and the deterioration of the electron transport chain has been shown to be a factor that contributes to neurodegeneration and plays a potential role in the pathogenesis of ALS. The regions of the central nervous system affected have high levels of reactive oxygen species (ROS) and reduced antioxidant defenses. Scientific studies propose treatment with antioxidants to combat the characteristic OS and the regeneration of nicotinamide adenine dinucleotide (NAD<sup>+</sup>) levels by the use of precursors. This review examines the possible roles of nicotinamide riboside and pterostilbene as therapeutic strategies in ALS.</p>
</abstract>
<kwd-group>
<kwd>amyotrophic lateral sclerosis</kwd>
<kwd>neurodegenerative diseases</kwd>
<kwd>oxidative stress</kwd>
<kwd>mitochondrial dysfunction</kwd>
<kwd>nicotinamide riboside</kwd>
<kwd>pterostilbene</kwd>
</kwd-group>
<counts>
<fig-count count="3"></fig-count>
<table-count count="2"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="535"></ref-count>
<page-count count="30"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="S1">
<title>Oxidative Stress</title>
<p>Most eukaryotic organisms need oxygen to ensure the normal functioning of cellular energy metabolism, which is an evolutionary advantage and a highly efficient form of energy production (<xref ref-type="bibr" rid="B226">Jie et al., 2013</xref>). In the electron transport chain (ETC), oxygen is partially reduced by the incorporation of an electron, generating a free radical as a secondary product (<xref ref-type="bibr" rid="B141">Falkowski and Godfrey, 2008</xref>; <xref ref-type="bibr" rid="B490">Venditti et al., 2013</xref>). Free radicals are atoms or molecules that have one or more unpaired electrons in their last orbital layer (<xref ref-type="bibr" rid="B74">Chandrasekaran et al., 2017</xref>), which makes them strongly reactive capable of carrying out chain reactions, responsible for the oxidative damage of cells and tissues (<xref ref-type="bibr" rid="B444">Solleiro-Villavicencio and Rivas-Arancibia, 2018</xref>). They are classified as ROS and reactive nitrogen species (RNS) (<xref ref-type="bibr" rid="B112">De Gara and Foyer, 2017</xref>). Also included are reactive iron species (RIS) (<xref ref-type="bibr" rid="B123">Dixon and Stockwell, 2014</xref>) and copper species (RCS) (<xref ref-type="bibr" rid="B186">Gyulkhandanyan et al., 2003</xref>). The main ROS are: superoxide anion radicals (O<inline-formula><mml:math id="INEQ1"><mml:msubsup><mml:mi></mml:mi><mml:mn>2</mml:mn><mml:mrow><mml:mi></mml:mi><mml:mo>∙</mml:mo><mml:mo>-</mml:mo></mml:mrow></mml:msubsup></mml:math></inline-formula>), hydroxyl radicals (OH<sup>∙</sup>) and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) (<xref ref-type="bibr" rid="B373">Popa-Wagner et al., 2013</xref>). The RNS include: nitric oxide radical (NO<sup>∙</sup>), nitroxyl anion (NO<sup>–</sup>), nitrosonium cation (NO<sup>+</sup>) and peroxynitrite anions (ONOO<sup>–</sup>) (<xref ref-type="bibr" rid="B190">Halliwell, 2012</xref>; <xref ref-type="bibr" rid="B401">Rogers et al., 2014</xref>; <xref ref-type="bibr" rid="B535">Zuo et al., 2015</xref>).</p>
<p>The production of ROS is mainly secondary to enzymatic reactions involved in the respiratory chain, activity of cytochrome p-450, synthesis of prostaglandins and phagocytosis (<xref ref-type="bibr" rid="B369">Pizzino et al., 2017</xref>). Mitochondrial activity and metabolism of cytochrome p-450 are the most contributing sources in mammalian cells (<xref ref-type="bibr" rid="B224">Jha et al., 2017</xref>) (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Physiopathogenesis of ALS. Oxidative stress is caused by an imbalance between antioxidant defenses and RONS in favor of these second ones. The endogenous production of ROS is secondary to different prooxidant agents: mitochondrial and cytochrome p-450 metabolism, prostaglandins synthesis, phagocytosis, NADPH oxidases, XO, LOX and COX. Among the endogenous sources of RNS it should be noted the activity of epithelial, neuronal and inducible NOS. Exogenous sources also can produce RONS: stress, tobacco, UV-light, pesticides, environmental pollution and malnutrition. OS affects the normal functioning of the ETC, producing mitochondrial dysfunction that generates more ROS, which leads to a “vicious-cycle” that increases metabolic stress. This situation characterizes neurodegenerative diseases such as: ALS, AD, PD, MS, HD, and SA. In the case of ALS, OS and mitochondrial dysfunction have been identified as two mechanisms involved in its pathogenesis. They are related to neuroinflammation, aggregation of TDP-43, mutations in the mtDNA that produce characteristic OS biomarkers such as 8-OHdG, aggregation of SOD1 which impairs energy metabolism and cellular respiration, affectation of ATP supply to neurons and disturbance of the intracellular calcium homeostasis that results in excitotoxicity. The formation of highly reactive end products such as MDA and 4-HNE, both secondary to the lipoperoxidation of the neuronal membranes, is also observed.</p>
</caption>
<graphic xlink:href="fphys-11-00063-g001"></graphic>
</fig>
<p>Mitochondrial production of ROS may occur on the external membrane, internal membrane or in the mitochondrial matrix, during physiological and pathological conditions (<xref ref-type="bibr" rid="B369">Pizzino et al., 2017</xref>). O<inline-formula><mml:math id="INEQ4"><mml:msubsup><mml:mi></mml:mi><mml:mn>2</mml:mn><mml:mrow><mml:mi></mml:mi><mml:mo>∙</mml:mo><mml:mo>-</mml:mo></mml:mrow></mml:msubsup></mml:math></inline-formula> production occurs when there is a buildup of nicotinamide adenine dinucleotide phosphate (NADPH) or when there is a reduced CoQ pool within the mitochondria (<xref ref-type="bibr" rid="B328">Murphy, 2009</xref>). O<inline-formula><mml:math id="INEQ5"><mml:msubsup><mml:mi></mml:mi><mml:mn>2</mml:mn><mml:mrow><mml:mi></mml:mi><mml:mo>∙</mml:mo><mml:mo>-</mml:mo></mml:mrow></mml:msubsup></mml:math></inline-formula> may also be secondary to the enzymatic activity of lipoxygenases (LOX) and cyclooxygenases (COX) (<xref ref-type="bibr" rid="B476">Valko et al., 2007</xref>) during the arachidonic acid metabolism and by endothelial and inflammatory cells (<xref ref-type="bibr" rid="B14">Al-Gubory et al., 2012</xref>). O<inline-formula><mml:math id="INEQ6"><mml:msubsup><mml:mi></mml:mi><mml:mn>2</mml:mn><mml:mrow><mml:mi></mml:mi><mml:mo>∙</mml:mo><mml:mo>-</mml:mo></mml:mrow></mml:msubsup></mml:math></inline-formula> may participate in reactions that produce H<sub>2</sub>O<sub>2</sub> or OH<sup>∙</sup> (<xref ref-type="bibr" rid="B258">Kumar and Pandey, 2015</xref>) (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<p>The cytochrome p-450 enzymes present in the liver are an important source of ROS production and their function is to catalyze O<inline-formula><mml:math id="INEQ8"><mml:msubsup><mml:mi></mml:mi><mml:mn>2</mml:mn><mml:mrow><mml:mi></mml:mi><mml:mo>∙</mml:mo><mml:mo>-</mml:mo></mml:mrow></mml:msubsup></mml:math></inline-formula> producing reactions by NADPH dependent mechanisms (<xref ref-type="bibr" rid="B280">Liochev, 2013</xref>). The risk of ROS production here is high because it contains transition ions, oxygen and electron transfer processes (<xref ref-type="bibr" rid="B280">Liochev, 2013</xref>). In addition, there are a group of NOX (NADPH oxidases) enzymes located on the cell membrane of polymorphonuclear cells, macrophages and endothelial cells, that facilitate the conversion of oxygen into superoxide on biological membranes using NADPH as an electron donor with ROS released as secondary products (<xref ref-type="bibr" rid="B25">Atashi et al., 2015</xref>) (<xref ref-type="fig" rid="F1">Figure 1</xref>). Endothelium xanthine dehydrogenase interacts with xanthine oxidase (XO) producing O<inline-formula><mml:math id="INEQ9"><mml:msubsup><mml:mi></mml:mi><mml:mn>2</mml:mn><mml:mrow><mml:mi></mml:mi><mml:mo>∙</mml:mo><mml:mo>-</mml:mo></mml:mrow></mml:msubsup></mml:math></inline-formula> and H<sub>2</sub>O<sub>2</sub>, and thus, generating another source of free radicals (<xref ref-type="bibr" rid="B473">Turrens, 2003</xref>) (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<p>Non-enzymatic reactions may also be responsible for the production of ROS by the reaction of oxygen with organic compounds and after cellular exposure to ionizing radiation (<xref ref-type="bibr" rid="B476">Valko et al., 2007</xref>) (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<p>The endogenous release of RNS, such as nitric oxide (NO<sup>∙</sup>), is produced from <sc>L</sc>-arginine in reactions of catalyze by three main isoforms of nitric oxide synthase (NOS): epithelial NOS, neuronal NOS and inducible NOS, which are activated in response to various endotoxin or cytokine signals (<xref ref-type="bibr" rid="B152">Förstermann and Sessa, 2012</xref>). Thus oxygen can react with this NO<sup>∙</sup> and form highly reactive molecules such as ONOO<sup>–</sup> (<xref ref-type="bibr" rid="B413">Salisbury and Bronas, 2015</xref>; <xref ref-type="bibr" rid="B430">Sharina and Martin, 2017</xref>) (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<p>Endogenous production of reactive oxygen and nitrogen species (RONS) can be conditioned by exogenous pro-oxidant factors: environmental and atmospheric pollution, water pollution, chemicals like pesticides or industrial solvents, heavy metals or transition metals, different types of xenobiotics, irradiation by UV-light, X-rays or gamma rays, stress, tobacco, smoked meat, the use of waste oil and malnutrition (<xref ref-type="bibr" rid="B366">Phaniendra et al., 2015</xref>; <xref ref-type="bibr" rid="B334">Niedzielska et al., 2016</xref>; <xref ref-type="bibr" rid="B444">Solleiro-Villavicencio and Rivas-Arancibia, 2018</xref>; <xref ref-type="bibr" rid="B524">Zewen et al., 2018</xref>) (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<p>Reactive oxygen and nitrogen species at physiological concentrations are regulators of numerous cellular functions: cellular signaling pathway, control of cell survival, regulation of vascular tone, signal transduction by cell membrane receptors, membrane renewal, synthesis and release of hormones, increase of inflammatory cytokine transcription regulation of the immune system (<xref ref-type="bibr" rid="B399">Robberecht, 2000</xref>; <xref ref-type="bibr" rid="B388">Ray et al., 2012</xref>), phosphorylation of proteins, action on ionic channels and transcription factors, production of thyroid hormones and crosslinking on extracellular matrix (<xref ref-type="bibr" rid="B56">Brieger et al., 2012</xref>).</p>
<p>The body tries to maintain redox homeostasis between the production of RONS and the capacity for their removal by antioxidant systems (<xref ref-type="bibr" rid="B535">Zuo et al., 2015</xref>), which allows the redox state to be re-established after temporary exposure to high concentrations of RONS and minimize the risk of a deteriorated redox homeostasis, which is an unbalanced state known as OS (<xref ref-type="bibr" rid="B436">Sies, 1986</xref>; <xref ref-type="bibr" rid="B104">Coyle and Puttfarcken, 1993</xref>; <xref ref-type="bibr" rid="B277">Liguori et al., 2018</xref>) (<xref ref-type="fig" rid="F1">Figure 1</xref>). However, redox homeostasis is conditioned by the magnitude and duration of exposure to free radicals, since constant exposure can have a serious impact on intracellular signals or genetic expression, resulting in irreversible pathological consequences (<xref ref-type="bibr" rid="B394">Rhee et al., 2003</xref>), since most reactions of the body are dependent on the redox state (<xref ref-type="bibr" rid="B457">Tan et al., 2018</xref>).</p>
<p>Diseases associated with OS, such as neurodegenerative diseases, are related to aging (<xref ref-type="bibr" rid="B277">Liguori et al., 2018</xref>), a physiological stage accompanied by progressive loss of tissue and organ function (<xref ref-type="bibr" rid="B149">Flatt, 2012</xref>), changes in regulatory processes, decrease in the antioxidant capacity of the organism and irreversible tissue damage by RONS that compromises the achievement of a redox balance (<xref ref-type="bibr" rid="B403">Romano et al., 2010</xref>). The damage caused by oxidation depends on the defects of the enzymes involved in the redox signaling pathways (<xref ref-type="bibr" rid="B457">Tan et al., 2018</xref>).</p>
<p>Free radicals can cross the cells and cause modifications in the main macromolecules (lipids, proteins and nucleic acids), damaging their structure and altering their normal function (<xref ref-type="bibr" rid="B413">Salisbury and Bronas, 2015</xref>). Lipid peroxidation is associated with different disease states and is responsible for an unstable cell membrane, oxidation of low-density lipoproteins (LDL) and poly-unsaturated fatty acids (PUFAs). The oxidation of different amino acids such as lysine, arginine, proline and threonine results in protein dysfunction. Oxidative damage of DNA generates severe mutations and adverse effects on transcription, producing an RNA more vulnerable to oxidation. Chronic persistence of this situation is capable of causing cell death (<xref ref-type="bibr" rid="B206">Huiyong et al., 2011</xref>; <xref ref-type="bibr" rid="B124">Dizdaroglu and Jaruga, 2012</xref>).</p>
<p>OS plays an important role in chronic, inflammatory pathologies (<xref ref-type="bibr" rid="B242">Kehrer and Klotz, 2015</xref>), progressive brain damage and the pathogenesis of neurodegenerative diseases such as: Amyotrophic lateral sclerosis (ALS), Alzheimer’s disease (AD), Parkinson’s disease (PD), Multiple sclerosis (MS), Huntington’s disease (HD), and Spinocerebellar ataxia (SA) (<xref ref-type="bibr" rid="B119">Dias et al., 2013</xref>; <xref ref-type="bibr" rid="B214">Islam, 2017</xref>; <xref ref-type="bibr" rid="B524">Zewen et al., 2018</xref>) (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
</sec>
<sec id="S2">
<title>Oxidative Stress and Neurodegenerative Diseases</title>
<p>The exact pathogenesis of neurodegenerative diseases remains unknown, although a complex and multifactorial origin has been established in which aspects such as genetic predisposition, certain endogenous factors and exposure to environmental factors are involved (<xref ref-type="bibr" rid="B100">Correia and Moreira, 2010</xref>; <xref ref-type="bibr" rid="B99">Correia et al., 2010</xref>; <xref ref-type="bibr" rid="B97">Coppedè and Migliore, 2015</xref>). ROS is a key factor in the etiology of these pathologies (<xref ref-type="bibr" rid="B43">Bhat et al., 2015</xref>) and in patients with a neurodegenerative disease, high levels of OS biomarkers have been observed (<xref ref-type="bibr" rid="B450">St-Pierre et al., 2006</xref>; <xref ref-type="bibr" rid="B334">Niedzielska et al., 2016</xref>). However, physiological concentrations of free radicals play an important role in normal brain function (<xref ref-type="bibr" rid="B113">De Silva and Miller, 2016</xref>; <xref ref-type="bibr" rid="B426">Scialò et al., 2017</xref>; <xref ref-type="bibr" rid="B78">Chen et al., 2018</xref>). Thus, ROS can contribute to: vascularization, cerebral perfusion, cellular signaling, synaptic plasticity, neurotransmitter secretion and cerebral vasodilation (<xref ref-type="bibr" rid="B301">Massaad and Klann, 2011</xref>; <xref ref-type="bibr" rid="B175">Grochowski et al., 2018</xref>; <xref ref-type="bibr" rid="B331">Neal and Richardson, 2018</xref>). A moderate increase of ROS secondary to mitochondrial activity produces preconditioning that leads to a neuroprotective function against harmful agents and is even preventive against massive ROS formation (<xref ref-type="bibr" rid="B122">Dirnagl and Meisel, 2008</xref>; <xref ref-type="bibr" rid="B233">Jou, 2008</xref>; <xref ref-type="bibr" rid="B121">Dirnagl et al., 2009</xref>). The origin of the problem lies in impaired redox homeostasis, which causes damage to cell membrane, compromising the viability and integrity of the central nervous system (CNS) (<xref ref-type="bibr" rid="B484">Van Horssen et al., 2011</xref>; <xref ref-type="bibr" rid="B359">Payne and Chinnery, 2015</xref>). The excess of ROS is related to changes in the microcirculation of the brain (<xref ref-type="bibr" rid="B154">Freeman and Keller, 2012</xref>; <xref ref-type="bibr" rid="B449">Staiculescu et al., 2014</xref>). O<inline-formula><mml:math id="INEQ12"><mml:msubsup><mml:mi></mml:mi><mml:mn>2</mml:mn><mml:mrow><mml:mi></mml:mi><mml:mo>∙</mml:mo><mml:mo>-</mml:mo></mml:mrow></mml:msubsup></mml:math></inline-formula> and H<sub>2</sub>O<sub>2</sub> are able to cause a contraction of cerebral blood vessels (<xref ref-type="bibr" rid="B15">Allen and Bayraktunan, 2009</xref>). Increased levels of H<sub>2</sub>O<sub>2</sub> are associated with increased pro-apoptotic agents in brain vascular cells (<xref ref-type="bibr" rid="B270">Li et al., 2003</xref>) and OS can alter cerebral vascular function through an interruption of NO<sup>∙</sup> signaling and consequently, its vasodilatory and anti-inflammatory capacity (<xref ref-type="bibr" rid="B313">Miller et al., 2010</xref>; <xref ref-type="bibr" rid="B113">De Silva and Miller, 2016</xref>). In addition, ROS contribute to the maintenance of a proinflammatory state, secondary to secretion of cytokines and chemokines (<xref ref-type="bibr" rid="B202">Hsieh and Yang, 2013</xref>; <xref ref-type="bibr" rid="B242">Kehrer and Klotz, 2015</xref>).</p>
<p>The CNS is especially susceptible to oxidative damage (<xref ref-type="bibr" rid="B98">Cordeiro, 2014</xref>). The brain is largely formed by PUFAs with high sensitivity to lipid peroxidation (<xref ref-type="bibr" rid="B343">Nunomura et al., 2006</xref>), motor neurons are highly sensitive to OS (<xref ref-type="bibr" rid="B437">Simpkins and Dykens, 2008</xref>) and the CNS has a poor antioxidant capacity with low activity of protective enzymes such as glutathione peroxidase (GPx), catalase (CAT) or superoxide dismutase (SOD) and poor capacity for cell regeneration (<xref ref-type="bibr" rid="B147">Fischer and Maier, 2015</xref>; <xref ref-type="bibr" rid="B247">Kim et al., 2015</xref>; <xref ref-type="bibr" rid="B151">Formella et al., 2018</xref>). Although the brain only accounts for 2% of body weight (<xref ref-type="bibr" rid="B309">Mergenthaler et al., 2013</xref>) and mitochondrial density is higher in myocytes than in neuronal cells (<xref ref-type="bibr" rid="B159">Gandhi and Abramov, 2012</xref>), it is an organ with a high metabolic rate that can consume up to 20% of the total oxygen of the body (<xref ref-type="bibr" rid="B325">Moreira et al., 2009</xref>; <xref ref-type="bibr" rid="B404">Ronnett et al., 2009</xref>). This means it has 10 times higher energy and glucose consumption than the other tissues and a high dependence on mitochondrial energy production, responsible for the increase of ROS (<xref ref-type="bibr" rid="B71">Carvalho and Moreira, 2018</xref>). Taking into account the high rate of demand and energy consumption of the brain, the majority of mitochondrial mutations can affect the functioning of the CNS and have been associated with neurodegenerative diseases (<xref ref-type="bibr" rid="B20">Angelova and Abramov, 2018</xref>). Thus, mitochondrial dysfunction is currently seen as a “convergence point” in neurodegeneration (<xref ref-type="bibr" rid="B99">Correia et al., 2010</xref>; <xref ref-type="bibr" rid="B40">Bennett et al., 2014</xref>; <xref ref-type="bibr" rid="B23">Arun et al., 2016</xref>; <xref ref-type="bibr" rid="B260">Kurtishi et al., 2018</xref>).</p>
<p>Mitochondrial dysfunction compromises the energy supply of ATP to neurons, calcium homeostasis and leads to high levels of ROS that accelerate the mutation rate of mitochondrial DNA (mtDNA) and lipoperoxidation of neuronal membranes, causing decomposition of PUFAs and the formation of highly reactive end products: malondialdehyde (MDA) and 4-hydroxy-2-nonenal (HNE) (the most toxic species related to cell damage and apoptosis) (<xref ref-type="bibr" rid="B364">Petrozzi et al., 2007</xref>; <xref ref-type="bibr" rid="B10">Albarracín et al., 2012</xref>; <xref ref-type="bibr" rid="B155">Fritz and Petersen, 2013</xref>) (<xref ref-type="fig" rid="F1">Figure 1</xref>). Accumulation of mutations in mtDNA causes an increase in oxidative damage, a decrease in energy rate and an increase in ROS. Thus, mitochondrial dysfunction generates a “vicious-cycle” responsible for neuronal damage, genetic mutations and metabolic stress, a situation that can lead to apoptosis (<xref ref-type="bibr" rid="B485">Van Houten et al., 2006</xref>; <xref ref-type="bibr" rid="B427">Selvaraji et al., 2019</xref>; <xref ref-type="bibr" rid="B500">Wang et al., 2019</xref>).</p>
<p>Mitochondrial dysfunction is considered as the main cause of neurodegenerative diseases pathogenesis (ALS, PD, AD, MS, HD) (<xref ref-type="bibr" rid="B278">Lin and Beal, 2006</xref>; <xref ref-type="bibr" rid="B142">Federico et al., 2012</xref>) (<xref ref-type="fig" rid="F1">Figure 1</xref>). Postmortem studies in brains of patients with these diseases have found that mitochondrial dysfunction is a common event leading to the degeneration and death of neuronal cells (<xref ref-type="bibr" rid="B424">Schon and Manfredi, 2003</xref>; <xref ref-type="bibr" rid="B31">Bao and Swaab, 2018</xref>; <xref ref-type="bibr" rid="B128">Du et al., 2018</xref>).</p>
<p>Brain aging increases sensitivity to OS and decreases the effectiveness of antioxidant defenses, causing functional deficiencies, inflammation, decreased elasticity and greater susceptibility to the etiological factors involved in the pathogenesis of neurodegenerative disease (<xref ref-type="bibr" rid="B142">Federico et al., 2012</xref>; <xref ref-type="bibr" rid="B182">Guo et al., 2013</xref>). It also contributes to the accumulation of mutations in the mtDNA, malfunctions in the oxidative phosphorylation pathway and impaired redox homeostasis (<xref ref-type="bibr" rid="B416">Sarasija and Norman, 2018</xref>).</p>
<p>ROS have currently been proposed as one of the main contributors to the development and progression of neurodegenerative diseases (<xref ref-type="bibr" rid="B324">Morató et al., 2014</xref>). There is evidence that indicates that the increase in RONS concentration is a inducer of tissue damage, activation of microglia and astrocytes, neuronal dysfunction, neurodegeneration and cell death (<xref ref-type="bibr" rid="B142">Federico et al., 2012</xref>; <xref ref-type="bibr" rid="B324">Morató et al., 2014</xref>; <xref ref-type="bibr" rid="B422">Schieber and Chandel, 2014</xref>). Thus, a “vicious cycle” between OS, mitochondrial dysfunction, aging and neuroinflammation has been demonstrated (<xref ref-type="bibr" rid="B506">Witte et al., 2010</xref>; <xref ref-type="bibr" rid="B482">Van Giau et al., 2018</xref>). However, further studies are necessary to understand the physiopathological mechanisms implicated (<xref ref-type="bibr" rid="B421">Schetters et al., 2018</xref>) because it is unknown whether OS is a primary cause that induces the initiation of neurodegenerative diseases or if it is a side effect associated with the spread of damage to nerve cells (<xref ref-type="bibr" rid="B221">Jenner, 2003</xref>; <xref ref-type="bibr" rid="B136">Emerit et al., 2004</xref>).</p>
</sec>
<sec id="S3">
<title>Amyotrophic Lateral Sclerosis</title>
<p>ALS, also known as Charcot’s disease or Lou Gehrig’s disease, was originally described by Jean-Martin Charcot and Joffrey (<xref ref-type="bibr" rid="B79">Chen et al., 2013</xref>; <xref ref-type="bibr" rid="B334">Niedzielska et al., 2016</xref>) and is the most common motor neuron disease (<xref ref-type="bibr" rid="B389">Rechtmann et al., 2015</xref>). It causes a selective loss of upper motor neurons (UMN) of the motor cortex and lower motor neurons (LMN) of the brainstem and spinal cord (<xref ref-type="bibr" rid="B59">Brown and Al-Chalabi, 2017</xref>; <xref ref-type="bibr" rid="B475">Valko and Ciesla, 2019</xref>).</p>
<p>Patients with ALS develop weakness, muscle denervation, atrophy and progressive paralysis of all muscles (bulbar and respiratory), dysphagia (<xref ref-type="bibr" rid="B12">Al-Chalabi and Hardiman, 2013</xref>; <xref ref-type="bibr" rid="B109">D’Amico et al., 2013</xref>; <xref ref-type="bibr" rid="B172">Gowland et al., 2019</xref>) and respiratory muscle weakness that leads to respiratory failure and death (<xref ref-type="bibr" rid="B429">Sferrazza-Papa et al., 2018</xref>). The survival rate is 3–5 years after the onset of symptoms (<xref ref-type="bibr" rid="B18">Andersen, 2006</xref>; <xref ref-type="bibr" rid="B170">Gordon, 2013</xref>; <xref ref-type="bibr" rid="B89">Coan and Mitchell, 2015</xref>; <xref ref-type="bibr" rid="B505">Wier et al., 2019</xref>).</p>
<p>The incidence and prevalence of ALS vary according to the geography and design of the study (<xref ref-type="bibr" rid="B298">Marin et al., 2017</xref>; <xref ref-type="bibr" rid="B241">Kaye et al., 2018</xref>) and there are differences between African–American and Hispanic populations (<xref ref-type="bibr" rid="B171">Gordon et al., 2013</xref>). The incidence is 2–3 cases for every 1.000.000 inhabitants/year and prevalence of 4.6 – 5 for every 100.000 inhabitants in Western European countries (<xref ref-type="bibr" rid="B84">Chiò et al., 2013</xref>; <xref ref-type="bibr" rid="B455">Talbot, 2016</xref>). A significant increase in the overall prevalence of ALS to 8.58 cases per 100.000 people is expected by the year 2020 and to 9.67 per 100,000 people by 2116. In the United Kingdom prevalence in the 2010 year was 1415 cases and is projected to increase to 1701 by 2020 and 2635 by 2116 (<xref ref-type="bibr" rid="B172">Gowland et al., 2019</xref>).</p>
<p>ALS typically occurs in white adults between the ages of 50–60 (<xref ref-type="bibr" rid="B84">Chiò et al., 2013</xref>; <xref ref-type="bibr" rid="B305">Mehta et al., 2018</xref>), and cases in children are very rare (<xref ref-type="bibr" rid="B300">Martin, 2010</xref>; <xref ref-type="bibr" rid="B33">Bäumer et al., 2014</xref>; <xref ref-type="bibr" rid="B211">Ingre et al., 2015</xref>). The age of onset is earlier in men than in women and men are more prone to spinal involvement, whereas bulbar involvement is more common in women (<xref ref-type="bibr" rid="B304">McCombe and Henderson, 2010</xref>).</p>
<p>ALS is classified into two types: familial ALS (fALS) and sporadic ALS (sALS). fALS represents approximately 5–10% of the cases and is related to heterogeneous mutations of a set of genes with an autosomal dominant inheritance pattern (<xref ref-type="bibr" rid="B319">Mitchell and Borasio, 2007</xref>). Up to 20% of cases of fALS is due to a mutation of the gene that encodes the enzyme Cu-Zn superoxide dismutase (SOD1). sALS occurs in up to 90–95% of the cases but its origin is still unknown (<xref ref-type="bibr" rid="B300">Martin, 2010</xref>; <xref ref-type="bibr" rid="B19">Andersen and Al-Chalabi, 2011</xref>; <xref ref-type="bibr" rid="B351">Pan et al., 2012</xref>). fALS and sALS can affect any voluntary muscle but their presentation, phenotype and progression are variable (<xref ref-type="bibr" rid="B502">Wei et al., 2019</xref>), hindering differential diagnosis (<xref ref-type="bibr" rid="B452">Swinnen and Robberecht, 2014</xref>; <xref ref-type="bibr" rid="B163">Ghasemi, 2016</xref>; <xref ref-type="bibr" rid="B481">Van Es et al., 2017</xref>). ALS may manifest double onset: involvement of the extremities (80% of cases) or bulbar involvement (20% of cases) (<xref ref-type="bibr" rid="B356">Parakh et al., 2013</xref>).</p>
<p>The death of motor neurons results in a characteristic clinical feature: spasticity, muscular weakness and atrophy, hyperreflexia, cramps, fasciculation, Babinski sign, loss of coordination, paralysis of voluntary musculature, dysphagia and difficulties in swallowing, speech and respiration (<xref ref-type="bibr" rid="B503">Weiduschat et al., 2014</xref>; <xref ref-type="bibr" rid="B534">Zufiría et al., 2016</xref>; <xref ref-type="bibr" rid="B444">Solleiro-Villavicencio and Rivas-Arancibia, 2018</xref>). It is associated with metabolic disorders such as weight loss, hypermetabolism and hyperlipidemia (<xref ref-type="bibr" rid="B131">Dupuis et al., 2011</xref>). fALS and sALS do not affect the senses (sight, smell, taste, hearing and touch) (<xref ref-type="bibr" rid="B145">Fiala et al., 2013</xref>).</p>
<p>Several factors have been identified related to the pathogenesis of ALS: OS, mitochondrial dysfunction, neuroinflammation, excitotoxicity due to an increase in the neurotransmitter glutamate, defect in axonal transmission and in the metabolism of RNA, apoptosis, cytoskeletal abnormalities, disruption of membrane trafficking, endoplasmic reticulum stress, protein misfolding and aggregation (<xref ref-type="bibr" rid="B355">Papadimitriou et al., 2010</xref>; <xref ref-type="bibr" rid="B49">Blokhuis et al., 2013</xref>; <xref ref-type="bibr" rid="B362">Peters et al., 2015</xref>; <xref ref-type="bibr" rid="B51">Bond et al., 2018</xref>; <xref ref-type="bibr" rid="B523">Yusuf et al., 2018</xref>) and cysteine modifications like oxidation or palmitoylation that contribute to a general aberration of cysteine residues proteostasis (<xref ref-type="bibr" rid="B477">Valle and Carrì, 2017</xref>). A relationship has been established between environmental conditions and the epidemiology of ALS: alcohol, tobacco, sedentary lifestyle, fungal and viral infections or exposure to electromagnetic radiation (<xref ref-type="bibr" rid="B521">Yu et al., 2014</xref>).</p>
<p>There are currently no effective treatments for ALS and therapy is limited to symptomatic and palliative treatment (<xref ref-type="bibr" rid="B45">Bhattacharya et al., 2019</xref>). Riluzole (<xref ref-type="bibr" rid="B316">Miller et al., 2012</xref>) and edaravone (<xref ref-type="bibr" rid="B406">Rothstein, 2017</xref>) are the only approved pharmacological therapies that increase the survival rate by 2–3 months (<xref ref-type="bibr" rid="B127">Dorst et al., 2017</xref>; <xref ref-type="bibr" rid="B196">Hodgkinson et al., 2018</xref>), but edaravone is only beneficial to a subset of people with early stage ALS (<xref ref-type="bibr" rid="B1">Abe et al., 2017</xref>). Other therapeutic routes indicate multidisciplinary treatment involving: nurses, dieticians, nutritionists, occupational therapists, physical therapists, psychologists, social workers and speech therapists (<xref ref-type="bibr" rid="B170">Gordon, 2013</xref>).</p>
</sec>
<sec id="S4">
<title>Oxidative Stress and Amyotrophic Lateral Sclerosis</title>
<p>Presence of OS biomarkers and high levels of ROS have been determined in the CNS regions specifically in ALS patients (<xref ref-type="bibr" rid="B164">Golenia et al., 2014</xref>), which indicates that impaired redox homeostasis is a relevant factor and associated with the development and progression of neurodegeneration in fALS and sALS (<xref ref-type="bibr" rid="B70">Carrì et al., 2015</xref>; <xref ref-type="bibr" rid="B363">Petrov et al., 2017</xref>; <xref ref-type="bibr" rid="B441">Smith et al., 2017</xref>). High levels of certain types of ROS (H<sub>2</sub>O<sub>2</sub> and O<inline-formula><mml:math id="INEQ14"><mml:msubsup><mml:mi></mml:mi><mml:mn>2</mml:mn><mml:mrow><mml:mi></mml:mi><mml:mo>∙</mml:mo><mml:mo>-</mml:mo></mml:mrow></mml:msubsup></mml:math></inline-formula>) have been observed in affected cells (<xref ref-type="bibr" rid="B36">Beal et al., 2005</xref>).</p>
<p>Loss of oxidative control and excessive ROS production are particularly linked to the mutated forms of SOD1 (<xref ref-type="bibr" rid="B144">Ferri et al., 2006</xref>; <xref ref-type="bibr" rid="B197">Hooten et al., 2015</xref>; <xref ref-type="bibr" rid="B20">Angelova and Abramov, 2018</xref>), which can have up to 150 different types of mutations (<xref ref-type="bibr" rid="B158">Gamez et al., 2006</xref>; <xref ref-type="bibr" rid="B13">Al-Chalabi et al., 2013</xref>). SOD1 is an antioxidant enzyme that catalyzes the conversion of O<inline-formula><mml:math id="INEQ15"><mml:msubsup><mml:mi></mml:mi><mml:mn>2</mml:mn><mml:mrow><mml:mi></mml:mi><mml:mo>∙</mml:mo><mml:mo>-</mml:mo></mml:mrow></mml:msubsup></mml:math></inline-formula> into H<sub>2</sub>O<sub>2</sub> and O<sub>2</sub>, and is key in the regulation of OS, cell damage (<xref ref-type="bibr" rid="B303">Mattiazzi et al., 2002</xref>; <xref ref-type="bibr" rid="B273">Li et al., 2011</xref>; <xref ref-type="bibr" rid="B360">Pehar et al., 2014</xref>), energy metabolism and cellular respiration (<xref ref-type="bibr" rid="B412">Saccon et al., 2013</xref>). Oxidation and/or misfolding of SOD1 results in a deterioration in the regulation of the above processes, mitochondrial dysfunction and increase in the production of superoxides (<xref ref-type="bibr" rid="B216">Israelson et al., 2010</xref>; <xref ref-type="bibr" rid="B367">Pickles et al., 2013</xref>, <xref ref-type="bibr" rid="B368">2016</xref>; <xref ref-type="bibr" rid="B395">Richardson et al., 2013</xref>). Its mutation predisposes cellular organelles to oxidative damage (<xref ref-type="bibr" rid="B115">Deng et al., 2006</xref>; <xref ref-type="bibr" rid="B7">Ahtoniemi et al., 2008</xref>) and excessive levels of ROS that attack astrocytes (<xref ref-type="bibr" rid="B214">Islam, 2017</xref>). OS contributes to the aggregation of SOD1 (<xref ref-type="bibr" rid="B60">Brujin et al., 2004</xref>) enhancing mitochondrial dysfunction (<xref ref-type="bibr" rid="B281">Liu et al., 2004</xref>; <xref ref-type="bibr" rid="B492">Vijayvergiya et al., 2005</xref>).</p>
<p>The transgenic mouse model of ALS (SOD1<sup>G93A</sup>) has enabled the identification of pathogenic mechanisms and the establishment of a “vicious cycle” between: OS, mitochondrial dysfunction and deterioration of the ETC (<xref ref-type="bibr" rid="B235">Jung et al., 2002</xref>; <xref ref-type="bibr" rid="B308">Menzies et al., 2002</xref>; <xref ref-type="bibr" rid="B365">Pfohl et al., 2015</xref>; <xref ref-type="bibr" rid="B508">Xiao et al., 2018</xref>). Most of the oxidative species that are formed in the CNS are secondary to oxidative phosphorylation (<xref ref-type="bibr" rid="B57">Brookes et al., 2004</xref>; <xref ref-type="bibr" rid="B29">Balaban et al., 2005</xref>; <xref ref-type="bibr" rid="B238">Karam et al., 2017</xref>) and mitochondrial dysfunction is the largest source of ROS production, so is a clear sign of affectation of motor neurons in the spinal cord and the motor cortex (<xref ref-type="bibr" rid="B39">Bendotti et al., 2001</xref>; <xref ref-type="bibr" rid="B240">Kawahara et al., 2004</xref>; <xref ref-type="bibr" rid="B286">Loizzo et al., 2010</xref>; <xref ref-type="bibr" rid="B105">Cozzolino and Carrì, 2012</xref>). Mitochondrial damage causes an alteration in intracellular calcium levels and in normal functioning of the ETC (<xref ref-type="bibr" rid="B51">Bond et al., 2018</xref>) that contributes to the increase of ROS and to the activation of chain reactions that lead to greater oxidative damage, reinforcing the “vicious cycle” (<xref ref-type="bibr" rid="B193">Harraz et al., 2008</xref>; <xref ref-type="bibr" rid="B142">Federico et al., 2012</xref>; <xref ref-type="bibr" rid="B402">Rojas et al., 2015</xref>; <xref ref-type="bibr" rid="B284">Loeffler et al., 2016</xref>; <xref ref-type="bibr" rid="B483">Van Horssen et al., 2017</xref>) and increasing cellular susceptibility to apoptosis (<xref ref-type="bibr" rid="B179">Guegan et al., 2001</xref>; <xref ref-type="bibr" rid="B217">Iverson and Orrenius, 2004</xref>).</p>
<p>Changes in antioxidant defense markers have been observed in patients with ALS (<xref ref-type="bibr" rid="B102">Cova et al., 2010</xref>). However, the results are random, due to the wide heterogeneity, form of presentation and variability of the pathogenic mechanisms of the disease (<xref ref-type="bibr" rid="B230">Johnson et al., 2012</xref>). Low levels of reduced glutathione (GSH) in erythrocytes (<xref ref-type="bibr" rid="B27">Babu et al., 2008</xref>) and in the motor cortex (<xref ref-type="bibr" rid="B208">Ikawa et al., 2015</xref>) of patients with ALS, a systemic pro-inflammatory state (increased levels of IL-6 and IL-8) and an impaired antioxidant system (<xref ref-type="bibr" rid="B134">Ehrhart et al., 2015</xref>) have been highlighted. One study compared <italic>in vivo</italic> levels of GSH in the motor cortex of 11 ALS patients with those in 11 age-matched healthy volunteers and determined that GSH levels were 31% lower in ALS patients than in healthy volunteers (<xref ref-type="bibr" rid="B503">Weiduschat et al., 2014</xref>). Also, decreased glutathione levels caused motor neuron degeneration in the hSOD1<sup>wt</sup> over-expressing mice model (hemizygous mice over-expressing wild-type hSOD1 at moderate levels) (<xref ref-type="bibr" rid="B244">Killoy et al., 2018</xref>) and accelerated motor neuron death in SOD1<sup>G93A</sup> mice (<xref ref-type="bibr" rid="B360">Pehar et al., 2014</xref>). Catalase (CAT) activity is decreased in erythrocytes of sALS patients (<xref ref-type="bibr" rid="B339">Nikolic-Kokic et al., 2006</xref>; <xref ref-type="bibr" rid="B27">Babu et al., 2008</xref>) and is significantly decreased compared to neurologically healthy controls (<xref ref-type="bibr" rid="B164">Golenia et al., 2014</xref>).</p>
<p>Studies conducted <italic>in vitro</italic> indicated that oxidative damage to nerve cells (astrocytes and oligodendrocytes) was related to neurodegeneration (<xref ref-type="bibr" rid="B372">Pollari et al., 2014</xref>). Oxidative imbalance decreases the number of glial cells and the ability to transmit the axonal signal (<xref ref-type="bibr" rid="B357">Park et al., 2007</xref>).</p>
<p>Markers for OS have been determined in the cerebrospinal fluid (CSF), tissues, blood and urine of patients with ALS (<xref ref-type="bibr" rid="B48">Blasco et al., 2017</xref>). After postmortem analysis of neuronal tissues in sALS and fALS patients, an increase of OS biomarkers was noted in proteins, lipids and DNA (<xref ref-type="bibr" rid="B35">Beal, 2002</xref>; <xref ref-type="bibr" rid="B4">Agar and Durham, 2003</xref>; <xref ref-type="bibr" rid="B249">Kim et al., 2003</xref>; <xref ref-type="bibr" rid="B472">Turner et al., 2013</xref>; <xref ref-type="bibr" rid="B54">Bozzo et al., 2016</xref>). The most frequently studied biomarkers include: carbonylated and/or glycosylated proteins, lipid peroxidation and DNA damage (<xref ref-type="bibr" rid="B433">Shibata et al., 2002</xref>).</p>
<p>In the nervous tissues of ALS patients, high levels of carbonylated proteins have been measured in the motor cortex (<xref ref-type="bibr" rid="B417">Sasaki et al., 2000</xref>; <xref ref-type="bibr" rid="B178">Guareschi et al., 2012</xref>; <xref ref-type="bibr" rid="B458">Tan et al., 2014</xref>) and high levels of advanced products of protein oxidation in the plasma of the erythrocytes of sALS patients (<xref ref-type="bibr" rid="B285">LoGerfo et al., 2014</xref>). In ALS-mouse models, non-functional proteins secondary to the oxidation of amino acid residues by peroxynitrite have been observed (<xref ref-type="bibr" rid="B519">Yoshino and Kimura, 2006</xref>). In addition, oxidative damage results in the aggregation of TDP-43, the major disease-associated protein involved in the pathogenesis of ALS (<xref ref-type="bibr" rid="B327">Moujalled et al., 2017</xref>; <xref ref-type="bibr" rid="B345">Oberstad et al., 2018</xref>) that promotes OS in neuronal cells (<xref ref-type="bibr" rid="B129">Duan et al., 2010</xref>; <xref ref-type="bibr" rid="B91">Cohen et al., 2012</xref>, <xref ref-type="bibr" rid="B90">2015</xref>; <xref ref-type="bibr" rid="B291">Magrané et al., 2014</xref>) (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<p>CNS lipids are susceptible to oxidative damage (<xref ref-type="bibr" rid="B337">Niki, 2014</xref>) and lipoperoxidation generates high levels of HNE, MDA (<xref ref-type="bibr" rid="B381">Radak et al., 2011</xref>) and F2-isoprostane (F2-IsoPS) (<xref ref-type="bibr" rid="B317">Milne et al., 2007</xref>; <xref ref-type="bibr" rid="B312">Milatovic et al., 2011</xref>; <xref ref-type="bibr" rid="B486">Van’t Erve et al., 2017</xref>) (<xref ref-type="fig" rid="F1">Figure 1</xref>). In the CSF of patients with ALS, high levels of HNE and 3-nitrotyrosine (3-NT) have been obtained (<xref ref-type="bibr" rid="B438">Simpson et al., 2004</xref>; <xref ref-type="bibr" rid="B130">Duffy et al., 2011</xref>; <xref ref-type="bibr" rid="B361">Perluigi et al., 2012</xref>; <xref ref-type="bibr" rid="B26">Ayala et al., 2014</xref>; <xref ref-type="bibr" rid="B415">Santa-Cruz and Tapia, 2014</xref>).</p>
<p>The guanine contained in DNA is highly susceptible to oxidation and acts as a target for ROS (<xref ref-type="bibr" rid="B267">Lee et al., 2007</xref>; <xref ref-type="bibr" rid="B77">Chang et al., 2008</xref>). 8-oxo-deoxyguanosine (8-OHdG) can be considered as a specific biomarker of oxidation of the motor cortex in ALS (<xref ref-type="bibr" rid="B95">Cooke et al., 2000</xref>, <xref ref-type="bibr" rid="B96">2002</xref>; <xref ref-type="bibr" rid="B207">Ihara et al., 2005</xref>; <xref ref-type="bibr" rid="B320">Mitsumoto et al., 2008</xref>) (<xref ref-type="fig" rid="F1">Figure 1</xref>). Increased levels of 8-OHdG and isoprostanoids have been observed in the urine of subjects affected by the disease compared to the control group (<xref ref-type="bibr" rid="B314">Miller et al., 2014</xref>).</p>
<p>The evaluation of GPx activity, glutathione reductase (GR), SOD, total serum antioxidant status (TAS), MDA and 8-OHdG in ALS patients, found a significant decrease in TAS levels and an increase of 8-OHdG and MDA levels, together with significantly higher oxidized/reduced glutathione (GSSG/GSH) ratio and IL-6 and IL-8 (<xref ref-type="bibr" rid="B48">Blasco et al., 2017</xref>).</p>
</sec>
<sec id="S5">
<title>Antioxidants and Amyotrophic Lateral Sclerosis</title>
<p>The evidence implicates free radicals and OS as factors related to the pathogenesis of ALS. Interest has focused on substances with antioxidant potential such as: vitamin E, carotenes, flavonoids, resveratrol, epigallocatechin gallate, curcumin, Co-enzyme Q10, melatonin and edaravone as useful agents in the management of this disease (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Antioxidant compounds used in the treatment of ALS.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Antioxidant</td>
<td align="left" colspan="1" rowspan="1" valign="top">Features</td>
<td align="left" colspan="1" rowspan="1" valign="top">Molecular mechanisms</td>
<td align="left" colspan="1" rowspan="1" valign="top">Curative effects and treatment object</td>
<td align="left" colspan="1" rowspan="1" valign="top">References</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Vitamin E</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Lipophilic antioxidant<break></break>- Ability to cross cell   membrane</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Protection against   lipoperoxidation <break></break>- Protection against ROS   and RNS</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Delay in the clinical onset of   the disease <break></break>- Increase GSH levels in   plasma <break></break>- Lower risk of dying by ALS <break></break>- Significant decrease in the   risk of the disease <break></break>- Lower ALS rates</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B184">Gurney et al., 1996</xref>; <xref ref-type="bibr" rid="B116">Desnuelle et al., 2001</xref>; <xref ref-type="bibr" rid="B24">Ascherio et al., 2005</xref>; <xref ref-type="bibr" rid="B489">Veldink et al., 2007</xref>; <xref ref-type="bibr" rid="B495">Wang H. et al., 2011</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Carotenes</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Natural pigments <break></break>- Different types:   ß-carotene, lutein,   astaxanthin and   lycopene</td>
<td align="left" colspan="1" rowspan="1" valign="top">Antioxidant and neutralizing properties against ROS</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Help prevention and/or delay   the onset of ALS <break></break>- Reduced risk of ALS <break></break>- Treating neuroinflammation   and apoptosis</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B148">Fitzgerald et al., 2013</xref>; <xref ref-type="bibr" rid="B256">Krishnaraj et al., 2016</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Flavonoids</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Natural substances of   fruits and vegetables <break></break>- Different types: 7,8-DHF,   fisetin and quercetein</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Protection against ROS <break></break>- Modulate metabolic   pathways</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Improve motor deficits and   enhance lower neuronal   survival <break></break>- Reduction of intracellular   ROS levels <break></break>- Reduction of motor neuron   loss <break></break>- Improve motor activity and   survival rate <break></break>- Inhibition of aggregation and   misfolding of SOD1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B252">Korkmaz et al., 2014</xref>; <xref ref-type="bibr" rid="B213">Ip et al., 2017</xref>; <xref ref-type="bibr" rid="B499">Wang et al., 2018</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Resveratrol</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Natural polyphenolic   compound <break></break>- In grapes, peanuts and   berries <break></break>- Produced in plants in   response to mechanical   injury, fungal infection,   and UV radiation <break></break>- Scavenger of free   radicals</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Interacts with mutant   SOD1 (G93A) protein <break></break>- Up-regulates SIRT1 <break></break>- Down-regulation of   AMPK/SIRT1 signaling in   bone marrow mesenchymal   stem cells</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Delays the onset of ALS <break></break>- Increases survival of spinal   motor neurons <break></break>- Preserves the function of the   lower and upper motor neuron <break></break>- Attenuates the loss of motor   neurons <break></break>- Improves muscle atrophy <break></break>- Improves mitochondrial   function of muscle fibers</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B292">Mancuso et al., 2014a</xref>, <xref ref-type="bibr" rid="B293">b</xref>; <xref ref-type="bibr" rid="B445">Song et al., 2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Epigallocatechin <break></break>gallate</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Catechin present in   green tea <break></break>- Crosses the blood-brain   barrier</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Modulates mitochondrial   responses to OS <break></break>- Protection against   lipoperoxidation <break></break>- Changes intracellular   signals <break></break>- Reduces the   concentration of NF-kB   caspase-3 and iNOS</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Prevents OS-induced death <break></break>- Delays the outbreak or   progression of ALS <break></break>- Delays the onset of the   disease <break></break>- Prolongs useful life <break></break>- Increases the number of   motor neurons <break></break>- Decreases the activation of   microglia</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B250">Koh et al., 2004</xref>, <xref ref-type="bibr" rid="B251">2006</xref>; <xref ref-type="bibr" rid="B510">Xu et al., 2006</xref>
<break></break></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Curcumin</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Natural and liposoluble   dye <break></break>- Obtained from turmeric <break></break>- Chemical instability <break></break>- Low oral bioavailability <break></break>- Low water solubility rate <break></break>- Different types: DMC</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Activates Nrf2 <break></break>- Decreases intracelullar   ROS levels <break></break>- Eliminates excitability   induced by TDP-43 <break></break>- DMC decreases   mitochondrial dysfunction</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Improves survival <break></break>- Decrease in ALS progression   and reduction of oxidative   damage <break></break></td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B6">Ahmadi et al., 2018</xref>; <xref ref-type="bibr" rid="B83">Chico et al., 2018</xref>
<break></break></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Co-enzyme Q10</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Endogenous antioxidant</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Cofactor of the ETC <break></break>- Action in redox balance <break></break>- Improves mitochondrial   dysfunction</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Increases survival rate</td>
<td align="left" colspan="1" rowspan="1" valign="top"><break></break><xref ref-type="bibr" rid="B302">Matthews et al., 1998</xref>; <xref ref-type="bibr" rid="B35">Beal, 2002</xref>
<break></break></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Melatonin</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Amphiphilic molecule <break></break>- Potent antioxidant</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Antioxidant <break></break>- Regulator of mitochondrial   bioenergetic function</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Delays the progression of the   disease <break></break>- Increases the survival rate</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B529">Zhang et al., 2013</xref>
<break></break><xref ref-type="bibr" rid="B504">Weishaupt et al., 2006</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Edaravone</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Low-molecular-weight   antioxidant drug <break></break>- Intravenously   administered <break></break>- Free radical scavenger <break></break>- Safe <break></break>- Crosses the blood-brain   barrier easily <break></break>- High brain penetration   capacity <break></break>- Amphiphilic capacity <break></break>- Scavenges lipid and   water soluble peroxyl   radicals and chain-  carrying lipid peroxyl   radicals</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Enhances prostacycling   production <break></break>- Traps hydroxyl radical and   quenches active oxygen</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Deletes lipid peroxides and   hydroxyl radicals during   cerebral ischemia <break></break>- Protects nerve cells within or   around the ischemic region   from free radical damage <break></break>- Ameliorates OS and   suppresses degeneration of   spinal motor neurons <break></break>- Anti-inflammatory and   protective effects on neurons,   microglia, astrocytes and   oligodendrocytes <break></break>- Delays the progression of   functional motor disturbances</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B209">Ikeda and Iwasaki, 2015</xref>; <xref ref-type="bibr" rid="B30">Banno et al., 2005</xref>; <xref ref-type="bibr" rid="B519">Yoshino and Kimura, 2006</xref>; <xref ref-type="bibr" rid="B321">Miyamoto et al., 2013</xref>; <xref ref-type="bibr" rid="B2">Abe et al., 2014</xref>; <xref ref-type="bibr" rid="B28">Bailly, 2019</xref></td>
</tr>
</tbody>
</table>
</table-wrap>
<sec id="S5.SS1">
<title>Vitamin E</title>
<p>Vitamin E (α-tocopherol) is one of the most studied lipophilic antioxidants due to its ability to cross the cell membrane and the protection that it provides against lipoperoxidation (<xref ref-type="bibr" rid="B64">Butterfield et al., 2002</xref>; <xref ref-type="bibr" rid="B117">Di Matteo and Esposito, 2003</xref>), ROS and RNS (<xref ref-type="bibr" rid="B32">Barber and Shaw, 2010</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>). The studies on nutritional supplementation with this vitamin have obtained contradictory results.</p>
<p>This antioxidant has been associated with a delay in the clinical onset of the disease (<xref ref-type="table" rid="T1">Table 1</xref>) in transgenic mice that express mutant copies of the gene encoding SOD1 (an animal model of ALS) (<xref ref-type="bibr" rid="B184">Gurney et al., 1996</xref>). Measurements of the erythrocyte activity of the three main radical scavenging enzymes (SOD1, CAT, and GPx) indicated that vitamin E supplementation (300–3000 U/day) in 14 ALS patients did not affect the activity of the three enzymes (<xref ref-type="bibr" rid="B378">Przedborski et al., 1996</xref>). One study showed an accumulation of vitamin E in the spinal cord and increased MDA levels over the lifetime of the mouse compared to non-transgenic mice (<xref ref-type="bibr" rid="B189">Hall et al., 1998</xref>).</p>
<p>In a double-blind placebo-controlled randomized clinical trial, vitamin E did not appear to affect survival and motor function in ALS. However, after 3 months of treatment with vitamin E and riluzole, an increase in plasma GSH levels (<xref ref-type="table" rid="T1">Table 1</xref>) and a decrease in plasma thiobarbituric acid reactive species (TBARS) levels were observed, markers typically altered in the plasma of the patients with ALS (<xref ref-type="bibr" rid="B116">Desnuelle et al., 2001</xref>). Vitamin E was associated with a slower progression of ALS (<xref ref-type="bibr" rid="B350">Orrell et al., 2004</xref>) and in one study it was observed that regular use of vitamin E supplements was associated with a lower risk of dying by ALS (<xref ref-type="bibr" rid="B24">Ascherio et al., 2005</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<p>Other similar studies did not detect significant differences between placebo and the group treated with α-tocopherol and indicated that there are insufficient results to claim that megadoses with vitamin E are effective in slowing the progression of the disease (<xref ref-type="bibr" rid="B173">Graf et al., 2005</xref>). Supplementation with 600 mg/day of vitamin E did not show differences with respect to the placebo group (<xref ref-type="bibr" rid="B157">Galbussera et al., 2006</xref>). In a case-control study with 132 patients suffering from ALS, a significant decrease in the risk of the disease (<xref ref-type="table" rid="T1">Table 1</xref>) was observed when the intake of vitamin E was higher than the average (<xref ref-type="bibr" rid="B489">Veldink et al., 2007</xref>). Supplementation with vitamin E over a prolonged period was associated with lower ALS rates (<xref ref-type="bibr" rid="B495">Wang H. et al., 2011</xref>) and a study that included 50 cases of male ALS patients concluded that in men with baseline serum α-tocopherol below the average, there was a non-significant decrease in ALS risk in those receiving α-tocopherol supplementation (50 mg/day) compared to those not receiving α-tocopherol. If baseline serum α-tocopherol was above the average, α-tocopherol supplementation had no effect on the risk of ALS. In this case, α-tocopherol supplementation did not have a significant protective effect on ALS risk (<xref ref-type="bibr" rid="B310">Michal-Freedman et al., 2013</xref>).</p>
</sec>
<sec id="S5.SS2">
<title>Carotenes</title>
<p>Carotenes are natural pigments, responsible for the orange, red (<xref ref-type="bibr" rid="B255">Krinsky and Johnson, 2005</xref>), yellow or green color of fruits and vegetables (<xref ref-type="bibr" rid="B180">Guest and Grant, 2016</xref>) with antioxidant and neutralizing properties against ROS (<xref ref-type="bibr" rid="B146">Fiedor et al., 2012</xref>; <xref ref-type="bibr" rid="B340">Nisar et al., 2015</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<p>There is a beneficial association between ALS and the intake of carotenes (<xref ref-type="bibr" rid="B348">Okamoto et al., 2009</xref>; <xref ref-type="bibr" rid="B336">Nieves et al., 2016</xref>). Thus, their consumption could help the prevention and/or delay the onset of ALS (<xref ref-type="bibr" rid="B148">Fitzgerald et al., 2013</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>) but in a case-controlled study with 77 Koreans diagnosed with ALS, it was determined that dietary intake of carotenes was negatively associated with ALS (<xref ref-type="bibr" rid="B228">Jin et al., 2014</xref>). A study conducted in 5 cohorts determined that a higher intake of these pigments was associated with a reduced risk of ALS and that high dietary intakes of ß-carotene and lutein were inversely associated with the risk of suffering from this disease. Astaxanthin and lycopene have shown a beneficial effect in ALS (<xref ref-type="bibr" rid="B287">Longecker et al., 2000</xref>; <xref ref-type="bibr" rid="B215">Isonaka et al., 2011</xref>) but in a study with the SOD1<sup>G93A</sup> mice model of ALS, a tomato-enriched food (rich in lycopene) did not affect disease onset and survival (<xref ref-type="bibr" rid="B137">Esposito et al., 2007</xref>). β-carotene could serve as a potential therapeutic molecule for treating neuroinflammation and apoptosis in ALS patients (<xref ref-type="bibr" rid="B256">Krishnaraj et al., 2016</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
</sec>
<sec id="S5.SS3">
<title>Flavonoids</title>
<p>Flavonoids are natural substances mainly present in fruits and vegetables (<xref ref-type="bibr" rid="B194">He et al., 2017</xref>) that have a protective effect against ROS (<xref ref-type="bibr" rid="B68">Cao et al., 1997</xref>), modulate the activity of different metabolic pathways (<xref ref-type="bibr" rid="B296">Mansuri et al., 2014</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>) related to the reduction of cognitive damage and neuronal dysfunction (<xref ref-type="bibr" rid="B488">Vauzour et al., 2008</xref>) and suppress neuroinflammation (<xref ref-type="bibr" rid="B443">Solanki et al., 2015</xref>).</p>
<p>7,8-dihydroxyflavone (7,8-DHF) has neuroprotective and regulatory properties on neuromuscular transmission (<xref ref-type="bibr" rid="B297">Mantilla and Ermilov, 2012</xref>). Chronic administration of 7,8-DHF significantly improved motor deficits and enhanced lower neuronal survival in the transgenic ALS mouse model (<xref ref-type="bibr" rid="B252">Korkmaz et al., 2014</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<p>Treatment with fisetin reduced intracellular ROS levels, motor neuron loss and improved motor activity and survival rate in three different hSOD1-related mutant models of ALS (Drosophila expressing hSOD1<sup><italic>G</italic>85R</sup>, hSOD1<sup>G93A</sup>NSC34 cells and transgenic mice hSOD1<sup>G93A</sup>) (<xref ref-type="bibr" rid="B499">Wang et al., 2018</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<p>Quercetin is an abundant flavonoid in the diet (onion, apple, broccoli and berries) (<xref ref-type="bibr" rid="B138">Esposito et al., 2002</xref>) that has been shown to reduce mitochondrial damage in various animal models of OS. Treatment with quercetin could be a therapeutic strategy for attenuating neuronal death against aluminum-induced neurodegeneration in the rat hippocampus (<xref ref-type="bibr" rid="B431">Sharma et al., 2016</xref>). Quercetin and its derivative, quercetin 3-β-<sc>D</sc>-glucoside (Q3BDG), could be therapeutic inhibitors of the aggregation and misfolding of SOD1 associated with ALS (<xref ref-type="bibr" rid="B213">Ip et al., 2017</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
</sec>
<sec id="S5.SS4">
<title>Resveratrol</title>
<p>Resveratrol (RES) can interact with mutant SOD1 (G93A) protein (a distinctive feature of ALS) (<xref ref-type="bibr" rid="B234">Julien, 2007</xref>; <xref ref-type="bibr" rid="B447">Srinivasan and Rajasekaran, 2018</xref>; <xref ref-type="bibr" rid="B265">Laudati et al., 2019</xref>) and has positive effects by up-regulating sirtuin 1 (SIRT1) expression in the mutant hSOD1-G93A-bearing motor neuron-like cell culture model of ALS (<xref ref-type="bibr" rid="B497">Wang J. et al., 2011</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>). It delays the onset of ALS, increases the survival of spinal motor neurons, preserves the function of the lower and upper motor neuron (<xref ref-type="bibr" rid="B292">Mancuso et al., 2014a</xref>, <xref ref-type="bibr" rid="B293">b</xref>), attenuates the loss of motor neurons and improves muscle atrophy and mitochondrial function of muscle fibers in a SOD1<sup>G93A</sup> mouse model of ALS (<xref ref-type="bibr" rid="B445">Song et al., 2014</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>). One study showed that bone marrow mesenchymal stem cells from ALS patients showed down-regulation of AMPK/SIRT1 signaling, which was recovered by treatment with RES (<xref ref-type="bibr" rid="B522">Yun et al., 2019</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
</sec>
<sec id="S5.SS5">
<title>Epigallocatechin Gallate</title>
<p>Epigallocatechin gallate (EGCG) is a catechin present in green tea (<xref ref-type="bibr" rid="B87">Chung et al., 2010</xref>) and to which an antineurodegenerative and antioxidant effect is attributed (<xref ref-type="bibr" rid="B333">Nie et al., 2002</xref>; <xref ref-type="bibr" rid="B354">Panickar et al., 2009</xref>), especially on the motor neurons (<xref ref-type="bibr" rid="B251">Koh et al., 2006</xref>) because it crosses the blood-brain barrier and modulates mitochondrial responses to OS (<xref ref-type="bibr" rid="B37">Bedlack et al., 2015</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>). It also protects against lipoperoxidation (<xref ref-type="table" rid="T1">Table 1</xref>) in <italic>in vitro</italic> studies by exposing ROS to the phospholipids of the cell membrane bilayer (<xref ref-type="bibr" rid="B464">Terao et al., 1994</xref>). It prevents OS-induced death of mutant SOD1 motor neuron cells by alteration of cell survival and death signals (<xref ref-type="bibr" rid="B250">Koh et al., 2004</xref>). Treatment with EGCG could delay the outbreak or progression of ALS through changes in intracellular signals, increases survival signals (like PI3-K and Akt) and reduces death signals (like GKS-3ß, cytosolic cytochrome c, activated caspase-3 and cleaved poly ADP-ribose polymerase) (<xref ref-type="bibr" rid="B268">Levites et al., 2002</xref>; <xref ref-type="bibr" rid="B294">Mandel et al., 2003</xref>, <xref ref-type="bibr" rid="B295">2005</xref>; <xref ref-type="bibr" rid="B251">Koh et al., 2006</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>). Oral administration of 10 mg/kg of EGCG from a presymptomatic stage delays the onset of the disease and prolongs useful life, in addition to increasing the number of motor neurons, decreasing the activation of the microglia, reducing the concentration of NF-kB, caspase-3 and iNOS in a transgenic mouse model of ALS (<xref ref-type="bibr" rid="B510">Xu et al., 2006</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
</sec>
<sec id="S5.SS6">
<title>Curcumin</title>
<p>Curcumin is a natural and liposoluble dye obtained from turmeric (<xref ref-type="table" rid="T1">Table 1</xref>). It has neuroprotective effects and provides protection against OS (<xref ref-type="bibr" rid="B246">Kim et al., 2012</xref>), mitochondrial dysfunction, inflammation and protein aggregation (<xref ref-type="bibr" rid="B474">Ullah et al., 2017</xref>; <xref ref-type="bibr" rid="B384">Rakotoarisoa and Angelova, 2018</xref>; <xref ref-type="bibr" rid="B162">Ghasemi et al., 2019</xref>).</p>
<p>Curcumin activates nuclear factor erythroid 2-related factor (Nrf2) target genes in primary spinal cord astrocytes, decreases the level of intracellular ROS and attenuates oxidative damage and mitochondrial dysfunction (<xref ref-type="bibr" rid="B225">Jiang et al., 2011</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>). It eliminates the excitability induced by TDP-43 (the major pathological protein in sporadic ALS) in a motor neuron-like cellular model of ALS (<xref ref-type="bibr" rid="B290">Mackenzie and Rademakers, 2008</xref>; <xref ref-type="bibr" rid="B126">Dong et al., 2014</xref>). Dimethoxy curcumin (DMC) could decrease mitochondrial dysfunction in mutated TDP-43 stably transfected cell lines (<xref ref-type="bibr" rid="B289">Lu et al., 2012</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>). It binds to the pre-fibrillar aggregates of SOD1, altering its amyloidogenic pathway and decreasing cytotoxicity (<xref ref-type="bibr" rid="B44">Bhatia et al., 2015</xref>). Curcumin may improve survival in patients with ALS, especially those with bulbar involvement (<xref ref-type="bibr" rid="B6">Ahmadi et al., 2018</xref>). In a double-blind therapeutic trial, treatment with curcumin showed a decrease in ALS progression and a reduction of oxidative damage (<xref ref-type="bibr" rid="B83">Chico et al., 2018</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<p>A study indicates that a drug delivery system based on curcumin will be proposed for the treatment of ALS (<xref ref-type="bibr" rid="B471">Tripodo et al., 2015</xref>) but others indicate that the use of curcumin as therapy in ALS has disadvantages: chemical instability and low oral bioavailability and water solubility rate (<xref ref-type="bibr" rid="B384">Rakotoarisoa and Angelova, 2018</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>). Therefore, it is necessary to develop new technologies to overcome these limitations (<xref ref-type="bibr" rid="B282">Liu et al., 2016</xref>).</p>
</sec>
<sec id="S5.SS7">
<title>Co-enzyme Q10</title>
<p>Co-enzyme Q10 (CoQ10) is an endogenous antioxidant and a cofactor in the ETC (<xref ref-type="bibr" rid="B363">Petrov et al., 2017</xref>) involved in redox balance (<xref ref-type="bibr" rid="B513">Yamamoto, 2016</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>). In the SOD1 transgenic mouse model of ALS, supplementation with CoQ10 extended survival by 6 days and increased brain mitochondrial concentration compared to controls (<xref ref-type="bibr" rid="B302">Matthews et al., 1998</xref>; <xref ref-type="bibr" rid="B451">Strong and Pattee, 2000</xref>; <xref ref-type="bibr" rid="B35">Beal, 2002</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>). After comparing the plasma redox status of CoQ10 in 20 sALS patients with those in healthy age/sex-matched controls, a significant increase in the oxidized form of CoQ10 in sALS was observed (<xref ref-type="bibr" rid="B442">Sohmiya et al., 2005</xref>). A study conducted on 31 subjects, showed that treatment with megadoses of 3000 mg/day of CoQ10 over 8 months could improve mitochondrial dysfunction in ALS (<xref ref-type="bibr" rid="B143">Ferrante et al., 2005</xref>). However, one study suggested that serum CoQ10 concentrations are unrelated to the risk of ALS (<xref ref-type="bibr" rid="B322">Molina et al., 2000</xref>; <xref ref-type="bibr" rid="B239">Kaufmann et al., 2009</xref>).</p>
</sec>
<sec id="S5.SS8">
<title>Melatonin</title>
<p>Melatonin is an amphiphilic molecule that has been identified as a potent antioxidant therapeutic agent in neurodegenerative diseases (<xref ref-type="bibr" rid="B370">Polimeni et al., 2014</xref>) associated with mitochondrial dysfunction (<xref ref-type="bibr" rid="B161">Ganie et al., 2016</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>). A study indicated that melatonin could be a candidate for neuroprotection in ALS (<xref ref-type="bibr" rid="B219">Jacob et al., 2002</xref>). In the SOD1<sup>G93A</sup> transgenic mouse model of ALS, high doses of melatonin administered orally delayed the progression of the disease and increased the survival rate (<xref ref-type="bibr" rid="B504">Weishaupt et al., 2006</xref>; <xref ref-type="bibr" rid="B529">Zhang et al., 2013</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>). However, evidence suggests that intraperitoneal melatonin is not neuroprotective and may exacerbate neurodegeneration (<xref ref-type="bibr" rid="B110">Dardiotis et al., 2013</xref>). Clinical trials employing melatonin in the range of 50–100 mg/day are required before its relative merits as a neuroprotective agent are definitively established (<xref ref-type="bibr" rid="B353">Pandi-Perumal et al., 2013</xref>). Recent studies suggest that riluzole but not melatonin ameliorates acute motor neuron degeneration and moderately inhibits SOD1-mediated excitotoxicity induced disrupted mitochondrial calcium signaling in ALS (<xref ref-type="bibr" rid="B220">Jaiswal, 2017</xref>).</p>
</sec>
<sec id="S5.SS9">
<title>Edaravone</title>
<p>Edaravone is a low-molecular-weight antioxidant drug (Radicava<sup>®</sup>), administered intravenously (<xref ref-type="bibr" rid="B363">Petrov et al., 2017</xref>) which acts as a free radical scavenger (<xref ref-type="bibr" rid="B218">Jackson et al., 2019</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>). In 2015, edaravone was approved for ALS treatment in Japan (<xref ref-type="bibr" rid="B347">Okada et al., 2018</xref>) and by the Food and Drug Administration of United States in 2017 (<xref ref-type="bibr" rid="B501">Watanabe et al., 2018</xref>).</p>
<p>Edaravone easily crosses the blood-brain-barrier and displays a high brain penetration capacity (<xref ref-type="bibr" rid="B227">Jin et al., 2017</xref>). Its amphiphilic capacity allows edaravone to scavenge both lipid and water soluble peroxyl radicals and chain-carrying lipid peroxyl radicals (<xref ref-type="bibr" rid="B329">Nagase et al., 2016</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<p>The antioxidant mechanisms of edaravone are: enhancement of prostacyclin production, hydroxyl radical trapping and quenching of active oxygen (<xref ref-type="bibr" rid="B420">Sawada, 2017</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>). Edaravone eliminates lipid peroxides and hydroxyl radicals during cerebral ischemia, protects nerve cells within or around the ischemic region from free radical damage (<xref ref-type="bibr" rid="B2">Abe et al., 2014</xref>), ameliorate OS and suppress degeneration of spinal motor neurons (<xref ref-type="bibr" rid="B209">Ikeda and Iwasaki, 2015</xref>). It is attributed anti-inflammatory (<xref ref-type="bibr" rid="B28">Bailly, 2019</xref>) and protective effects in neurons, microglia, astrocytes and oligodendrocytes (<xref ref-type="bibr" rid="B30">Banno et al., 2005</xref>; <xref ref-type="bibr" rid="B321">Miyamoto et al., 2013</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<p>Investigation of the safety and efficacy of edaravone in 20 ALS patients who received this antioxidant intravenously indicated that this drug is safe and may delay the progression of functional motor disturbances by reducing OS (<xref ref-type="bibr" rid="B519">Yoshino and Kimura, 2006</xref>) (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
</sec>
</sec>
<sec id="S6">
<title>Nicotinamide Riboside and Neurodegenerative Diseases</title>
<sec id="S6.SS1">
<title>NAD<sup>+</sup> Role and Levels</title>
<p>NAD<sup>+</sup> is a coenzyme that takes part in critical redox reactions (its reduced form is NADH) for the operation of mitochondrial metabolism (<xref ref-type="bibr" rid="B41">Berger et al., 2004</xref>; <xref ref-type="bibr" rid="B520">Yoshino et al., 2018</xref>). Is an important biological mediator due to its many essential functions for survival: redox reactions, signaling pathways, energy metabolism, mitochondrial function, calcium homeostasis, DNA repair, gene expression (<xref ref-type="bibr" rid="B177">Guarente, 2014</xref>; <xref ref-type="bibr" rid="B512">Yaku et al., 2018</xref>), brain metabolism, neurotransmission, learning, memory, axonal neuroprotection (<xref ref-type="bibr" rid="B22">Araki et al., 2004</xref>; <xref ref-type="bibr" rid="B94">Conforti et al., 2006</xref>; <xref ref-type="bibr" rid="B167">Gong et al., 2013</xref>) and participation in the NAD<sup>+</sup>/PARP/SIRT1 axis related to aging (<xref ref-type="bibr" rid="B307">Mendelsohn and Larrick, 2017</xref>) (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Nicotinamide riboside action mechanism. NR gets into the cell and there, it is converted into NAD<sup>+</sup> through two mechanisms. One of them is Nrk1 and Nrk2 and the other is PNP and NAMPT. NAD<sup>+</sup> is a cosubstrate of PARPS which is related to repair of DNA damage by ROS. NAD<sup>+</sup> is also SIRT cosubstrate which is associated with energy metabolism, inflammation regulation, DNA repair and mitochondrial metabolism. The activation of SIRT increases the resistance against OS through an increase in metabolic pathways that detoxify ROS, like SOD2 and Cat. SIRT1 activates PGC-1α which involves an increase of antioxidant defense through SOD2 and GSH. SIRT3 activates SOD2 and Cat. Thus, SIRT regulates mitochondrial function and aging processes as well as is involved in ROS detoxification.</p>
</caption>
<graphic xlink:href="fphys-11-00063-g002"></graphic>
</fig>
<p>NAD<sup>+</sup> can act as a cosubstrate for sirtuins (SIRT) (<xref ref-type="bibr" rid="B491">Verdin, 2015</xref>), class III histone deacetylase enzymes whose activity is dependent on NAD<sup>+</sup> levels (<xref ref-type="bibr" rid="B459">Tang, 2016</xref>; <xref ref-type="bibr" rid="B223">Jęśko et al., 2017</xref>) and for poly(ADP-ribose) polymerases (PARPs), a family of proteins essential for repairing DNA damaged by ROS (<xref ref-type="bibr" rid="B432">Shen et al., 2015</xref>) (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<p>Sirtuins are related to the metabolic status of cells and are key in cellular metabolism, regulation of the expression of certain genes (<xref ref-type="bibr" rid="B346">O’Callaghan and Vassilopoulos, 2017</xref>), energy and mitochondrial metabolism (<xref ref-type="bibr" rid="B103">Covington and Bajpeyi, 2016</xref>), inflammation and DNA repair (<xref ref-type="bibr" rid="B460">Tang, 2017</xref>). They can be found in the cytoplasm, nucleus and mitochondria (<xref ref-type="bibr" rid="B259">Kupis et al., 2016</xref>). In neurodegenerative diseases and in aging they organize the response to OS and damage to DNA and are related to the functionality of the respiratory machinery and the production of ROS in different tissues (<xref ref-type="bibr" rid="B204">Huang et al., 2010</xref>).</p>
<p>Activation of SIRT increases resistance to OS (<xref ref-type="bibr" rid="B188">Haigis and Sinclair, 2010</xref>) through an increase in metabolic pathways responsible for the detoxification of ROS (<xref ref-type="bibr" rid="B414">Salvatori et al., 2017</xref>) such as superoxide dismutase 2 (SOD2), isocitrate dehydrogenase 2 (IDH2) and CAT (<xref ref-type="bibr" rid="B463">Tennen and Chua, 2011</xref>). They improve metabolic capacity, promote mitochondrial oxidative metabolism and facilitate repair of DNA damage (<xref ref-type="bibr" rid="B188">Haigis and Sinclair, 2010</xref>) (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<p>SIRT1 acts on the pathway of the peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) (<xref ref-type="bibr" rid="B16">Alquilano et al., 2013</xref>; <xref ref-type="bibr" rid="B459">Tang, 2016</xref>), a fundamental regulator of energy metabolism (<xref ref-type="bibr" rid="B34">Bayer et al., 2017</xref>; <xref ref-type="bibr" rid="B467">Thirupathi and de Souza, 2017</xref>) and mitochondrial dynamics (<xref ref-type="bibr" rid="B439">Singh et al., 2016</xref>) associated with an increase in antioxidant defenses through SOD2 and GSH (<xref ref-type="bibr" rid="B276">Liang and Ward, 2006</xref>; <xref ref-type="bibr" rid="B530">Zhong and Xu, 2008</xref>; <xref ref-type="bibr" rid="B498">Wang et al., 2015</xref>) (<xref ref-type="fig" rid="F2">Figure 2</xref>). Reduction of SIRT1 activity compromises oxidative metabolism and antioxidant capacity, affecting complex I of the ETC, mitochondrial function and biogenesis (<xref ref-type="bibr" rid="B400">Rodgers et al., 2005</xref>). This effect has been observed in aging and different pathologies: neurodegenerative diseases, metabolic disorders and cancer (<xref ref-type="bibr" rid="B387">Rass et al., 2007</xref>; <xref ref-type="bibr" rid="B199">Hou et al., 2017b</xref>; <xref ref-type="bibr" rid="B223">Jęśko et al., 2017</xref>). In ALS, alterations in SIRT1 levels have been determined in postmortem tissues from patients (<xref ref-type="bibr" rid="B253">Körner et al., 2013</xref>) and in mouse models of ALS (<xref ref-type="bibr" rid="B191">Han et al., 2012</xref>).</p>
<p>Sirtuin 3 (SIRT3) regulates mitochondrial function and the aging processes (<xref ref-type="bibr" rid="B61">Buck et al., 2017</xref>) by activating SOD2 and CAT (<xref ref-type="bibr" rid="B414">Salvatori et al., 2017</xref>) that are involved in the detoxification of ROS (<xref ref-type="bibr" rid="B379">Qiu et al., 2010</xref>; <xref ref-type="bibr" rid="B243">Kida and Goligorsky, 2016</xref>) (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<p>The decrease in NAD<sup>+</sup> levels may be secondary to a defect in its biosynthesis or to depletion (<xref ref-type="bibr" rid="B210">Imai and Guarente, 2014</xref>) and leads to a deficiency in the activities of SIRTs in the nucleus and mitochondria (<xref ref-type="bibr" rid="B75">Chang and Guarente, 2013</xref>; <xref ref-type="bibr" rid="B165">Gomes et al., 2013</xref>; <xref ref-type="bibr" rid="B306">Mendelsohn and Larrick, 2014</xref>; <xref ref-type="bibr" rid="B153">Frederick et al., 2016</xref>), reduces the mitochondrial unfolded protein response (<xref ref-type="bibr" rid="B307">Mendelsohn and Larrick, 2017</xref>), disrupts ATP biosynthesis, decreases the ability to pump calcium against the intracellular gradient (<xref ref-type="bibr" rid="B65">Camandola and Mattson, 2011</xref>), disrupts calcium homeostasis, increases excitotoxicity (<xref ref-type="bibr" rid="B411">Rzheshevsky, 2014</xref>) and has deleterious effects on muscle health (<xref ref-type="bibr" rid="B169">Goody and Henry, 2018</xref>).</p>
<p>The lower bioavailability of NAD<sup>+</sup> levels is involved in many diseases such as neurodegenerative pathologies (<xref ref-type="bibr" rid="B139">Essa et al., 2013</xref>; <xref ref-type="bibr" rid="B229">Johnson and Imai, 2018</xref>) and affects the production of energy, lowers the levels of ATP and limits the protection of SIRT1 (<xref ref-type="bibr" rid="B201">Houtkooper et al., 2010</xref>; <xref ref-type="bibr" rid="B66">Cantó et al., 2012</xref>; <xref ref-type="bibr" rid="B210">Imai and Guarente, 2014</xref>), an aspect that could worsen in these diseases because of its progressive nature (<xref ref-type="bibr" rid="B67">Cantó et al., 2015</xref>). NAD<sup>+</sup> levels have been shown to decrease with age, leading to low levels in the brain (<xref ref-type="bibr" rid="B532">Zhu et al., 2015</xref>). Several studies have demonstrated that NAD<sup>+</sup> metabolism is involved in neuronal function and in the pathophysiology of neurodegenerative diseases (<xref ref-type="bibr" rid="B195">Hikosaka et al., 2019</xref>) and that NAD<sup>+</sup> levels in tissues can produce beneficial therapeutical effects in this type of diseases (<xref ref-type="bibr" rid="B17">Aman et al., 2018</xref>; <xref ref-type="bibr" rid="B257">Kulikova et al., 2018</xref>).</p>
<p>The activation of metabolic pathways related to mitochondria and the production of energy through the NAD<sup>+</sup> and SIRT1 is currently suggested as a therapeutic strategy (<xref ref-type="bibr" rid="B517">Yang and Sauve, 2016</xref>; <xref ref-type="bibr" rid="B460">Tang, 2017</xref>; <xref ref-type="bibr" rid="B383">Rajman et al., 2018</xref>; <xref ref-type="bibr" rid="B528">Zhang and Sauve, 2018</xref>).</p>
<p>Recovery and/or increase of NAD<sup>+</sup> levels can protect skeletal muscle from progressive deterioration (<xref ref-type="bibr" rid="B150">Fletcher et al., 2017</xref>), reverse the damage to cerebral energy metabolism, increase the protection against OS (<xref ref-type="bibr" rid="B288">López-Otín et al., 2013</xref>; <xref ref-type="bibr" rid="B58">Brown et al., 2014</xref>; <xref ref-type="bibr" rid="B491">Verdin, 2015</xref>), promote the activity of SIRTs and proteins involved in mitochondrial function (<xref ref-type="bibr" rid="B52">Bonkowski and Sinclair, 2016</xref>), confers resistance against peroxide toxicity, decreases mitochondrial ROS (<xref ref-type="bibr" rid="B192">Harlan et al., 2016</xref>), protection against neurodegeneration (<xref ref-type="bibr" rid="B418">Sasaki et al., 2006</xref>) and upkeep of dependent enzymes that are involved in synaptic plasticity and neuronal stress resistance (<xref ref-type="bibr" rid="B266">Lautrup et al., 2019</xref>).</p>
<p>Therefore, the repletion of NAD<sup>+</sup> levels using precursors can ameliorate this age-associated functional defects (<xref ref-type="bibr" rid="B210">Imai and Guarente, 2014</xref>), helping to reverse the pathogenic processes characteristic of neurodegenerative diseases (<xref ref-type="bibr" rid="B526">Zhang et al., 2016</xref>).</p>
</sec>
<sec id="S6.SS2">
<title>Precursors of NAD<sup>+</sup></title>
<p>The precursors of NAD<sup>+</sup> include nicotinamide mononucleotide (NMN), nicotinamide (NAM), nicotinic acid (NA) and nicotinamide riboside (NR) (<xref ref-type="bibr" rid="B192">Harlan et al., 2016</xref>). Most of the NAD<sup>+</sup> precursors are more stable and have higher ability to enter neurons than NAD<sup>+</sup> (<xref ref-type="bibr" rid="B418">Sasaki et al., 2006</xref>). NMN and NR are the most used and both have shown an increase in NAD<sup>+</sup> levels in the cell (<xref ref-type="bibr" rid="B338">Nikiforov et al., 2011</xref>) (<xref ref-type="table" rid="T2">Table 2</xref>). Most evidence concludes that NR has a greater ability to stimulate a significant increase in NAD<sup>+</sup> levels (<xref ref-type="bibr" rid="B66">Cantó et al., 2012</xref>) and advantages over the use of other precursors (<xref ref-type="table" rid="T2">Table 2</xref>).</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Comparison between the different NAD<sup>+</sup> precursors.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">NAD<sup>+</sup> precursor</td>
<td align="left" colspan="1" rowspan="1" valign="top">Advantages</td>
<td align="left" colspan="1" rowspan="1" valign="top">Disadvantages</td>
<td align="left" colspan="1" rowspan="1" valign="top">References</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Niacin (NA)</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Prevents Pellagra <break></break>- Regulation of lipid levels (total   cholesterol, triglycerides and LDL)</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Produces cutaneous   flushing <break></break>- Not a NAD<sup>+</sup> precursor in   the majority of the cells <break></break></td>
<td align="left" colspan="1" rowspan="1" valign="top"><break></break><xref ref-type="bibr" rid="B111">Davidson, 2008</xref>; <xref ref-type="bibr" rid="B181">Guille et al., 2008</xref>; <xref ref-type="bibr" rid="B377">Prousky et al., 2011</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Nicotinamide mononucleotide (NMN)</td>
<td align="left" colspan="1" rowspan="1" valign="top">- One of the most used <break></break>- Has shown an increase in NAD<sup>+</sup>   levels in the cell</td>
<td align="left" colspan="1" rowspan="1" valign="top">- No consensus on how is   transported to the cell <break></break></td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B338">Nikiforov et al., 2011</xref>; <xref ref-type="bibr" rid="B176">Grozio et al., 2019</xref>; <xref ref-type="bibr" rid="B423">Schmidt and Brenner, 2019</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Nicotinamide (NAM)</td>
<td align="left" colspan="1" rowspan="1" valign="top">  Can be a stimulator in cells</td>
<td align="left" colspan="1" rowspan="1" valign="top">  Smaller increase in NAD<sup>+</sup>   compared to NR</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B66">Cantó et al., 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Nicotinamide riboside (NR)</td>
<td align="left" colspan="1" rowspan="1" valign="top">- Action on <break></break>  mammalian cells <break></break>- Minimal toxicity <break></break>- High bioavailability <break></break>- High capacity to cross the blood-  brain barrier <break></break>- Supports neuronal NAD<sup>+</sup> synthesis <break></break>- Greater ability to stimulate a   significant increase in NAD<sup>+</sup> levels   and intermediate precursors</td>
<td align="left" colspan="1" rowspan="1" valign="top">  No evidence</td>
<td align="left" colspan="1" rowspan="1" valign="top"><break></break><xref ref-type="bibr" rid="B514">Yang H. et al., 2007</xref>; <xref ref-type="bibr" rid="B50">Bogan and Brenner, 2008</xref>; <xref ref-type="bibr" rid="B66">Cantó et al., 2012</xref>; <xref ref-type="bibr" rid="B468">Trammell et al., 2016</xref>; <xref ref-type="bibr" rid="B8">Airhart et al., 2017</xref>; <xref ref-type="bibr" rid="B299">Martens et al., 2018</xref>
<break></break></td>
</tr>
</tbody>
</table>
</table-wrap>
<p>NA prevents Pellagra (<xref ref-type="bibr" rid="B377">Prousky et al., 2011</xref>) and has positive effects on the regulation of lipids (total cholesterol, triglycerides and LDL) (<xref ref-type="bibr" rid="B181">Guille et al., 2008</xref>) (Tabla 2). However, produces cutaneous flushing and does not work as NAD<sup>+</sup> precursor in the majority of cells (<xref ref-type="bibr" rid="B111">Davidson, 2008</xref>) (<xref ref-type="table" rid="T2">Table 2</xref>). One of the most important advantages of NR over NA is that supports neuronal NAD<sup>+</sup> synthesis (<xref ref-type="bibr" rid="B50">Bogan and Brenner, 2008</xref>) and has action on several types of cultured mammalian cells, including mouse and human cells (<xref ref-type="bibr" rid="B514">Yang H. et al., 2007</xref>) (<xref ref-type="table" rid="T2">Table 2</xref>).</p>
<p>There is no consensus on how NMN is transported to the cell (<xref ref-type="bibr" rid="B176">Grozio et al., 2019</xref>; <xref ref-type="bibr" rid="B423">Schmidt and Brenner, 2019</xref>) (<xref ref-type="table" rid="T2">Table 2</xref>). However, NR is five times more effective than NMN in increasing intracellular NAD<sup>+</sup> levels in skeletal muscles (<xref ref-type="bibr" rid="B344">Oakey et al., 2018</xref>) (<xref ref-type="table" rid="T2">Table 2</xref>).</p>
<p>After comparing NR with NA and NAM in mice, NR showed a significant higher peak of NAD<sup>+</sup> concentration and a significant increase of intermediate NAD<sup>+</sup> precursors including NMN, NA mononucleotide and NA adenine dinucleotide (<xref ref-type="bibr" rid="B468">Trammell et al., 2016</xref>) (<xref ref-type="table" rid="T2">Table 2</xref>). NR has a different time course compared to NAM and NA and produces more NAD<sup>+</sup> than the other precursors in equivalent doses (<xref ref-type="bibr" rid="B468">Trammell et al., 2016</xref>). NR increases the ratio of NAD<sup>+</sup>/NADH more significantly compared NMN, NAM and NA and this can contribute to improving the oxidative capacity of mitochondria (<xref ref-type="bibr" rid="B66">Cantó et al., 2012</xref>) and to decrease the rate of oxidative damage against DNA and mitochondrial stress (<xref ref-type="bibr" rid="B385">Ramamoorthy et al., 2012</xref>; <xref ref-type="bibr" rid="B448">Srivastava, 2016</xref>; <xref ref-type="bibr" rid="B125">Dolopikou et al., 2019</xref>) (<xref ref-type="table" rid="T2">Table 2</xref>).</p>
<p>NR is a nucleoside that incorporates a nicotinamide and a ribose (<xref ref-type="bibr" rid="B38">Belenky et al., 2007</xref>; <xref ref-type="bibr" rid="B82">Chi and Sauve, 2013</xref>) group. It is a trace nutrient known as vitamin B3 (<xref ref-type="bibr" rid="B264">Lanska, 2012</xref>), available in certain foods (dairy products, fish, eggs, and vegetables) (<xref ref-type="bibr" rid="B318">Minto et al., 2017</xref>), nutritional supplements and fortified foods (<xref ref-type="bibr" rid="B92">Colbourne et al., 2013</xref>). Its effects are associated with energy metabolism and neuroprotection (<xref ref-type="bibr" rid="B82">Chi and Sauve, 2013</xref>). When the NR enters the cells it is converted to NAD<sup>+</sup> by at least two types of metabolic pathway. The first requires the participation of the nicotinamide riboside kinases (NRKs) (<xref ref-type="bibr" rid="B82">Chi and Sauve, 2013</xref>) in two of its isoforms (NRK1 and NRK2) (<xref ref-type="bibr" rid="B47">Bieganowski and Brenner, 2004</xref>) and the second requires the action of purine nucleoside phosphorylase (PNP) and nicotinamide phosphoribosyltransferase (NAMPT) (<xref ref-type="bibr" rid="B63">Burgos et al., 2013</xref>) (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<p>The conversion of NR into NAD<sup>+</sup> has been observed in animal tissues of muscle and brain (<xref ref-type="bibr" rid="B82">Chi and Sauve, 2013</xref>) and treatment by exogenous supplementation of NR is able to increase intracellular concentrations of NAD<sup>+</sup> and promote its beneficial effects (<xref ref-type="bibr" rid="B55">Braidy et al., 2008</xref>) (<xref ref-type="fig" rid="F2">Figure 2</xref>). NR enhances protection against aging and related diseases, with positive results on longevity in multiple animal models (<xref ref-type="bibr" rid="B326">Mouchiroud et al., 2013</xref>; <xref ref-type="bibr" rid="B371">Poljsak and Milisav, 2016</xref>) and has been recently reported that NR protects against excitotoxicity induced axonal degeneration (<xref ref-type="bibr" rid="B487">Vaur et al., 2017</xref>). The increase of NAD<sup>+</sup> levels by supplementation with precursors such as NR improves mitochondrial and muscular function and the function of neuronal cells in mice (<xref ref-type="bibr" rid="B307">Mendelsohn and Larrick, 2017</xref>). A study performed in mice supplemented nutritionally with 400 mg/kg/day of synthetic NR showed an increase in NAD<sup>+</sup> levels in muscle and liver tissue (<xref ref-type="bibr" rid="B66">Cantó et al., 2012</xref>). As NR increases the NAD<sup>+</sup>/NADH ratio, it could be related to an improvement of the oxidative capacity of the mitochondrial pathway and could be a therapeutic strategy of interest in those diseases that are associated with mitochondrial dysfunction and OS such as neurodegenerative diseases (<xref ref-type="bibr" rid="B66">Cantó et al., 2012</xref>). Improvement of NAD<sup>+</sup> levels provides greater mitochondrial resistance against OS (<xref ref-type="bibr" rid="B515">Yang T. et al., 2007</xref>) and prevents cell death due to the protective function of SIRT3 (<xref ref-type="bibr" rid="B187">Hafner et al., 2010</xref>), which stimulates SOD, responsible for enhancing the “detoxification” of ROS (<xref ref-type="bibr" rid="B80">Chen et al., 2011</xref>) (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<p>Supplementation with NR is safe in mice and humans and has minimal toxicity, high bioavailability and high capacity to cross the blood-brain barrier (<xref ref-type="bibr" rid="B468">Trammell et al., 2016</xref>; <xref ref-type="bibr" rid="B8">Airhart et al., 2017</xref>; <xref ref-type="bibr" rid="B299">Martens et al., 2018</xref>) (<xref ref-type="table" rid="T2">Table 2</xref>).</p>
</sec>
<sec id="S6.SS3">
<title>Nicotinamide Riboside</title>
<p>Neurodegenerative diseases are associated with a progressive decrease in muscle mass and strength and an increase in their weakness (<xref ref-type="bibr" rid="B168">González et al., 2017</xref>; <xref ref-type="bibr" rid="B480">Van Damme et al., 2017</xref>; <xref ref-type="bibr" rid="B108">Dahlqvist et al., 2019</xref>). Muscle contractility dysfunction precedes the loss of motor unit connectivity in the SOD1<sup>G93A</sup> mouse model of ALS (<xref ref-type="bibr" rid="B505">Wier et al., 2019</xref>) with neurodegeneration being one of the determinant risk factors for muscle quality (<xref ref-type="bibr" rid="B118">Di Pietro et al., 2017</xref>; <xref ref-type="bibr" rid="B323">Moon et al., 2018</xref>). Treatment with NR improves muscle function in aged mice (<xref ref-type="bibr" rid="B66">Cantó et al., 2012</xref>) and has benefits on muscle strength and skeletal muscle resistance in knock out mice that have specific elimination of NAMPT and a decrease of 85% in the intramuscular content of NAD<sup>+</sup> (<xref ref-type="bibr" rid="B153">Frederick et al., 2016</xref>). This would indicate that the maintenance of NAD<sup>+</sup> homeostasis is critical for muscle mass and its contractile function (<xref ref-type="bibr" rid="B306">Mendelsohn and Larrick, 2014</xref>; <xref ref-type="bibr" rid="B153">Frederick et al., 2016</xref>). NR induces rejuvenation in muscle and brain stem cells (<xref ref-type="bibr" rid="B410">Ryu et al., 2016</xref>) and an increase in neurogenesis and muscle function (<xref ref-type="bibr" rid="B526">Zhang et al., 2016</xref>). NAD<sup>+</sup> is a fundamental modulator of muscle senescence and after treatment with NR, there is an acceleration of muscle regeneration in both young and old mice and an improvement in running times, maximum distances, grip strength of the extremities of aged mice and increased expression of cell cycle genes (<xref ref-type="bibr" rid="B526">Zhang et al., 2016</xref>).</p>
<p>Levels of PGC-1α are decreased in Alzheimer’s disease (AD) and this is related to the formation of ß-amyloid plaques and greater deposition of this substance (main characteristics of AD) (<xref ref-type="bibr" rid="B507">Wu et al., 2006</xref>; <xref ref-type="bibr" rid="B380">Quin et al., 2009</xref>). Studies conducted in animal models of AD established a relationship between the levels of NAD<sup>+</sup> and a decrease in the toxicity of the amyloid substance (<xref ref-type="bibr" rid="B245">Kim et al., 2007</xref>; <xref ref-type="bibr" rid="B380">Quin et al., 2009</xref>). For this reason, the therapeutic strategy based on nutritional supplementation with NR could be of interest in AD cases to stop the onset and progression of the dementia (<xref ref-type="bibr" rid="B400">Rodgers et al., 2005</xref>) and to improve cognitive function and synaptic plasticity by promoting the function of PGC-1α as demonstrated in Tg2576 mice (mouse model of ALS) (<xref ref-type="bibr" rid="B167">Gong et al., 2013</xref>). After analyzing the effect of NR on the physiopathology and cellular mechanisms in the 3xTgAD/Polß<sup>±</sup> mouse model (mice deficient in DNA repair that exacerbates the main characteristics of AD in humans) it was observed that supplementation with NR significantly increased the NAD<sup>+</sup>/NADH ratio, reduced neuroinflammation, apoptosis and damage to DNA, increased neurogenesis, restored synaptic plasticity, improved learning capacity and reversed memory deficits (<xref ref-type="bibr" rid="B198">Hou et al., 2017a</xref>). Treatment with NR improves cognition in transgenic mice with AD by reducing the phosphorylation of the Tau protein (pTau) (a form that accumulates in the brain of AD patients and is the hallmark of the disease) (<xref ref-type="bibr" rid="B174">Green et al., 2008</xref>; <xref ref-type="bibr" rid="B407">Rüb et al., 2017</xref>; <xref ref-type="bibr" rid="B341">Nizynski et al., 2017</xref>). In the case of PD, the repletion of NAD<sup>+</sup> through the use of NR prevents aging related to the loss of dopaminergic neurons and the reduction of motor function in Drosophila fly model of PD (<xref ref-type="bibr" rid="B435">Sidransky et al., 2009</xref>). NR improves mitochondrial function in PD neurons, increases the markers of mitochondrial biogenesis, significantly decreases the production of mtROS (mitochondrial ROS), reduces mitochondrial membrane potential and increases the levels of NAD<sup>+</sup> and NADH (<xref ref-type="bibr" rid="B425">Schöndorf et al., 2018</xref>).</p>
<p>Axonal degeneration occurs in most neurodegenerative diseases (AD, PD, ALS) (<xref ref-type="bibr" rid="B382">Raff et al., 2002</xref>; <xref ref-type="bibr" rid="B93">Coleman, 2005</xref>). The increase in NAD<sup>+</sup> synthesis through the use of precursors such as NR promotes axonal protection (<xref ref-type="bibr" rid="B496">Wang et al., 2005</xref>; <xref ref-type="bibr" rid="B418">Sasaki et al., 2006</xref>). Improvement of the NAD<sup>+</sup> recovery pathway reverses the toxicity of primary astrocytes expressing the SOD1 mutation related to ALS, decreasing the mitochondrial production of ROS and reversing the neurotoxic effects (<xref ref-type="bibr" rid="B192">Harlan et al., 2016</xref>). Excitotoxicity is a process that takes place in most neurodegenerative disorders like ALS and is related to strong NAD<sup>+</sup> depletion in neurons. NR protects against excitotoxicity-induced axonal generation (<xref ref-type="bibr" rid="B487">Vaur et al., 2017</xref>).</p>
<p>In Duchenne’s muscular dystrophy disease, supplementation with NR reverses progressive wear and improves resistance in skeletal muscle NAMPT in the knock out mouse model (<xref ref-type="bibr" rid="B410">Ryu et al., 2016</xref>).</p>
</sec>
</sec>
<sec id="S7">
<title>Pterostilbene and Neurodegenerative Diseases</title>
<p>Polyphenols are organic metabolites present in plants (<xref ref-type="bibr" rid="B101">Cory et al., 2018</xref>) and widely distributed in a variety of dietary sources (<xref ref-type="bibr" rid="B5">Aherne and O’Brien, 2002</xref>; <xref ref-type="bibr" rid="B248">Kim et al., 2009</xref>): fruits, vegetables, legumes, whole grains, seeds, nuts, extra virgin olive oil, red wine, coffee, tea, chocolate, herbs and spices (<xref ref-type="bibr" rid="B409">Rusconi and Conti, 2010</xref>; <xref ref-type="bibr" rid="B156">Fu et al., 2011</xref>; <xref ref-type="bibr" rid="B390">Regueiro et al., 2014</xref>; <xref ref-type="bibr" rid="B479">Vallverdú-Queralt et al., 2014</xref>, <xref ref-type="bibr" rid="B478">2015</xref>; <xref ref-type="bibr" rid="B456">Talhaoui et al., 2016</xref>). Despite their zero energy contribution (<xref ref-type="bibr" rid="B408">Ruiz et al., 2009</xref>) they act as bioactive dietary components associated with multiple positive health effects (<xref ref-type="bibr" rid="B21">An-Na et al., 2014</xref>; <xref ref-type="bibr" rid="B160">Ganesan and Xu, 2017</xref>; <xref ref-type="bibr" rid="B454">Szwajgier et al., 2017</xref>; <xref ref-type="bibr" rid="B393">Renaud and Martinoli, 2019</xref>) due to their regulating action on metabolism, chronic diseases and cell proliferation (<xref ref-type="bibr" rid="B470">Tressera-Rimbau et al., 2017</xref>). Polyphenols have a chemical structure with properties that make them the compounds with the greatest antioxidant action: <italic>o</italic>-diphenolic group, 2-3 double bond conjugated with the 4-oxo function and hydroxyl groups (OH) in positions 3 and 5 (<xref ref-type="bibr" rid="B408">Ruiz et al., 2009</xref>). They have antioxidant (<xref ref-type="bibr" rid="B203">Hua and Rong, 2016</xref>; <xref ref-type="bibr" rid="B461">Tarique et al., 2016</xref>), anti-inflammatory (<xref ref-type="bibr" rid="B349">Oliviero et al., 2018</xref>), anticarcinogenic (<xref ref-type="bibr" rid="B335">Niedzwiecki et al., 2016</xref>), antiallergic (<xref ref-type="bibr" rid="B236">Juríková et al., 2015</xref>), antibiotic (<xref ref-type="bibr" rid="B509">Xie et al., 2017</xref>), and immunomodulatory (<xref ref-type="bibr" rid="B342">Nour et al., 2018</xref>) properties.</p>
<p>Polyphenols can be a useful therapeutic strategy in pathologies that present OS such as neurodegenerative diseases (<xref ref-type="bibr" rid="B46">Bhullar and Vasantha, 2013</xref>; <xref ref-type="bibr" rid="B386">Raskin et al., 2015</xref>; <xref ref-type="bibr" rid="B391">Reinisalo et al., 2015</xref>; <xref ref-type="bibr" rid="B72">Carvalho et al., 2018</xref>), cancer and cardiovascular diseases (<xref ref-type="bibr" rid="B106">Crozier et al., 2009</xref>; <xref ref-type="bibr" rid="B62">Bulotta et al., 2014</xref>; <xref ref-type="bibr" rid="B262">Lamuela-Raventós et al., 2014</xref>). Taking into account that nutrition is a factor that modulates processes such as cognition or progression of CNS diseases (<xref ref-type="bibr" rid="B185">Gustafson et al., 2015</xref>; <xref ref-type="bibr" rid="B205">Huhn et al., 2015</xref>), polyphenols have recently been associated with: prevention, repair of oxidative damage (<xref ref-type="bibr" rid="B263">Lange and Li, 2018</xref>), synaptic plasticity, neuronal signaling and autophagy (<xref ref-type="bibr" rid="B315">Miller and Shukitt-Hale, 2012</xref>; <xref ref-type="bibr" rid="B375">Poulose et al., 2014</xref>).</p>
<p>Among the polyphenols with important pharmaceutical activity are the stilbenes (<xref ref-type="bibr" rid="B132">Dvorakova and Landa, 2017</xref>), a group of non-flavonoid phytochemicals of polyphenolic structure with a 1,2-diphenylethylene core, which are produced naturally in plants via the phenylpropanoid pathway (<xref ref-type="bibr" rid="B440">Sirerol et al., 2016</xref>) to protect the plant from fungal infection and toxins (<xref ref-type="bibr" rid="B9">Akinwumi et al., 2018</xref>). There is a wide variety of forms because of a common structure to which various substituents can be added in different positions and they have an acidic and amphiphilic character (<xref ref-type="bibr" rid="B332">Neves et al., 2012</xref>). Although the <italic>trans</italic> isomer is the most common form of presentation (since it is the most stable), it can also be found in the <italic>cis</italic> isomer (<xref ref-type="bibr" rid="B398">Rivière et al., 2012</xref>). The following properties have been attributed to them: antioxidant, anti-inflammatory, neuroprotective, cardioprotective, anti-carcinogenic (<xref ref-type="bibr" rid="B263">Lange and Li, 2018</xref>), hypolipidemic and anti-diabetic (<xref ref-type="bibr" rid="B493">Voloshyna et al., 2013</xref>; <xref ref-type="bibr" rid="B453">Szkudelski and Szkudelska, 2015</xref>). They have great utility potential in the field of neurodegenerative diseases. They reduce the formation of amyloid plaques in the brain, decrease the production of ROS and could be of interest in other situations such as: ischemia-reperfusion injury, atherosclerosis, diabetes, cancer, obesity, platelet aggregation, blood pressure, depigmentation and cardiomyocyte and cardiac hypertrophy (<xref ref-type="bibr" rid="B465">Thandapilly et al., 2011</xref>; <xref ref-type="bibr" rid="B166">Gomez-Zorita et al., 2013</xref>; <xref ref-type="bibr" rid="B533">Zordoky et al., 2015</xref>; <xref ref-type="bibr" rid="B183">Guo et al., 2016</xref>; <xref ref-type="bibr" rid="B9">Akinwumi et al., 2018</xref>).</p>
<p>One of the most studied stilbenes has been Resveratrol (RES) (3,5,4’-trihydroxy-trans-stilbene), due to its benefits in cardiovascular health (<xref ref-type="bibr" rid="B533">Zordoky et al., 2015</xref>; <xref ref-type="bibr" rid="B53">Bonnefont-Rousselot, 2016</xref>; <xref ref-type="bibr" rid="B133">Dyck et al., 2019</xref>). However, recent studies focus their interest on pterostilbene (PTER) (trans-3,5-dimethoxy-4hydroxystilbene), a dimethylated natural stilbene (<xref ref-type="bibr" rid="B11">Albassam and Frye, 2019</xref>) with 1 hydroxyl group and 2 methoxy groups (<xref ref-type="bibr" rid="B88">Cichocki et al., 2008</xref>; <xref ref-type="bibr" rid="B140">Estrela et al., 2013</xref>; <xref ref-type="bibr" rid="B469">Traversi et al., 2016</xref>), which provides greater oral bioavailability, half-life, lipophilicity and higher permeability to targeted tissue (<xref ref-type="bibr" rid="B237">Kapetanovic et al., 2011</xref>; <xref ref-type="bibr" rid="B518">Yeo et al., 2013</xref>) with respect to RES (3 hydroxyl groups). In addition, PTER is less susceptible to phase II liver metabolism (<xref ref-type="bibr" rid="B531">Zhou et al., 2016</xref>). These particular characteristics improve its biological potential (<xref ref-type="bibr" rid="B518">Yeo et al., 2013</xref>) and its high bioavailability <italic>in vivo</italic> is an advantage over RES (<xref ref-type="bibr" rid="B85">Chiou et al., 2011</xref>; <xref ref-type="bibr" rid="B69">Carey et al., 2013</xref>; <xref ref-type="bibr" rid="B279">Lin et al., 2016</xref>). PTER presents a bioavailability of 80% compared to 20% for RES and plasma levels of PTER and PTER sulfate were significantly higher than plasma levels of RES and RES sulfate in a mouse model (<xref ref-type="bibr" rid="B237">Kapetanovic et al., 2011</xref>). After administration of PTER and RES at the same dose to male and female mice for 8 weeks, PTER reached higher concentrations in the serum and in the brain than RES (<xref ref-type="bibr" rid="B76">Chang et al., 2012</xref>).</p>
<p>The high lipophilicity of PTER allows it to easily cross the blood-brain barrier (<xref ref-type="bibr" rid="B462">Temsamani et al., 2015</xref>), resulting in greater neuroprotection than RES (<xref ref-type="bibr" rid="B86">Choo et al., 2014</xref>). In AD, PTER presents superior neuroprotection than RES (<xref ref-type="bibr" rid="B76">Chang et al., 2012</xref>) and is the stilbene with the highest inhibitory potential for 5-lipoxygenase (5-LOX) (<xref ref-type="bibr" rid="B261">Kutil et al., 2015</xref>), decreasing the levels of lipid and protein oxidation (<xref ref-type="bibr" rid="B107">Czpaski et al., 2012</xref>). It is a more potent anticancer and anti-inflammatory agent than RES (<xref ref-type="bibr" rid="B85">Chiou et al., 2011</xref>) and it distributes widely among the main target organs (brain, liver, kidney, heart and lung) for what seems to be a promising (<xref ref-type="bibr" rid="B86">Choo et al., 2014</xref>) and safe (<xref ref-type="bibr" rid="B396">Riche et al., 2013</xref>) therapeutic strategy. A study in male and female Swiss mice examined the sub-chronic toxicity and the possible adverse effects of PTER and concluded that, even with the highest dose administered, PTER was not toxic (<xref ref-type="bibr" rid="B408">Ruiz et al., 2009</xref>).</p>
<sec id="S7.SS1">
<title>Molecular Mechanisms of PTER</title>
<p>The physiological activities of PTER include: antioxidant and anti-inflammatory activity, ability to restore intracellular calcium and cognitive function (<xref ref-type="bibr" rid="B275">Li Y. R. et al., 2018</xref>) (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Pterostilbene properties and action mechanism. The antioxidant mechanism of Pter is associated with Cat, GSH, SOD, Nrf2 and SIRT1 pathways, which leads to an inhibition of the oxidation and lipoperoxidation processes, decreasing the levels of MDA, HNE, 8-OHdG and carbonilated proteins. Its action on NF-kß involves an anti-inflammatory effect due to the decrease in the levels of TNF-α and interleukins such as IL-1β, IL-6 and IL-18. Its role on NF-kß, LPS and PPAR-α mediates the cognitive function of Pter, which is expressed through cognition modulation, inhibition of microglia activation and protection against neuronal damage. In addition, Pter presents protection against excitotoxicity due to the increase in cellular restoration and the reduction of the recovery time after cellular depolarization.</p>
</caption>
<graphic xlink:href="fphys-11-00063-g003"></graphic>
</fig>
<sec id="S7.SS1.SSS1">
<title>Antioxidant Activity</title>
<p>PTER stands out for its antioxidant action against numerous types of free radicals: HO, H<sub>2</sub>O<sub>2</sub> (<xref ref-type="bibr" rid="B73">Castellani et al., 2008</xref>; <xref ref-type="bibr" rid="B311">Mikstacka et al., 2010</xref>; <xref ref-type="bibr" rid="B3">Acharya and Ghaskadbi, 2013</xref>) and NO<sup>∙</sup> (<xref ref-type="bibr" rid="B352">Pan et al., 2008</xref>; <xref ref-type="bibr" rid="B527">Zhang et al., 2012</xref>). It is able to neutralize metal-induced radicals (<xref ref-type="bibr" rid="B405">Rossi et al., 2013</xref>; <xref ref-type="bibr" rid="B419">Saw et al., 2014</xref>) and to inhibit oxidation and lipoperoxidation processes (<xref ref-type="bibr" rid="B397">Rimando et al., 2002</xref>) causing a decrease in carbonylated proteins and oxidation by-products: MDA, HNE and 8-OHdG (<xref ref-type="bibr" rid="B275">Li Y. R. et al., 2018</xref>) (<xref ref-type="fig" rid="F3">Figure 3</xref>). The administration of PTER improves the antioxidant defenses of the brain by raising the levels of CAT, GSH and the activity of SOD (<xref ref-type="bibr" rid="B330">Naik et al., 2017</xref>) (<xref ref-type="fig" rid="F3">Figure 3</xref>). In addition, diet supplemented with PTER increases the expression of SOD2 (<xref ref-type="bibr" rid="B120">Ding et al., 2007</xref>). Pre-treatment with PTER has a potent antioxidant function that increases SOD activity in hypoxic-ischemic brain injury in the P7 rat model (<xref ref-type="bibr" rid="B269">Li D. et al., 2016</xref>). Treatment with PTER reduces glutamate-induced OS injury by reducing ROS and increasing the function of SOD and GSH by activating the Nrf2 signaling pathway in neuronal cells (<xref ref-type="bibr" rid="B494">Wang et al., 2016</xref>), a target factor for the prevention of diseases related to aging such as neurodegenerative diseases (<xref ref-type="bibr" rid="B42">Bhakkiyalakshmi et al., 2016</xref>; <xref ref-type="bibr" rid="B275">Li Y. R. et al., 2018</xref>) (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p>
<p>The potent antioxidant mechanism of PTER is associated with SIRT1 signaling activation (<xref ref-type="bibr" rid="B271">Li et al., 2015</xref>; <xref ref-type="bibr" rid="B183">Guo et al., 2016</xref>; <xref ref-type="bibr" rid="B283">Liu et al., 2017</xref>) leading to the attenuation of the skeletal muscle OS injury and mitochondrial dysfunction induced by ischemia-reperfusion injury in male Sprague-Dawley rats (<xref ref-type="bibr" rid="B81">Cheng et al., 2016</xref>). PTER acts on Nrf2 (<xref ref-type="bibr" rid="B419">Saw et al., 2014</xref>; <xref ref-type="bibr" rid="B525">Zhang et al., 2014</xref>; <xref ref-type="bibr" rid="B511">Xue et al., 2017</xref>) and attenuates high glucose-induced central nervous system injury <italic>in vitro</italic> through the activation of Nrf2 signaling, displaying protective effects against mitochondrial dysfunction-derived OS (<xref ref-type="bibr" rid="B516">Yang et al., 2017</xref>).</p>
</sec>
<sec id="S7.SS1.SSS2">
<title>Anti-inflammatory Activity</title>
<p>PTER has been recognized as an anti-inflammatory agent (<xref ref-type="bibr" rid="B392">Remsberg et al., 2008</xref>; <xref ref-type="bibr" rid="B376">Poulose et al., 2015</xref>; <xref ref-type="bibr" rid="B254">Kosuru et al., 2016</xref>) able to protect neurons against neuroinflammation due to the inhibition of ROS production (<xref ref-type="bibr" rid="B434">Shin et al., 2010</xref>). It acts on NF-kB and suppresses the action of various proinflammatory cytokines: TNF-α, IL-1β, IL-6 and IL-18 (<xref ref-type="bibr" rid="B88">Cichocki et al., 2008</xref>; <xref ref-type="bibr" rid="B358">Paul et al., 2009</xref>; <xref ref-type="bibr" rid="B200">Hou et al., 2014</xref>; <xref ref-type="bibr" rid="B135">El-Sayed et al., 2015</xref>) (<xref ref-type="fig" rid="F3">Figure 3</xref>). PTER inhibits amyloid-β-induced neuroinflammation in microglia by inactivating the NLRP3/caspase-1 inflammasome pathway and reduces the secretion levels of IL-6, IL-1β and TNF-α, thereby attenuating the neuroinflammatory response, which would indicate that it could be a useful therapeutic strategy in neurodegenerative diseases (<xref ref-type="bibr" rid="B272">Li Q. et al., 2018</xref>; <xref ref-type="bibr" rid="B428">Seo et al., 2018</xref>).</p>
</sec>
<sec id="S7.SS1.SSS3">
<title>Ability to Restore Intracellular Calcium</title>
<p>PTER is able to increase the capacity of intracellular calcium restoration by reducing recovery time after cell depolarization (<xref ref-type="bibr" rid="B231">Joseph et al., 2008</xref>). It protects against excitotoxicity, an aspect that would be interesting since it has been observed that the increase in intracellular ROS levels is related to damage in the cell membrane, impaired calcium homeostasis (<xref ref-type="bibr" rid="B466">Thibault et al., 2007</xref>; <xref ref-type="bibr" rid="B232">Joseph et al., 2011</xref>) and increased excitotoxicity (<xref ref-type="bibr" rid="B411">Rzheshevsky, 2014</xref>) (<xref ref-type="fig" rid="F3">Figure 3</xref>). In the Sprague-Dawley rat model, PTER improves cholinergic transmission due to the decrease in the activity of acetylcholinesterase and increases the action of ATPases (Na<sup>+</sup>, K<sup>+</sup>, Ca<sup>2+</sup>, and Mg<sup>2+</sup>), which is indicative of the maintenance of the cell membrane potential (<xref ref-type="bibr" rid="B330">Naik et al., 2017</xref>).</p>
</sec>
<sec id="S7.SS1.SSS4">
<title>Cognitive Function</title>
<p>After determining if PTER was effective in reversing the effects of aging in old Fischer rats, it was concluded that memory functioning was related to PTER levels in the hippocampus and that a diet supplemented with this antioxidant is effective in reversing deficits in cognitive behavior (<xref ref-type="bibr" rid="B231">Joseph et al., 2008</xref>). PTER attenuated lipopolysaccharide (LPS) induced learning and memory impairment, which is associated with an inhibition of the activation of microglia and therefore a protective effect against neuronal damage (<xref ref-type="bibr" rid="B200">Hou et al., 2014</xref>) (<xref ref-type="fig" rid="F3">Figure 3</xref>). It reduces memory loss in the intracerebroventricular administered streptozotocin-induced memory decline in Sprague–Dawley rats (<xref ref-type="bibr" rid="B330">Naik et al., 2017</xref>) and mediates neuroprotection against oxidative toxicity via the estrogen receptor signaling pathway in human neuronal SH-SY5Y cells (<xref ref-type="bibr" rid="B446">Song et al., 2015</xref>).</p>
<p>In AD, supplementation with PTER reduces the phosphorylation of pTau (<xref ref-type="bibr" rid="B374">Porquet et al., 2013</xref>). The derivatives of PTER showed antioxidant and inhibitory activity against the aggregation of β-amyloid plaques, as well as cholinesterase inhibition, which would be useful in the treatment of patients with AD (<xref ref-type="bibr" rid="B274">Li Y. et al., 2016</xref>) and vascular dementia (<xref ref-type="bibr" rid="B263">Lange and Li, 2018</xref>).</p>
<p>PTER is a modulator of cognition and the OS due to the increased expression of peroxisome proliferator activator receptor alpha (PPAR-α) (<xref ref-type="bibr" rid="B76">Chang et al., 2012</xref>) (<xref ref-type="fig" rid="F3">Figure 3</xref>). After comparing the effectiveness of dietary supplementation with RES and PTER in the improvement of functional deficits characteristic of AD in the SAMP8 mouse model (a model of accelerated aging that is increasingly being validated as a model of sporadic and age-related AD), it was concluded that PTER and not RES, is able to modulate the markers of cellular stress and inflammation, causing an upregulation of PPAR-α (<xref ref-type="bibr" rid="B76">Chang et al., 2012</xref>) and a suppression of the activation of NF-kB (<xref ref-type="bibr" rid="B212">Inoue et al., 2003</xref>), which is a conservative factor against the loss of cognitive function (<xref ref-type="bibr" rid="B222">Jeong et al., 2012</xref>; <xref ref-type="bibr" rid="B200">Hou et al., 2014</xref>) (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p>
<p>Due to the activation of metabolic pathways related to OS protection, inflammation, regulation of excitotoxicity and preservation of neuronal functions, PTER is a protective factor against neurodegenerative diseases (<xref ref-type="bibr" rid="B376">Poulose et al., 2015</xref>).</p>
</sec>
</sec>
</sec>
<sec id="S8">
<title>Conclusion</title>
<p>OS is involved in neuroinflammation, development and progression of ALS. The complex interaction between all the factors does not allow definitive determination if OS is a primary cause or if it is a secondary effect to the propagation of damage in the nervous cells. However, a clear relationship has been established between OS, mitochondrial dysfunction and neuroinflammation, aspects that promote a “vicious cycle” that causes a decrease in the capacity of ATP biosynthesis and an increase in ROS levels.</p>
<p>Currently, there is no cure for ALS but the use of different antioxidant substances has been proposed as a possible therapeutic strategy, the purpose of which is to increase the body’s antioxidant defenses and maintain the redox balance. However, there are cases in which the use of these antioxidants has disadvantages or requires a higher number of studies since few results are available or these are contradictory, inconclusive or scarcely significant at the statistical level. Taking into account the pathogenic mechanisms of ALS, the new therapeutic strategies have as the main goal to activate the metabolic pathways related to the mitochondria, production of energy and increase the antioxidant defense levels.</p>
<p>NAD<sup>+</sup> acts on energy metabolism, mitochondrial function and is key in brain metabolism, aspects involved in the pathogenesis of ALS. Restoration of NAD<sup>+</sup> levels by administrating the precursor NR provides greater mitochondrial resistance against impairment of redox balance and, therefore, could play a key role in those diseases that are associated with mitochondrial dysfunction and OS.</p>
<p>PTER has great biological potential due to its ability to activate metabolic pathways related to protection against OS, mitochondrial dysfunction, inflammation, intracellular calcium restoration and cognitive function, thus resulting in a neuroprotective function against the pathogenic mechanisms of ALS.</p>
<p>In a randomized, double-blind, placebo-controlled study in humans, it was determined that repeated doses of a combination therapy with NR and PTER increased NAD<sup>+</sup> levels safely and effectively (<xref ref-type="bibr" rid="B114">Dellinger et al., 2017</xref>). Treatment with NR and PTER is effective and safe and therefore it could be a promising therapeutic strategy in ALS, due to its action on the pathogenesis of this disease.</p>
</sec>
<sec id="S9">
<title>Author Contributions</title>
<p>SC-J and MM wrote the manuscript. SC-J, MM, and ED conceived and designed the figures. CB, JR, and ED reviewed the manuscript.</p>
</sec>
<sec id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>We wish to thank Universidad Católica de Valencia “San Vicente Mártir” for its financial help (Grant: 2019-802-001) in the revision and edition of the language in the manuscript and Professor José María Lajara from Universidad Católica de Valencia “San Vicente Mártir”, for his technical assistance in the design of the figures.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>K.</given-names></name><name><surname>Aoki</surname><given-names>M.</given-names></name><name><surname>Tsuji</surname><given-names>S.</given-names></name><name><surname>Itoyama</surname><given-names>Y.</given-names></name><name><surname>Sobue</surname><given-names>G.</given-names></name><name><surname>Togo</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled trial.</article-title>
<source/><italic>Lancet Neurol.</italic>
<volume>16</volume>
<fpage>505</fpage>–<lpage>512</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(17)30115-1</pub-id>
<pub-id pub-id-type="pmid">28522181</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>K.</given-names></name><name><surname>Itoyama</surname><given-names>Y.</given-names></name><name><surname>Sobue</surname><given-names>G.</given-names></name><name><surname>Tsuji</surname><given-names>S.</given-names></name><name><surname>Aoki</surname><given-names>M.</given-names></name><name><surname>Doyu</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in Amyotrophic lateral sclerosis patients.</article-title>
<source/><italic>Amyotroph. Lateral Scler. Frontotemporal. Degener.</italic>
<volume>15</volume>
<fpage>610</fpage>–<lpage>617</lpage>. <pub-id pub-id-type="doi">10.3109/21678421.2014.959024</pub-id>
<pub-id pub-id-type="pmid">25286015</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acharya</surname><given-names>J. D.</given-names></name><name><surname>Ghaskadbi</surname><given-names>S. S.</given-names></name></person-group> (<year>2013</year>). <article-title>Protective effect of pterostilbene against free radical mediated oxidative damage.</article-title>
<source/><italic>BMC Complement. Altern. Med.</italic>
<volume>13</volume>:<issue>238</issue>. <pub-id pub-id-type="doi">10.1186/1472-6882-13-238</pub-id>
<pub-id pub-id-type="pmid">24070177</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agar</surname><given-names>J.</given-names></name><name><surname>Durham</surname><given-names>H.</given-names></name></person-group> (<year>2003</year>). <article-title>Relevance of oxidative injury in the pathogenesis of motor neuron diseases.</article-title>
<source/><italic>Amyotroph. Lateral Scler. Other Motor Neuron Disord.</italic>
<volume>4</volume>
<fpage>232</fpage>–<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1080/14660820310011278</pub-id>
<pub-id pub-id-type="pmid">14753657</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aherne</surname><given-names>S. A.</given-names></name><name><surname>O’Brien</surname><given-names>N. M.</given-names></name></person-group> (<year>2002</year>). <article-title>Dietary flavonols: chemistry, food content, and metabolism.</article-title>
<source/><italic>Nutrition</italic>
<volume>18</volume>
<fpage>75</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="pmid">11827770</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmadi</surname><given-names>M.</given-names></name><name><surname>Agah</surname><given-names>E.</given-names></name><name><surname>Nafissi</surname><given-names>S.</given-names></name><name><surname>Jaafari</surname><given-names>M. R.</given-names></name><name><surname>Harirchian</surname><given-names>M. H.</given-names></name><name><surname>Sarraf</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Safety and efficacy of nanocurcumin as add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a pilot randomized clinical trial.</article-title>
<source/><italic>Neurotherapeutics</italic>
<volume>15</volume>
<fpage>430</fpage>–<lpage>438</lpage>. <pub-id pub-id-type="doi">10.1007/s13311-018-0606-7</pub-id>
<pub-id pub-id-type="pmid">29352425</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahtoniemi</surname><given-names>T.</given-names></name><name><surname>Jaronen</surname><given-names>M.</given-names></name><name><surname>Keksa-Goldstein</surname><given-names>V.</given-names></name><name><surname>Goldsteins</surname><given-names>G.</given-names></name><name><surname>Koistiaho</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Mutant SOD1 from spinal cord of G93A rats is destabilized and binds to inner mitochondrial membrane.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>32</volume>
<fpage>479</fpage>–<lpage>485</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2008.08.010</pub-id>
<pub-id pub-id-type="pmid">18817872</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Airhart</surname><given-names>S. E.</given-names></name><name><surname>Shireman</surname><given-names>L. M.</given-names></name><name><surname>Risler</surname><given-names>L. J.</given-names></name><name><surname>Anderson</surname><given-names>G. D.</given-names></name><name><surname>Nagana-Gowda</surname><given-names>G. A.</given-names></name><name><surname>Raftery</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers.</article-title>
<source/><italic>PLoS One</italic>
<volume>12</volume>:<issue>e0186459</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0186459</pub-id>
<pub-id pub-id-type="pmid">29211728</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akinwumi</surname><given-names>B. C.</given-names></name><name><surname>Bordu</surname><given-names>K. A. M.</given-names></name><name><surname>Anderson</surname><given-names>H. D.</given-names></name></person-group> (<year>2018</year>). <article-title>Biological activities of stilbenoids.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>19</volume>:<issue>E792</issue>. <pub-id pub-id-type="doi">10.3390/ijms19030792</pub-id>
<pub-id pub-id-type="pmid">29522491</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albarracín</surname><given-names>S. L.</given-names></name><name><surname>Stab</surname><given-names>B.</given-names></name><name><surname>Casas</surname><given-names>Z.</given-names></name><name><surname>Sutachan</surname><given-names>J. J.</given-names></name><name><surname>Samudio</surname><given-names>I.</given-names></name><name><surname>González</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Effects of natural antioxidants in neurodegenerative diseases.</article-title>
<source/><italic>Nutr. Neurosci.</italic>
<volume>15</volume>
<fpage>1</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1179/1476830511Y.0000000028</pub-id>
<pub-id pub-id-type="pmid">22305647</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albassam</surname><given-names>A. A.</given-names></name><name><surname>Frye</surname><given-names>R. F.</given-names></name></person-group> (<year>2019</year>). <article-title>Effect os pterostilbene on <italic>in vitro</italic> drug metabolizing enzyme activity.</article-title>
<source/><italic>Saudi Pharm. J.</italic>
<volume>27</volume>
<fpage>406</fpage>–<lpage>412</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsps.2019.01.001</pub-id>
<pub-id pub-id-type="pmid">30976185</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Chalabi</surname><given-names>A.</given-names></name><name><surname>Hardiman</surname><given-names>O.</given-names></name></person-group> (<year>2013</year>). <article-title>The epidemiology of ALS: a conspiracy of genes, environment and time.</article-title>
<source/><italic>Nat. Rev. Neurol.</italic>
<volume>9</volume>
<fpage>617</fpage>–<lpage>628</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2013.203</pub-id>
<pub-id pub-id-type="pmid">24126629</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Chalabi</surname><given-names>A.</given-names></name><name><surname>Kwak</surname><given-names>S.</given-names></name><name><surname>Mehler</surname><given-names>M.</given-names></name><name><surname>Rouleau</surname><given-names>G.</given-names></name><name><surname>Siddique</surname><given-names>T.</given-names></name><name><surname>Strong</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Genetic and epigenetic studies of amyotrophic lateral sclerosis.</article-title>
<source/><italic>Amyotroph. Lateral Scler. Frontotemporal. Degener.</italic>
<volume>14</volume>
<fpage>44</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.3109/21678421.2013.778571</pub-id>
<pub-id pub-id-type="pmid">23678879</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Gubory</surname><given-names>K. H.</given-names></name><name><surname>Garrel</surname><given-names>C.</given-names></name><name><surname>Faure</surname><given-names>P.</given-names></name><name><surname>Sugino</surname><given-names>N.</given-names></name></person-group> (<year>2012</year>). <article-title>Roles of antioxidant enzymes in corpus luteum rescue from reactive oxygen species-induced oxidative stress.</article-title>
<source/><italic>Reprod. Biomed.</italic>
<volume>25</volume>
<fpage>551</fpage>–<lpage>560</lpage>. <pub-id pub-id-type="doi">10.1016/j.rbmo.2012.08.004</pub-id>
<pub-id pub-id-type="pmid">23063822</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>C. L.</given-names></name><name><surname>Bayraktunan</surname><given-names>U.</given-names></name></person-group> (<year>2009</year>). <article-title>Oxidative stress and its role in the pathogenesis of ischaemic stroke.</article-title>
<source/><italic>Int. J. Stroke</italic>
<volume>4</volume>
<fpage>461</fpage>–<lpage>470</lpage>. <pub-id pub-id-type="doi">10.1111/j.1747-4949.2009.00387.x</pub-id>
<pub-id pub-id-type="pmid">19930058</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alquilano</surname><given-names>K.</given-names></name><name><surname>Baldelli</surname><given-names>S.</given-names></name><name><surname>Paglieli</surname><given-names>B.</given-names></name><name><surname>Ciriolo</surname><given-names>M. R.</given-names></name></person-group> (<year>2013</year>). <article-title>Extranuclear localization of SIRT1 and PGC-1α: an insight into possible roles in diseases associated with mitochondrial dysfunction.</article-title>
<source/><italic>Curr. Mol. Med.</italic>
<volume>13</volume>
<fpage>140</fpage>–<lpage>154</lpage>. <pub-id pub-id-type="pmid">22834844</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aman</surname><given-names>Y.</given-names></name><name><surname>Qiu</surname><given-names>Y.</given-names></name><name><surname>Tao</surname><given-names>J.</given-names></name><name><surname>Fang</surname><given-names>E. F.</given-names></name></person-group> (<year>2018</year>). <article-title>Therapeutic potential of boosting NAD+ in aging and age-related diseases.</article-title>
<source/><italic>Transl. Med. Aging</italic>
<volume>2</volume>
<fpage>30</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/j.tma.2018.08.003</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>P. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene.</article-title>
<source/><italic>Curr. Neurol. Neurosci. Rep.</italic>
<volume>6</volume>
<fpage>37</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="pmid">16469270</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>P. M.</given-names></name><name><surname>Al-Chalabi</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Clinical genetics of amyotrophic lateral sclerosis: what do we really know?</article-title>
<source/><italic>Nat. Rev. Neurol.</italic>
<volume>7</volume>
<fpage>603</fpage>–<lpage>615</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2011.150</pub-id>
<pub-id pub-id-type="pmid">21989245</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angelova</surname><given-names>P. R.</given-names></name><name><surname>Abramov</surname><given-names>A. Y.</given-names></name></person-group> (<year>2018</year>). <article-title>Role of mitochondrial ROS in the brain: from physiology to neurodegeneration.</article-title>
<source/><italic>FEBS. Lett.</italic>
<volume>592</volume>
<fpage>692</fpage>–<lpage>702</lpage>. <pub-id pub-id-type="doi">10.1002/1873-3468.12964</pub-id>
<pub-id pub-id-type="pmid">29292494</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>An-Na</surname><given-names>L.</given-names></name><name><surname>Sha</surname><given-names>L.</given-names></name><name><surname>Yu-Jie</surname><given-names>Z.</given-names></name><name><surname>Xiang-Rong</surname><given-names>X.</given-names></name><name><surname>Yu-Ming</surname><given-names>C.</given-names></name><name><surname>Hua-Bin</surname><given-names>L.</given-names></name></person-group> (<year>2014</year>). <article-title>Resources and biological activities of natural polyphenols.</article-title>
<source/><italic>Nutrients</italic>
<volume>6</volume>
<fpage>6020</fpage>–<lpage>6047</lpage>. <pub-id pub-id-type="doi">10.3390/nu6126020</pub-id>
<pub-id pub-id-type="pmid">25533011</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araki</surname><given-names>T.</given-names></name><name><surname>Sasaki</surname><given-names>Y.</given-names></name><name><surname>Milbrandt</surname><given-names>T.</given-names></name></person-group> (<year>2004</year>). <article-title>Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration.</article-title>
<source/><italic>Science</italic>
<volume>305</volume>
<fpage>1010</fpage>–<lpage>1013</lpage>. <pub-id pub-id-type="doi">10.1126/science.1098014</pub-id>
<pub-id pub-id-type="pmid">15310905</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arun</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Donmez</surname><given-names>G.</given-names></name></person-group> (<year>2016</year>). <article-title>Mitochondrial biology and neurological diseases.</article-title>
<source/><italic>Curr. Neuropharmacol.</italic>
<volume>14</volume>
<fpage>143</fpage>–<lpage>154</lpage>.<pub-id pub-id-type="pmid">26903445</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ascherio</surname><given-names>A.</given-names></name><name><surname>Weisskopf</surname><given-names>M. G.</given-names></name><name><surname>O’reilly</surname><given-names>E. J.</given-names></name><name><surname>Jacobs</surname><given-names>E. J.</given-names></name><name><surname>McCullough</surname><given-names>M. L.</given-names></name><name><surname>Calle</surname><given-names>E. E.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Vitamin E intake and risk of amyotrophic lateral sclerosis.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>57</volume>
<fpage>104</fpage>–<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1002/ana.20316</pub-id>
<pub-id pub-id-type="pmid">15529299</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atashi</surname><given-names>F.</given-names></name><name><surname>Modarressi</surname><given-names>A.</given-names></name><name><surname>Pepper</surname><given-names>M. S.</given-names></name></person-group> (<year>2015</year>). <article-title>The role of reactive oxygen species in mesenchymal stem cell adipogenic and osteogenic di?erentiation: a review.</article-title>
<source/><italic>Stem Cells Dev.</italic>
<volume>24</volume>
<fpage>1150</fpage>–<lpage>1163</lpage>. <pub-id pub-id-type="doi">10.1089/scd.2014.0484</pub-id>
<pub-id pub-id-type="pmid">25603196</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayala</surname><given-names>A.</given-names></name><name><surname>Muñoz</surname><given-names>M. F.</given-names></name><name><surname>Argüelles</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-Hydroxy-2 nonenal.</article-title>
<source/><italic>Oxid. Med. Cell. Longev.</italic>
<volume>2014</volume>:<issue>360438</issue>. <pub-id pub-id-type="doi">10.1155/2014/360438</pub-id>
<pub-id pub-id-type="pmid">24999379</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babu</surname><given-names>G. N.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Chandra</surname><given-names>R.</given-names></name><name><surname>Puri</surname><given-names>S. K.</given-names></name><name><surname>Singh</surname><given-names>R. L.</given-names></name><name><surname>Kalita</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Oxidant-antioxidant imbalance in the erythrocytes of sporadic amyotrophic lateral sclerosis patients correlates with the progression of disease.</article-title>
<source/><italic>Neurochem. Int.</italic>
<volume>52</volume>
<fpage>1284</fpage>–<lpage>1289</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2008.01.009</pub-id>
<pub-id pub-id-type="pmid">18308427</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailly</surname><given-names>C.</given-names></name></person-group> (<year>2019</year>). <article-title>Potential use of edaravone to reduce specific side effects of chemo-, radio- and immuno-therapy of cancers.</article-title>
<source/><italic>Int. Immunopharmacol.</italic>
<volume>77</volume>:<issue>105967</issue>. <pub-id pub-id-type="doi">10.1016/j.intimp.2019.105967</pub-id>
<pub-id pub-id-type="pmid">31670091</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balaban</surname><given-names>R. S.</given-names></name><name><surname>Nemoto</surname><given-names>S.</given-names></name><name><surname>Finkel</surname><given-names>T.</given-names></name></person-group> (<year>2005</year>). <article-title>Mitochondria, oxidants and aging.</article-title>
<source/><italic>Cell</italic>
<volume>120</volume>
<fpage>483</fpage>–<lpage>495</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2005.02.001</pub-id>
<pub-id pub-id-type="pmid">15734681</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banno</surname><given-names>M.</given-names></name><name><surname>Mizuno</surname><given-names>T.</given-names></name><name><surname>Kato</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Kawanokuchi</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>The radical scavenger edaravone prevents oxidative neurotoxicity induced by peroxynitrite and activated microglia.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>48</volume>
<fpage>283</fpage>–<lpage>290</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2004.10.002</pub-id>
<pub-id pub-id-type="pmid">15695167</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bao</surname><given-names>A. M.</given-names></name><name><surname>Swaab</surname><given-names>D. F.</given-names></name></person-group> (<year>2018</year>). <article-title>The art of matching brain tissue from patients and controls for postmortem research.</article-title>
<source/><italic>Handb. Clin. Neurol.</italic>
<volume>150</volume>
<fpage>197</fpage>–<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-444-63639-3.00015-3</pub-id>
<pub-id pub-id-type="pmid">29496142</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barber</surname><given-names>S. C.</given-names></name><name><surname>Shaw</surname><given-names>P. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Oxidative stress in ALS: key role in motor neuron injury and therpaeutic target.</article-title>
<source/><italic>Free Radic. Biol. Med.</italic>
<volume>48</volume>
<fpage>629</fpage>–<lpage>641</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2009.11.018</pub-id>
<pub-id pub-id-type="pmid">19969067</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bäumer</surname><given-names>D.</given-names></name><name><surname>Talbot</surname><given-names>K.</given-names></name><name><surname>Turner</surname><given-names>M. R.</given-names></name></person-group> (<year>2014</year>). <article-title>Advances in motor neuron disease.</article-title>
<source/><italic>J. R. Soc. Med.</italic>
<volume>107</volume>
<fpage>14</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1177/0141076813511451</pub-id>
<pub-id pub-id-type="pmid">24399773</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bayer</surname><given-names>H.</given-names></name><name><surname>Lang</surname><given-names>K.</given-names></name><name><surname>Buck</surname><given-names>E.</given-names></name><name><surname>Higelin</surname><given-names>J.</given-names></name><name><surname>Barteczko</surname><given-names>L.</given-names></name><name><surname>Pasquarelli</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissues.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>97</volume>(<issue>Pt A</issue>), <fpage>36</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2016.11.001</pub-id>
<pub-id pub-id-type="pmid">27818323</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beal</surname><given-names>M. F.</given-names></name></person-group> (<year>2002</year>). <article-title>Oxidatively modified protein in aging and disease.</article-title>
<source/><italic>Free Radic. Biol. Med.</italic>
<volume>32</volume>
<fpage>797</fpage>–<lpage>803</lpage>.<pub-id pub-id-type="pmid">11978481</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beal</surname><given-names>M. F.</given-names></name><name><surname>Lang</surname><given-names>A. E.</given-names></name><name><surname>Ludolph</surname><given-names>A.</given-names></name></person-group> (<year>2005</year>). <article-title>Neurodegenerative diseases: neurobiology, pathogenesis, and therapeutics.</article-title>
<source/><italic>J. Neurol. Neurosurg. Psychiatry</italic>
<volume>77</volume>:<issue>284</issue>
<pub-id pub-id-type="doi">10.1136/jnnp.2005.072710</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bedlack</surname><given-names>R. S.</given-names></name><name><surname>Joyce</surname><given-names>N.</given-names></name><name><surname>Carter</surname><given-names>G. T.</given-names></name><name><surname>Pagononi</surname><given-names>S.</given-names></name><name><surname>Karam</surname><given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>Complementary and alternative therapies in ALS.</article-title>
<source/><italic>Neurol. Clin.</italic>
<volume>33</volume>
<fpage>909</fpage>–<lpage>936</lpage>. <pub-id pub-id-type="doi">10.1016/j.ncl.2015.07.008</pub-id>
<pub-id pub-id-type="pmid">26515629</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belenky</surname><given-names>P.</given-names></name><name><surname>Racette</surname><given-names>F. G.</given-names></name><name><surname>Bogan</surname><given-names>K. L.</given-names></name><name><surname>McClure</surname><given-names>J. M.</given-names></name><name><surname>Smith</surname><given-names>J. S.</given-names></name><name><surname>Brenner</surname><given-names>C.</given-names></name></person-group> (<year>2007</year>). <article-title>Nicotinamide riboside promotes Sir2 silencing and extends lifespan via Nrk and Urh1/Pnp1/Meu1 pathways to NAD+.</article-title>
<source/><italic>Cell</italic>
<volume>129</volume>
<fpage>473</fpage>–<lpage>484</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2007.03.024</pub-id>
<pub-id pub-id-type="pmid">17482543</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bendotti</surname><given-names>C.</given-names></name><name><surname>Tortarolo</surname><given-names>M.</given-names></name><name><surname>Suchak</surname><given-names>S. K.</given-names></name><name><surname>Calvaresi</surname><given-names>N.</given-names></name><name><surname>Carvelli</surname><given-names>L.</given-names></name><name><surname>Bastone</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>79</volume>
<fpage>737</fpage>–<lpage>746</lpage>. <pub-id pub-id-type="pmid">11723166</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>G. J.</given-names></name><name><surname>Doyle</surname><given-names>T.</given-names></name><name><surname>Salvemini</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>Mitotoxicity in distal symmetrical sensory peripheral neuropathies.</article-title>
<source/><italic>Nat. Rev. Neurol.</italic>
<volume>10</volume>
<fpage>326</fpage>–<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2014.77</pub-id>
<pub-id pub-id-type="pmid">24840972</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berger</surname><given-names>F.</given-names></name><name><surname>Ramírez-Hernández</surname><given-names>M. H.</given-names></name><name><surname>Ziegler</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>The new life of a centenarian: signalling functions of NAD(P).</article-title>
<source/><italic>Trends Biochem. Sci.</italic>
<volume>29</volume>
<fpage>111</fpage>–<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibs.2004.01.007</pub-id>
<pub-id pub-id-type="pmid">15003268</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhakkiyalakshmi</surname><given-names>E.</given-names></name><name><surname>Dineshkumar</surname><given-names>K.</given-names></name><name><surname>Karthik</surname><given-names>S.</given-names></name><name><surname>Sireesh</surname><given-names>D.</given-names></name><name><surname>Hopper</surname><given-names>W.</given-names></name><name><surname>Paulmurugan</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Pterostilbene-mediated Nrf2 activation: mechanistic insights on Keap1: Nrf2 interface.</article-title>
<source/><italic>Bioorg. Med. Chem.</italic>
<volume>24</volume>
<fpage>3378</fpage>–<lpage>3386</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmc.2016.05.011</pub-id>
<pub-id pub-id-type="pmid">27312421</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhat</surname><given-names>A. H.</given-names></name><name><surname>Dar</surname><given-names>K. B.</given-names></name><name><surname>Anees</surname><given-names>S.</given-names></name><name><surname>Zargar</surname><given-names>M. A.</given-names></name><name><surname>Masood</surname><given-names>A.</given-names></name><name><surname>Sofi</surname><given-names>M. A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Oxidative stress, mitocondrial dysfunction and neurodegenerative diseases; a mechanistic insight.</article-title>
<source/><italic>Biomed. Pharmacother.</italic>
<volume>74</volume>
<fpage>101</fpage>–<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2015.07.025</pub-id>
<pub-id pub-id-type="pmid">26349970</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhatia</surname><given-names>N. K.</given-names></name><name><surname>Srivastava</surname><given-names>A.</given-names></name><name><surname>Katyal</surname><given-names>N.</given-names></name><name><surname>Jain</surname><given-names>N.</given-names></name><name><surname>Khan</surname><given-names>M. A.</given-names></name><name><surname>Kundu</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Curcumin binds to the pre-fibrillar aggregates of Cu/Zn superoxide dismutase (SOD1) and alters its amyloidogenic pathway resulting in reduced cytotoxicity.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1854</volume>
<fpage>426</fpage>–<lpage>436</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbapap.2015.01.014</pub-id>
<pub-id pub-id-type="pmid">25666897</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>R.</given-names></name><name><surname>Harvey</surname><given-names>R. A.</given-names></name><name><surname>Abraham</surname><given-names>K.</given-names></name><name><surname>Rosen</surname><given-names>J.</given-names></name><name><surname>Mehta</surname><given-names>P.</given-names></name></person-group> (<year>2019</year>). <article-title>Amyotrophic lateral sclerosis among patients with a Medicare Advantage prescription drug plan; prevalence, survival and patient characteristics.</article-title>
<source/><italic>Amyotroph. Lateral Scler. Frontotemporal. Degener.</italic>
<volume>20</volume>
<fpage>1</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1080/21678421.2019.1582674</pub-id>
<pub-id pub-id-type="pmid">30892090</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhullar</surname><given-names>K. S.</given-names></name><name><surname>Vasantha</surname><given-names>H. P.</given-names></name></person-group> (<year>2013</year>). <article-title>Polyphenols: multipotent therapeutic agents in neurodegenerative diseases.</article-title>
<source/><italic>Oxid. Med. Cell. Longev.</italic>
<volume>2013</volume>:<issue>891748</issue>. <pub-id pub-id-type="doi">10.1155/2013/891748</pub-id>
<pub-id pub-id-type="pmid">23840922</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bieganowski</surname><given-names>P.</given-names></name><name><surname>Brenner</surname><given-names>C.</given-names></name></person-group> (<year>2004</year>). <article-title>Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans.</article-title>
<source/><italic>Cell</italic>
<volume>117</volume>
<fpage>495</fpage>–<lpage>502</lpage>. <pub-id pub-id-type="pmid">15137942</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blasco</surname><given-names>H.</given-names></name><name><surname>Garcon</surname><given-names>G.</given-names></name><name><surname>Patin</surname><given-names>F.</given-names></name><name><surname>Veyrat-Durebex</surname><given-names>C.</given-names></name><name><surname>Boyer</surname><given-names>J.</given-names></name><name><surname>Devos</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Panel of oxidative stress and inflammatory biomarkers in ALS: a pilot study.</article-title>
<source/><italic>Can. J. Neurol. Sci.</italic>
<volume>44</volume>
<fpage>90</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1017/cjn.2016.284</pub-id>
<pub-id pub-id-type="pmid">27774920</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blokhuis</surname><given-names>A. M.</given-names></name><name><surname>Groen</surname><given-names>E. J. N.</given-names></name><name><surname>Koppers</surname><given-names>M.</given-names></name><name><surname>Van Den Berg</surname><given-names>L.-H.</given-names></name><name><surname>Pasterkamp</surname><given-names>R. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Protein aggregation in amyotrophic lateral sclerosis.</article-title>
<source/><italic>Acta Neuropathol.</italic>
<volume>125</volume>
<fpage>777</fpage>–<lpage>794</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-013-1125-6</pub-id>
<pub-id pub-id-type="pmid">23673820</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bogan</surname><given-names>K. L.</given-names></name><name><surname>Brenner</surname><given-names>C.</given-names></name></person-group> (<year>2008</year>). <article-title>Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition.</article-title>
<source/><italic>Annu. Rev. Nutr.</italic>
<volume>28</volume>
<fpage>115</fpage>–<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.nutr.28.061807.155443</pub-id>
<pub-id pub-id-type="pmid">18429699</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bond</surname><given-names>L.</given-names></name><name><surname>Bernhardt</surname><given-names>K.</given-names></name><name><surname>Madria</surname><given-names>P.</given-names></name><name><surname>Sorrentino</surname><given-names>K.</given-names></name><name><surname>Scelsi</surname><given-names>H.</given-names></name><name><surname>Mitchell</surname><given-names>C. S.</given-names></name></person-group> (<year>2018</year>). <article-title>A metadata analysis of oxidative stress etiology in preclinical amyotrophic lateral sclerosis: benefits of antioxidant therapy.</article-title>
<source/><italic>Front. Neurosci.</italic>
<volume>12</volume>:<issue>10</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2018.00010</pub-id>
<pub-id pub-id-type="pmid">29416499</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonkowski</surname><given-names>M. S.</given-names></name><name><surname>Sinclair</surname><given-names>D. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Slowing ageing by design: the rise of NAD+ and sirtuin-activation compounds.</article-title>
<source/><italic>Nat. Rev. Mol. Cell Biol.</italic>
<volume>17</volume>
<fpage>679</fpage>–<lpage>690</lpage>. <pub-id pub-id-type="doi">10.1038/nrm.2016.93</pub-id>
<pub-id pub-id-type="pmid">27552971</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonnefont-Rousselot</surname><given-names>D.</given-names></name></person-group> (<year>2016</year>). <article-title>Resveratrol and cardiovascular diseases.</article-title>
<source/><italic>Nutrients</italic>
<volume>8</volume>:<issue>E250</issue>. <pub-id pub-id-type="doi">10.3390/nu8050250</pub-id>
<pub-id pub-id-type="pmid">27144581</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozzo</surname><given-names>F.</given-names></name><name><surname>Mirra</surname><given-names>A.</given-names></name><name><surname>Carrì</surname><given-names>M. T.</given-names></name></person-group> (<year>2016</year>). <article-title>Oxidative stress and mitochondrial damage in the pathogenesis of ALS: new perspectives.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>636</volume>
<fpage>3</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2016.04.065</pub-id>
<pub-id pub-id-type="pmid">27150074</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braidy</surname><given-names>N.</given-names></name><name><surname>Guillemin</surname><given-names>G.</given-names></name><name><surname>Grant</surname><given-names>R.</given-names></name></person-group> (<year>2008</year>). <article-title>Promotion of cellular NAD(+) anabolism: therapeutic potential for oxidative stress in ageing and Alzheimer’s disease.</article-title>
<source/><italic>Neurotox. Res.</italic>
<volume>13</volume>
<fpage>173</fpage>–<lpage>184</lpage>.<pub-id pub-id-type="pmid">18522897</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brieger</surname><given-names>K.</given-names></name><name><surname>Schiavone</surname><given-names>S.</given-names></name><name><surname>Miller</surname><given-names>F. J.</given-names></name><name><surname>Krause</surname><given-names>K. H.</given-names></name></person-group> (<year>2012</year>). <article-title>Reactive oxygen species: from health to disease.</article-title>
<source/><italic>Swiss Med. Wkly</italic>.
<volume>142</volume>:<issue>w13659</issue>. <pub-id pub-id-type="doi">10.4414/smw.2012.13659</pub-id>
<pub-id pub-id-type="pmid">22903797</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brookes</surname><given-names>P. S.</given-names></name><name><surname>Yoon</surname><given-names>Y.</given-names></name><name><surname>Robotham</surname><given-names>J. L.</given-names></name><name><surname>Anders</surname><given-names>M. W.</given-names></name><name><surname>Sheu</surname><given-names>S. S.</given-names></name></person-group> (<year>2004</year>). <article-title>Calcium, ATP and ROS. A mitochondrial love-hate triangle.</article-title>
<source/><italic>Am. J. Physiol. Cell Physiol.</italic>
<volume>287</volume>
<fpage>C817</fpage>–<lpage>C833</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00139.2004</pub-id>
<pub-id pub-id-type="pmid">15355853</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>K. D.</given-names></name><name><surname>Maqsood</surname><given-names>S.</given-names></name><name><surname>Huang</surname><given-names>J. Y.</given-names></name><name><surname>Pan</surname><given-names>Y.</given-names></name><name><surname>Harkcom</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Activation of SIRT3 by the NAD+ precursor nicotinamide riboside protects from noise-induced hearing loss.</article-title>
<source/><italic>Cell Metab.</italic>
<volume>20</volume>
<fpage>1059</fpage>–<lpage>1068</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2014.11.003</pub-id>
<pub-id pub-id-type="pmid">25470550</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>R. H.</given-names></name><name><surname>Al-Chalabi</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Amyotrophic lateral sclerosis.</article-title>
<source/><italic>N. Engl. J. Med.</italic>
<volume>377</volume>
<fpage>162</fpage>–<lpage>172</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra1603471</pub-id>
<pub-id pub-id-type="pmid">28700839</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brujin</surname><given-names>L. I.</given-names></name><name><surname>Miller</surname><given-names>T. M.</given-names></name><name><surname>Cleveland</surname><given-names>D. W.</given-names></name></person-group> (<year>2004</year>). <article-title>Unraveling the mechanism involved in motor neuron degeneration in ALS.</article-title>
<source/><italic>Annu. Rev. Neurosci.</italic>
<volume>27</volume>
<fpage>723</fpage>–<lpage>749</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.neuro.27.070203.144244</pub-id>
<pub-id pub-id-type="pmid">15217349</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buck</surname><given-names>E.</given-names></name><name><surname>Bayer</surname><given-names>H.</given-names></name><name><surname>Lindenberg</surname><given-names>K. S.</given-names></name><name><surname>Hanselmann</surname><given-names>J.</given-names></name><name><surname>Pasquarelli</surname><given-names>N.</given-names></name><name><surname>Ludolph</surname><given-names>A. C.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Comparison of sirtuin 3 levels in ALS and Huntington’s disease-differential effects in human tissue samples vs. transgenic mouse models.</article-title>
<source/><italic>Front. Mol. Neurosci.</italic>
<volume>10</volume>:<issue>156</issue>. <pub-id pub-id-type="doi">10.3389/fnmol.2017.00156</pub-id>
<pub-id pub-id-type="pmid">28603486</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulotta</surname><given-names>S.</given-names></name><name><surname>Celano</surname><given-names>M.</given-names></name><name><surname>Lepore</surname><given-names>S. M.</given-names></name><name><surname>Montalcini</surname><given-names>T.</given-names></name><name><surname>Pujia</surname><given-names>A.</given-names></name><name><surname>Russo</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>Beneficial effects of olive oil phenolic components oleuropein and hydroxytirosol: focus on protection against cardiovascular and metabolic diseases.</article-title>
<source/><italic>J. Transl. Med.</italic>
<volume>12</volume>:<issue>219</issue>. <pub-id pub-id-type="doi">10.1186/s12967-014-0219-9</pub-id>
<pub-id pub-id-type="pmid">25086598</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burgos</surname><given-names>E. S.</given-names></name><name><surname>Vetticatt</surname><given-names>M. J.</given-names></name><name><surname>Schramm</surname><given-names>V. L.</given-names></name></person-group> (<year>2013</year>). <article-title>Recycling nicotinamide. The transition-state structure of human nicotinamide phosphoribosyltransferase.</article-title>
<source/><italic>J. Am. Chem. Soc.</italic>
<volume>135</volume>
<fpage>3485</fpage>–<lpage>3493</lpage>. <pub-id pub-id-type="doi">10.1021/ja310180c</pub-id>
<pub-id pub-id-type="pmid">23373462</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butterfield</surname><given-names>D. A.</given-names></name><name><surname>Castegna</surname><given-names>A.</given-names></name><name><surname>Drake</surname><given-names>J.</given-names></name><name><surname>Scapagnini</surname><given-names>G.</given-names></name><name><surname>Calabrese</surname><given-names>V.</given-names></name></person-group> (<year>2002</year>). <article-title>Vitamin E and neurodegenerative disorders associated with oxidative stress.</article-title>
<source/><italic>Nutr. Neurosci.</italic>
<volume>5</volume>
<fpage>229</fpage>–<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1080/10284150290028954</pub-id>
<pub-id pub-id-type="pmid">12168685</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camandola</surname><given-names>S.</given-names></name><name><surname>Mattson</surname><given-names>M. P.</given-names></name></person-group> (<year>2011</year>). <article-title>Aberrant subcellular neuronal calcium regulation in aging and Alzheimer’s disease.</article-title>
<source/><italic>Biochim. Biophys. Acta.</italic>
<volume>1813</volume>
<fpage>965</fpage>–<lpage>973</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2010.10.005</pub-id>
<pub-id pub-id-type="pmid">20950656</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cantó</surname><given-names>C.</given-names></name><name><surname>Houtkooper</surname><given-names>R. H.</given-names></name><name><surname>Pirinen</surname><given-names>E.</given-names></name><name><surname>Youn</surname><given-names>D. Y.</given-names></name><name><surname>Oosterveer</surname><given-names>M. H.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>The NAD+ precursor nicotinamide riboside enhances oxidative metabolism and protects against high fat diet-induced obesity.</article-title>
<source/><italic>Cell Metab.</italic>
<volume>15</volume>
<fpage>838</fpage>–<lpage>847</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2012.04.022</pub-id>
<pub-id pub-id-type="pmid">22682224</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cantó</surname><given-names>C.</given-names></name><name><surname>Menzies</surname><given-names>K. J.</given-names></name><name><surname>Auwers</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>NAD(+) metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus.</article-title>
<source/><italic>Cell Metab.</italic>
<volume>22</volume>
<fpage>31</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2015.05.023</pub-id>
<pub-id pub-id-type="pmid">26118927</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>G.</given-names></name><name><surname>Sofic</surname><given-names>E.</given-names></name><name><surname>Prior</surname><given-names>R. L.</given-names></name></person-group> (<year>1997</year>). <article-title>Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships.</article-title>
<source/><italic>Free Radic. Biol. Med.</italic>
<volume>22</volume>
<fpage>749</fpage>–<lpage>760</lpage>. <pub-id pub-id-type="pmid">9119242</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carey</surname><given-names>A. N.</given-names></name><name><surname>Fisher</surname><given-names>D. R.</given-names></name><name><surname>Rimando</surname><given-names>A. M.</given-names></name><name><surname>Gomes</surname><given-names>S. M.</given-names></name><name><surname>Bielinski</surname><given-names>D. F.</given-names></name><name><surname>Shukitt-Hale</surname><given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>Stilbenes and anthocyanins reduce stress signaling in BV-2 mouse microglia.</article-title>
<source/><italic>J. Agric. Food. Chem.</italic>
<volume>61</volume>
<fpage>5979</fpage>–<lpage>5986</lpage>. <pub-id pub-id-type="doi">10.1021/jf400342g</pub-id>
<pub-id pub-id-type="pmid">23731018</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrì</surname><given-names>M. T.</given-names></name><name><surname>Valle</surname><given-names>C.</given-names></name><name><surname>Bozzo</surname><given-names>F.</given-names></name><name><surname>Cozzolino</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Oxidative stress and mitochondrial damage: importance in non-SOD1 ALS.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>9</volume>:<issue>41</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2015.00041</pub-id>
<pub-id pub-id-type="pmid">25741238</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>C.</given-names></name><name><surname>Moreira</surname><given-names>P. I.</given-names></name></person-group> (<year>2018</year>). <article-title>Oxidative stress: a major player in cerebrovascular alterations associated to neurodegenerative events.</article-title>
<source/><italic>Front. Physiol.</italic>
<volume>9</volume>:<issue>806</issue>. <pub-id pub-id-type="doi">10.3389/fphys.2018.00806</pub-id>
<pub-id pub-id-type="pmid">30018565</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>J. C. T.</given-names></name><name><surname>Fernandes</surname><given-names>C. P.</given-names></name><name><surname>Daleprane</surname><given-names>J. B.</given-names></name><name><surname>Alves</surname><given-names>M. S.</given-names></name><name><surname>Stien</surname><given-names>D.</given-names></name><name><surname>Dhammika</surname><given-names>N. P.</given-names></name></person-group> (<year>2018</year>). <article-title>Role of natural antioxidants from functional foods in neurodegenerative and metabolic disorders.</article-title>
<source/><italic>Oxid. Med. Cell. Longev.</italic>
<volume>2018</volume>:<issue>1459753</issue>. <pub-id pub-id-type="doi">10.1155/2018/1459753</pub-id>
<pub-id pub-id-type="pmid">30405873</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castellani</surname><given-names>R. J.</given-names></name><name><surname>Lee</surname><given-names>H. G.</given-names></name><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Perry</surname><given-names>G.</given-names></name><name><surname>Smith</surname><given-names>M. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Alzheimer diseases pathology as a host response.</article-title>
<source/><italic>J. Neurpathol. Exp. Neurol.</italic>
<volume>67</volume>
<fpage>523</fpage>–<lpage>531</lpage>. <pub-id pub-id-type="doi">10.1097/NEN.0b013e318177eaf4</pub-id>
<pub-id pub-id-type="pmid">18520771</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandrasekaran</surname><given-names>A.</given-names></name><name><surname>Idelchik</surname><given-names>M. D. P. S.</given-names></name><name><surname>Melendez</surname><given-names>J. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Redox control of senescence and age-related disease.</article-title>
<source/><italic>Redox. Biol.</italic>
<volume>11</volume>
<fpage>91</fpage>–<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1016/j.redox.2016.11.005</pub-id>
<pub-id pub-id-type="pmid">27889642</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>H. C.</given-names></name><name><surname>Guarente</surname><given-names>L.</given-names></name></person-group> (<year>2013</year>). <article-title>SIRT1 mediates central circadian control in the SCN by a mechanism that decays with aging.</article-title>
<source/><italic>Cell</italic>
<volume>153</volume>
<fpage>1448</fpage>–<lpage>1460</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.05.027</pub-id>
<pub-id pub-id-type="pmid">23791176</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>J.</given-names></name><name><surname>Rimando</surname><given-names>A.</given-names></name><name><surname>Pallas</surname><given-names>M.</given-names></name><name><surname>Camins</surname><given-names>A.</given-names></name><name><surname>Porquet</surname><given-names>D.</given-names></name><name><surname>Reeves</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Low-dose perostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer’s disease.</article-title>
<source/><italic>Neurobiol. Aging</italic>
<volume>33</volume>
<fpage>2062</fpage>–<lpage>2071</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2011.08.015</pub-id>
<pub-id pub-id-type="pmid">21982274</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>Y.</given-names></name><name><surname>Kong</surname><given-names>Q.</given-names></name><name><surname>Shan</surname><given-names>X.</given-names></name><name><surname>Tian</surname><given-names>G.</given-names></name><name><surname>Ilievea</surname><given-names>H.</given-names></name><name><surname>Cleveland</surname><given-names>D. W.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Messenger RNA oxidation occurs early in disease pathogenesis and promotes motor neuron degeneration in ALS.</article-title>
<source/><italic>PLoS One</italic>
<volume>3</volume>:<issue>e2849</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0002849</pub-id>
<pub-id pub-id-type="pmid">18682740</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Xiao</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name></person-group> (<year>2018</year>). <article-title>Reactive oxygen species: key regulators in vascular health and diseases.</article-title>
<source/><italic>Br. J. Pharmacol.</italic>
<volume>175</volume>
<fpage>1279</fpage>–<lpage>1292</lpage>. <pub-id pub-id-type="doi">10.1111/bph.13828</pub-id>
<pub-id pub-id-type="pmid">28430357</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Sayana</surname><given-names>P.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Le</surname><given-names>W.</given-names></name></person-group> (<year>2013</year>). <article-title>Genetics of amyotrophic lateral sclerosis: an update.</article-title>
<source/><italic>Mol. Neurodegener.</italic>
<volume>8</volume>:<issue>28</issue>. <pub-id pub-id-type="doi">10.1186/1750-1326-8-28</pub-id>
<pub-id pub-id-type="pmid">23941283</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Lin</surname><given-names>Y.</given-names></name><name><surname>Lei</surname><given-names>Q.</given-names></name><name><surname>Guan</surname><given-names>K. L.</given-names></name><name><surname>Zhao</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS.</article-title>
<source/><italic>EMBO Rep.</italic>
<volume>12</volume>
<fpage>534</fpage>–<lpage>541</lpage>. <pub-id pub-id-type="doi">10.1038/embor.2011.65</pub-id>
<pub-id pub-id-type="pmid">21566644</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>Y.</given-names></name><name><surname>Di</surname><given-names>S.</given-names></name><name><surname>Fan</surname><given-names>C.</given-names></name><name><surname>Cai</surname><given-names>L.</given-names></name><name><surname>Gao</surname><given-names>C.</given-names></name><name><surname>Jiang</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>SIRT1 activation by pterostilbene attenuates the skeletal muscle oxidative stress injury and mitochondrial dysfunction induced by ischemia reperfusion injury.</article-title>
<source/><italic>Apoptosis</italic>
<volume>21</volume>
<fpage>905</fpage>–<lpage>916</lpage>. <pub-id pub-id-type="doi">10.1007/s10495-016-1258-x</pub-id>
<pub-id pub-id-type="pmid">27270300</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chi</surname><given-names>Y.</given-names></name><name><surname>Sauve</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Nicotinamide riboside, a trace nutrient in foods, is a Vitamina B3 with effects on energy metabolism and neuroprotection.</article-title>
<source/><italic>Curr. Opin. Clin. Nutr. Metab. Care</italic>
<volume>16</volume>
<fpage>657</fpage>–<lpage>661</lpage>. <pub-id pub-id-type="doi">10.1097/MCO.0b013e32836510c0</pub-id>
<pub-id pub-id-type="pmid">24071780</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chico</surname><given-names>L.</given-names></name><name><surname>Lenco</surname><given-names>E. C.</given-names></name><name><surname>Bisordi</surname><given-names>C.</given-names></name><name><surname>Lo Gerfo</surname><given-names>A.</given-names></name><name><surname>Petrozzi</surname><given-names>L.</given-names></name><name><surname>Petrucci</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Amyotrophic lateral sclerosis and oxidative stress: a double-blind therapeutic trial after curcumin supplementation.</article-title>
<source/><italic>CNS Neurol. Disord. Drug Targets</italic>
<volume>17</volume>
<fpage>767</fpage>–<lpage>779</lpage>. <pub-id pub-id-type="doi">10.2174/1871527317666180720162029</pub-id>
<pub-id pub-id-type="pmid">30033879</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiò</surname><given-names>A.</given-names></name><name><surname>Logroscino</surname><given-names>G.</given-names></name><name><surname>Traynor</surname><given-names>B. J.</given-names></name><name><surname>Collins</surname><given-names>J.</given-names></name><name><surname>Simeone</surname><given-names>J. C.</given-names></name><name><surname>Goldstein</surname><given-names>L. A.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature.</article-title>
<source/><italic>Neuroepidemiology</italic>
<volume>41</volume>
<fpage>118</fpage>–<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1159/000351153</pub-id>
<pub-id pub-id-type="pmid">23860588</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiou</surname><given-names>Y. S.</given-names></name><name><surname>Tsai</surname><given-names>M. L.</given-names></name><name><surname>Nagabhusanam</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>Y. J.</given-names></name><name><surname>Wu</surname><given-names>C. H.</given-names></name><name><surname>Ho</surname><given-names>C. T.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Pterostilbene is more potent that resveratrol in preventing azoxymethane (AOM)-induced colon tumorigenesis via activation of the NF-E2-related factor 2 (Nrfe2)-mediated antioxidant signaling pathway.</article-title>
<source/><italic>J. Agric. Food Chem.</italic>
<volume>59</volume>
<fpage>2725</fpage>–<lpage>2733</lpage>. <pub-id pub-id-type="doi">10.1021/jf2000103</pub-id>
<pub-id pub-id-type="pmid">21355597</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choo</surname><given-names>Q. Y.</given-names></name><name><surname>Ming-Yeo</surname><given-names>S. C.</given-names></name><name><surname>Ho</surname><given-names>P. C.</given-names></name><name><surname>Tanaka</surname><given-names>Y.</given-names></name><name><surname>Lin</surname><given-names>H. S.</given-names></name></person-group> (<year>2014</year>). <article-title>Pterostilbene surpassed resveratrol for anti-inflammatory application: potency consideration and pharmacokinetics perspective.</article-title>
<source/><italic>J. Funct. Food</italic>
<volume>11</volume>
<fpage>352</fpage>–<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1016/j.jff.2014.10.018</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>S.</given-names></name><name><surname>Yao</surname><given-names>H.</given-names></name><name><surname>Caito</surname><given-names>S.</given-names></name><name><surname>Hwang</surname><given-names>J. W.</given-names></name><name><surname>Arunachalam</surname><given-names>G.</given-names></name><name><surname>Rahman</surname><given-names>I.</given-names></name></person-group> (<year>2010</year>). <article-title>Regulation of SIRT1 in cellular functions: role of polyphenols.</article-title>
<source/><italic>Arch. Biochem. Biophys.</italic>
<volume>501</volume>
<fpage>79</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.abb.2010.05.003</pub-id>
<pub-id pub-id-type="pmid">20450879</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cichocki</surname><given-names>M.</given-names></name><name><surname>Paluszczak</surname><given-names>J.</given-names></name><name><surname>Szaefer</surname><given-names>H.</given-names></name><name><surname>Piechowiak</surname><given-names>A.</given-names></name><name><surname>Rimando</surname><given-names>A. M.</given-names></name><name><surname>Baer-Dubowska</surname><given-names>W.</given-names></name></person-group> (<year>2008</year>). <article-title>Pterostilbene is equally as potent as resveratrol in inhibiting 12-O-tetradecanoylphorbol-13-acetate activated NFkappaB, AP-1. <italic>COX-</italic>2 and iNOS in mouse epidermis.</article-title>
<source/><italic>Mol. Nutr. Food Res.</italic>
<volume>52</volume>(<issue>Suppl. 1</issue>), <fpage>S62</fpage>–<lpage>S70</lpage>. <pub-id pub-id-type="doi">10.1002/mnfr.200700466</pub-id>
<pub-id pub-id-type="pmid">18551458</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coan</surname><given-names>G.</given-names></name><name><surname>Mitchell</surname><given-names>C. S.</given-names></name></person-group> (<year>2015</year>). <article-title>An assessment of possible neuropathology and clinical relationships in 46 sporadic amyotrophic lateral sclerosis patient autopsies.</article-title>
<source/><italic>Neurodegener. Dis.</italic>
<volume>15</volume>
<fpage>301</fpage>–<lpage>312</lpage>. <pub-id pub-id-type="doi">10.1159/000433581</pub-id>
<pub-id pub-id-type="pmid">26183171</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>T. J.</given-names></name><name><surname>Hwang</surname><given-names>A. W.</given-names></name><name><surname>Restrepo</surname><given-names>C. X.</given-names></name><name><surname>Yuan</surname><given-names>J. Q.</given-names></name><name><surname>Trojanowski</surname><given-names>J. Q.</given-names></name><name><surname>Lee</surname><given-names>V. M.</given-names></name></person-group> (<year>2015</year>). <article-title>An acetylation switch controls TDP-43 function and aggregation propensity.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>6</volume>:<issue>5845</issue>. <pub-id pub-id-type="doi">10.1038/ncomms6845</pub-id>
<pub-id pub-id-type="pmid">25556531</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>T. J.</given-names></name><name><surname>Hwang</surname><given-names>A. W.</given-names></name><name><surname>Unger</surname><given-names>T.</given-names></name><name><surname>Trojanowski</surname><given-names>J. Q.</given-names></name><name><surname>Lee</surname><given-names>V. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Redox signaling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking.</article-title>
<source/><italic>EMBO J.</italic>
<volume>31</volume>
<fpage>1241</fpage>–<lpage>1252</lpage>. <pub-id pub-id-type="doi">10.1038/emboj.2011.471</pub-id>
<pub-id pub-id-type="pmid">22193716</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colbourne</surname><given-names>J.</given-names></name><name><surname>Baker</surname><given-names>N.</given-names></name><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Tucker</surname><given-names>C.</given-names></name><name><surname>Roebothan</surname><given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>Adequacy of niacin, folate, and vitamin B12 intakes from foods among Newfoundland and Labrador adults.</article-title>
<source/><italic>Can. J. Diet. Pract. Res.</italic>
<volume>74</volume>
<fpage>63</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.3148/74.2.2013.63</pub-id>
<pub-id pub-id-type="pmid">23750977</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>Axon degeneration mechanisms: commonality amid diversity.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>6</volume>
<fpage>889</fpage>–<lpage>898</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1788</pub-id>
<pub-id pub-id-type="pmid">16224497</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conforti</surname><given-names>L.</given-names></name><name><surname>Fang</surname><given-names>G.</given-names></name><name><surname>Beirowski</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>M. S.</given-names></name><name><surname>Sorci</surname><given-names>L.</given-names></name><name><surname>Asress</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>NAD(+) and axon degeneration revisited: Nmnat 1 cannot substitute for Wld(S) to delay Wallerian degeneration.</article-title>
<source/><italic>Cell Death Differ.</italic>
<volume>14</volume>
<fpage>116</fpage>–<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1038/sj.cdd.4401944</pub-id>
<pub-id pub-id-type="pmid">16645633</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooke</surname><given-names>M. S.</given-names></name><name><surname>Evans</surname><given-names>M. D.</given-names></name><name><surname>Herbert</surname><given-names>K. E.</given-names></name><name><surname>Lunec</surname><given-names>J.</given-names></name></person-group> (<year>2000</year>). <article-title>Urinary 8-oxo-2’-deoxyguanosine—source, significance and supplements.</article-title>
<source/><italic>Free Radic. Res.</italic>
<volume>32</volume>
<fpage>381</fpage>–<lpage>397</lpage>. <pub-id pub-id-type="pmid">10766407</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooke</surname><given-names>M. S.</given-names></name><name><surname>Lunec</surname><given-names>J.</given-names></name><name><surname>Evans</surname><given-names>M. D.</given-names></name></person-group> (<year>2002</year>). <article-title>Progress in the analysis of urine oxidative DNA damage.</article-title>
<source/><italic>Free Radic. Biol. Med.</italic>
<volume>33</volume>
<fpage>1601</fpage>–<lpage>1614</lpage>. <pub-id pub-id-type="pmid">12488129</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coppedè</surname><given-names>F.</given-names></name><name><surname>Migliore</surname><given-names>L.</given-names></name></person-group> (<year>2015</year>). <article-title>DNA damage in neurodegenerative diseases.</article-title>
<source/><italic>Mutat. Res.</italic>
<volume>776</volume>
<fpage>84</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1016/j.mrfmmm.2014.11.010</pub-id>
<pub-id pub-id-type="pmid">26255941</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cordeiro</surname><given-names>R. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Reactive oxygen species at phospholipid bilayers: distribution, mobility and permation.</article-title>
<source/><italic>Biochim. Biophys. Acta.</italic>
<volume>1838</volume>
<fpage>438</fpage>–<lpage>444</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamem.2013.09.016</pub-id>
<pub-id pub-id-type="pmid">24095673</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Correia</surname><given-names>S. C.</given-names></name><name><surname>Carvalho</surname><given-names>C.</given-names></name><name><surname>Cardoso</surname><given-names>S.</given-names></name><name><surname>Santos</surname><given-names>R. X.</given-names></name><name><surname>Santos</surname><given-names>M. S.</given-names></name><name><surname>Oliveira</surname><given-names>C. R.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Mitochondrial preconditioning: a potential neuroprotective strategy.</article-title>
<source/><italic>Front. Aging Neurosci.</italic>
<volume>2</volume>:<issue>138</issue>. <pub-id pub-id-type="doi">10.3389/fnagi.2010.00138</pub-id>
<pub-id pub-id-type="pmid">20838473</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Correia</surname><given-names>S. C.</given-names></name><name><surname>Moreira</surname><given-names>P. I.</given-names></name></person-group> (<year>2010</year>). <article-title>Hypoxia-inducible factor 1: a new hope to counteract neurodegeneration?</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>112</volume>
<fpage>1</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06443.x</pub-id>
<pub-id pub-id-type="pmid">19845827</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cory</surname><given-names>H.</given-names></name><name><surname>Passarelli</surname><given-names>S.</given-names></name><name><surname>Szeto</surname><given-names>J.</given-names></name><name><surname>Tamez</surname><given-names>M.</given-names></name><name><surname>Mattei</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>The role of polyphenols in human health and food systems: a mini-review.</article-title>
<source/><italic>Front. Nutr.</italic>
<volume>5</volume>:<issue>87</issue>. <pub-id pub-id-type="doi">10.3389/fnut.2018.00087</pub-id>
<pub-id pub-id-type="pmid">30298133</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cova</surname><given-names>E.</given-names></name><name><surname>Bongioanni</surname><given-names>P.</given-names></name><name><surname>Cereda</surname><given-names>C.</given-names></name><name><surname>Metelli</surname><given-names>M. R.</given-names></name><name><surname>Salvaneschi</surname><given-names>L.</given-names></name><name><surname>Bernuzzi</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Time course of oxidant markers and antioxidant defenses in subgroups of amyotrophic lateral sclerosis patients.</article-title>
<source/><italic>Neurochem. Int.</italic>
<volume>56</volume>
<fpage>687</fpage>–<lpage>693</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2010.02.004</pub-id>
<pub-id pub-id-type="pmid">20152873</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Covington</surname><given-names>J. D.</given-names></name><name><surname>Bajpeyi</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>The sirtuins: markers of metabolic health.</article-title>
<source/><italic>Mol. Nutr. Food Res.</italic>
<volume>60</volume>
<fpage>79</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1002/mnfr.201500340</pub-id>
<pub-id pub-id-type="pmid">26463981</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coyle</surname><given-names>J. T.</given-names></name><name><surname>Puttfarcken</surname><given-names>P.</given-names></name></person-group> (<year>1993</year>). <article-title>Oxidative stress, glutamate and neurodegenerative disorders.</article-title>
<source/><italic>Science</italic>
<volume>262</volume>
<fpage>689</fpage>–<lpage>695</lpage>.<pub-id pub-id-type="pmid">7901908</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cozzolino</surname><given-names>M.</given-names></name><name><surname>Carrì</surname><given-names>M. T.</given-names></name></person-group> (<year>2012</year>). <article-title>Mitochondrial dysfunction in ALS.</article-title>
<source/><italic>Prog. Neurobiol.</italic>
<volume>97</volume>
<fpage>54</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2011.06.003</pub-id>
<pub-id pub-id-type="pmid">21827820</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crozier</surname><given-names>A.</given-names></name><name><surname>Jaganath</surname><given-names>I. B.</given-names></name><name><surname>Clifford</surname><given-names>M. N.</given-names></name></person-group> (<year>2009</year>). <article-title>Dietary phenolics: chemistry, bioavailability and effects on health.</article-title>
<source/><italic>Nat. Prod. Rep.</italic>
<volume>26</volume>
<fpage>1001</fpage>–<lpage>1043</lpage>. <pub-id pub-id-type="doi">10.1039/b802662a</pub-id>
<pub-id pub-id-type="pmid">19636448</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czpaski</surname><given-names>G. A.</given-names></name><name><surname>Czubowicz</surname><given-names>K.</given-names></name><name><surname>Strosznajder</surname><given-names>R. P.</given-names></name></person-group> (<year>2012</year>). <article-title>Evaluation of the antioxidative properties of lypoxygenase inhibitors.</article-title>
<source/><italic>Pharmacol. Rep.</italic>
<volume>64</volume>
<fpage>1179</fpage>–<lpage>1188</lpage>.<pub-id pub-id-type="pmid">23238474</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahlqvist</surname><given-names>J. R.</given-names></name><name><surname>Oestergaard</surname><given-names>S. T.</given-names></name><name><surname>Poulsen</surname><given-names>N. S.</given-names></name><name><surname>Kank</surname><given-names>K. L.</given-names></name><name><surname>Thomsen</surname><given-names>C.</given-names></name><name><surname>Vissing</surname><given-names>J.</given-names></name></person-group> (<year>2019</year>). <article-title>Muscle contractility in spinobulbar muscular atrophy.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>9</volume>:<issue>4680</issue>. <pub-id pub-id-type="doi">10.1038/s41598-019-41240-y</pub-id>
<pub-id pub-id-type="pmid">30886222</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Amico</surname><given-names>E.</given-names></name><name><surname>Factor-Litvak</surname><given-names>P.</given-names></name><name><surname>Santella</surname><given-names>R. M.</given-names></name><name><surname>Mitsumoto</surname><given-names>H.</given-names></name></person-group> (<year>2013</year>). <article-title>Clinical perspective of oxidative stress in sporadic ALS.</article-title>
<source/><italic>Free Radic. Biol. Med.</italic>
<volume>65</volume>
<fpage>509</fpage>–<lpage>527</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2013.06.029</pub-id>
<pub-id pub-id-type="pmid">23797033</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dardiotis</surname><given-names>E.</given-names></name><name><surname>Panayiotou</surname><given-names>E.</given-names></name><name><surname>Feldman</surname><given-names>M. L.</given-names></name><name><surname>Hadjisavvas</surname><given-names>A.</given-names></name><name><surname>Malas</surname><given-names>S.</given-names></name><name><surname>Vonta</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Intraperitoneal melatonin is not neuroprotective in the g93asod1 transgenic mouse model of familial als and may exacerbate neurodegeneration.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>548</volume>
<fpage>170</fpage>–<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2013.05.058</pub-id>
<pub-id pub-id-type="pmid">23748038</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>M. H.</given-names></name></person-group> (<year>2008</year>). <article-title>Niacin use and cutaneous flushing: mechanisms and strategies for prevention.</article-title>
<source/><italic>Am. J. Cardiol.</italic>
<volume>101</volume>
<fpage>14B</fpage>–<lpage>19B</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjcard.2008.02.028</pub-id>
<pub-id pub-id-type="pmid">18375236</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Gara</surname><given-names>L.</given-names></name><name><surname>Foyer</surname><given-names>C. H.</given-names></name></person-group> (<year>2017</year>). <article-title>Ying and Yang interplay between reactive oxygen and reactive nitrogen species controls cells functions.</article-title>
<source/><italic>Plant Cell Environ.</italic>
<volume>40</volume>
<fpage>459</fpage>–<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1111/pce.12936</pub-id>
<pub-id pub-id-type="pmid">28236324</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Silva</surname><given-names>T. M.</given-names></name><name><surname>Miller</surname><given-names>A. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Cerebral small vessel diseases: targeting oxidative stress as a novel therapeutic strategy?</article-title>
<source/><italic>Front. Pharmacol.</italic>
<volume>17</volume>:<issue>61</issue>
<pub-id pub-id-type="doi">10.3389/fphar.2016.00061</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dellinger</surname><given-names>R. W.</given-names></name><name><surname>Roel-Santos</surname><given-names>S.</given-names></name><name><surname>Morris</surname><given-names>M.</given-names></name><name><surname>Evans</surname><given-names>M.</given-names></name><name><surname>Alminana</surname><given-names>D.</given-names></name><name><surname>Guarente</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, doublé-blind, placebo-controlled study.</article-title>
<source/><italic>NPJ Aging Mech. Dis.</italic>
<volume>3</volume>:<issue>17</issue>. <pub-id pub-id-type="doi">10.1038/s41514-017-0016-9</pub-id>
<pub-id pub-id-type="pmid">30155270</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>H. X.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Furukawa</surname><given-names>Y.</given-names></name><name><surname>Zhai</surname><given-names>H.</given-names></name><name><surname>Fu</surname><given-names>R.</given-names></name><name><surname>Liu</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>103</volume>
<fpage>7142</fpage>–<lpage>7147</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0602046103</pub-id>
<pub-id pub-id-type="pmid">16636275</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desnuelle</surname><given-names>C.</given-names></name><name><surname>Dib</surname><given-names>M.</given-names></name><name><surname>Garrel</surname><given-names>C.</given-names></name><name><surname>Favier</surname><given-names>A.</given-names></name></person-group> (<year>2001</year>). <article-title>A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group.</article-title>
<source/><italic>Amyotroph. Lateral Scler. Other Motor Neuron Disord.</italic>
<volume>2</volume>
<fpage>9</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="pmid">11465936</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Matteo</surname><given-names>V.</given-names></name><name><surname>Esposito</surname><given-names>E.</given-names></name></person-group> (<year>2003</year>). <article-title>Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis.</article-title>
<source/><italic>Curr. Drug Targets CNS Neurol. Disord.</italic>
<volume>2</volume>
<fpage>95</fpage>–<lpage>107</lpage>. <pub-id pub-id-type="pmid">12769802</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Pietro</surname><given-names>L.</given-names></name><name><surname>Baranzini</surname><given-names>M.</given-names></name><name><surname>Berardinelli</surname><given-names>M. G.</given-names></name><name><surname>Lattanzi</surname><given-names>W.</given-names></name><name><surname>Monforte</surname><given-names>M.</given-names></name><name><surname>Tasca</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Potential therapeutic targets for ALS: MIR206, MIR208b and MIR499 are modulated during disease progression in the skeletal muscle of patients.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>7</volume>:<issue>9538</issue>. <pub-id pub-id-type="doi">10.1038/s41598-017-10161-z</pub-id>
<pub-id pub-id-type="pmid">28842714</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dias</surname><given-names>V.</given-names></name><name><surname>Junn</surname><given-names>E.</given-names></name><name><surname>Mouradian</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>The role of oxidative stress in Parkinson’s diseases.</article-title>
<source/><italic>J. Parkinsons Dis.</italic>
<volume>3</volume>
<fpage>461</fpage>–<lpage>491</lpage>. <pub-id pub-id-type="doi">10.3233/JPD-130230</pub-id>
<pub-id pub-id-type="pmid">24252804</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>G.</given-names></name><name><surname>Fu</surname><given-names>M.</given-names></name><name><surname>Quin</surname><given-names>Q.</given-names></name><name><surname>Lewis</surname><given-names>W.</given-names></name><name><surname>Kim</surname><given-names>H. W.</given-names></name><name><surname>Fukai</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Cardiac peroxisome proliferator-activated receptor gamma is essential in protecting cardiomyocytes from oxidative damage.</article-title>
<source/><italic>Cardiovasc. Res.</italic>
<volume>76</volume>
<fpage>269</fpage>–<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1016/j.cardiores.2007.06.027</pub-id>
<pub-id pub-id-type="pmid">17678635</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dirnagl</surname><given-names>U.</given-names></name><name><surname>Becker</surname><given-names>K.</given-names></name><name><surname>Meisel</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.</article-title>
<source/><italic>Lancet Neurol.</italic>
<volume>8</volume>
<fpage>398</fpage>–<lpage>412</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(09)70054-7</pub-id>
<pub-id pub-id-type="pmid">19296922</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dirnagl</surname><given-names>U.</given-names></name><name><surname>Meisel</surname><given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Endogenous neuroprotection: mitochondria as gateways to cerebral preconditioning?</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>55</volume>
<fpage>334</fpage>–<lpage>344</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2008.02.017</pub-id>
<pub-id pub-id-type="pmid">18402985</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixon</surname><given-names>S. J.</given-names></name><name><surname>Stockwell</surname><given-names>B. R.</given-names></name></person-group> (<year>2014</year>). <article-title>The role of iron and reactive oxygen species in cell death.</article-title>
<source/><italic>Nat. Chem. Biol.</italic>
<volume>10</volume>
<fpage>9</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.1416</pub-id>
<pub-id pub-id-type="pmid">24346035</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dizdaroglu</surname><given-names>M.</given-names></name><name><surname>Jaruga</surname><given-names>P.</given-names></name></person-group> (<year>2012</year>). <article-title>Mechanism of free radical-induced damage to DNA.</article-title>
<source/><italic>Free Radic. Res.</italic>
<volume>46</volume>
<fpage>382</fpage>–<lpage>419</lpage>. <pub-id pub-id-type="doi">10.3109/10715762.2011.653969</pub-id>
<pub-id pub-id-type="pmid">22276778</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolopikou</surname><given-names>C. F.</given-names></name><name><surname>Kourtzidis</surname><given-names>I. A.</given-names></name><name><surname>Margaritelis</surname><given-names>N. V.</given-names></name><name><surname>Vrabas</surname><given-names>I. S.</given-names></name><name><surname>Koidou</surname><given-names>I.</given-names></name><name><surname>Kyparos</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Acute nicotinamide riboside supplementation improves redox homeostasis and exercise performance in old individuals: a double-blind cross-over study.</article-title>
<source/><italic>Eur. J. Nutr.</italic>
<pub-id pub-id-type="doi">10.1007/s00394-019-01919-4</pub-id>
<comment>[Epub ahead of print]</comment>. <pub-id pub-id-type="pmid">30725213</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>H.</given-names></name><name><surname>Xu</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Duan</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Curcumin abolishes mutant TDP-43 induced excitability in a motoneuron-like cellular model of ALS.</article-title>
<source/><italic>Neuroscience</italic>
<volume>272</volume>
<fpage>141</fpage>–<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2014.04.032</pub-id>
<pub-id pub-id-type="pmid">24785678</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorst</surname><given-names>J.</given-names></name><name><surname>Ludolph</surname><given-names>A. C.</given-names></name><name><surname>Huebers</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis.</article-title>
<source/><italic>Ther. Adv. Neurol. Disord.</italic>
<volume>11</volume>:<issue>1756285617734734</issue>. <pub-id pub-id-type="doi">10.1177/1756285617734734</pub-id>
<pub-id pub-id-type="pmid">29399045</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>H. T.</given-names></name><name><surname>Quin</surname><given-names>X. Y.</given-names></name><name><surname>Cao</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Cao</surname><given-names>Z. Z.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Postmortem brain, cerebrospinal fluid, and blood neurotrophic factor levels in Alzheimer’s disease: a systematic review and meta-analysis.</article-title>
<source/><italic>J. Mol. Neurosci.</italic>
<volume>65</volume>
<fpage>289</fpage>–<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1007/s12031-018-1100-8</pub-id>
<pub-id pub-id-type="pmid">29956088</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name></person-group> (<year>2010</year>). <article-title>Mutant TAR DNA-binding protein-43 induces oxidative injury in motor neuron-like cell.</article-title>
<source/><italic>Neuroscience</italic>
<volume>169</volume>
<fpage>1621</fpage>–<lpage>1629</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2010.06.018</pub-id>
<pub-id pub-id-type="pmid">20600671</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duffy</surname><given-names>L. M.</given-names></name><name><surname>Chapman</surname><given-names>A. L.</given-names></name><name><surname>Shaw</surname><given-names>P. J.</given-names></name><name><surname>Grierson</surname><given-names>A. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Review: the role of mitochondria in the pathogenesis of amyotrophic lateral sclerosis.</article-title>
<source/><italic>Neuropathol. Appl. Neurobiol.</italic>
<volume>37</volume>
<fpage>336</fpage>–<lpage>352</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2990.2011.01166.x</pub-id>
<pub-id pub-id-type="pmid">21299590</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dupuis</surname><given-names>L.</given-names></name><name><surname>Pradat</surname><given-names>P. F.</given-names></name><name><surname>Ludolph</surname><given-names>A. C.</given-names></name><name><surname>Loeffler</surname><given-names>J. P.</given-names></name></person-group> (<year>2011</year>). <article-title>Energy metabolism in amyotrophic lateral sclerosis.</article-title>
<source/><italic>Lancet Neurol.</italic>
<volume>10</volume>
<fpage>75</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(10)70224-6</pub-id>
<pub-id pub-id-type="pmid">21035400</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dvorakova</surname><given-names>M.</given-names></name><name><surname>Landa</surname><given-names>P.</given-names></name></person-group> (<year>2017</year>). <article-title>Anti-inflammatory activity of natural stilbenoids: a review.</article-title>
<source/><italic>Pharmacol. Res.</italic>
<volume>124</volume>
<fpage>126</fpage>–<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2017.08.002</pub-id>
<pub-id pub-id-type="pmid">28803136</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dyck</surname><given-names>G. J. B.</given-names></name><name><surname>Raj</surname><given-names>P.</given-names></name><name><surname>Zieroth</surname><given-names>S.</given-names></name><name><surname>Dyck</surname><given-names>J. R. B.</given-names></name><name><surname>Ezekowitz</surname><given-names>J. A.</given-names></name></person-group> (<year>2019</year>). <article-title>The effects of resveratrol in patients with cardiovascular disease and heart failure: a narrative review.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>20</volume>:<issue>E904</issue>. <pub-id pub-id-type="doi">10.3390/ijms20040904</pub-id>
<pub-id pub-id-type="pmid">30791450</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrhart</surname><given-names>J.</given-names></name><name><surname>Smith</surname><given-names>A. J.</given-names></name><name><surname>Kuzmin-Nichols</surname><given-names>N.</given-names></name><name><surname>Zesiewicz</surname><given-names>T. A.</given-names></name><name><surname>Jahan</surname><given-names>I.</given-names></name><name><surname>Shytle</surname><given-names>R. D.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Humoral factors in ALS patients during disease progression.</article-title>
<source/><italic>J. Neuroinflammation</italic>
<volume>12</volume>:<issue>127</issue>. <pub-id pub-id-type="doi">10.1186/s12974-015-0350-4</pub-id>
<pub-id pub-id-type="pmid">26126965</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Sayed</surname><given-names>S. M.</given-names></name><name><surname>Mansour</surname><given-names>A. M.</given-names></name><name><surname>Nady</surname><given-names>M. E.</given-names></name></person-group> (<year>2015</year>). <article-title>Protective effects of pterostilbene against actaminophen-induced hepatotoxicity in rats.</article-title>
<source/><italic>J. Biochem. Mol. Toxicol.</italic>
<volume>29</volume>
<fpage>35</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1002/jbt.21604</pub-id>
<pub-id pub-id-type="pmid">25201704</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emerit</surname><given-names>J.</given-names></name><name><surname>Edeas</surname><given-names>M.</given-names></name><name><surname>Bricaire</surname><given-names>F.</given-names></name></person-group> (<year>2004</year>). <article-title>Neurodegenerative diseases and oxidative stress.</article-title>
<source/><italic>Biomed. Pharmacother.</italic>
<volume>58</volume>
<fpage>39</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="pmid">14739060</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname><given-names>E.</given-names></name><name><surname>Capasso</surname><given-names>M.</given-names></name><name><surname>di Tomasso</surname><given-names>N.</given-names></name><name><surname>Corona</surname><given-names>C.</given-names></name><name><surname>Pellegrini</surname><given-names>F.</given-names></name><name><surname>Uncini</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Antioxidant strategies based on tomato- enriched food or pyruvate do not affect disease onset and survival in an animal model of amyotrophic lateral sclerosis.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1168</volume>
<fpage>90</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2007.06.095</pub-id>
<pub-id pub-id-type="pmid">17706944</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname><given-names>E.</given-names></name><name><surname>Rotilio</surname><given-names>D.</given-names></name><name><surname>Di Matteo</surname><given-names>V.</given-names></name><name><surname>Di Giulio</surname><given-names>C.</given-names></name><name><surname>Cacchio</surname><given-names>M.</given-names></name><name><surname>Algeri</surname><given-names>S.</given-names></name></person-group> (<year>2002</year>). <article-title>A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes.</article-title>
<source/><italic>Neurobiol. Aging</italic>
<volume>23</volume>
<fpage>719</fpage>–<lpage>735</lpage>. <pub-id pub-id-type="pmid">12392777</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Essa</surname><given-names>M. M.</given-names></name><name><surname>Subash</surname><given-names>S.</given-names></name><name><surname>Braidy</surname><given-names>N.</given-names></name><name><surname>Adawi</surname><given-names>S.</given-names></name><name><surname>Lim</surname><given-names>C. K.</given-names></name><name><surname>Manivasagam</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Role of NAD+, oxidative and tryptophan metabolism in autism spectrum disorders.</article-title>
<source/><italic>Int. J. Tryptophan Res.</italic>
<volume>6</volume>
<fpage>15</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="doi">10.4137/IJTR.S11355</pub-id>
<pub-id pub-id-type="pmid">23922500</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Estrela</surname><given-names>J. M.</given-names></name><name><surname>Ortega</surname><given-names>A.</given-names></name><name><surname>Mena</surname><given-names>S.</given-names></name><name><surname>Rodriguez</surname><given-names>M. L.</given-names></name><name><surname>Asensi</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Pterostilbene: biomedical applications.</article-title>
<source/><italic>Crit. Rev. Clin. Lab. Sci.</italic>
<volume>50</volume>
<fpage>65</fpage>–<lpage>78</lpage>. <pub-id pub-id-type="doi">10.3109/10408363.2013.805182</pub-id>
<pub-id pub-id-type="pmid">23808710</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falkowski</surname><given-names>P. G.</given-names></name><name><surname>Godfrey</surname><given-names>L. V.</given-names></name></person-group> (<year>2008</year>). <article-title>Electrons, life an the evolution of Earth’s oxygen cycle.</article-title>
<source/><italic>Philos. Trans. R. Soc. Lond. B Biol. Sci.</italic>
<volume>363</volume>
<fpage>2705</fpage>–<lpage>2716</lpage>. <pub-id pub-id-type="doi">10.1098/rstb.2008.0054</pub-id>
<pub-id pub-id-type="pmid">18487127</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Federico</surname><given-names>A.</given-names></name><name><surname>Cardaioli</surname><given-names>E.</given-names></name><name><surname>Da Pozzo</surname><given-names>P.</given-names></name><name><surname>Formichi</surname><given-names>P.</given-names></name><name><surname>Gallus</surname><given-names>G. N.</given-names></name><name><surname>Radi</surname><given-names>E.</given-names></name></person-group> (<year>2012</year>). <article-title>Mitochondria, oxidative stress and neurodegeneration.</article-title>
<source/><italic>J. Neurol. Sci.</italic>
<volume>322</volume>
<fpage>254</fpage>–<lpage>262</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2012.05.030</pub-id>
<pub-id pub-id-type="pmid">22669122</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrante</surname><given-names>K. L.</given-names></name><name><surname>Shefner</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Betensky</surname><given-names>R.</given-names></name><name><surname>O’Brien</surname><given-names>M.</given-names></name><name><surname>Yu</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS.</article-title>
<source/><italic>Neurology</italic>
<volume>56</volume>
<fpage>1834</fpage>–<lpage>1836</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000187070.35365.d7</pub-id>
<pub-id pub-id-type="pmid">16344537</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferri</surname><given-names>A.</given-names></name><name><surname>Cozzolino</surname><given-names>M.</given-names></name><name><surname>Crosio</surname><given-names>C.</given-names></name><name><surname>Nencini</surname><given-names>M.</given-names></name><name><surname>Casciati</surname><given-names>A.</given-names></name><name><surname>Gralla</surname><given-names>E. B.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Familial ALS-superoxide dismutases associate with mitocondria and shift their redox potentials.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>103</volume>
<fpage>13860</fpage>–<lpage>13865</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0605814103</pub-id>
<pub-id pub-id-type="pmid">16945901</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiala</surname><given-names>M.</given-names></name><name><surname>Mizwicki</surname><given-names>M. T.</given-names></name><name><surname>Weitzman</surname><given-names>R.</given-names></name><name><surname>Magpantay</surname><given-names>L.</given-names></name><name><surname>Nishimoto</surname><given-names>N.</given-names></name></person-group> (<year>2013</year>). <article-title>Tocilizumab infusión therapy normalizes inflammation in sporadic ALS patients.</article-title>
<source/><italic>Am. J. Neurodegener. Dis.</italic>
<volume>2</volume>
<fpage>129</fpage>–<lpage>139</lpage>.<pub-id pub-id-type="pmid">23844337</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiedor</surname><given-names>J.</given-names></name><name><surname>Sulikowska</surname><given-names>A.</given-names></name><name><surname>Orzechowska</surname><given-names>A.</given-names></name><name><surname>Fiedor</surname><given-names>L.</given-names></name><name><surname>Burda</surname><given-names>K.</given-names></name></person-group> (<year>2012</year>). <article-title>Antioxidant effects of carotenoids in a model pigment-protein complex.</article-title>
<source/><italic>Acta Biochim. Pol.</italic>
<volume>59</volume>
<fpage>61</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="pmid">22428149</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>R.</given-names></name><name><surname>Maier</surname><given-names>O.</given-names></name></person-group> (<year>2015</year>). <article-title>Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF.</article-title>
<source/><italic>Oxid. Med. Cell. Longev.</italic>
<volume>2015</volume>:<issue>610813</issue>. <pub-id pub-id-type="doi">10.1155/2015/610813</pub-id>
<pub-id pub-id-type="pmid">25834699</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fitzgerald</surname><given-names>K. C.</given-names></name><name><surname>O’Reilly</surname><given-names>ÉJ.</given-names></name><name><surname>Fondell</surname><given-names>E.</given-names></name><name><surname>Falcone</surname><given-names>G. J.</given-names></name><name><surname>McCullough</surname><given-names>M. L.</given-names></name><name><surname>Park</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Intakes of vitamin C and carotenoids and risk of amyotrophic lateral sclerosis: pooled results from 5 cohort studies.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>73</volume>
<fpage>236</fpage>–<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1002/ana.23820</pub-id>
<pub-id pub-id-type="pmid">23362045</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flatt</surname><given-names>T.</given-names></name></person-group> (<year>2012</year>). <article-title>A new definition of aging?</article-title>
<source/><italic>Front. Genet.</italic>
<volume>3</volume>:<issue>148</issue>
<pub-id pub-id-type="doi">10.3389/fgene.2012.00148</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fletcher</surname><given-names>R. S.</given-names></name><name><surname>Ratajczak</surname><given-names>J.</given-names></name><name><surname>Doig</surname><given-names>C. L.</given-names></name><name><surname>Oakey</surname><given-names>L. A.</given-names></name><name><surname>Callingham</surname><given-names>R.</given-names></name><name><surname>Da Silva-Xavier</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells.</article-title>
<source/><italic>Mol. Metab.</italic>
<volume>6</volume>
<fpage>819</fpage>–<lpage>832</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmet.2017.05.011</pub-id>
<pub-id pub-id-type="pmid">28752046</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Formella</surname><given-names>I.</given-names></name><name><surname>Svahn</surname><given-names>A. J.</given-names></name><name><surname>Radford</surname><given-names>R. A. W.</given-names></name><name><surname>Don</surname><given-names>E. K.</given-names></name><name><surname>Cole</surname><given-names>N. J.</given-names></name><name><surname>Hogan</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Real-time visualization of oxidateive stress-mediated neurodegeneration of individual spinal motor neurons <italic>in vivo</italic>.</article-title>
<source/><italic>Redox. Biol.</italic>
<volume>19</volume>
<fpage>226</fpage>–<lpage>234</lpage>. <pub-id pub-id-type="doi">10.1016/j.redox.2018.08.011</pub-id>
<pub-id pub-id-type="pmid">30193184</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Förstermann</surname><given-names>U.</given-names></name><name><surname>Sessa</surname><given-names>W. C.</given-names></name></person-group> (<year>2012</year>). <article-title>Nitric oxide synthases: regulation and function.</article-title>
<source/><italic>Eur. Heart. J.</italic>
<volume>33</volume>
<fpage>829</fpage>–<lpage>837</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehr304</pub-id>
<pub-id pub-id-type="pmid">21890489</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frederick</surname><given-names>D. W.</given-names></name><name><surname>Loro</surname><given-names>E.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Davila</surname><given-names>A. J.</given-names></name><name><surname>Chellappa</surname><given-names>K.</given-names></name><name><surname>Silverman</surname><given-names>I. M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Loss of NAD homeostasis leads to progressive and reversible degeneration of skeletal muscle.</article-title>
<source/><italic>Cell Metab.</italic>
<volume>24</volume>
<fpage>269</fpage>–<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2016.07.005</pub-id>
<pub-id pub-id-type="pmid">27508874</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>L. R.</given-names></name><name><surname>Keller</surname><given-names>J. N.</given-names></name></person-group> (<year>2012</year>). <article-title>Oxidative stress and cerebral endotelial cells: regulation of the blood-brain-barrier and antioxidant based interventions.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1822</volume>
<fpage>822</fpage>–<lpage>829</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2011.12.009</pub-id>
<pub-id pub-id-type="pmid">22206999</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fritz</surname><given-names>K. S.</given-names></name><name><surname>Petersen</surname><given-names>D. R.</given-names></name></person-group> (<year>2013</year>). <article-title>An overview of the chemistry and biology of reactive aldehydes.</article-title>
<source/><italic>Free. Radic. Biol. Med.</italic>
<volume>59</volume>
<fpage>85</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2012.06.025</pub-id>
<pub-id pub-id-type="pmid">22750507</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>B. T.</given-names></name><name><surname>Gan</surname><given-names>R. Y.</given-names></name><name><surname>Zhang</surname><given-names>Y. A.</given-names></name><name><surname>Xu</surname><given-names>R.</given-names></name><name><surname>Xia</surname><given-names>E. Q.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Total phenolic contents and antioxidant capacities of herbal and tea infusions.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>12</volume>
<fpage>2112</fpage>–<lpage>2124</lpage>. <pub-id pub-id-type="doi">10.3390/ijms12042112</pub-id>
<pub-id pub-id-type="pmid">21731430</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galbussera</surname><given-names>A.</given-names></name><name><surname>Tremolizzo</surname><given-names>L.</given-names></name><name><surname>Brighina</surname><given-names>L.</given-names></name><name><surname>Testa</surname><given-names>D.</given-names></name><name><surname>Lovati</surname><given-names>R.</given-names></name><name><surname>Ferrarese</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Vitamin E intake and quality of life in amyotrophic lateral sclerosis patients: a follow-up case series study.</article-title>
<source/><italic>Neurol. Sci.</italic>
<volume>27</volume>
<fpage>190</fpage>–<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1007/s10072-006-0668-x</pub-id>
<pub-id pub-id-type="pmid">16897634</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gamez</surname><given-names>J.</given-names></name><name><surname>Corbera-Bellalta</surname><given-names>M.</given-names></name><name><surname>Nogales</surname><given-names>G.</given-names></name><name><surname>Raguer</surname><given-names>N.</given-names></name><name><surname>García-Arumí</surname><given-names>E.</given-names></name><name><surname>Badia-Canto</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Mutational analysis of the Cu/Zn superoxide dismutase gen in a Catalan ALS population: should all sporadic ALS cases also be screened for SOD1?</article-title>
<source/><italic>J. Neurol. Sci.</italic>
<volume>247</volume>
<fpage>21</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2006.03.006</pub-id>
<pub-id pub-id-type="pmid">16674979</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gandhi</surname><given-names>S.</given-names></name><name><surname>Abramov</surname><given-names>A. Y.</given-names></name></person-group> (<year>2012</year>). <article-title>Mechanism of oxidative stress in neurodegeneration.</article-title>
<source/><italic>Oxid. Med. Cell. Longev.</italic>
<volume>2012</volume>:<issue>428010</issue>. <pub-id pub-id-type="doi">10.1155/2012/428010</pub-id>
<pub-id pub-id-type="pmid">22685618</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganesan</surname><given-names>K.</given-names></name><name><surname>Xu</surname><given-names>B.</given-names></name></person-group> (<year>2017</year>). <article-title>Polyphenol-rich lentils ant their health promoting effects.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>18</volume>:<issue>E2390</issue>. <pub-id pub-id-type="doi">10.3390/ijms18112390</pub-id>
<pub-id pub-id-type="pmid">29125587</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganie</surname><given-names>S. A.</given-names></name><name><surname>Dar</surname><given-names>T. A.</given-names></name><name><surname>Bhat</surname><given-names>A. H.</given-names></name><name><surname>Dar</surname><given-names>K. B.</given-names></name><name><surname>Anees</surname><given-names>S.</given-names></name><name><surname>Zargar</surname><given-names>M. A.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Melatonin: a potential anti-oxidant therapeutic agent for mitochondrial dysfunctions and related disorders.</article-title>
<source/><italic>Rejuvenation Res.</italic>
<volume>19</volume>
<fpage>21</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1089/rej.2015.1704</pub-id>
<pub-id pub-id-type="pmid">26087000</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghasemi</surname><given-names>F.</given-names></name><name><surname>Bagheri</surname><given-names>H.</given-names></name><name><surname>Barreto</surname><given-names>G. E.</given-names></name><name><surname>Read</surname><given-names>M. I.</given-names></name><name><surname>Sahebkar</surname><given-names>A.</given-names></name></person-group> (<year>2019</year>). <article-title>Effects of curcumin on microgial cells.</article-title>
<source/><italic>Neurotox. Res.</italic>
<volume>36</volume>
<fpage>12</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1007/s12640-019-00030-0</pub-id>
<pub-id pub-id-type="pmid">30949950</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghasemi</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Amyotrophic lateral sclerosis mimic syndromes.</article-title>
<source/><italic>Iran. J. Neurol.</italic>
<volume>15</volume>
<fpage>85</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="pmid">27326363</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golenia</surname><given-names>A.</given-names></name><name><surname>Leskiewicz</surname><given-names>M.</given-names></name><name><surname>Regulska</surname><given-names>M.</given-names></name><name><surname>Budziszewska</surname><given-names>B.</given-names></name><name><surname>Szczesny</surname><given-names>E.</given-names></name><name><surname>Jagiella</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Catalase activity in blood fractions of patients with sporadic ALS.</article-title>
<source/><italic>Pharmacol. Rep.</italic>
<volume>66</volume>
<fpage>704</fpage>–<lpage>707</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharep.2014.02.021</pub-id>
<pub-id pub-id-type="pmid">24948075</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>A. P.</given-names></name><name><surname>Price</surname><given-names>N. L.</given-names></name><name><surname>Ling</surname><given-names>A. J.</given-names></name><name><surname>Moslehi</surname><given-names>J. J.</given-names></name><name><surname>Montogomery</surname><given-names>M. K.</given-names></name><name><surname>Rajman</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging.</article-title>
<source/><italic>Cell</italic>
<volume>155</volume>
<fpage>1624</fpage>–<lpage>1638</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.11.037</pub-id>
<pub-id pub-id-type="pmid">24360282</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Zorita</surname><given-names>S.</given-names></name><name><surname>Tréguer</surname><given-names>K.</given-names></name><name><surname>Mercader</surname><given-names>J.</given-names></name><name><surname>Carpéné</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Resveratrol directly affects <italic>in vitro</italic> lipolysis and glucose transport in human fat cells.</article-title>
<source/><italic>J. Physiol. Biochem.</italic>
<volume>69</volume>
<fpage>585</fpage>–<lpage>593</lpage>. <pub-id pub-id-type="doi">10.1007/s13105-012-0229-220</pub-id>
<pub-id pub-id-type="pmid">23315205</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>B.</given-names></name><name><surname>Pan</surname><given-names>Y.</given-names></name><name><surname>Vempati</surname><given-names>P.</given-names></name><name><surname>Zhao</surname><given-names>W.</given-names></name><name><surname>Knable</surname><given-names>L.</given-names></name><name><surname>Ho</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated ß-secretase 1 degradation and mitochondrial gene expression in Alzheimer’s mouse models.</article-title>
<source/><italic>Neurobiol. Aging</italic>
<volume>34</volume>
<fpage>1581</fpage>–<lpage>1588</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2012.12.005</pub-id>
<pub-id pub-id-type="pmid">23312803</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>González</surname><given-names>D.</given-names></name><name><surname>Contreras</surname><given-names>O.</given-names></name><name><surname>Rebolledo</surname><given-names>D. L.</given-names></name><name><surname>Espinoza</surname><given-names>J. P.</given-names></name><name><surname>Van Zundert</surname><given-names>B.</given-names></name><name><surname>Brandan</surname><given-names>E.</given-names></name></person-group> (<year>2017</year>). <article-title>ALS skeletal muscle shows enhanced TGF-ß signaling, fibrosis and induction of fibro/adipogenic progenitor markers.</article-title>
<source/><italic>PLoS One</italic>
<volume>12</volume>:<issue>e0177649</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0177649</pub-id>
<pub-id pub-id-type="pmid">28520806</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goody</surname><given-names>M. F.</given-names></name><name><surname>Henry</surname><given-names>C. A.</given-names></name></person-group> (<year>2018</year>). <article-title>A need for NAD+ in muscle development, homeostasis, and aging.</article-title>
<source/><italic>Skelet. Muscle</italic>
<volume>8</volume>:<issue>9</issue>. <pub-id pub-id-type="doi">10.1186/s13395-018-0154-1</pub-id>
<pub-id pub-id-type="pmid">29514713</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>P. H.</given-names></name></person-group> (<year>2013</year>). <article-title>Amyotrophic lateral sclerosis: an update for 2013 clinical features, pathophysiology, management and therapeutic trials.</article-title>
<source/><italic>Aging Dis.</italic>
<volume>4</volume>
<fpage>295</fpage>–<lpage>310</lpage>. <pub-id pub-id-type="doi">10.14336/AD.2013.0400295</pub-id>
<pub-id pub-id-type="pmid">24124634</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>P. H.</given-names></name><name><surname>Mehal</surname><given-names>J. M.</given-names></name><name><surname>Holamn</surname><given-names>R. C.</given-names></name><name><surname>Rowland</surname><given-names>L. P.</given-names></name><name><surname>Rowland</surname><given-names>A. S.</given-names></name><name><surname>Cheek</surname><given-names>J. E.</given-names></name></person-group> (<year>2013</year>). <article-title>Incidence of amyotrophic lateral sclerosis among American Indians and Alaska natives.</article-title>
<source/><italic>JAMA Neurol.</italic>
<volume>70</volume>
<fpage>476</fpage>–<lpage>480</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2013.929</pub-id>
<pub-id pub-id-type="pmid">23440294</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gowland</surname><given-names>A.</given-names></name><name><surname>Opie-Martin</surname><given-names>S.</given-names></name><name><surname>Scott</surname><given-names>K. M.</given-names></name><name><surname>Jones</surname><given-names>A. R.</given-names></name><name><surname>Mehta</surname><given-names>P. R.</given-names></name><name><surname>Batts</surname><given-names>C. J.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Predicting the future of ALS: the impact of demographic change and potential new treatments on the prevalence of ALS in the United Kingdom, 2020-2116.</article-title>
<source/><italic>Amyotroph. Lateral Scler. Frontotemporal. Degener.</italic>
<volume>20</volume>
<fpage>264</fpage>–<lpage>274</lpage>. <pub-id pub-id-type="doi">10.1080/21678421.2019.1587629</pub-id>
<pub-id pub-id-type="pmid">30961394</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graf</surname><given-names>M.</given-names></name><name><surname>Ecker</surname><given-names>D.</given-names></name><name><surname>Horowski</surname><given-names>R.</given-names></name><name><surname>Kramer</surname><given-names>B.</given-names></name><name><surname>Riederer</surname><given-names>P.</given-names></name><name><surname>Gerlach</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study.</article-title>
<source/><italic>J. Neural Transm.</italic>
<volume>112</volume>
<fpage>649</fpage>–<lpage>660</lpage>. <pub-id pub-id-type="doi">10.1007/s00702-004-0220-1</pub-id>
<pub-id pub-id-type="pmid">15517433</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>K. N.</given-names></name><name><surname>Steffan</surname><given-names>J. S.</given-names></name><name><surname>Martínez-Coria</surname><given-names>H.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Schreiber</surname><given-names>S. S.</given-names></name><name><surname>Thompson</surname><given-names>L. M.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Nicotinamide restores cognition in Alzheimer’s disease transgenic mice via mechanism involving sirtuin inhibiton and selective reduction of Thr231-phosphotau.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>28</volume>
<fpage>11500</fpage>–<lpage>11510</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3203-08.2008</pub-id><pub-id pub-id-type="pmid">18987186</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grochowski</surname><given-names>C.</given-names></name><name><surname>Litak</surname><given-names>J.</given-names></name><name><surname>Kamieniak</surname><given-names>P.</given-names></name><name><surname>Maciejewski</surname><given-names>R.</given-names></name></person-group> (<year>2018</year>). <article-title>Oxidative stress in small vessel disease. Role of reactive species.</article-title>
<source/><italic>Free Radic. Res.</italic>
<volume>52</volume>
<fpage>1</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1080/10715762.2017.1402304</pub-id>
<pub-id pub-id-type="pmid">29166803</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grozio</surname><given-names>A.</given-names></name><name><surname>Mills</surname><given-names>K. F.</given-names></name><name><surname>Yoshino</surname><given-names>J.</given-names></name><name><surname>Bruzzone</surname><given-names>S.</given-names></name><name><surname>Sociali</surname><given-names>G.</given-names></name><name><surname>Tokizane</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Slc12a8 is a nicotinamide mononucleotide transporter.</article-title>
<source/><italic>Nat. Metab.</italic>
<volume>1</volume>
<fpage>47</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1038/s42255-018-0009-4</pub-id>
<pub-id pub-id-type="pmid">31131364</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guarente</surname><given-names>L.</given-names></name></person-group> (<year>2014</year>). <article-title>Linking DNA damage, NAD(<sup>+</sup>)/SIRT1, and aging.</article-title>
<source/><italic>Cell. Metab.</italic>
<volume>20</volume>
<fpage>706</fpage>–<lpage>707</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2014.10.015</pub-id>
<pub-id pub-id-type="pmid">25440052</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guareschi</surname><given-names>S.</given-names></name><name><surname>Cova</surname><given-names>E.</given-names></name><name><surname>Cereda</surname><given-names>C.</given-names></name><name><surname>Ceroni</surname><given-names>M.</given-names></name><name><surname>Donetti</surname><given-names>E.</given-names></name><name><surname>Bosco</surname><given-names>D. A.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>109</volume>
<fpage>5074</fpage>–<lpage>5079</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1115402109</pub-id>
<pub-id pub-id-type="pmid">22416121</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guegan</surname><given-names>C.</given-names></name><name><surname>Vila</surname><given-names>M.</given-names></name><name><surname>Rosoklija</surname><given-names>G.</given-names></name><name><surname>Hays</surname><given-names>A. P.</given-names></name><name><surname>Przedborski</surname><given-names>S.</given-names></name></person-group> (<year>2001</year>). <article-title>Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>21</volume>
<fpage>6569</fpage>–<lpage>6576</lpage>. <pub-id pub-id-type="pmid">11517246</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guest</surname><given-names>J.</given-names></name><name><surname>Grant</surname><given-names>R.</given-names></name></person-group> (<year>2016</year>). <article-title>Carotenoids and neurobiological health.</article-title>
<source/><italic>Adv. Neurobiol.</italic>
<volume>12</volume>
<fpage>199</fpage>–<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-319-28383-8_11</pub-id>
<pub-id pub-id-type="pmid">27651255</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guille</surname><given-names>A.</given-names></name><name><surname>Bodor</surname><given-names>E. T.</given-names></name><name><surname>Ahmed</surname><given-names>K.</given-names></name><name><surname>Offermanns</surname><given-names>S.</given-names></name></person-group> (<year>2008</year>). <article-title>Nicotinic acid: pharmacological effects and mechanisms of action.</article-title>
<source/><italic>Annu. Rev. Pharmacol. Toxicol.</italic>
<volume>48</volume>
<fpage>79</fpage>–<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.pharmtox.48.113006.094746</pub-id>
<pub-id pub-id-type="pmid">17705685</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>C.</given-names></name><name><surname>Sun</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>D.</given-names></name></person-group> (<year>2013</year>). <article-title>Oxidative stress, mitochondrial damage and neurodegenerative diseases.</article-title>
<source/><italic>Neural Regen. Res.</italic>
<volume>8</volume>
<fpage>2003</fpage>–<lpage>2014</lpage>. <pub-id pub-id-type="doi">10.3969/j.issn.1673-5374.2013.21.009</pub-id>
<pub-id pub-id-type="pmid">25206509</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Hu</surname><given-names>C. P.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name></person-group> (<year>2016</year>). <article-title>Restoration of sirt1 function by pterostilbene attenuates hypoxia-reoxygenation injury in cardiomyocytes.</article-title>
<source/><italic>Eur. J. Pharmacol.</italic>
<volume>776</volume>
<fpage>26</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2016.02.052</pub-id>
<pub-id pub-id-type="pmid">26921129</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurney</surname><given-names>M. E.</given-names></name><name><surname>Cutting</surname><given-names>F. B.</given-names></name><name><surname>Zhai</surname><given-names>P.</given-names></name><name><surname>Doble</surname><given-names>A.</given-names></name><name><surname>Taylor</surname><given-names>C. P.</given-names></name><name><surname>Andrus</surname><given-names>P. K.</given-names></name><etal></etal></person-group> (<year>1996</year>). <article-title>Benefit of vitamin E, riuzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>39</volume>
<fpage>147</fpage>–<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410390203</pub-id>
<pub-id pub-id-type="pmid">8967745</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gustafson</surname><given-names>D. R.</given-names></name><name><surname>Clare Morris</surname><given-names>M.</given-names></name><name><surname>Scarmeas</surname><given-names>N.</given-names></name><name><surname>Shah</surname><given-names>R. C.</given-names></name><name><surname>Sijben</surname><given-names>J.</given-names></name><name><surname>Yaffe</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>New perspectives on Alzheimer’s disease and nutrition.</article-title>
<source/><italic>J. Alzheimers Dis.</italic>
<volume>46</volume>
<fpage>1111</fpage>–<lpage>1127</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-150084</pub-id>
<pub-id pub-id-type="pmid">26402637</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gyulkhandanyan</surname><given-names>A. V.</given-names></name><name><surname>Feeney</surname><given-names>C. J.</given-names></name><name><surname>Pennefather</surname><given-names>P. S.</given-names></name></person-group> (<year>2003</year>). <article-title>Modulation of mitochondrial membrane potential and reactive oxygen species production by copper in astrocytes.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>87</volume>
<fpage>448</fpage>–<lpage>460</lpage>. <pub-id pub-id-type="pmid">14511122</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hafner</surname><given-names>A. V.</given-names></name><name><surname>Dai</surname><given-names>J.</given-names></name><name><surname>Gomes</surname><given-names>A. P.</given-names></name><name><surname>Xiao</surname><given-names>C. Y.</given-names></name><name><surname>Palmeira</surname><given-names>C. M.</given-names></name><name><surname>Rosenzweig</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy.</article-title>
<source/><italic>Aging</italic>
<volume>2</volume>
<fpage>914</fpage>–<lpage>923</lpage>. <pub-id pub-id-type="doi">10.18632/aging.100252</pub-id>
<pub-id pub-id-type="pmid">21212461</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haigis</surname><given-names>M. C.</given-names></name><name><surname>Sinclair</surname><given-names>D. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Mammalian sirtuins: biological insights and disease relevance.</article-title>
<source/><italic>Annu. Rev. Pathol.</italic>
<volume>5</volume>
<fpage>253</fpage>–<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.pathol.4.110807.092250</pub-id>
<pub-id pub-id-type="pmid">20078221</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>E. D.</given-names></name><name><surname>Andrus</surname><given-names>P. K.</given-names></name><name><surname>Oostveen</surname><given-names>J. A.</given-names></name><name><surname>Fleck</surname><given-names>T. J.</given-names></name><name><surname>Gurney</surname><given-names>M. E.</given-names></name></person-group> (<year>1998</year>). <article-title>Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS.</article-title>
<source/><italic>J. Neurosci. Res.</italic>
<volume>53</volume>
<fpage>66</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="pmid">9670993</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halliwell</surname><given-names>B.</given-names></name></person-group> (<year>2012</year>). <article-title>Free radicals and antioxidants: updating a personal view.</article-title>
<source/><italic>Nutr. Rev.</italic>
<volume>70</volume>
<fpage>257</fpage>–<lpage>265</lpage>. <pub-id pub-id-type="doi">10.1111/j.1753-4887.2012.00476.x</pub-id>
<pub-id pub-id-type="pmid">22537212</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>S.</given-names></name><name><surname>Choi</surname><given-names>J. R.</given-names></name><name><surname>Soon-Shin</surname><given-names>K.</given-names></name><name><surname>Kang</surname><given-names>S. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Resveratrol upregulated heat shock proteins and extended the survival of G93A-SOD1 mice.</article-title>
<source/><italic>Brain Res.</italic>
<volume>5</volume>
<fpage>112</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2012.09.022</pub-id>
<pub-id pub-id-type="pmid">23000195</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harlan</surname><given-names>B. A.</given-names></name><name><surname>Pehar</surname><given-names>M.</given-names></name><name><surname>Sharma</surname><given-names>D. R.</given-names></name><name><surname>Beeson</surname><given-names>G.</given-names></name><name><surname>Beeson</surname><given-names>C. C.</given-names></name><name><surname>Vargas</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Enhancing NAD+ salvage pathway reverts the toxicity of primary astrocytes expressing amyotrophic lateral sclerosis-linked mutant SOD1.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>291</volume>
<fpage>10836</fpage>–<lpage>10846</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M115.698779</pub-id>
<pub-id pub-id-type="pmid">27002158</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harraz</surname><given-names>M. M.</given-names></name><name><surname>Marden</surname><given-names>J. J.</given-names></name><name><surname>Zhou</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Williams</surname><given-names>A.</given-names></name><name><surname>Sharov</surname><given-names>V. S.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>SOD1 mutations disrupt redox-sensitive.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>118</volume>
<fpage>659</fpage>–<lpage>670</lpage>. <pub-id pub-id-type="doi">10.1172/JCI34060</pub-id>
<pub-id pub-id-type="pmid">18219391</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>L.</given-names></name><name><surname>He</surname><given-names>T.</given-names></name><name><surname>Farrar</surname><given-names>S.</given-names></name><name><surname>Ji</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name></person-group> (<year>2017</year>). <article-title>Antioxidants maintain cellular redox homeostasis by elimination of reactive oxygen species.</article-title>
<source/><italic>Cell. Physiol. Biochem.</italic>
<volume>44</volume>
<fpage>532</fpage>–<lpage>553</lpage>. <pub-id pub-id-type="doi">10.1159/000485089</pub-id>
<pub-id pub-id-type="pmid">29145191</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hikosaka</surname><given-names>K.</given-names></name><name><surname>Yaku</surname><given-names>K.</given-names></name><name><surname>Okabe</surname><given-names>K.</given-names></name><name><surname>Nakagawa</surname><given-names>T.</given-names></name></person-group> (<year>2019</year>). <article-title>Implications of NAD metabolism in pathophysiology and therapeutics for neurodegenerative diseases.</article-title>
<source/><italic>Nutr. Neurosci.</italic>
<volume>7</volume>
<fpage>1</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1080/1028415X.2019.1637504</pub-id>
<pub-id pub-id-type="pmid">31280708</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodgkinson</surname><given-names>V. L.</given-names></name><name><surname>Lounsberry</surname><given-names>J.</given-names></name><name><surname>Mirian</surname><given-names>A.</given-names></name><name><surname>Genge</surname><given-names>A.</given-names></name><name><surname>Benstead</surname><given-names>T.</given-names></name><name><surname>Briemberg</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Provincial differences in the diagnosis and care of amyotrophic lateral sclerosis.</article-title>
<source/><italic>Can. J. Neurol. Sci.</italic>
<volume>45</volume>
<fpage>652</fpage>–<lpage>659</lpage>. <pub-id pub-id-type="doi">10.1017/cjn.2018.311</pub-id>
<pub-id pub-id-type="pmid">30430962</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hooten</surname><given-names>K. G.</given-names></name><name><surname>Beers</surname><given-names>D. R.</given-names></name><name><surname>Zhao</surname><given-names>W.</given-names></name><name><surname>Appel</surname><given-names>S. H.</given-names></name></person-group> (<year>2015</year>). <article-title>Protective and toxic neuroinflammation in amyotrophic lateral sclerosis.</article-title>
<source/><italic>Neurotherapeutics</italic>
<volume>12</volume>
<fpage>364</fpage>–<lpage>375</lpage>. <pub-id pub-id-type="doi">10.1007/s13311-014-0329-3</pub-id>
<pub-id pub-id-type="pmid">25567201</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>Y.</given-names></name><name><surname>Lautrup</surname><given-names>S.</given-names></name><name><surname>Cordonnier</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Croteau</surname><given-names>D. L.</given-names></name><name><surname>Zavala</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2017a</year>). <article-title>NAD+ supplementation normalizes key Alzheimer’s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>115</volume>
<fpage>E1876</fpage>–<lpage>E1885</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1718819115</pub-id>
<pub-id pub-id-type="pmid">29432159</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>Y.</given-names></name><name><surname>Song</surname><given-names>H.</given-names></name><name><surname>Croteau</surname><given-names>D. L.</given-names></name><name><surname>Akbari</surname><given-names>M.</given-names></name><name><surname>Bohr</surname><given-names>V. A.</given-names></name></person-group> (<year>2017b</year>). <article-title>Genome instability in Alzheimer disease.</article-title>
<source/><italic>Mech. Ageing Dev.</italic>
<volume>161</volume>(<issue>Pt A</issue>), <fpage>83</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.mad.2016.04.005</pub-id>
<pub-id pub-id-type="pmid">27105872</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>Y.</given-names></name><name><surname>Xie</surname><given-names>G.</given-names></name><name><surname>Miao</surname><given-names>F.</given-names></name><name><surname>Ding</surname><given-names>L.</given-names></name><name><surname>Mou</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Pterostilbene attenuates lipopolysaccharide-induced learning and memory impairment possibily via inhibiting microglia activation and protecting neuronal injury in mice.</article-title>
<source/><italic>Prog. Neuropsychopharmacol. Biol. Psychiatry</italic>
<volume>54</volume>
<fpage>92</fpage>–<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2014.03.015</pub-id>
<pub-id pub-id-type="pmid">24709550</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houtkooper</surname><given-names>R. H.</given-names></name><name><surname>Cantó</surname><given-names>C.</given-names></name><name><surname>Wanders</surname><given-names>R. J.</given-names></name><name><surname>Auwerx</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways.</article-title>
<source/><italic>Endocr. Rev.</italic>
<volume>31</volume>
<fpage>194</fpage>–<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1210/er.2009-0026</pub-id>
<pub-id pub-id-type="pmid">20007326</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>C. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Role of redox signaling in neuroinflammation and neurodegenerative diseases.</article-title>
<source/><italic>Biomed. Res. Int.</italic>
<volume>2013</volume>:<issue>484613</issue>. <pub-id pub-id-type="doi">10.1155/2013/484613</pub-id>
<pub-id pub-id-type="pmid">24455696</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hua</surname><given-names>Z.</given-names></name><name><surname>Rong</surname><given-names>T.</given-names></name></person-group> (<year>2016</year>). <article-title>Dietary polyphenols, oxidative stress and antioxidant and anti-inflammatory effects.</article-title>
<source/><italic>Curr. Opin. Food Sci.</italic>
<volume>8</volume>
<fpage>33</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.cofs.2016.02.002</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>J. Y.</given-names></name><name><surname>Hirschey</surname><given-names>M. D.</given-names></name><name><surname>Shimazu</surname><given-names>T.</given-names></name><name><surname>Ho</surname><given-names>L.</given-names></name><name><surname>Verdin</surname><given-names>E.</given-names></name></person-group> (<year>2010</year>). <article-title>Mitochondrial sirtuins.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1804</volume>
<fpage>1645</fpage>–<lpage>1651</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbapap.2009.12.021</pub-id>
<pub-id pub-id-type="pmid">20060508</pub-id></mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huhn</surname><given-names>S.</given-names></name><name><surname>Kharabian Masouleh</surname><given-names>S.</given-names></name><name><surname>Stumvoll</surname><given-names>M.</given-names></name><name><surname>Villringer</surname><given-names>A.</given-names></name><name><surname>Witte</surname><given-names>V.</given-names></name></person-group> (<year>2015</year>). <article-title>Components of a Mediterranean diet and their impacto n cognitive functions in aging.</article-title>
<source/><italic>Front. Aging Neurosci.</italic>
<volume>7</volume>:<issue>132</issue>. <pub-id pub-id-type="doi">10.3389/fnagi.2015.00132</pub-id>
<pub-id pub-id-type="pmid">26217224</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huiyong</surname><given-names>Y.</given-names></name><name><surname>Libin</surname><given-names>X.</given-names></name><name><surname>Porter</surname><given-names>N.</given-names></name></person-group> (<year>2011</year>). <article-title>Free radical lipid peroxidation: mechanism and analysis.</article-title>
<source/><italic>Chem. Rev.</italic>
<volume>111</volume>
<fpage>5944</fpage>–<lpage>5972</lpage>. <pub-id pub-id-type="doi">10.1021/cr200084z</pub-id>
<pub-id pub-id-type="pmid">21861450</pub-id></mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ihara</surname><given-names>Y.</given-names></name><name><surname>Nobukuni</surname><given-names>K.</given-names></name><name><surname>Takata</surname><given-names>H.</given-names></name><name><surname>Hayabara</surname><given-names>T.</given-names></name></person-group> (<year>2005</year>). <article-title>Oxidative stress and metal content in blood and cerebrospinal fluid in amyotrophic lateral sclerosis patients with and without a Cu, Zn superoxide dismutase mutation.</article-title>
<source/><italic>Neurol. Res.</italic>
<volume>27</volume>
<fpage>105</fpage>–<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1179/016164105X18430</pub-id>
<pub-id pub-id-type="pmid">15829169</pub-id></mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikawa</surname><given-names>M.</given-names></name><name><surname>Okazawa</surname><given-names>H.</given-names></name><name><surname>Tsujikawa</surname><given-names>T.</given-names></name><name><surname>Muramatsu</surname><given-names>T.</given-names></name><name><surname>Kishitani</surname><given-names>T.</given-names></name><name><surname>Kamisawa</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Increased oxidative stress is related to disease severity in the ALS motor cortex: a PET study.</article-title>
<source/><italic>Neurology</italic>
<volume>84</volume>
<fpage>2033</fpage>–<lpage>2039</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000001588</pub-id>
<pub-id pub-id-type="pmid">25904686</pub-id></mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>K.</given-names></name><name><surname>Iwasaki</surname><given-names>Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Edaravone, a free radical scavenger, delayed symptomatic and pathological progression of motor neuron disease in the wobbler mouse.</article-title>
<source/><italic>PLoS One</italic>
<volume>10</volume>:<issue>e0140316</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0140316</pub-id>
<pub-id pub-id-type="pmid">26469273</pub-id></mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imai</surname><given-names>S.</given-names></name><name><surname>Guarente</surname><given-names>L.</given-names></name></person-group> (<year>2014</year>). <article-title>NAD+ and sirtuins in aging and disease.</article-title>
<source/><italic>Trends Cell Biol.</italic>
<volume>24</volume>
<fpage>464</fpage>–<lpage>471</lpage>. <pub-id pub-id-type="doi">10.1016/j.tcb.2014.04.002</pub-id>
<pub-id pub-id-type="pmid">24786309</pub-id></mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingre</surname><given-names>C.</given-names></name><name><surname>Roos</surname><given-names>P. M.</given-names></name><name><surname>Piehl</surname><given-names>F.</given-names></name><name><surname>Kamel</surname><given-names>F.</given-names></name><name><surname>Fang</surname><given-names>F.</given-names></name></person-group> (<year>2015</year>). <article-title>Risk factors for amyotrophic lateral sclerosis.</article-title>
<source/><italic>Clin. Epidemiol.</italic>
<volume>12</volume>
<fpage>181</fpage>–<lpage>193</lpage>. <pub-id pub-id-type="doi">10.2147/CLEP.S37505</pub-id>
<pub-id pub-id-type="pmid">25709501</pub-id></mixed-citation>
</ref>
<ref id="B212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>H.</given-names></name><name><surname>Jiang</surname><given-names>X. F.</given-names></name><name><surname>Katayama</surname><given-names>T.</given-names></name><name><surname>Osada</surname><given-names>S.</given-names></name><name><surname>Umesono</surname><given-names>K.</given-names></name><name><surname>Namura</surname><given-names>S.</given-names></name></person-group> (<year>2003</year>). <article-title>Brain protection by reeratrol and fenofibrate against stroke requieres peroxsiome proliferator-activated receptor alpha in mice.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>352</volume>
<fpage>203</fpage>–<lpage>206</lpage>.<pub-id pub-id-type="pmid">14625020</pub-id></mixed-citation>
</ref>
<ref id="B213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ip</surname><given-names>P.</given-names></name><name><surname>Sharda</surname><given-names>P. R.</given-names></name><name><surname>Cunningham</surname><given-names>A.</given-names></name><name><surname>Chakrabartty</surname><given-names>S.</given-names></name><name><surname>Pande</surname><given-names>V.</given-names></name><name><surname>Chakrabartty</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Quercitrin and quercetin 3-β-d-glucoside as chemical chaperones for the A4V SOD1 ALS-causing mutant.</article-title>
<source/><italic>Protein Eng. Des. Sel.</italic>
<volume>30</volume>
<fpage>431</fpage>–<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1093/protein/gzx025</pub-id>
<pub-id pub-id-type="pmid">28475686</pub-id></mixed-citation>
</ref>
<ref id="B214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Islam</surname><given-names>M. T.</given-names></name></person-group> (<year>2017</year>). <article-title>Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders.</article-title>
<source/><italic>Neurol. Res.</italic>
<volume>39</volume>
<fpage>73</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1080/01616412.2016.1251711</pub-id>
<pub-id pub-id-type="pmid">27809706</pub-id></mixed-citation>
</ref>
<ref id="B215">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isonaka</surname><given-names>R.</given-names></name><name><surname>Hiruma</surname><given-names>H.</given-names></name><name><surname>Katakura</surname><given-names>T.</given-names></name><name><surname>Kawakami</surname><given-names>T.</given-names></name></person-group> (<year>2011</year>). <article-title>Inhibition of superoxide dismutase selectively suppresses growth of rat spinal motor neurons: comparison with phosphorylated neurofilament-containing spinal neurons.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1425</volume>
<fpage>13</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2011.09.046</pub-id>
<pub-id pub-id-type="pmid">22018668</pub-id></mixed-citation>
</ref>
<ref id="B216">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Israelson</surname><given-names>A.</given-names></name><name><surname>Arbel</surname><given-names>N.</given-names></name><name><surname>Da Cruz</surname><given-names>S.</given-names></name><name><surname>Ilieva</surname><given-names>H.</given-names></name><name><surname>Yamanaka</surname><given-names>K.</given-names></name><name><surname>Shoshan-Barmatz</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS.</article-title>
<source/><italic>Neuron</italic>
<volume>67</volume>
<fpage>575</fpage>–<lpage>587</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.07.019</pub-id>
<pub-id pub-id-type="pmid">20797535</pub-id></mixed-citation>
</ref>
<ref id="B217">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iverson</surname><given-names>S. L.</given-names></name><name><surname>Orrenius</surname><given-names>S.</given-names></name></person-group> (<year>2004</year>). <article-title>The cardiolipin-cytochrome c interaction and the mitochondrial regulation of apoptosis.</article-title>
<source/><italic>Arch. Biochem. Biophys.</italic>
<volume>423</volume>
<fpage>37</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="pmid">14989263</pub-id></mixed-citation>
</ref>
<ref id="B218">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>C.</given-names></name><name><surname>Heiman-Patterson</surname><given-names>T.</given-names></name><name><surname>Kittrell</surname><given-names>P.</given-names></name><name><surname>Baranovsky</surname><given-names>T.</given-names></name><name><surname>Mcananama</surname><given-names>G.</given-names></name><name><surname>Bower</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Radicava (edaravone) for amyotrophic lateral sclerosis: US experience at 1 year after launch.</article-title>
<source/><italic>Amyotroph. Lateral Scler. Frontotemporal. Degener.</italic>
<volume>20</volume>
<fpage>1</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1080/21678421.2019.1645858</pub-id>
<pub-id pub-id-type="pmid">31364409</pub-id></mixed-citation>
</ref>
<ref id="B219">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>S.</given-names></name><name><surname>Poeggler</surname><given-names>B.</given-names></name><name><surname>Weishaupt</surname><given-names>J. H.</given-names></name><name><surname>Sirén</surname><given-names>A. L.</given-names></name><name><surname>Hardeland</surname><given-names>R.</given-names></name><name><surname>Bähr</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Melatonin as a candidate compound for neuroprotection in amyotrophic lateral sclerosis (ALS): high tolerability of daily oral melatonin administration in ALS patients.</article-title>
<source/><italic>J. Pineal Res.</italic>
<volume>33</volume>
<fpage>186</fpage>–<lpage>187</lpage>.<pub-id pub-id-type="pmid">12220335</pub-id></mixed-citation>
</ref>
<ref id="B220">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaiswal</surname><given-names>M. K.</given-names></name></person-group> (<year>2017</year>). <article-title>Riluzole but not melatonin ameliorates acute motor neuron degeneration and moderately inhibits sod1-mediated excitotoxicity induced disrupted mitochondrial ca<sup>2+</sup> signaling in amyotrophic lateral sclerosis.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>10</volume>:<issue>295</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2016.00295</pub-id>
<pub-id pub-id-type="pmid">28111541</pub-id></mixed-citation>
</ref>
<ref id="B221">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenner</surname><given-names>P.</given-names></name></person-group> (<year>2003</year>). <article-title>Oxidative stress in Parkinson’s disease.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>53</volume>(<issue>Suppl. 3</issue>), <fpage>S26</fpage>–<lpage>S36</lpage>.<pub-id pub-id-type="pmid">12666096</pub-id></mixed-citation>
</ref>
<ref id="B222">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>J. K.</given-names></name><name><surname>Moon</surname><given-names>M. H.</given-names></name><name><surname>Bae</surname><given-names>B. C.</given-names></name><name><surname>Lee</surname><given-names>Y. J.</given-names></name><name><surname>Seol</surname><given-names>J. W.</given-names></name><name><surname>Kang</surname><given-names>H. S.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Autophagy induced by resveratrol prevents human prion protein-mediated neurotoxicity.</article-title>
<source/><italic>Neurosci. Res.</italic>
<volume>73</volume>
<fpage>99</fpage>–<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.neures.2012.03.005</pub-id>
<pub-id pub-id-type="pmid">22465415</pub-id></mixed-citation>
</ref>
<ref id="B223">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jęśko</surname><given-names>H.</given-names></name><name><surname>Wencel</surname><given-names>P.</given-names></name><name><surname>Strosznajder</surname><given-names>R. P.</given-names></name><name><surname>Strosznajder</surname><given-names>J. B.</given-names></name></person-group> (<year>2017</year>). <article-title>Sirtuins and their roles in brain aging and neurodegenerative disorders.</article-title>
<source/><italic>Neurochem. Res.</italic>
<volume>42</volume>
<fpage>876</fpage>–<lpage>890</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-016-2110-y</pub-id>
<pub-id pub-id-type="pmid">27882448</pub-id></mixed-citation>
</ref>
<ref id="B224">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jha</surname><given-names>N.</given-names></name><name><surname>Ryu</surname><given-names>J. J.</given-names></name><name><surname>Choi</surname><given-names>E. H.</given-names></name><name><surname>Kaushik</surname><given-names>N. K.</given-names></name></person-group> (<year>2017</year>). <article-title>Generation and role of reactive oxygen and nitrogen species induced by plasma, lasers, chemical agents, and other systems in dentistry.</article-title>
<source/><italic>Oxid. Med. Cell. Longev.</italic>
<volume>2017</volume>:<issue>7542540</issue>. <pub-id pub-id-type="doi">10.1155/2017/7542540</pub-id>
<pub-id pub-id-type="pmid">29204250</pub-id></mixed-citation>
</ref>
<ref id="B225">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>H.</given-names></name><name><surname>Tian</surname><given-names>X.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Duan</surname><given-names>W.</given-names></name><name><surname>Bu</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name></person-group> (<year>2011</year>). <article-title>Activation of nuclear factor erythroid 2-related factor 2 cytoprotective signaling by curcumin protect primary spinal cord astrocytes against oxidative toxicity.</article-title>
<source/><italic>Biol. Pharm. Bull.</italic>
<volume>34</volume>
<fpage>1194</fpage>–<lpage>1197</lpage>. <pub-id pub-id-type="pmid">21804205</pub-id></mixed-citation>
</ref>
<ref id="B226">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jie</surname><given-names>L.</given-names></name><name><surname>Wuliji</surname><given-names>O.</given-names></name><name><surname>Wei</surname><given-names>L.</given-names></name><name><surname>Zhi-Gang</surname><given-names>J.</given-names></name><name><surname>Hossein</surname><given-names>A. G.</given-names></name></person-group> (<year>2013</year>). <article-title>Oxidative stress and neurodegenerative disorders.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>14</volume>
<fpage>24438</fpage>–<lpage>24475</lpage>. <pub-id pub-id-type="doi">10.3390/ijms141224438</pub-id>
<pub-id pub-id-type="pmid">24351827</pub-id></mixed-citation>
</ref>
<ref id="B227">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>Q.</given-names></name><name><surname>Cai</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Lu</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Edaravone –encapsuled agonistic micelles rescue ischemic brain tissue by tuning blood-brain barrier permability.</article-title>
<source/><italic>Theranostics</italic>
<volume>7</volume>
<fpage>884</fpage>–<lpage>898</lpage>. <pub-id pub-id-type="doi">10.7150/thno.18219</pub-id>
<pub-id pub-id-type="pmid">28382161</pub-id></mixed-citation>
</ref>
<ref id="B228">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>Y.</given-names></name><name><surname>Oh</surname><given-names>K.</given-names></name><name><surname>Oh</surname><given-names>S. I.</given-names></name><name><surname>Baek</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>S. H.</given-names></name><name><surname>Park</surname><given-names>Y.</given-names></name></person-group> (<year>2014</year>). <article-title>Dietary intake of fruits and beta-carotene is negatively associated with amyotrophic lateral sclerosis risk in Koreans: a case-control study.</article-title>
<source/><italic>Nutr. Neurosci.</italic>
<volume>17</volume>
<fpage>104</fpage>–<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1179/1476830513Y.0000000071</pub-id>
<pub-id pub-id-type="pmid">23710627</pub-id></mixed-citation>
</ref>
<ref id="B229">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>S.</given-names></name><name><surname>Imai</surname><given-names>S. I.</given-names></name></person-group> (<year>2018</year>). <article-title>NAD + biosynthesis, aging, and disease.</article-title>
<source/><italic>F1000Research</italic>
<volume>7</volume>:<issue>132</issue>. <pub-id pub-id-type="doi">10.12688/f1000research.12120.1</pub-id>
<pub-id pub-id-type="pmid">29744033</pub-id></mixed-citation>
</ref>
<ref id="B230">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>W. M.</given-names></name><name><surname>Wilson-Delfosse</surname><given-names>A. L.</given-names></name><name><surname>Mieyal</surname><given-names>J. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Dysregulation of glutathione homeostasis in neurodegenerative diseases.</article-title>
<source/><italic>Nutrients</italic>
<volume>4</volume>
<fpage>1399</fpage>–<lpage>1440</lpage>. <pub-id pub-id-type="doi">10.3390/nu4101399</pub-id>
<pub-id pub-id-type="pmid">23201762</pub-id></mixed-citation>
</ref>
<ref id="B231">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joseph</surname><given-names>J. A.</given-names></name><name><surname>Fisher</surname><given-names>D. R.</given-names></name><name><surname>Cheng</surname><given-names>V.</given-names></name><name><surname>Rimando</surname><given-names>A. M.</given-names></name><name><surname>Shukitt-Hale</surname><given-names>B.</given-names></name></person-group> (<year>2008</year>). <article-title>Cellular and behavioral effects of stilbene resveratrol analogues: implications for reducing the deleterious effects of aging.</article-title>
<source/><italic>J. Agric. Food Chem.</italic>
<volume>56</volume>
<fpage>10544</fpage>–<lpage>10551</lpage>. <pub-id pub-id-type="doi">10.1021/jf802279h</pub-id>
<pub-id pub-id-type="pmid">18954071</pub-id></mixed-citation>
</ref>
<ref id="B232">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joseph</surname><given-names>J. A.</given-names></name><name><surname>Shukitt-Hale</surname><given-names>B.</given-names></name><name><surname>Brewer</surname><given-names>G. J.</given-names></name><name><surname>Weikel</surname><given-names>K. A.</given-names></name><name><surname>Wilhelmina</surname><given-names>K.</given-names></name><name><surname>Fisher</surname><given-names>D. R.</given-names></name></person-group> (<year>2011</year>). <article-title>Differential protection among fractionated blueberry polyphenolic families against DA-, Aβ42 and LPS-induced decrements in Ca<sup>2+</sup> buffering in primary hippocampal cells.</article-title>
<source/><italic>J. Agric. Food Chem.</italic>
<volume>58</volume>
<fpage>8196</fpage>–<lpage>8204</lpage>. <pub-id pub-id-type="doi">10.1021/jf100144y</pub-id>
<pub-id pub-id-type="pmid">20597478</pub-id></mixed-citation>
</ref>
<ref id="B233">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jou</surname><given-names>M. J.</given-names></name></person-group> (<year>2008</year>). <article-title>Pathophysiological and pharmacological implications of mitochondria-targeted reactive oxygen species generation in astrocytes.</article-title>
<source/><italic>Adv. Drug Deliv. Rev.</italic>
<volume>60</volume>
<fpage>1512</fpage>–<lpage>1526</lpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2008.06.004</pub-id>
<pub-id pub-id-type="pmid">18692534</pub-id></mixed-citation>
</ref>
<ref id="B234">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Julien</surname><given-names>J. P.</given-names></name></person-group> (<year>2007</year>). <article-title>ALS: astrocytes move in as deadly neighbors.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>10</volume>
<fpage>535</fpage>–<lpage>537</lpage>. <pub-id pub-id-type="doi">10.1038/nn0507-535</pub-id>
<pub-id pub-id-type="pmid">17453052</pub-id></mixed-citation>
</ref>
<ref id="B235">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>C.</given-names></name><name><surname>Higgins</surname><given-names>C. M.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name></person-group> (<year>2002</year>). <article-title>Mitochondrial electron transport chain complex dysfunction in a transgenic mouse model for amyotrophic lateral sclerosis.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>83</volume>
<fpage>535</fpage>–<lpage>545</lpage>. <pub-id pub-id-type="pmid">12390515</pub-id></mixed-citation>
</ref>
<ref id="B236">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juríková</surname><given-names>T.</given-names></name><name><surname>Mlcek</surname><given-names>J.</given-names></name><name><surname>Sochor</surname><given-names>J.</given-names></name><name><surname>Hegedusová</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Polyphenols and their mechanism of action in allergic immune response.</article-title>
<source/><italic>Glob. J. Allergy</italic>
<volume>1</volume>
<fpage>37</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.17352/2455-8141.000008</pub-id></mixed-citation>
</ref>
<ref id="B237">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapetanovic</surname><given-names>J. M.</given-names></name><name><surname>Muzzio</surname><given-names>M.</given-names></name><name><surname>Huang</surname><given-names>Z.</given-names></name><name><surname>Thompson</surname><given-names>T. N.</given-names></name><name><surname>McCormick</surname><given-names>D. L.</given-names></name></person-group> (<year>2011</year>). <article-title>Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats.</article-title>
<source/><italic>Cancer Chemother. Pharmacol.</italic>
<volume>68</volume>
<fpage>593</fpage>–<lpage>601</lpage>. <pub-id pub-id-type="doi">10.1007/s00280-010-1525-4</pub-id>
<pub-id pub-id-type="pmid">21116625</pub-id></mixed-citation>
</ref>
<ref id="B238">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karam</surname><given-names>C.</given-names></name><name><surname>Yi</surname><given-names>J.</given-names></name><name><surname>Xiao</surname><given-names>Y.</given-names></name><name><surname>Dhakal</surname><given-names>K.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Abscence of physiological Ca 2+ transients is an initial trigger for mitochondrial dysfunction in skeletal muscle following denervation.</article-title>
<source/><italic>Skelet. Muscle</italic>
<volume>7</volume>:<issue>6</issue>. <pub-id pub-id-type="doi">10.1186/s13395-017-0123-0</pub-id>
<pub-id pub-id-type="pmid">28395670</pub-id></mixed-citation>
</ref>
<ref id="B239">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>P.</given-names></name><name><surname>Thompson</surname><given-names>J. L.</given-names></name><name><surname>Levy</surname><given-names>G.</given-names></name><name><surname>Buchsbaum</surname><given-names>R.</given-names></name><name><surname>Shefner</surname><given-names>J.</given-names></name><name><surname>Krivickas</surname><given-names>L. S.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>66</volume>
<fpage>235</fpage>–<lpage>244</lpage>. <pub-id pub-id-type="doi">10.1002/ana.21743</pub-id>
<pub-id pub-id-type="pmid">19743457</pub-id></mixed-citation>
</ref>
<ref id="B240">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawahara</surname><given-names>Y.</given-names></name><name><surname>Ito</surname><given-names>K.</given-names></name><name><surname>Sun</surname><given-names>H.</given-names></name><name><surname>Aizawa</surname><given-names>H.</given-names></name><name><surname>Kanazawa</surname><given-names>I.</given-names></name><name><surname>Kwak</surname><given-names>S.</given-names></name></person-group> (<year>2004</year>). <article-title>Glutamate receptors: RNA editing and death of motor neurons.</article-title>
<source/><italic>Nature</italic>
<volume>427</volume>:<issue>801</issue>. <pub-id pub-id-type="doi">10.1038/427801a</pub-id>
<pub-id pub-id-type="pmid">14985749</pub-id></mixed-citation>
</ref>
<ref id="B241">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaye</surname><given-names>W. E.</given-names></name><name><surname>Wagner</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>R.</given-names></name><name><surname>Metha</surname><given-names>P.</given-names></name></person-group> (<year>2018</year>). <article-title>Evaluating the completeness of the national ALS registry, United States.</article-title>
<source/><italic>Amyotroph. Lateral Scler. Frontotemporal. Degener.</italic>
<volume>19</volume>
<fpage>112</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1080/21678421.2017.1384021</pub-id>
<pub-id pub-id-type="pmid">29020837</pub-id></mixed-citation>
</ref>
<ref id="B242">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kehrer</surname><given-names>J. P.</given-names></name><name><surname>Klotz</surname><given-names>L. O.</given-names></name></person-group> (<year>2015</year>). <article-title>Free radicals and related reactive species as mediators of tissue injury and disease: implications for health.</article-title>
<source/><italic>Crit. Rev. Toxicol.</italic>
<volume>45</volume>
<fpage>765</fpage>–<lpage>798</lpage>. <pub-id pub-id-type="doi">10.3109/10408444.2015.1074159</pub-id>
<pub-id pub-id-type="pmid">26610815</pub-id></mixed-citation>
</ref>
<ref id="B243">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kida</surname><given-names>Y.</given-names></name><name><surname>Goligorsky</surname><given-names>M. S.</given-names></name></person-group> (<year>2016</year>). <article-title>Sirtuins, cell senescence, and vascular aging.</article-title>
<source/><italic>Can. J. Cardiol.</italic>
<volume>32</volume>
<fpage>634</fpage>–<lpage>641</lpage>. <pub-id pub-id-type="doi">10.1016/j.cjca.2015.11.022</pub-id>
<pub-id pub-id-type="pmid">26948035</pub-id></mixed-citation>
</ref>
<ref id="B244">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Killoy</surname><given-names>K. M.</given-names></name><name><surname>Harlan</surname><given-names>B. A.</given-names></name><name><surname>Pehar</surname><given-names>M.</given-names></name><name><surname>Helke</surname><given-names>K. L.</given-names></name><name><surname>Johnson</surname><given-names>J. A.</given-names></name><name><surname>Vargas</surname><given-names>M. R.</given-names></name></person-group> (<year>2018</year>). <article-title>Decreased glutathione levels cause overt motor neuron degeneration in hSOD1WT over-expressing mice.</article-title>
<source/><italic>Exp. Neurol.</italic>
<volume>302</volume>
<fpage>129</fpage>–<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2018.01.004</pub-id>
<pub-id pub-id-type="pmid">29307609</pub-id></mixed-citation>
</ref>
<ref id="B245">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D.</given-names></name><name><surname>Nguyen</surname><given-names>M. D.</given-names></name><name><surname>Dobbin</surname><given-names>M. M.</given-names></name><name><surname>Fischer</surname><given-names>A.</given-names></name><name><surname>Sananbenesi</surname><given-names>F.</given-names></name><name><surname>Rodgers</surname><given-names>J. T.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer’s disease and amyotrophic lateral sclerosis.</article-title>
<source/><italic>EMBO J.</italic>
<volume>26</volume>
<fpage>3169</fpage>–<lpage>3179</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7601758</pub-id>
<pub-id pub-id-type="pmid">17581637</pub-id></mixed-citation>
</ref>
<ref id="B246">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D. S.</given-names></name><name><surname>Kim</surname><given-names>J. Y.</given-names></name><name><surname>Han</surname><given-names>Y.</given-names></name></person-group> (<year>2012</year>). <article-title>Curcuminoids in neurodegenerative diseases.</article-title>
<source/><italic>Recent Pat. CNS Drug Discov.</italic>
<volume>7</volume>
<fpage>184</fpage>–<lpage>204</lpage>. <pub-id pub-id-type="pmid">22742420</pub-id></mixed-citation>
</ref>
<ref id="B247">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>G. H.</given-names></name><name><surname>Kim</surname><given-names>J. E.</given-names></name><name><surname>Rhie</surname><given-names>S. J.</given-names></name><name><surname>Yoon</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>The role of oxidative stress in neurodegenerative diseases.</article-title>
<source/><italic>Exp. Neurobiol.</italic>
<volume>24</volume>
<fpage>325</fpage>–<lpage>340</lpage>. <pub-id pub-id-type="doi">10.5607/en.2015.24.4.325</pub-id>
<pub-id pub-id-type="pmid">26713080</pub-id></mixed-citation>
</ref>
<ref id="B248">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J. S.</given-names></name><name><surname>Ha</surname><given-names>T. Y.</given-names></name><name><surname>Ahn</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>H. J.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Pterostilbene from Vitis coignetiae rotect H2O2-induced inhibition of gap junctional intercelular communication in rat liver cell line.</article-title>
<source/><italic>Food Chem. Toxicol.</italic>
<volume>47</volume>
<fpage>404</fpage>–<lpage>409</lpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2008.11.038</pub-id>
<pub-id pub-id-type="pmid">19101604</pub-id></mixed-citation>
</ref>
<ref id="B249">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S. H.</given-names></name><name><surname>Henkel</surname><given-names>J. S.</given-names></name><name><surname>Beers</surname><given-names>D. R.</given-names></name><name><surname>Sengun</surname><given-names>I. S.</given-names></name><name><surname>Simpson</surname><given-names>E. P.</given-names></name><name><surname>Goodman</surname><given-names>J. C.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>PARP expression is increased in astrocytes but decreased in motor neurons in the spinal cord of sporadic ALS patients.</article-title>
<source/><italic>J. Neuropathol. Exp. Neurol.</italic>
<volume>62</volume>
<fpage>88</fpage>–<lpage>103</lpage>. <pub-id pub-id-type="pmid">12528821</pub-id></mixed-citation>
</ref>
<ref id="B250">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname><given-names>S. H.</given-names></name><name><surname>Kwon</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>K. S.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>M. H.</given-names></name><name><surname>Yu</surname><given-names>H. J.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Epigallocatechin gallate prevents oxidative-stress-induced death of mutant Cu/Zn-superoxide dismutase (G93A) motoneuron cells by alteration of cell survival and death signals.</article-title>
<source/><italic>Toxicology</italic>
<volume>202</volume>
<fpage>213</fpage>–<lpage>225</lpage>. <pub-id pub-id-type="doi">10.1016/j.tox.2004.05.008</pub-id>
<pub-id pub-id-type="pmid">15337584</pub-id></mixed-citation>
</ref>
<ref id="B251">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname><given-names>S. H.</given-names></name><name><surname>Lee</surname><given-names>S. M.</given-names></name><name><surname>Kim</surname><given-names>H. Y.</given-names></name><name><surname>Lee</surname><given-names>K. Y.</given-names></name><name><surname>Kim</surname><given-names>H. T.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>395</volume>
<fpage>103</fpage>–<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2005.10.056</pub-id>
<pub-id pub-id-type="pmid">16356650</pub-id></mixed-citation>
</ref>
<ref id="B252">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korkmaz</surname><given-names>O. T.</given-names></name><name><surname>Aytan</surname><given-names>N.</given-names></name><name><surname>Carreras</surname><given-names>I.</given-names></name><name><surname>Choi</surname><given-names>J. K.</given-names></name><name><surname>Kowall</surname><given-names>N. W.</given-names></name><name><surname>Jenkins</surname><given-names>B. G.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>7,8-Dihydroxyflavone improves motor performance and enhances lower motor neuronal survival in a mouse model of amyotrophic lateral sclerosis.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>566</volume>
<fpage>286</fpage>–<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2014.02.058</pub-id>
<pub-id pub-id-type="pmid">24637017</pub-id></mixed-citation>
</ref>
<ref id="B253">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Körner</surname><given-names>S.</given-names></name><name><surname>Böselt</surname><given-names>S.</given-names></name><name><surname>Thau</surname><given-names>N.</given-names></name><name><surname>Rath</surname><given-names>K. J.</given-names></name><name><surname>Dengler</surname><given-names>R.</given-names></name><name><surname>Petri</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Differential sirtuin expression patterns in amyotrophic lateral sclerosis (ALS) postmortem tissue: neuroprotective or neurotoxic properties of sirtuins in ALS?</article-title>
<source/><italic>Neurodegener. Dis.</italic>
<volume>11</volume>
<fpage>141</fpage>–<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1159/000338048</pub-id>
<pub-id pub-id-type="pmid">22796962</pub-id></mixed-citation>
</ref>
<ref id="B254">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosuru</surname><given-names>R.</given-names></name><name><surname>Rai</surname><given-names>U.</given-names></name><name><surname>Prakash</surname><given-names>S.</given-names></name><name><surname>Singh</surname><given-names>A.</given-names></name><name><surname>Singh</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>Promising therapeutical potential of pterostilbene and its mechanistic insight based on preclinical evidence.</article-title>
<source/><italic>Eur. J. Pharmacol.</italic>
<volume>789</volume>
<fpage>229</fpage>–<lpage>243</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2016.07.046</pub-id>
<pub-id pub-id-type="pmid">27475678</pub-id></mixed-citation>
</ref>
<ref id="B255">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krinsky</surname><given-names>N. I.</given-names></name><name><surname>Johnson</surname><given-names>E. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Carotenoid actions and their relation to health and disease.</article-title>
<source/><italic>Mol. Aspects Med.</italic>
<volume>26</volume>
<fpage>459</fpage>–<lpage>516</lpage>. <pub-id pub-id-type="doi">10.1016/j.mam.2005.10.001</pub-id>
<pub-id pub-id-type="pmid">16309738</pub-id></mixed-citation>
</ref>
<ref id="B256">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnaraj</surname><given-names>R. N.</given-names></name><name><surname>Kumari</surname><given-names>S. S.</given-names></name><name><surname>Mukhopadahyay</surname><given-names>S. S.</given-names></name></person-group> (<year>2016</year>). <article-title>Antagonistic molecular interactions of photosynthetic pigments with molecular disease targets: a new approach to treat AD and ALS.</article-title>
<source/><italic>J. Recept. Signal Transduct. Res.</italic>
<volume>36</volume>
<fpage>67</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.3109/10799893.2015.1024851</pub-id>
<pub-id pub-id-type="pmid">26053508</pub-id></mixed-citation>
</ref>
<ref id="B257">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulikova</surname><given-names>V. A.</given-names></name><name><surname>Gromyko</surname><given-names>D. V.</given-names></name><name><surname>Nikiforov</surname><given-names>A. A.</given-names></name></person-group> (<year>2018</year>). <article-title>The regulatory role of NAD in human and animal cells.</article-title>
<source/><italic>Biochemistry</italic>
<volume>83</volume>
<fpage>800</fpage>–<lpage>812</lpage>. <pub-id pub-id-type="doi">10.1134/S0006297918070040</pub-id>
<pub-id pub-id-type="pmid">30200865</pub-id></mixed-citation>
</ref>
<ref id="B258">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Pandey</surname><given-names>A. K.</given-names></name></person-group> (<year>2015</year>). <article-title>Free radicals: health implications and their mitigation by herbals.</article-title>
<source/><italic>Br. J. Med. Med. Res.</italic>
<volume>7</volume>
<fpage>438</fpage>–<lpage>457</lpage>. <pub-id pub-id-type="doi">10.9734/BJMMR/2015/16284</pub-id></mixed-citation>
</ref>
<ref id="B259">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kupis</surname><given-names>W.</given-names></name><name><surname>Palyga</surname><given-names>J.</given-names></name><name><surname>Tomal</surname><given-names>E.</given-names></name><name><surname>Niewiadomska</surname><given-names>E.</given-names></name></person-group> (<year>2016</year>). <article-title>The role of sirtuins in cellular homeostasis.</article-title>
<source/><italic>J. Physiol. Biochem.</italic>
<volume>72</volume>
<fpage>371</fpage>–<lpage>380</lpage>. <pub-id pub-id-type="doi">10.1007/s13105-016-0492-6</pub-id>
<pub-id pub-id-type="pmid">27154583</pub-id></mixed-citation>
</ref>
<ref id="B260">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurtishi</surname><given-names>A.</given-names></name><name><surname>Rosen</surname><given-names>B.</given-names></name><name><surname>Patil</surname><given-names>K. S.</given-names></name><name><surname>Alves</surname><given-names>G. W.</given-names></name><name><surname>Moller</surname><given-names>S. G.</given-names></name></person-group> (<year>2018</year>). <article-title>Cellular proteostasis in neurodegeneration.</article-title>
<source/><italic>Mol. Neurobiol.</italic>
<volume>56</volume>
<fpage>3676</fpage>–<lpage>3689</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-018-1334-z</pub-id>
<pub-id pub-id-type="pmid">30182337</pub-id></mixed-citation>
</ref>
<ref id="B261">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kutil</surname><given-names>Z.</given-names></name><name><surname>Pribylova</surname><given-names>M.</given-names></name><name><surname>Temml</surname><given-names>V.</given-names></name><name><surname>Schuster</surname><given-names>D.</given-names></name><name><surname>Marsik</surname><given-names>P.</given-names></name><name><surname>Susimamani</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Effect of dietary stilbenes on 5-lipoxygenase and cyclooxygenase activities <italic>in vitro</italic>.</article-title>
<source/><italic>Int. J. Food Prop.</italic>
<volume>18</volume>
<fpage>1471</fpage>–<lpage>1477</lpage>. <pub-id pub-id-type="doi">10.1080/10942912.2014.903416</pub-id></mixed-citation>
</ref>
<ref id="B262">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamuela-Raventós</surname><given-names>R. M.</given-names></name><name><surname>Vallverdú-Queralt</surname><given-names>A.</given-names></name><name><surname>Jáuregui</surname><given-names>O.</given-names></name><name><surname>Martínez-Huélamo</surname><given-names>P.</given-names></name><name><surname>Quifer-Rada</surname><given-names>P.</given-names></name></person-group> (<year>2014</year>). <article-title>Improved characterization of polyphenols using liquid chromatography.</article-title>
<source/><italic>Polyphenols Plants</italic>
<volume>14</volume>
<fpage>261</fpage>–<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-12-397934-6.00014-0</pub-id></mixed-citation>
</ref>
<ref id="B263">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lange</surname><given-names>K. W.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>Resveratrol, pterostilbene and dementia.</article-title>
<source/><italic>Biofactors</italic>
<volume>44</volume>
<fpage>83</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1002/biof.1396</pub-id>
<pub-id pub-id-type="pmid">29168580</pub-id></mixed-citation>
</ref>
<ref id="B264">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanska</surname><given-names>D. J.</given-names></name></person-group> (<year>2012</year>). <article-title>The discovery of niacin, biotin, and panthotenic acid.</article-title>
<source/><italic>Ann. Nutr. Metab.</italic>
<volume>61</volume>
<fpage>246</fpage>–<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1159/000343115</pub-id>
<pub-id pub-id-type="pmid">23183297</pub-id></mixed-citation>
</ref>
<ref id="B265">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laudati</surname><given-names>G.</given-names></name><name><surname>Mascolo</surname><given-names>L.</given-names></name><name><surname>Guida</surname><given-names>N.</given-names></name><name><surname>Sirabella</surname><given-names>R.</given-names></name><name><surname>Pizzorusso</surname><given-names>V.</given-names></name><name><surname>Bruzznati</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Resveratrol treatment reduces the vulnerability of SH-SY5Y cells and cortical neurons overexpressing SOD1-G93A to Thimerosal toxicity through SIRT1/DREAM/PDYN pathway.</article-title>
<source/><italic>Neurotoxicology</italic>
<volume>71</volume>
<fpage>6</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuro.2018.11.009</pub-id>
<pub-id pub-id-type="pmid">30503815</pub-id></mixed-citation>
</ref>
<ref id="B266">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lautrup</surname><given-names>S.</given-names></name><name><surname>Sinclair</surname><given-names>D. A.</given-names></name><name><surname>Mattson</surname><given-names>M. P.</given-names></name><name><surname>Fang</surname><given-names>E. F.</given-names></name></person-group> (<year>2019</year>). <article-title>NAD+ in brain aging and neurodegenerative disorders.</article-title>
<source/><italic>Cell Metab.</italic>
<volume>30</volume>
<fpage>630</fpage>–<lpage>655</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2019.09.001</pub-id>
<pub-id pub-id-type="pmid">31577933</pub-id></mixed-citation>
</ref>
<ref id="B267">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y. A.</given-names></name><name><surname>Yun</surname><given-names>B. H.</given-names></name><name><surname>Kim</surname><given-names>S. K.</given-names></name><name><surname>Margolin</surname><given-names>Y.</given-names></name><name><surname>Dedon</surname><given-names>P. C.</given-names></name><name><surname>Geacintov</surname><given-names>N. E.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Mechanisms of oxidation of guanine in DNA by carbonate radical anion, a decomposition product of nitrosoperoxycarbonate.</article-title>
<source/><italic>Chemistry</italic>
<volume>13</volume>
<fpage>4571</fpage>–<lpage>4581</lpage>. <pub-id pub-id-type="doi">10.1002/chem.200601434</pub-id>
<pub-id pub-id-type="pmid">17335089</pub-id></mixed-citation>
</ref>
<ref id="B268">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levites</surname><given-names>Y.</given-names></name><name><surname>Amit</surname><given-names>T.</given-names></name><name><surname>Youdim</surname><given-names>M. B.</given-names></name><name><surname>Mandel</surname><given-names>S.</given-names></name></person-group> (<year>2002</year>). <article-title>Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>277</volume>
<fpage>30574</fpage>–<lpage>30580</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M202832200</pub-id>
<pub-id pub-id-type="pmid">12058035</pub-id></mixed-citation>
</ref>
<ref id="B269">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>Song</surname><given-names>T.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>C.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name></person-group> (<year>2016</year>). <article-title>Neuroprotective actions of pterostilbene on hypoxic-ischemic brain damage in neonatal rats through upregulation of heme oxygenase-1.</article-title>
<source/><italic>Int. J. Dev. Neurosci.</italic>
<volume>54</volume>
<fpage>22</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijdevneu.2016.08.005</pub-id>
<pub-id pub-id-type="pmid">27576146</pub-id></mixed-citation>
</ref>
<ref id="B270">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Su</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Altura</surname><given-names>B. T.</given-names></name><name><surname>Altura</surname><given-names>B. M.</given-names></name></person-group> (<year>2003</year>). <article-title>Hydrogen peroxide induces apoptosis in cerebral vascular smooth muscle cells: possible relation to neurodegenerative diseases and strokes.</article-title>
<source/><italic>Brain Res. Bull.</italic>
<volume>62</volume>
<fpage>101</fpage>–<lpage>106</lpage>. <pub-id pub-id-type="pmid">14638383</pub-id></mixed-citation>
</ref>
<ref id="B271">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Sun</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Chang</surname><given-names>T.</given-names></name><name><surname>Man</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Overexpression of SIRT1 induced by resveratrol and inhibitor of miR-204 suppresses activation and proliferation of microglia.</article-title>
<source/><italic>J. Mol. Neurosci.</italic>
<volume>56</volume>
<fpage>858</fpage>–<lpage>867</lpage>. <pub-id pub-id-type="doi">10.1007/s12031-015-0526-5</pub-id>
<pub-id pub-id-type="pmid">25725784</pub-id></mixed-citation>
</ref>
<ref id="B272">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Cao</surname><given-names>Y.</given-names></name><name><surname>Bai</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Pterostilbene inhibits amyloid-β-induced neuroinflammation in a microglia cell line by inactivating the NLRP3/caspase-1 inflammasome pathway.</article-title>
<source/><italic>J. Cell. Biochem.</italic>
<volume>119</volume>
<fpage>7053</fpage>–<lpage>7062</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.27023</pub-id>
<pub-id pub-id-type="pmid">29737568</pub-id></mixed-citation>
</ref>
<ref id="B273">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Spencer</surname><given-names>N. Y.</given-names></name><name><surname>Pantazis</surname><given-names>N. J.</given-names></name><name><surname>Engelhardt</surname><given-names>J. F.</given-names></name></person-group> (<year>2011</year>). <article-title>Alsin and SOD1(G93A) proteins regulate endosomal reactive oxygen specie production by glial cells and proinflammatory pathways responsable for neurotoxicity.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>286</volume>
<fpage>40151</fpage>–<lpage>40162</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.279711</pub-id>
<pub-id pub-id-type="pmid">21937428</pub-id></mixed-citation>
</ref>
<ref id="B274">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Quiang</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Luo</surname><given-names>L.</given-names></name><name><surname>Xiao</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer’s disease.</article-title>
<source/><italic>Bioorg. Med. Chem. Lett.</italic>
<volume>26</volume>
<fpage>2035</fpage>–<lpage>2039</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2016.02.079</pub-id>
<pub-id pub-id-type="pmid">26947607</pub-id></mixed-citation>
</ref>
<ref id="B275">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y. R.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Lin</surname><given-names>C. C.</given-names></name></person-group> (<year>2018</year>). <article-title>Effect of resveratrol and pterostilbene on aging and logenvity.</article-title>
<source/><italic>Biofactors</italic>
<volume>44</volume>
<fpage>69</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1002/biof.1400</pub-id>
<pub-id pub-id-type="pmid">29210129</pub-id></mixed-citation>
</ref>
<ref id="B276">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>H.</given-names></name><name><surname>Ward</surname><given-names>W. F.</given-names></name></person-group> (<year>2006</year>). <article-title>PGC-1alpha: a key regulator of energy metabolism.</article-title>
<source/><italic>Adv. Physiol. Educ.</italic>
<volume>30</volume>
<fpage>145</fpage>–<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1152/advan.00052.2006</pub-id>
<pub-id pub-id-type="pmid">17108241</pub-id></mixed-citation>
</ref>
<ref id="B277">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liguori</surname><given-names>I.</given-names></name><name><surname>Russo</surname><given-names>G.</given-names></name><name><surname>Curcio</surname><given-names>F.</given-names></name><name><surname>Bulli</surname><given-names>G.</given-names></name><name><surname>Aran</surname><given-names>L.</given-names></name><name><surname>Della-Morte</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Oxidative stress, aging and diseases.</article-title>
<source/><italic>Clin. Interv. Aging</italic>
<volume>13</volume>
<fpage>757</fpage>–<lpage>772</lpage>. <pub-id pub-id-type="doi">10.2147/CIA.S158513</pub-id>
<pub-id pub-id-type="pmid">29731617</pub-id></mixed-citation>
</ref>
<ref id="B278">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>M. T.</given-names></name><name><surname>Beal</surname><given-names>M. F.</given-names></name></person-group> (<year>2006</year>). <article-title>Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.</article-title>
<source/><italic>Nature</italic>
<volume>443</volume>
<fpage>787</fpage>–<lpage>795</lpage>. <pub-id pub-id-type="doi">10.1038/nature05292</pub-id>
<pub-id pub-id-type="pmid">17051205</pub-id></mixed-citation>
</ref>
<ref id="B279">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Y. J.</given-names></name><name><surname>Ding</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Ning</surname><given-names>B. T.</given-names></name></person-group> (<year>2016</year>). <article-title>Pterostilbene as treatment for severe acute pancreatitis.</article-title>
<source/><italic>Genet. Mol. Res.</italic>
<volume>15</volume>:<issue>15038330</issue>. <pub-id pub-id-type="doi">10.4238/gmr.15038330</pub-id>
<pub-id pub-id-type="pmid">27525946</pub-id></mixed-citation>
</ref>
<ref id="B280">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liochev</surname><given-names>S. I.</given-names></name></person-group> (<year>2013</year>). <article-title>Reactive oxygen species and the free radical theory of aging.</article-title>
<source/><italic>Free Radic. Biol. Med.</italic>
<volume>60</volume>
<fpage>1</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2013.02.011</pub-id>
<pub-id pub-id-type="pmid">23434764</pub-id></mixed-citation>
</ref>
<ref id="B281">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Lillo</surname><given-names>C.</given-names></name><name><surname>Jonsson</surname><given-names>P. A.</given-names></name><name><surname>Vande Velde</surname><given-names>C.</given-names></name><name><surname>Ward</surname><given-names>C. M.</given-names></name><name><surname>Miller</surname><given-names>T. M.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria.</article-title>
<source/><italic>Neuron</italic>
<volume>43</volume>
<fpage>5</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2004.06.016</pub-id>
<pub-id pub-id-type="pmid">15233913</pub-id></mixed-citation>
</ref>
<ref id="B282">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Zhai</surname><given-names>Y.</given-names></name><name><surname>Heng</surname><given-names>X.</given-names></name><name><surname>Che</surname><given-names>F. Y.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Sun</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Oral bioavailability of curcumin: problems and advancements.</article-title>
<source/><italic>J. Drug Target.</italic>
<volume>24</volume>
<fpage>694</fpage>–<lpage>702</lpage>. <pub-id pub-id-type="doi">10.3109/1061186X.2016.1157883</pub-id>
<pub-id pub-id-type="pmid">26942997</pub-id></mixed-citation>
</ref>
<ref id="B283">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Han</surname><given-names>L.</given-names></name><name><surname>Ye</surname><given-names>F.</given-names></name><name><surname>Liu</surname><given-names>M.</given-names></name><name><surname>Fan</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Pterostilbene alleviates polymicrobial sepsis-induced liver injury: possible role of SIRT1signaling.</article-title>
<source/><italic>Int. Immunopharmacol.</italic>
<volume>49</volume>
<fpage>50</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2017.05.022</pub-id>
<pub-id pub-id-type="pmid">28550734</pub-id></mixed-citation>
</ref>
<ref id="B284">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loeffler</surname><given-names>J. P.</given-names></name><name><surname>Picchiarelli</surname><given-names>G.</given-names></name><name><surname>Dupuis</surname><given-names>L.</given-names></name><name><surname>Gonzalez de Aguilar</surname><given-names>J. L.</given-names></name></person-group> (<year>2016</year>). <article-title>The role of skeletal muscle in amyotrophic lateral sclerosis.</article-title>
<source/><italic>Brain Pathol.</italic>
<volume>26</volume>
<fpage>227</fpage>–<lpage>236</lpage>. <pub-id pub-id-type="doi">10.1111/bpa.12350</pub-id>
<pub-id pub-id-type="pmid">26780251</pub-id></mixed-citation>
</ref>
<ref id="B285">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LoGerfo</surname><given-names>A.</given-names></name><name><surname>Chico</surname><given-names>L.</given-names></name><name><surname>Borgia</surname><given-names>L.</given-names></name><name><surname>Petrozzi</surname><given-names>L.</given-names></name><name><surname>Rocchi</surname><given-names>A.</given-names></name><name><surname>D’Amelio</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Lack of association between nuclear factor erythroid-derived 2-like 2 promoter gene polymorphisms and oxidative stress biomarkers in amyotrophic lateral sclerosis patients.</article-title>
<source/><italic>Oxid. Med. Cell. Longev</italic>.
<volume>2014</volume>:<issue>432626</issue>. <pub-id pub-id-type="doi">10.1155/2014/432626</pub-id>
<pub-id pub-id-type="pmid">24672634</pub-id></mixed-citation>
</ref>
<ref id="B286">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loizzo</surname><given-names>S.</given-names></name><name><surname>Pieri</surname><given-names>M.</given-names></name><name><surname>Ferri</surname><given-names>A.</given-names></name><name><surname>Carrì</surname><given-names>M. T.</given-names></name><name><surname>Zona</surname><given-names>C.</given-names></name><name><surname>Fortuna</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Dynamic NAD(P)H post-synaptic autofluorescence signals for the assessment of mitochondrial function in a neurodegenerative disease: monitoring the primary motor cortex of G93A mice, an amyotrophic lateral sclerosis model.</article-title>
<source/><italic>Mitochondrion</italic>
<volume>10</volume>
<fpage>108</fpage>–<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1016/j.mito.2009.11.001</pub-id>
<pub-id pub-id-type="pmid">19900586</pub-id></mixed-citation>
</ref>
<ref id="B287">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longecker</surname><given-names>M. P.</given-names></name><name><surname>Kamel</surname><given-names>F.</given-names></name><name><surname>Umbach</surname><given-names>D. M.</given-names></name><name><surname>Munsat</surname><given-names>T. L.</given-names></name><name><surname>Shefner</surname><given-names>J. M.</given-names></name><name><surname>Landsell</surname><given-names>L. W.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Dietary intake of calcium, magnesium and antioxidants in relation to risk of amyotrophic lateral sclerosis.</article-title>
<source/><italic>Neuroepidemiology</italic>
<volume>19</volume>
<fpage>210</fpage>–<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1159/000026258</pub-id>
<pub-id pub-id-type="pmid">10859501</pub-id></mixed-citation>
</ref>
<ref id="B288">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>López-Otín</surname><given-names>C.</given-names></name><name><surname>Blasco</surname><given-names>M. A.</given-names></name><name><surname>Partridge</surname><given-names>L.</given-names></name><name><surname>Serrano</surname><given-names>M.</given-names></name><name><surname>Kroemer</surname><given-names>G.</given-names></name></person-group> (<year>2013</year>). <article-title>The hallmarks of aging.</article-title>
<source/><italic>Cell</italic>
<volume>153</volume>
<fpage>1194</fpage>–<lpage>1217</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.05.039</pub-id>
<pub-id pub-id-type="pmid">23746838</pub-id></mixed-citation>
</ref>
<ref id="B289">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>Duan</surname><given-names>W.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Jiang</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Mitochondrial dysfunction in human TDP-43 transfected NSC34 cell lines and the protective effect of dimethoxy curcumin.</article-title>
<source/><italic>Brain Res. Bull.</italic>
<volume>89</volume>
<fpage>185</fpage>–<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresbull.2012.09.005</pub-id>
<pub-id pub-id-type="pmid">22986236</pub-id></mixed-citation>
</ref>
<ref id="B290">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackenzie</surname><given-names>I. R. A.</given-names></name><name><surname>Rademakers</surname><given-names>R.</given-names></name></person-group> (<year>2008</year>). <article-title>The role of TDP-43 in amyotrophic lateral sclerosis and frontotemporal dementia.</article-title>
<source/><italic>Curr. Opin. Neurol.</italic>
<volume>21</volume>
<fpage>693</fpage>–<lpage>700</lpage>. <pub-id pub-id-type="doi">10.1097/WCO.0b013e3283168d1d</pub-id>
<pub-id pub-id-type="pmid">18989115</pub-id></mixed-citation>
</ref>
<ref id="B291">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magrané</surname><given-names>J.</given-names></name><name><surname>Cortez</surname><given-names>C.</given-names></name><name><surname>Gan</surname><given-names>W. B.</given-names></name><name><surname>Manfredi</surname><given-names>G.</given-names></name></person-group> (<year>2014</year>). <article-title>Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>23</volume>
<fpage>1413</fpage>–<lpage>1424</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt528</pub-id>
<pub-id pub-id-type="pmid">24154542</pub-id></mixed-citation>
</ref>
<ref id="B292">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mancuso</surname><given-names>R.</given-names></name><name><surname>del Valle</surname><given-names>J.</given-names></name><name><surname>Modol</surname><given-names>L.</given-names></name><name><surname>Martinez</surname><given-names>A.</given-names></name><name><surname>Granado-Serrano</surname><given-names>A. B.</given-names></name><name><surname>Ramírez-Núñez</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2014a</year>). <article-title>Resveratrol improves motoneuron function and extends survival in SOD1(G93A) ALS mice.</article-title>
<source/><italic>Neurotherapeutics</italic>
<volume>11</volume>
<fpage>419</fpage>–<lpage>432</lpage>. <pub-id pub-id-type="doi">10.1007/s13311-013-0253-y</pub-id>
<pub-id pub-id-type="pmid">24414863</pub-id></mixed-citation>
</ref>
<ref id="B293">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mancuso</surname><given-names>R.</given-names></name><name><surname>del Valle</surname><given-names>J.</given-names></name><name><surname>Morell</surname><given-names>M.</given-names></name><name><surname>Pallás</surname><given-names>M.</given-names></name><name><surname>Osta</surname><given-names>R.</given-names></name><name><surname>Navarro</surname><given-names>X.</given-names></name></person-group> (<year>2014b</year>). <article-title>Lack of synergistic effect of resveratrol and sigma-1 receptor agonist (PRE-084) in SOD1G93A ALS mice: overlapping effects or limited therapeutic opportunity?</article-title>
<source/><italic>Orphanet J. Rare Dis.</italic>
<volume>9</volume>:<issue>78</issue>. <pub-id pub-id-type="doi">10.1186/1750-1172-9-78</pub-id>
<pub-id pub-id-type="pmid">24885036</pub-id></mixed-citation>
</ref>
<ref id="B294">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandel</surname><given-names>S.</given-names></name><name><surname>Reznichenko</surname><given-names>L.</given-names></name><name><surname>Amit</surname><given-names>T.</given-names></name><name><surname>Youdim</surname><given-names>M. B.</given-names></name></person-group> (<year>2003</year>). <article-title>Green tea polyphenol (-)-epigallocatechin-3-gallate protects rat PC12 cells from apoptosis induced by serum withdrawal independent of P13-Akt pathway.</article-title>
<source/><italic>Neurotox. Res.</italic>
<volume>5</volume>
<fpage>419</fpage>–<lpage>424</lpage>. <pub-id pub-id-type="pmid">14715445</pub-id></mixed-citation>
</ref>
<ref id="B295">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandel</surname><given-names>S. A.</given-names></name><name><surname>Avramovich-Tirosh</surname><given-names>Y.</given-names></name><name><surname>Reznichenko</surname><given-names>L.</given-names></name><name><surname>Zheng</surname><given-names>H.</given-names></name><name><surname>Weinreb</surname><given-names>O.</given-names></name><name><surname>Amit</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway.</article-title>
<source/><italic>Neurosignals</italic>
<volume>14</volume>
<fpage>46</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1159/000085385</pub-id>
<pub-id pub-id-type="pmid">15956814</pub-id></mixed-citation>
</ref>
<ref id="B296">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansuri</surname><given-names>M. L.</given-names></name><name><surname>Parihar</surname><given-names>P.</given-names></name><name><surname>Solanki</surname><given-names>I.</given-names></name><name><surname>Parihar</surname><given-names>M. S.</given-names></name></person-group> (<year>2014</year>). <article-title>Flavonoids in modulation of cell survival signalling pathways.</article-title>
<source/><italic>Genes Nutr.</italic>
<volume>9</volume>:<issue>400</issue>. <pub-id pub-id-type="doi">10.1007/s12263-014-0400-z</pub-id>
<pub-id pub-id-type="pmid">24682883</pub-id></mixed-citation>
</ref>
<ref id="B297">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mantilla</surname><given-names>C. B.</given-names></name><name><surname>Ermilov</surname><given-names>L. G.</given-names></name></person-group> (<year>2012</year>). <article-title>The novel TrkB receptor agonist 7,8-dihydroxyflavone enhances neuromuscular transmission.</article-title>
<source/><italic>Muscle Nerve</italic>
<volume>45</volume>
<fpage>274</fpage>–<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1002/mus.22295</pub-id>
<pub-id pub-id-type="pmid">22246885</pub-id></mixed-citation>
</ref>
<ref id="B298">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marin</surname><given-names>B.</given-names></name><name><surname>Boumedine</surname><given-names>F.</given-names></name><name><surname>Logroscino</surname><given-names>G.</given-names></name><name><surname>Couratier</surname><given-names>P.</given-names></name><name><surname>Babron</surname><given-names>M. C.</given-names></name><name><surname>Leutenegger</surname><given-names>A. L.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis.</article-title>
<source/><italic>Int. J. Epidemiol.</italic>
<volume>46</volume>
<fpage>57</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1093/ije/dyw061</pub-id>
<pub-id pub-id-type="pmid">27185810</pub-id></mixed-citation>
</ref>
<ref id="B299">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martens</surname><given-names>C. R.</given-names></name><name><surname>Denman</surname><given-names>B. A.</given-names></name><name><surname>Mazzo</surname><given-names>M. R.</given-names></name><name><surname>Armstrong</surname><given-names>M. L.</given-names></name><name><surname>Reisdorph</surname><given-names>N.</given-names></name><name><surname>McQueen</surname><given-names>M. B.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>9</volume>:<issue>1286</issue>. <pub-id pub-id-type="doi">10.1038/s41467-018-03421-7</pub-id>
<pub-id pub-id-type="pmid">29599478</pub-id></mixed-citation>
</ref>
<ref id="B300">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>L. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Mitochondrial patohiology in Parkinson’s disease and amyotrophic lateral sclerosis.</article-title>
<source/><italic>J. Alzheimers Dis.</italic>
<volume>20</volume>(<issue>Suppl. 2</issue>), <fpage>S335</fpage>–<lpage>S356</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2010-100348</pub-id>
<pub-id pub-id-type="pmid">20413846</pub-id></mixed-citation>
</ref>
<ref id="B301">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massaad</surname><given-names>C. A.</given-names></name><name><surname>Klann</surname><given-names>E.</given-names></name></person-group> (<year>2011</year>). <article-title>Reactive oxygen species in the regulation of synaptic plasticity and memory.</article-title>
<source/><italic>Antioxid. Redox. Signal.</italic>
<volume>14</volume>
<fpage>2013</fpage>–<lpage>2054</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2010.3208</pub-id>
<pub-id pub-id-type="pmid">20649473</pub-id></mixed-citation>
</ref>
<ref id="B302">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matthews</surname><given-names>R. T.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Browmne</surname><given-names>S.</given-names></name><name><surname>Baik</surname><given-names>M.</given-names></name><name><surname>Beal</surname><given-names>M. F.</given-names></name></person-group> (<year>1998</year>). <article-title>Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>95</volume>
<fpage>8892</fpage>–<lpage>8897</lpage>. <pub-id pub-id-type="pmid">9671775</pub-id></mixed-citation>
</ref>
<ref id="B303">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattiazzi</surname><given-names>M.</given-names></name><name><surname>D’Aurelio</surname><given-names>M.</given-names></name><name><surname>Gajewski</surname><given-names>C. D.</given-names></name><name><surname>Martushova</surname><given-names>K.</given-names></name><name><surname>Kiaei</surname><given-names>M.</given-names></name><name><surname>Beal</surname><given-names>M. F.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitocondria of transgenic mice.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>277</volume>
<fpage>29626</fpage>–<lpage>29633</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M203065200</pub-id>
<pub-id pub-id-type="pmid">12050154</pub-id></mixed-citation>
</ref>
<ref id="B304">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCombe</surname><given-names>P. A.</given-names></name><name><surname>Henderson</surname><given-names>R. D.</given-names></name></person-group> (<year>2010</year>). <article-title>Effects of gender in amyotrophic lateral sclerosis.</article-title>
<source/><italic>Gend. Med.</italic>
<volume>7</volume>
<fpage>557</fpage>–<lpage>570</lpage>. <pub-id pub-id-type="doi">10.1016/j.genm.2010.11.010</pub-id>
<pub-id pub-id-type="pmid">21195356</pub-id></mixed-citation>
</ref>
<ref id="B305">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>P.</given-names></name><name><surname>Kaye</surname><given-names>W.</given-names></name><name><surname>Raymond</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>R.</given-names></name><name><surname>Larson</surname><given-names>T.</given-names></name><name><surname>Punjani</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Prevalence of amyotrophic lateral sclerosis - United States, 2014.</article-title>
<source/><italic>Morb. Mortal. Wkly. Rep.</italic>
<volume>67</volume>
<fpage>216</fpage>–<lpage>218</lpage>. <pub-id pub-id-type="doi">10.15585/mmwr.mm6707a3</pub-id>
<pub-id pub-id-type="pmid">29470458</pub-id></mixed-citation>
</ref>
<ref id="B306">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendelsohn</surname><given-names>A. R.</given-names></name><name><surname>Larrick</surname><given-names>J. W.</given-names></name></person-group> (<year>2014</year>). <article-title>Partial reversal of skeletal muscle aging by restoration of normal NAD+ levels.</article-title>
<source/><italic>Rejuvenation Res.</italic>
<volume>17</volume>
<fpage>62</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1089/rej.2014.1546</pub-id>
<pub-id pub-id-type="pmid">24410488</pub-id></mixed-citation>
</ref>
<ref id="B307">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendelsohn</surname><given-names>A. R.</given-names></name><name><surname>Larrick</surname><given-names>J. W.</given-names></name></person-group> (<year>2017</year>). <article-title>The NAD+/PARP1/SIRT1 axis in aging.</article-title>
<source/><italic>Rejuvenation Res.</italic>
<volume>20</volume>
<fpage>244</fpage>–<lpage>247</lpage>. <pub-id pub-id-type="doi">10.1089/rej.2017.1980</pub-id>
<pub-id pub-id-type="pmid">28537485</pub-id></mixed-citation>
</ref>
<ref id="B308">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menzies</surname><given-names>F. M.</given-names></name><name><surname>Ince</surname><given-names>P. G.</given-names></name><name><surname>Shaw</surname><given-names>P. J.</given-names></name></person-group> (<year>2002</year>). <article-title>Mitochondrial involvement damage in patients with sporadic amyotrophic lateral sclerosis.</article-title>
<source/><italic>Neurochem. Int.</italic>
<volume>40</volume>
<fpage>543</fpage>–<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1016/S0197-0186(01)00125-5</pub-id><pub-id pub-id-type="pmid">11850111</pub-id></mixed-citation>
</ref>
<ref id="B309">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mergenthaler</surname><given-names>P.</given-names></name><name><surname>Lindauer</surname><given-names>U.</given-names></name><name><surname>Dienel</surname><given-names>G. A.</given-names></name><name><surname>Meisel</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Sugar for the brain: the role of glucose in physiological and pathological brain function.</article-title>
<source/><italic>Trends Neurosci.</italic>
<volume>36</volume>
<fpage>587</fpage>–<lpage>597</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2013.07.001</pub-id>
<pub-id pub-id-type="pmid">23968694</pub-id></mixed-citation>
</ref>
<ref id="B310">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michal-Freedman</surname><given-names>D.</given-names></name><name><surname>Kuncl</surname><given-names>R. W.</given-names></name><name><surname>Weinstein</surname><given-names>S. J.</given-names></name><name><surname>Malila</surname><given-names>N.</given-names></name><name><surname>Virtamo</surname><given-names>J.</given-names></name><name><surname>Albanes</surname><given-names>D.</given-names></name></person-group> (<year>2013</year>). <article-title>Vitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosis.</article-title>
<source/><italic>Amyotroph. Lateral Scler. Frontotemporal. Degener.</italic>
<volume>14</volume>
<fpage>246</fpage>–<lpage>251</lpage>. <pub-id pub-id-type="doi">10.3109/21678421.2012.745570</pub-id>
<pub-id pub-id-type="pmid">23286756</pub-id></mixed-citation>
</ref>
<ref id="B311">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikstacka</surname><given-names>R.</given-names></name><name><surname>Rimando</surname><given-names>A. M.</given-names></name><name><surname>Ignatowicz</surname><given-names>E.</given-names></name></person-group> (<year>2010</year>). <article-title>Antioxidant effect of trans-resveratrol, pterostilbene, quercetin and their combinations in human erythrocytes <italic>in vitro</italic>.</article-title>
<source/><italic>Plant Foods Hum. Nutr.</italic>
<volume>65</volume>
<fpage>57</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1007/s11130-010-0154-8</pub-id>
<pub-id pub-id-type="pmid">20108046</pub-id></mixed-citation>
</ref>
<ref id="B312">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milatovic</surname><given-names>D.</given-names></name><name><surname>Montine</surname><given-names>T. J.</given-names></name><name><surname>Aschner</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Measurement of isoprostanes as markers of oxidative stress.</article-title>
<source/><italic>Methods Mol. Biol.</italic>
<volume>758</volume>
<fpage>195</fpage>–<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-61779-170-3_13</pub-id>
<pub-id pub-id-type="pmid">21815067</pub-id></mixed-citation>
</ref>
<ref id="B313">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>A. A.</given-names></name><name><surname>Budzyn</surname><given-names>K.</given-names></name><name><surname>Sobey</surname><given-names>G. G.</given-names></name></person-group> (<year>2010</year>). <article-title>Vascular dysfunction in cerebrovascular disease: mechanisms and therapeutic intervention.</article-title>
<source/><italic>Clin. Sci.</italic>
<volume>119</volume>
<fpage>1</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1042/CS20090649</pub-id>
<pub-id pub-id-type="pmid">20370718</pub-id></mixed-citation>
</ref>
<ref id="B314">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>E.</given-names></name><name><surname>Morel</surname><given-names>A.</given-names></name><name><surname>Saso</surname><given-names>L.</given-names></name><name><surname>Saluk</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Isoprostanes and neuroprostanes as biomarkers of oxidative stress in neurodegenerative diseases.</article-title>
<source/><italic>Oxid. Med. Cell. Longev.</italic>
<volume>2014</volume>:<issue>572491</issue>. <pub-id pub-id-type="doi">10.1155/2014/572491</pub-id>
<pub-id pub-id-type="pmid">24868314</pub-id></mixed-citation>
</ref>
<ref id="B315">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>M. G.</given-names></name><name><surname>Shukitt-Hale</surname><given-names>B.</given-names></name></person-group> (<year>2012</year>). <article-title>Berry fruit enhances beneficial signaling in the brain.</article-title>
<source/><italic>J. Agric. Food. Chem.</italic>
<volume>60</volume>
<fpage>5709</fpage>–<lpage>5715</lpage>. <pub-id pub-id-type="doi">10.1021/jf2036033</pub-id>
<pub-id pub-id-type="pmid">22264107</pub-id></mixed-citation>
</ref>
<ref id="B316">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>R. G.</given-names></name><name><surname>Mitchell</surname><given-names>J. D.</given-names></name><name><surname>Moore</surname><given-names>D. H.</given-names></name></person-group> (<year>2012</year>). <article-title>Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).</article-title>
<source/><italic>Cochrane Database Syst. Rev.</italic>
<volume>14</volume>:<issue>CD001447</issue>. <pub-id pub-id-type="doi">10.1002/14651858.CD001447.pub3</pub-id>
<pub-id pub-id-type="pmid">22419278</pub-id></mixed-citation>
</ref>
<ref id="B317">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milne</surname><given-names>G. L.</given-names></name><name><surname>Sanchez</surname><given-names>S. C.</given-names></name><name><surname>Musiek</surname><given-names>E. S.</given-names></name><name><surname>Morrow</surname><given-names>J. D.</given-names></name></person-group> (<year>2007</year>). <article-title>Quantification of F2-isoprostanes as biomarker of oxidative stress.</article-title>
<source/><italic>Nat. Protoc.</italic>
<volume>2</volume>
<fpage>221</fpage>–<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2006.375</pub-id>
<pub-id pub-id-type="pmid">17401357</pub-id></mixed-citation>
</ref>
<ref id="B318">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minto</surname><given-names>C.</given-names></name><name><surname>Vecchio</surname><given-names>M. G.</given-names></name><name><surname>Lamprecht</surname><given-names>M.</given-names></name><name><surname>Gregori</surname><given-names>D.</given-names></name></person-group> (<year>2017</year>). <article-title>Definition of a tolerable upper intake level of niacin: a systematic review and meta-analysis of the doe-dependent effects of nicotinamide and nicotinic acid supplementation.</article-title>
<source/><italic>Nutr. Rev.</italic>
<volume>75</volume>
<fpage>471</fpage>–<lpage>490</lpage>. <pub-id pub-id-type="doi">10.1093/nutrit/nux011</pub-id>
<pub-id pub-id-type="pmid">28541582</pub-id></mixed-citation>
</ref>
<ref id="B319">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>J.</given-names></name><name><surname>Borasio</surname><given-names>G.</given-names></name></person-group> (<year>2007</year>). <article-title>Amyotrophic lateral sclerosis.</article-title>
<source/><italic>Lancet</italic>
<volume>369</volume>
<fpage>2031</fpage>–<lpage>2041</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(07)60944-1</pub-id>
<pub-id pub-id-type="pmid">17574095</pub-id></mixed-citation>
</ref>
<ref id="B320">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitsumoto</surname><given-names>H.</given-names></name><name><surname>Santella</surname><given-names>R. M.</given-names></name><name><surname>Xinhau</surname><given-names>L.</given-names></name><name><surname>Bogdanov</surname><given-names>M.</given-names></name><name><surname>Zipprich</surname><given-names>J.</given-names></name><name><surname>Hui-Chen</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Oxidative Stress biomarkers in sporadic ALS.</article-title>
<source/><italic>Amyotroph. Lateral Scler.</italic>
<volume>9</volume>
<fpage>177</fpage>–<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1080/17482960801933942</pub-id>
<pub-id pub-id-type="pmid">18574762</pub-id></mixed-citation>
</ref>
<ref id="B321">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto</surname><given-names>N.</given-names></name><name><surname>Maki</surname><given-names>T.</given-names></name><name><surname>Pham</surname><given-names>L. D.</given-names></name><name><surname>Hayakawa</surname><given-names>K.</given-names></name><name><surname>Seo</surname><given-names>J. H.</given-names></name><name><surname>Mandeville</surname><given-names>E. T.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Oxidative stress interferes with White matter renewal after prolonged cerebral hypoperfusion in mice.</article-title>
<source/><italic>Stroke</italic>
<volume>44</volume>
<fpage>3516</fpage>–<lpage>3521</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.113.002813</pub-id>
<pub-id pub-id-type="pmid">24072001</pub-id></mixed-citation>
</ref>
<ref id="B322">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molina</surname><given-names>J. A.</given-names></name><name><surname>De Bustos</surname><given-names>F.</given-names></name><name><surname>Jiménez-Jiménez</surname><given-names>F. J.</given-names></name><name><surname>Gómez-Escalonilla</surname><given-names>C.</given-names></name><name><surname>García-Redondo</surname><given-names>A.</given-names></name><name><surname>Esteban</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Serum levels of coenzyme Q10 in patients with amyotrophic lateral sclerosis.</article-title>
<source/><italic>J. Neural Transm.</italic>
<volume>107</volume>
<fpage>1021</fpage>–<lpage>1026</lpage>. <pub-id pub-id-type="doi">10.1007/s007020070050</pub-id>
<pub-id pub-id-type="pmid">11041280</pub-id></mixed-citation>
</ref>
<ref id="B323">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moon</surname><given-names>Y.</given-names></name><name><surname>Choi</surname><given-names>Y. J.</given-names></name><name><surname>Kim</surname><given-names>J. O.</given-names></name><name><surname>Han</surname><given-names>S. H.</given-names></name></person-group> (<year>2018</year>). <article-title>Muscle profile and cognition in patients with Alzheimer’s disease dementia.</article-title>
<source/><italic>Neurol. Sci.</italic>
<volume>39</volume>
<fpage>1861</fpage>–<lpage>1866</lpage>. <pub-id pub-id-type="doi">10.1007/s10072-018-3505-0</pub-id>
<pub-id pub-id-type="pmid">30084072</pub-id></mixed-citation>
</ref>
<ref id="B324">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morató</surname><given-names>L.</given-names></name><name><surname>Bertini</surname><given-names>E.</given-names></name><name><surname>Verrigini</surname><given-names>D.</given-names></name><name><surname>Ardissone</surname><given-names>A.</given-names></name><name><surname>Ruiz</surname><given-names>M.</given-names></name><name><surname>Ferrer</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Mitochondrial dysfunction in central nervous system white matters disorders.</article-title>
<source/><italic>Glia</italic>
<volume>62</volume>
<fpage>1878</fpage>–<lpage>1894</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22670</pub-id>
<pub-id pub-id-type="pmid">24865954</pub-id></mixed-citation>
</ref>
<ref id="B325">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreira</surname><given-names>P. I.</given-names></name><name><surname>Duarte</surname><given-names>A. I.</given-names></name><name><surname>Santos</surname><given-names>M. S.</given-names></name><name><surname>Rego</surname><given-names>A. C.</given-names></name><name><surname>Oliveira</surname><given-names>C. R.</given-names></name></person-group> (<year>2009</year>). <article-title>An integrative view of the role of oxidative stress, mitocondria and insulin in Alzheimer’s disease.</article-title>
<source/><italic>J. Alzheimers. Dis.</italic>
<volume>16</volume>
<fpage>741</fpage>–<lpage>761</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2009-0972</pub-id>
<pub-id pub-id-type="pmid">19387110</pub-id></mixed-citation>
</ref>
<ref id="B326">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mouchiroud</surname><given-names>L.</given-names></name><name><surname>Houtkooper</surname><given-names>R. H.</given-names></name><name><surname>Moullan</surname><given-names>N.</given-names></name><name><surname>Katsyuba</surname><given-names>E.</given-names></name><name><surname>Ryu</surname><given-names>D.</given-names></name><name><surname>Cantó</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>The NAD(+)/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling.</article-title>
<source/><italic>Cell</italic>
<volume>154</volume>
<fpage>430</fpage>–<lpage>441</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.06.016</pub-id>
<pub-id pub-id-type="pmid">23870130</pub-id></mixed-citation>
</ref>
<ref id="B327">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moujalled</surname><given-names>D.</given-names></name><name><surname>Grubman</surname><given-names>A.</given-names></name><name><surname>Acevedo</surname><given-names>K.</given-names></name><name><surname>Yang</surname><given-names>S.</given-names></name><name><surname>Ke</surname><given-names>Y. D.</given-names></name><name><surname>Moujalled</surname><given-names>D. M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>TDP-43 mutations causing amyotrophic lateral sclerosis are associated with altered expression of RNA-binding protein hnRNP K and affect the Nrf2 antioxidant pathway.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>26</volume>
<fpage>1732</fpage>–<lpage>1746</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddx093</pub-id>
<pub-id pub-id-type="pmid">28334913</pub-id></mixed-citation>
</ref>
<ref id="B328">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>M. P.</given-names></name></person-group> (<year>2009</year>). <article-title>How mitochondria produce reactive oxygen species.</article-title>
<source/><italic>Biochem. J.</italic>
<volume>417</volume>
<fpage>1</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20081386</pub-id>
<pub-id pub-id-type="pmid">19061483</pub-id></mixed-citation>
</ref>
<ref id="B329">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagase</surname><given-names>M.</given-names></name><name><surname>Yamamoto</surname><given-names>Y.</given-names></name><name><surname>Miyazaki</surname><given-names>Y.</given-names></name><name><surname>Yoshino</surname><given-names>H.</given-names></name></person-group> (<year>2016</year>). <article-title>Increased oxidative stress in patients with amyotrophic lateral sclerosis and the effect of edaravone administration.</article-title>
<source/><italic>Redox. Rep.</italic>
<volume>21</volume>
<fpage>104</fpage>–<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1179/1351000215Y.0000000026</pub-id>
<pub-id pub-id-type="pmid">26191780</pub-id></mixed-citation>
</ref>
<ref id="B330">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naik</surname><given-names>B.</given-names></name><name><surname>Nirwane</surname><given-names>A.</given-names></name><name><surname>Majumdar</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Pterostilbene ameliorates intracerebroventricular streptozotocin induced memory decline in rats.</article-title>
<source/><italic>Cogn. Neurodyn.</italic>
<volume>11</volume>
<fpage>35</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1007/s11571-016-9413-1</pub-id>
<pub-id pub-id-type="pmid">28174611</pub-id></mixed-citation>
</ref>
<ref id="B331">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neal</surname><given-names>M.</given-names></name><name><surname>Richardson</surname><given-names>J. R.</given-names></name></person-group> (<year>2018</year>). <article-title>Time to get personal: a framework for personalized targeting of oxidative stress in neurotoxicity and neurodegenerative disease.</article-title>
<source/><italic>Curr. Opin. Toxicol.</italic>
<volume>7</volume>
<fpage>127</fpage>–<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1016/j.cotox.2018.02.003</pub-id>
<pub-id pub-id-type="pmid">30272040</pub-id></mixed-citation>
</ref>
<ref id="B332">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neves</surname><given-names>A. R.</given-names></name><name><surname>Lúcio</surname><given-names>M.</given-names></name><name><surname>Lima</surname><given-names>J. L. C.</given-names></name><name><surname>Reis</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrana interactions.</article-title>
<source/><italic>Curr. Med. Chem.</italic>
<volume>19</volume>
<fpage>1663</fpage>–<lpage>1681</lpage>. <pub-id pub-id-type="pmid">22257059</pub-id></mixed-citation>
</ref>
<ref id="B333">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nie</surname><given-names>G.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>B.</given-names></name></person-group> (<year>2002</year>). <article-title>Protective effects of green tea polyphenols and their major component, (-)-epigallocatechin-3-gallate (EGCG), on 6-hydroxydopamine-induced apoptosis in PC12 cells.</article-title>
<source/><italic>Redox. Rep.</italic>
<volume>7</volume>
<fpage>171</fpage>–<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1179/135100002125000424</pub-id>
<pub-id pub-id-type="pmid">12189048</pub-id></mixed-citation>
</ref>
<ref id="B334">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niedzielska</surname><given-names>E.</given-names></name><name><surname>Smaga</surname><given-names>I.</given-names></name><name><surname>Gawlik</surname><given-names>M.</given-names></name><name><surname>Moniczewski</surname><given-names>A.</given-names></name><name><surname>Stankowicz</surname><given-names>P.</given-names></name><name><surname>Pera</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Oxidative stress in neurodegenerative diseases.</article-title>
<source/><italic>Mol. Neurobiol.</italic>
<volume>53</volume>
<fpage>4094</fpage>–<lpage>4125</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-015-9337-5</pub-id>
<pub-id pub-id-type="pmid">26198567</pub-id></mixed-citation>
</ref>
<ref id="B335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niedzwiecki</surname><given-names>A.</given-names></name><name><surname>Roomi</surname><given-names>M. W.</given-names></name><name><surname>Kalinovsky</surname><given-names>T.</given-names></name><name><surname>Rath</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Anticancer efficacy of polyphenols and their combinations.</article-title>
<source/><italic>Nutrients</italic>
<volume>8</volume>:<issue>552</issue>. <pub-id pub-id-type="doi">10.3390/nu8090552</pub-id>
<pub-id pub-id-type="pmid">27618095</pub-id></mixed-citation>
</ref>
<ref id="B336">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieves</surname><given-names>J. W.</given-names></name><name><surname>Gennings</surname><given-names>C.</given-names></name><name><surname>Factor- Litvak</surname><given-names>P.</given-names></name><name><surname>Hupf</surname><given-names>J.</given-names></name><name><surname>Singleton</surname><given-names>J.</given-names></name><name><surname>Sharf</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Association between dietary intake and function in amyotrophic lateral sclerosis.</article-title>
<source/><italic>JAMA Neurol.</italic>
<volume>73</volume>
<fpage>1425</fpage>–<lpage>1432</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2016.3401</pub-id>
<pub-id pub-id-type="pmid">27775751</pub-id></mixed-citation>
</ref>
<ref id="B337">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niki</surname><given-names>E.</given-names></name></person-group> (<year>2014</year>). <article-title>Biomarkers in lipid peroxidation in clinical material.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1840</volume>
<fpage>809</fpage>–<lpage>817</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbagen.2013.03.020</pub-id>
<pub-id pub-id-type="pmid">23541987</pub-id></mixed-citation>
</ref>
<ref id="B338">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikiforov</surname><given-names>A.</given-names></name><name><surname>Dolle</surname><given-names>C.</given-names></name><name><surname>Niere</surname><given-names>M.</given-names></name><name><surname>Ziegler</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracelullar precursors to mitochondrial NAD generation.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>286</volume>
<fpage>21767</fpage>–<lpage>21778</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.213298</pub-id>
<pub-id pub-id-type="pmid">21504897</pub-id></mixed-citation>
</ref>
<ref id="B339">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikolic-Kokic</surname><given-names>A.</given-names></name><name><surname>Stevic</surname><given-names>Z.</given-names></name><name><surname>Blagojevic</surname><given-names>D.</given-names></name><name><surname>Davidovic</surname><given-names>B.</given-names></name><name><surname>Jones</surname><given-names>D. R.</given-names></name><name><surname>Spasic</surname><given-names>M. B.</given-names></name></person-group> (<year>2006</year>). <article-title>Alterations in anti-oxidative defence enzymes in erythrocytes sporadic amyotrophic lateral sclerosis (SALS) and familial ALS patients.</article-title>
<source/><italic>Clin. Chem. Lab. Med.</italic>
<volume>44</volume>
<fpage>589</fpage>–<lpage>593</lpage>. <pub-id pub-id-type="doi">10.1515/CCLM.2006.111</pub-id>
<pub-id pub-id-type="pmid">16681429</pub-id></mixed-citation>
</ref>
<ref id="B340">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nisar</surname><given-names>N.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Lu</surname><given-names>S.</given-names></name><name><surname>Khin</surname><given-names>N. C.</given-names></name><name><surname>Pogson</surname><given-names>B. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Carotenoid metabolism in plants.</article-title>
<source/><italic>Mol. Plant</italic>
<volume>8</volume>
<fpage>68</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.molp.2014.12.007</pub-id>
<pub-id pub-id-type="pmid">25578273</pub-id></mixed-citation>
</ref>
<ref id="B341">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nizynski</surname><given-names>B.</given-names></name><name><surname>Dzwolak</surname><given-names>W.</given-names></name><name><surname>Nieznanski</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Amyloidogenesis of Tau protein.</article-title>
<source/><italic>Protein Sci.</italic>
<volume>26</volume>
<fpage>2126</fpage>–<lpage>2150</lpage>. <pub-id pub-id-type="doi">10.1002/pro.3275</pub-id>
<pub-id pub-id-type="pmid">28833749</pub-id></mixed-citation>
</ref>
<ref id="B342">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nour</surname><given-names>Y.</given-names></name><name><surname>Nawal</surname><given-names>A.</given-names></name><name><surname>Majed</surname><given-names>J.</given-names></name><name><surname>Chantal</surname><given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>The immunomodulatory and anti-inflammatory role of polyphenols.</article-title>
<source/><italic>Nutrients</italic>
<volume>10</volume>:<issue>1618</issue>. <pub-id pub-id-type="doi">10.3390/nu10111618</pub-id>
<pub-id pub-id-type="pmid">30400131</pub-id></mixed-citation>
</ref>
<ref id="B343">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunomura</surname><given-names>A.</given-names></name><name><surname>Honda</surname><given-names>K.</given-names></name><name><surname>Takeda</surname><given-names>A.</given-names></name><name><surname>Hirai</surname><given-names>K.</given-names></name><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Smith</surname><given-names>M. A.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Oxidative damage to RNA in neurodegenerative diseases.</article-title>
<source/><italic>J. Biomed. Biotechnol.</italic>
<volume>2006</volume>:<issue>82323</issue>. <pub-id pub-id-type="doi">10.1155/JBB/2006/82323</pub-id>
<pub-id pub-id-type="pmid">17047315</pub-id></mixed-citation>
</ref>
<ref id="B344">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oakey</surname><given-names>L. A.</given-names></name><name><surname>Fletcher</surname><given-names>R. S.</given-names></name><name><surname>Elhassan</surname><given-names>Y. S.</given-names></name><name><surname>Cartwright</surname><given-names>D. M.</given-names></name><name><surname>Doig</surname><given-names>C. L.</given-names></name><name><surname>Garten</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Metabolic tracing reveals novel adaptations to skeletal muscle cell energy production pathways in response to NAD + depletion.</article-title>
<source/><italic>Wellcome Open Res.</italic>
<volume>3</volume>:<issue>147</issue>. <pub-id pub-id-type="doi">10.12688/wellcomeopenres.14898.2</pub-id>
<pub-id pub-id-type="pmid">30607371</pub-id></mixed-citation>
</ref>
<ref id="B345">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oberstad</surname><given-names>M.</given-names></name><name><surname>Stieler</surname><given-names>J.</given-names></name><name><surname>Simpong</surname><given-names>D. L.</given-names></name><name><surname>Römuß</surname><given-names>U.</given-names></name><name><surname>Urban</surname><given-names>N.</given-names></name><name><surname>Schaefer</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>TDP-43 self-interaction is modulated by redox-active compounds Auranofin, Chelerythrine and Riluzole.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>8</volume>:<issue>2248</issue>. <pub-id pub-id-type="doi">10.1038/s41598-018-20565-0</pub-id>
<pub-id pub-id-type="pmid">29396541</pub-id></mixed-citation>
</ref>
<ref id="B346">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Callaghan</surname><given-names>C.</given-names></name><name><surname>Vassilopoulos</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Sirtuins at the crossroads of stemness, aging, and cáncer.</article-title>
<source/><italic>Aging Cell</italic>
<volume>16</volume>
<fpage>1208</fpage>–<lpage>1218</lpage>. <pub-id pub-id-type="doi">10.1111/acel.12685</pub-id>
<pub-id pub-id-type="pmid">28994177</pub-id></mixed-citation>
</ref>
<ref id="B347">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okada</surname><given-names>M.</given-names></name><name><surname>Yamashita</surname><given-names>S.</given-names></name><name><surname>Uevama</surname><given-names>H.</given-names></name><name><surname>Ishizaki</surname><given-names>M.</given-names></name><name><surname>Maeda</surname><given-names>Y.</given-names></name><name><surname>Ando</surname><given-names>Y.</given-names></name></person-group> (<year>2018</year>). <article-title>Long-term effects of edaravone on survival of patients with amyotrophic lateral sclerosis.</article-title>
<source/><italic>Neurol. Sci.</italic>
<volume>11</volume>
<fpage>11</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.ensci.2018.05.001</pub-id>
<pub-id pub-id-type="pmid">29928711</pub-id></mixed-citation>
</ref>
<ref id="B348">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okamoto</surname><given-names>K.</given-names></name><name><surname>Kihira</surname><given-names>T.</given-names></name><name><surname>Kobashi</surname><given-names>G.</given-names></name><name><surname>Washio</surname><given-names>M.</given-names></name><name><surname>Sasaki</surname><given-names>S.</given-names></name><name><surname>Yokoyama</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Fruit and vegetable intake and risk of amyotrophic lateral sclerosis in Japan.</article-title>
<source/><italic>Neuroepidemiology</italic>
<volume>32</volume>
<fpage>251</fpage>–<lpage>256</lpage>. <pub-id pub-id-type="doi">10.1159/000201563</pub-id>
<pub-id pub-id-type="pmid">19209004</pub-id></mixed-citation>
</ref>
<ref id="B349">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliviero</surname><given-names>F.</given-names></name><name><surname>Scanu</surname><given-names>A.</given-names></name><name><surname>Zamudio-Cuevas</surname><given-names>Y.</given-names></name><name><surname>Punzi</surname><given-names>L.</given-names></name><name><surname>Spinella</surname><given-names>P.</given-names></name></person-group> (<year>2018</year>). <article-title>Anti-inflammatory effects of polyphenols in arthritis.</article-title>
<source/><italic>J. Sci. Food Agric.</italic>
<volume>98</volume>
<fpage>1653</fpage>–<lpage>1659</lpage>. <pub-id pub-id-type="doi">10.1002/jsfa.8664</pub-id>
<pub-id pub-id-type="pmid">28886220</pub-id></mixed-citation>
</ref>
<ref id="B350">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orrell</surname><given-names>R. W.</given-names></name><name><surname>Lane</surname><given-names>J. M.</given-names></name><name><surname>Ross</surname><given-names>M. A.</given-names></name></person-group> (<year>2004</year>). <article-title>Antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease.</article-title>
<source/><italic>Cochrane Database Syst. Rev.</italic>
<volume>18</volume>:<issue>CD002829</issue>. <pub-id pub-id-type="doi">10.1002/14651858.CD002829.pub2</pub-id>
<pub-id pub-id-type="pmid">15495036</pub-id></mixed-citation>
</ref>
<ref id="B351">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>L.</given-names></name><name><surname>Yoshii</surname><given-names>Y.</given-names></name><name><surname>Otomo</surname><given-names>A.</given-names></name><name><surname>Ogawa</surname><given-names>H.</given-names></name><name><surname>Iwasaki</surname><given-names>Y.</given-names></name><name><surname>Shang</surname><given-names>H. F.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Different human copper-zinc superoxide dismutase mutants, SOD1, and SOD1 exert distinct harmful effect on gross phenotype in mice.</article-title>
<source/><italic>PLoS One</italic>
<volume>7</volume>:<issue>e33409</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0033409</pub-id>
<pub-id pub-id-type="pmid">22438926</pub-id></mixed-citation>
</ref>
<ref id="B352">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>M. H.</given-names></name><name><surname>Chang</surname><given-names>Y. H.</given-names></name><name><surname>Tsai</surname><given-names>M. L.</given-names></name><name><surname>Lai</surname><given-names>C. S.</given-names></name><name><surname>Ho</surname><given-names>S. Y.</given-names></name><name><surname>Badmaev</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Pterostilbene suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages.</article-title>
<source/><italic>J. Agric. Food Chem.</italic>
<volume>56</volume>
<fpage>7502</fpage>–<lpage>7509</lpage>. <pub-id pub-id-type="doi">10.1021/jf800820y</pub-id>
<pub-id pub-id-type="pmid">18656926</pub-id></mixed-citation>
</ref>
<ref id="B353">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandi-Perumal</surname><given-names>S. R.</given-names></name><name><surname>BaHammam</surname><given-names>A. S.</given-names></name><name><surname>Brown</surname><given-names>G. M.</given-names></name><name><surname>Spence</surname><given-names>D. W.</given-names></name><name><surname>Bharti</surname><given-names>V. K.</given-names></name><name><surname>Kaur</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.</article-title>
<source/><italic>Neurotox. Res.</italic>
<volume>23</volume>
<fpage>267</fpage>–<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1007/s12640-012-9337-4</pub-id>
<pub-id pub-id-type="pmid">22739839</pub-id></mixed-citation>
</ref>
<ref id="B354">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panickar</surname><given-names>K. S.</given-names></name><name><surname>Polansky</surname><given-names>M. M.</given-names></name><name><surname>Anderson</surname><given-names>R. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Green tea polyphenols attenuate glial swelling and mitochondrial dysfunction following oxygen-glucose deprivation in cultures.</article-title>
<source/><italic>Nutr. Neurosci.</italic>
<volume>12</volume>
<fpage>105</fpage>–<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1179/147683009X423300</pub-id>
<pub-id pub-id-type="pmid">19356313</pub-id></mixed-citation>
</ref>
<ref id="B355">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papadimitriou</surname><given-names>D.</given-names></name><name><surname>Le Verche</surname><given-names>V.</given-names></name><name><surname>Jacquier</surname><given-names>A.</given-names></name><name><surname>Ikiz</surname><given-names>B.</given-names></name><name><surname>Przedborski</surname><given-names>S.</given-names></name><name><surname>Re</surname><given-names>D. B.</given-names></name></person-group> (<year>2010</year>). <article-title>Inflammation in ALS and SMA: sorting out the good from the evil.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>37</volume>
<fpage>493</fpage>–<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2009.10.005</pub-id>
<pub-id pub-id-type="pmid">19833209</pub-id></mixed-citation>
</ref>
<ref id="B356">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parakh</surname><given-names>S.</given-names></name><name><surname>Spencer</surname><given-names>D. M.</given-names></name><name><surname>Halloran</surname><given-names>M. A.</given-names></name><name><surname>Soo</surname><given-names>K. Y.</given-names></name><name><surname>Atkin</surname><given-names>J. D.</given-names></name></person-group> (<year>2013</year>). <article-title>Redox regulation in amyotrophic lateral sclerosis.</article-title>
<source/><italic>Oxid. Med. Cell. Longev.</italic>
<volume>2013</volume>:<issue>408681</issue>. <pub-id pub-id-type="doi">10.1155/2013/408681</pub-id>
<pub-id pub-id-type="pmid">23533690</pub-id></mixed-citation>
</ref>
<ref id="B357">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J. H.</given-names></name><name><surname>Hong</surname><given-names>Y. H.</given-names></name><name><surname>Kim</surname><given-names>H. J.</given-names></name><name><surname>Kim</surname><given-names>S. M.</given-names></name><name><surname>Park</surname><given-names>K. S.</given-names></name><name><surname>Sung</surname><given-names>J. J.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Pyruvate slows disease progression in a G93A SOD1 mutant transgenic mouse model.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>413</volume>
<fpage>265</fpage>–<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2006.11.058</pub-id>
<pub-id pub-id-type="pmid">17174029</pub-id></mixed-citation>
</ref>
<ref id="B358">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname><given-names>S.</given-names></name><name><surname>Rimando</surname><given-names>A. M.</given-names></name><name><surname>Lee</surname><given-names>H. J.</given-names></name><name><surname>Ji</surname><given-names>Y.</given-names></name><name><surname>Reddy</surname><given-names>B. S.</given-names></name><name><surname>Suh</surname><given-names>N.</given-names></name></person-group> (<year>2009</year>). <article-title>Anti-inflammatory action of pterostilbene is mediated through the p38 mitogen-activated protein kinase pathway in colon cancer cells.</article-title>
<source/><italic>Cancer Prev. Res.</italic>
<volume>2</volume>
<fpage>650</fpage>–<lpage>657</lpage>. <pub-id pub-id-type="doi">10.1158/1940-6207.CAPR-08-0224</pub-id>
<pub-id pub-id-type="pmid">19549798</pub-id></mixed-citation>
</ref>
<ref id="B359">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Payne</surname><given-names>B. A.</given-names></name><name><surname>Chinnery</surname><given-names>P. F.</given-names></name></person-group> (<year>2015</year>). <article-title>Mitochondrial dysfunction in aging: much progress but many unresolved questions.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1847</volume>
<fpage>1347</fpage>–<lpage>1353</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbabio.2015.05.022</pub-id>
<pub-id pub-id-type="pmid">26050973</pub-id></mixed-citation>
</ref>
<ref id="B360">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pehar</surname><given-names>M.</given-names></name><name><surname>Beeson</surname><given-names>G.</given-names></name><name><surname>Beeson</surname><given-names>C. C.</given-names></name><name><surname>Johnson</surname><given-names>J. A.</given-names></name><name><surname>Vargas</surname><given-names>M. R.</given-names></name></person-group> (<year>2014</year>). <article-title>Mitochondria-targeted catalase reverts the neurotoxicity of h SOD1G(9)(3) A astrocytes without extending the survival of ALS-linked mutant hSOD1 mice.</article-title>
<source/><italic>PLoS One</italic>
<volume>9</volume>:<issue>e103438</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0103438</pub-id>
<pub-id pub-id-type="pmid">25054289</pub-id></mixed-citation>
</ref>
<ref id="B361">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perluigi</surname><given-names>M.</given-names></name><name><surname>Coccia</surname><given-names>R.</given-names></name><name><surname>Butterfield</surname><given-names>D. A.</given-names></name></person-group> (<year>2012</year>). <article-title>4-Hydroxy-2-Nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies.</article-title>
<source/><italic>Antioxid. Redox Signal.</italic>
<volume>17</volume>
<fpage>1590</fpage>–<lpage>1609</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2011.4406</pub-id>
<pub-id pub-id-type="pmid">22114878</pub-id></mixed-citation>
</ref>
<ref id="B362">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>O. M.</given-names></name><name><surname>Ghasemi</surname><given-names>M.</given-names></name><name><surname>Brown</surname><given-names>R. H.</given-names></name></person-group> (<year>2015</year>). <article-title>Emerging mechanisms of molecular pathology in ALS.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>125</volume>
<fpage>1767</fpage>–<lpage>1779</lpage>. <pub-id pub-id-type="doi">10.1172/JCI71601</pub-id>
<pub-id pub-id-type="pmid">25932674</pub-id></mixed-citation>
</ref>
<ref id="B363">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrov</surname><given-names>D.</given-names></name><name><surname>Mansfield</surname><given-names>C.</given-names></name><name><surname>Moussy</surname><given-names>A.</given-names></name><name><surname>Hermine</surname><given-names>O.</given-names></name></person-group> (<year>2017</year>). <article-title>ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment?</article-title>
<source/><italic>Front. Aging Neurosci.</italic>
<volume>9</volume>:<issue>68</issue>. <pub-id pub-id-type="doi">10.3389/fnagi.2017.00068</pub-id>
<pub-id pub-id-type="pmid">28382000</pub-id></mixed-citation>
</ref>
<ref id="B364">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrozzi</surname><given-names>L.</given-names></name><name><surname>Ricci</surname><given-names>G.</given-names></name><name><surname>Giglioli</surname><given-names>N. J.</given-names></name><name><surname>Sicialiano</surname><given-names>G.</given-names></name><name><surname>Mancuso</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>Mitochondria and neurodegeneration.</article-title>
<source/><italic>Biosci. Rep.</italic>
<volume>27</volume>
<fpage>87</fpage>–<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1007/s10540-007-9038-z</pub-id>
<pub-id pub-id-type="pmid">17486441</pub-id></mixed-citation>
</ref>
<ref id="B365">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfohl</surname><given-names>S. R.</given-names></name><name><surname>Halicek</surname><given-names>M. T.</given-names></name><name><surname>Mitchell</surname><given-names>C. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Characterization of the contribution of genetic brackground and gender to disease progression in the SOD1 G93A mouse model of amyotrophic lateral sclerosis: a meta-analysis.</article-title>
<source/><italic>J. Neuromuscul. Dis.</italic>
<volume>2</volume>
<fpage>137</fpage>–<lpage>150</lpage>. <pub-id pub-id-type="doi">10.3233/JND-140068</pub-id>
<pub-id pub-id-type="pmid">26594635</pub-id></mixed-citation>
</ref>
<ref id="B366">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phaniendra</surname><given-names>A.</given-names></name><name><surname>Jestadi</surname><given-names>D. B.</given-names></name><name><surname>Periyasamy</surname><given-names>L.</given-names></name></person-group> (<year>2015</year>). <article-title>Free radicals: properties, sources, targets, and their implication in various diseases.</article-title>
<source/><italic>Indian J. Clin. Biochem.</italic>
<volume>30</volume>
<fpage>11</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1007/s12291-014-0446-0</pub-id>
<pub-id pub-id-type="pmid">25646037</pub-id></mixed-citation>
</ref>
<ref id="B367">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pickles</surname><given-names>S.</given-names></name><name><surname>Destroismaisons</surname><given-names>L.</given-names></name><name><surname>Peyrard</surname><given-names>S. L.</given-names></name><name><surname>Cadot</surname><given-names>S.</given-names></name><name><surname>Rouleau</surname><given-names>G. A.</given-names></name><name><surname>Brown</surname><given-names>R. H.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Mitochondrial damage revealed by immunoselection for ALS-linked misfolded SOD1.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>22</volume>
<fpage>3947</fpage>–<lpage>3959</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt249</pub-id>
<pub-id pub-id-type="pmid">23736301</pub-id></mixed-citation>
</ref>
<ref id="B368">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pickles</surname><given-names>S.</given-names></name><name><surname>Semmler</surname><given-names>H. R.</given-names></name><name><surname>Broom</surname><given-names>L.</given-names></name><name><surname>Destroismaisons</surname><given-names>L.</given-names></name><name><surname>Legroux</surname><given-names>N.</given-names></name><name><surname>Arbour</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>ALS-linked misfolded SOD1 species have divergent impacts on mitocondria.</article-title>
<source/><italic>Acta Neuropathol. Commun.</italic>
<volume>4</volume>:<issue>43</issue>. <pub-id pub-id-type="doi">10.1186/s40478-016-0313-8</pub-id>
<pub-id pub-id-type="pmid">27121871</pub-id></mixed-citation>
</ref>
<ref id="B369">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pizzino</surname><given-names>G.</given-names></name><name><surname>Irrera</surname><given-names>N.</given-names></name><name><surname>Cucinotta</surname><given-names>M.</given-names></name><name><surname>Pallio</surname><given-names>G.</given-names></name><name><surname>Mannino</surname><given-names>F.</given-names></name><name><surname>Arcoraci</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Oxidative stress: harms and benefics for human health.</article-title>
<source/><italic>Oxid. Med. Cell. Longev.</italic>
<volume>2017</volume>:<issue>8416763</issue>. <pub-id pub-id-type="doi">10.1155/2017/8416763</pub-id>
<pub-id pub-id-type="pmid">28819546</pub-id></mixed-citation>
</ref>
<ref id="B370">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polimeni</surname><given-names>G.</given-names></name><name><surname>Esposito</surname><given-names>E.</given-names></name><name><surname>Bevelacqua</surname><given-names>V.</given-names></name><name><surname>Guarneri</surname><given-names>C.</given-names></name><name><surname>Cuzzocrea</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Role of melatonin supplementation in neurodegenerative disorders.</article-title>
<source/><italic>Front. Biosci.</italic>
<volume>19</volume>
<fpage>429</fpage>–<lpage>446</lpage>. <pub-id pub-id-type="doi">10.2741/4217</pub-id>
<pub-id pub-id-type="pmid">24389194</pub-id></mixed-citation>
</ref>
<ref id="B371">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poljsak</surname><given-names>B.</given-names></name><name><surname>Milisav</surname><given-names>I.</given-names></name></person-group> (<year>2016</year>). <article-title>NAD+ as the link between oxidative stress, inflammation, caloric restriction, exercise, DNA repair, longevity, and health span.</article-title>
<source/><italic>Rejuvenation Res.</italic>
<volume>19</volume>
<fpage>406</fpage>–<lpage>413</lpage>. <pub-id pub-id-type="doi">10.1089/rej.2015.1767</pub-id>
<pub-id pub-id-type="pmid">26725653</pub-id></mixed-citation>
</ref>
<ref id="B372">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollari</surname><given-names>E.</given-names></name><name><surname>Goldsteins</surname><given-names>G.</given-names></name><name><surname>Bart</surname><given-names>G.</given-names></name><name><surname>Koistinaho</surname><given-names>J.</given-names></name><name><surname>Giniatullin</surname><given-names>R.</given-names></name></person-group> (<year>2014</year>). <article-title>The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>8</volume>:<issue>131</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2014.00131</pub-id>
<pub-id pub-id-type="pmid">24860432</pub-id></mixed-citation>
</ref>
<ref id="B373">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Popa-Wagner</surname><given-names>A.</given-names></name><name><surname>Mitran</surname><given-names>S.</given-names></name><name><surname>Sivanesan</surname><given-names>S.</given-names></name><name><surname>Chang</surname><given-names>E.</given-names></name><name><surname>Buga</surname><given-names>A. M.</given-names></name></person-group> (<year>2013</year>). <article-title>ROS and brain diseases: the good, the bad and the ugly.</article-title>
<source/><italic>Oxid. Med. Cell. Longev.</italic>
<volume>2013</volume>:<issue>963520</issue>. <pub-id pub-id-type="doi">10.1155/2013/963520</pub-id>
<pub-id pub-id-type="pmid">24381719</pub-id></mixed-citation>
</ref>
<ref id="B374">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porquet</surname><given-names>D.</given-names></name><name><surname>Casadesus</surname><given-names>C.</given-names></name><name><surname>Bayod</surname><given-names>S.</given-names></name><name><surname>Vicente</surname><given-names>A.</given-names></name><name><surname>Canudas</surname><given-names>A. M.</given-names></name><name><surname>Vilaplana</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Dietary resveratrol prevents Alzheimer’s markers and increases life span in SAMP8.</article-title>
<source/><italic>Age</italic>
<volume>35</volume>
<fpage>1851</fpage>–<lpage>1865</lpage>. <pub-id pub-id-type="doi">10.1007/s11357-012-9489-4</pub-id>
<pub-id pub-id-type="pmid">23129026</pub-id></mixed-citation>
</ref>
<ref id="B375">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poulose</surname><given-names>S. M.</given-names></name><name><surname>Miller</surname><given-names>M. G.</given-names></name><name><surname>Shukitt-Hale</surname><given-names>B.</given-names></name></person-group> (<year>2014</year>). <article-title>Role of walnuts in maintaining brain health with age.</article-title>
<source/><italic>J. Nutr.</italic>
<volume>144</volume>(<issue>4 Suppl.</issue>), <fpage>561S</fpage>–<lpage>566S</lpage>. <pub-id pub-id-type="doi">10.3945/jn.113.184838</pub-id>
<pub-id pub-id-type="pmid">24500933</pub-id></mixed-citation>
</ref>
<ref id="B376">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poulose</surname><given-names>S. M.</given-names></name><name><surname>Thanthaeng</surname><given-names>N.</given-names></name><name><surname>Miller</surname><given-names>M. G.</given-names></name><name><surname>Shukitt-Hale</surname><given-names>B.</given-names></name></person-group> (<year>2015</year>). <article-title>Effects of pterostilbene and resveratrol on brain and behaviour.</article-title>
<source/><italic>Neurochem. Int.</italic>
<volume>89</volume>
<fpage>227</fpage>–<lpage>233</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2015.07.017</pub-id>
<pub-id pub-id-type="pmid">26212523</pub-id></mixed-citation>
</ref>
<ref id="B377">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prousky</surname><given-names>J.</given-names></name><name><surname>Millman</surname><given-names>C. G.</given-names></name><name><surname>Kikland</surname><given-names>J. B.</given-names></name></person-group> (<year>2011</year>). <article-title>Pharmacologic use of niacin.</article-title>
<source/><italic>J. Evid. Based Intedr. Med.</italic>
<volume>16</volume>
<fpage>91</fpage>–<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1177/2156587211399579</pub-id></mixed-citation>
</ref>
<ref id="B378">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Przedborski</surname><given-names>S.</given-names></name><name><surname>Donaldson</surname><given-names>D. M.</given-names></name><name><surname>Murphy</surname><given-names>P. L.</given-names></name><name><surname>Hirsch</surname><given-names>O.</given-names></name><name><surname>Lange</surname><given-names>D.</given-names></name><name><surname>Naini</surname><given-names>A. B.</given-names></name><etal></etal></person-group> (<year>1996</year>). <article-title>Blood superoxide dismutase, catalase and glutathione peroxidase activities in familial and sporadic amyotrophic lateral sclerosis.</article-title>
<source/><italic>Neurodegeneration</italic>
<volume>5</volume>
<fpage>57</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="pmid">8731383</pub-id></mixed-citation>
</ref>
<ref id="B379">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>X.</given-names></name><name><surname>Brown</surname><given-names>K.</given-names></name><name><surname>Hirschey</surname><given-names>M. D.</given-names></name><name><surname>Verdin</surname><given-names>E.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name></person-group> (<year>2010</year>). <article-title>Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation.</article-title>
<source/><italic>Cell Metab.</italic>
<volume>12</volume>
<fpage>662</fpage>–<lpage>667</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2010.11.015</pub-id>
<pub-id pub-id-type="pmid">21109198</pub-id></mixed-citation>
</ref>
<ref id="B380">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quin</surname><given-names>W.</given-names></name><name><surname>Haroutunian</surname><given-names>V.</given-names></name><name><surname>Katsel</surname><given-names>P.</given-names></name><name><surname>Cardozo</surname><given-names>C. P.</given-names></name><name><surname>Ho</surname><given-names>L.</given-names></name><name><surname>Buxbaum</surname><given-names>J. D.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>PGC-1 alpha expression decreases in the Alzheimer diasease brain as a function of dementia.</article-title>
<source/><italic>Arch. Neurol.</italic>
<volume>66</volume>
<fpage>352</fpage>–<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1001/archneurol.2008.588</pub-id>
<pub-id pub-id-type="pmid">19273754</pub-id></mixed-citation>
</ref>
<ref id="B381">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radak</surname><given-names>Z.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name><name><surname>Goto</surname><given-names>S.</given-names></name><name><surname>Koltai</surname><given-names>E.</given-names></name></person-group> (<year>2011</year>). <article-title>Age-associated neurodegeneration and oxidative damage to lipids, proteins and DNA.</article-title>
<source/><italic>Mol. Aspects Med.</italic>
<volume>32</volume>
<fpage>305</fpage>–<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1016/j.mam.2011.10.010</pub-id>
<pub-id pub-id-type="pmid">22020115</pub-id></mixed-citation>
</ref>
<ref id="B382">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raff</surname><given-names>M. C.</given-names></name><name><surname>Whitmore</surname><given-names>A. V.</given-names></name><name><surname>Finn</surname><given-names>J. T.</given-names></name></person-group> (<year>2002</year>). <article-title>Axonal self-destruction and neurodegeneration.</article-title>
<source/><italic>Science</italic>
<volume>296</volume>
<fpage>868</fpage>–<lpage>871</lpage>. <pub-id pub-id-type="doi">10.1126/science.1068613</pub-id>
<pub-id pub-id-type="pmid">11988563</pub-id></mixed-citation>
</ref>
<ref id="B383">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajman</surname><given-names>L.</given-names></name><name><surname>Chwalek</surname><given-names>K.</given-names></name><name><surname>Sinclair</surname><given-names>D. A.</given-names></name></person-group> (<year>2018</year>). <article-title>Therapeutic potential of NAD-boosting molecules: the <italic>in vivo</italic> evidence.</article-title>
<source/><italic>Cell Metab.</italic>
<volume>27</volume>
<fpage>529</fpage>–<lpage>547</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2018.02.011</pub-id>
<pub-id pub-id-type="pmid">29514064</pub-id></mixed-citation>
</ref>
<ref id="B384">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rakotoarisoa</surname><given-names>M.</given-names></name><name><surname>Angelova</surname><given-names>A.</given-names></name></person-group> (<year>2018</year>). <article-title>Amphiphilic nanocarrier systems for curcumin delivery in neurodegenerative disorders.</article-title>
<source/><italic>Medicines</italic>
<volume>5</volume>:<issue>E126</issue>. <pub-id pub-id-type="doi">10.3390/medicines5040126</pub-id>
<pub-id pub-id-type="pmid">30477087</pub-id></mixed-citation>
</ref>
<ref id="B385">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramamoorthy</surname><given-names>M.</given-names></name><name><surname>Sykora</surname><given-names>P.</given-names></name><name><surname>Scheibye-Knudsen</surname><given-names>M.</given-names></name><name><surname>Dunn</surname><given-names>C.</given-names></name><name><surname>Kasmer</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Sporadic Alzheimer disease fibroblasts display an oxidative stress pehnotype.</article-title>
<source/><italic>Free Radic. Biol. Med.</italic>
<volume>53</volume>
<fpage>1371</fpage>–<lpage>1380</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2012.07.018</pub-id>
<pub-id pub-id-type="pmid">22885031</pub-id></mixed-citation>
</ref>
<ref id="B386">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raskin</surname><given-names>J.</given-names></name><name><surname>Cummings</surname><given-names>J.</given-names></name><name><surname>Hardy</surname><given-names>J.</given-names></name><name><surname>Schuh</surname><given-names>K.</given-names></name><name><surname>Dean</surname><given-names>R. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Neurobiology of Alzheimer’s Disease: integrated molecular, physiological, anatomical, biomarker, and cognitive dimensions.</article-title>
<source/><italic>Curr. Alzheimer Res.</italic>
<volume>12</volume>
<fpage>712</fpage>–<lpage>722</lpage>.<pub-id pub-id-type="pmid">26412218</pub-id></mixed-citation>
</ref>
<ref id="B387">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rass</surname><given-names>U.</given-names></name><name><surname>Ahel</surname><given-names>I.</given-names></name><name><surname>West</surname><given-names>S. C.</given-names></name></person-group> (<year>2007</year>). <article-title>Defective DNA repair and neurodegenerative disease.</article-title>
<source/><italic>Cell</italic>
<volume>130</volume>
<fpage>991</fpage>–<lpage>1004</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2007.08.043</pub-id>
<pub-id pub-id-type="pmid">17889645</pub-id></mixed-citation>
</ref>
<ref id="B388">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ray</surname><given-names>P. D.</given-names></name><name><surname>Huang</surname><given-names>B. W.</given-names></name><name><surname>Tsuji</surname><given-names>Y.</given-names></name></person-group> (<year>2012</year>). <article-title>Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling.</article-title>
<source/><italic>Cell Signal.</italic>
<volume>24</volume>
<fpage>981</fpage>–<lpage>990</lpage>. <pub-id pub-id-type="doi">10.1016/j.cellsig.2012.01.008</pub-id>
<pub-id pub-id-type="pmid">22286106</pub-id></mixed-citation>
</ref>
<ref id="B389">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rechtmann</surname><given-names>L.</given-names></name><name><surname>Wagner</surname><given-names>L.</given-names></name><name><surname>Kaye</surname><given-names>W.</given-names></name><name><surname>Villanacci</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Update prevalence and demographic characteristics for ALS cases in Texas, 2009-2011.</article-title>
<source/><italic>South. Med. J.</italic>
<volume>108</volume>
<fpage>483</fpage>–<lpage>486</lpage>. <pub-id pub-id-type="doi">10.14423/SMJ.0000000000000324</pub-id>
<pub-id pub-id-type="pmid">26280775</pub-id></mixed-citation>
</ref>
<ref id="B390">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regueiro</surname><given-names>J.</given-names></name><name><surname>Sánchez-González</surname><given-names>C.</given-names></name><name><surname>Vallverdú-Queralt</surname><given-names>A.</given-names></name><name><surname>Simal-Gándara</surname><given-names>J.</given-names></name><name><surname>Lamuela-Raventós</surname><given-names>R.</given-names></name><name><surname>Izquierdo-Pulido</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Comprehensive identification of walnut polyphenols by liquid chromatography coupled to linear ion trap– Orbitrap mass spectrometry.</article-title>
<source/><italic>Food Chem.</italic>
<volume>152</volume>
<fpage>340</fpage>–<lpage>348</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2013.11.158</pub-id>
<pub-id pub-id-type="pmid">24444946</pub-id></mixed-citation>
</ref>
<ref id="B391">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinisalo</surname><given-names>M.</given-names></name><name><surname>Karlund</surname><given-names>A.</given-names></name><name><surname>Koskela</surname><given-names>A.</given-names></name><name><surname>Kaarniranta</surname><given-names>K.</given-names></name><name><surname>Karjalainen</surname><given-names>R. O.</given-names></name></person-group> (<year>2015</year>). <article-title>Polyphenol stilbenes: molecular mechanisms of defence against oxidative stress and aging-related diseases.</article-title>
<source/><italic>Oxid. Med. Cell. Longev.</italic>
<volume>2015</volume>:<issue>340520</issue>. <pub-id pub-id-type="doi">10.1155/2015/340520</pub-id>
<pub-id pub-id-type="pmid">26180583</pub-id></mixed-citation>
</ref>
<ref id="B392">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Remsberg</surname><given-names>C. M.</given-names></name><name><surname>Yáñez</surname><given-names>J. A.</given-names></name><name><surname>Ohgami</surname><given-names>Y.</given-names></name><name><surname>Vega-Villa</surname><given-names>K. R.</given-names></name><name><surname>Rimando</surname><given-names>A. M.</given-names></name><name><surname>Davies</surname><given-names>N. M.</given-names></name></person-group> (<year>2008</year>). <article-title>Pharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity.</article-title>
<source/><italic>Phytother. Res.</italic>
<volume>22</volume>
<fpage>169</fpage>–<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.2277</pub-id>
<pub-id pub-id-type="pmid">17726731</pub-id></mixed-citation>
</ref>
<ref id="B393">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renaud</surname><given-names>J.</given-names></name><name><surname>Martinoli</surname><given-names>M. G.</given-names></name></person-group> (<year>2019</year>). <article-title>Consideration for the use of polyphenols as therapies in neurodegenerative diseases.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>20</volume>:<issue>E1883</issue>. <pub-id pub-id-type="doi">10.3390/ijms20081883</pub-id>
<pub-id pub-id-type="pmid">26996169</pub-id></mixed-citation>
</ref>
<ref id="B394">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhee</surname><given-names>S. G.</given-names></name><name><surname>Chang</surname><given-names>T. S.</given-names></name><name><surname>Bae</surname><given-names>Y. S.</given-names></name><name><surname>Lee</surname><given-names>S. R.</given-names></name><name><surname>Kang</surname><given-names>S. W.</given-names></name></person-group> (<year>2003</year>). <article-title>Cellular regulation by hydrogen peroxide.</article-title>
<source/><italic>J. Am. Soc. Nephrol.</italic>
<volume>14</volume>(<issue>8 Suppl. 3</issue>), <fpage>S211</fpage>–<lpage>S215</lpage>. <pub-id pub-id-type="doi">10.1097/01.asn.0000077404.45564.7e</pub-id>
<pub-id pub-id-type="pmid">12874433</pub-id></mixed-citation>
</ref>
<ref id="B395">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>K.</given-names></name><name><surname>Allen</surname><given-names>S. P.</given-names></name><name><surname>Mortiboys</surname><given-names>H.</given-names></name><name><surname>Grierson</surname><given-names>A. J.</given-names></name><name><surname>Wharton</surname><given-names>S. B.</given-names></name><name><surname>Ince</surname><given-names>P. G.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>The effect of SOD1 mutation on cellular bioenergetics profile and viability in response to oxidative stress and influence of mutation-type.</article-title>
<source/><italic>PLoS One</italic>
<volume>8</volume>:<issue>e68256</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0068256</pub-id>
<pub-id pub-id-type="pmid">23840839</pub-id></mixed-citation>
</ref>
<ref id="B396">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riche</surname><given-names>D. M.</given-names></name><name><surname>McEwen</surname><given-names>C. L.</given-names></name><name><surname>Riche</surname><given-names>K. D.</given-names></name><name><surname>Sherman</surname><given-names>J. J.</given-names></name><name><surname>Wofford</surname><given-names>M. R.</given-names></name><name><surname>Deschamp</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Analysis of safety from a human clinical trial with pterostilbene.</article-title>
<source/><italic>J. Toxicol.</italic>
<volume>2013</volume>:<issue>463595</issue>. <pub-id pub-id-type="doi">10.1155/2013/463595</pub-id>
<pub-id pub-id-type="pmid">23431291</pub-id></mixed-citation>
</ref>
<ref id="B397">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rimando</surname><given-names>A. M.</given-names></name><name><surname>Cuendet</surname><given-names>M.</given-names></name><name><surname>Desmarchelier</surname><given-names>C.</given-names></name><name><surname>Mehta</surname><given-names>R. G.</given-names></name><name><surname>Pezzuto</surname><given-names>J. M.</given-names></name><name><surname>Duko</surname><given-names>S. O.</given-names></name></person-group> (<year>2002</year>). <article-title>Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally ocurring analogue of resveratrol.</article-title>
<source/><italic>J. Agric. Food Chem.</italic>
<volume>50</volume>
<fpage>3453</fpage>–<lpage>3457</lpage>.<pub-id pub-id-type="pmid">12033810</pub-id></mixed-citation>
</ref>
<ref id="B398">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivière</surname><given-names>C.</given-names></name><name><surname>Pawlus</surname><given-names>A. D.</given-names></name><name><surname>Mérillon</surname><given-names>J. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Natural stilbenoids: distribution in the plant kingdom and chemotaxonomic interest in vitaceae.</article-title>
<source/><italic>Nat. Prod. Rep.</italic>
<volume>29</volume>
<fpage>1317</fpage>–<lpage>1333</lpage>. <pub-id pub-id-type="doi">10.1039/c2np20049j</pub-id>
<pub-id pub-id-type="pmid">23014926</pub-id></mixed-citation>
</ref>
<ref id="B399">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robberecht</surname><given-names>W.</given-names></name></person-group> (<year>2000</year>). <article-title>Oxidative stress in amyotrophic lateral sclerosis.</article-title>
<source/><italic>J. Neurol.</italic>
<volume>247</volume>(<issue>Suppl. 1</issue>), <fpage>1</fpage>–<lpage>6</lpage>.</mixed-citation>
</ref>
<ref id="B400">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodgers</surname><given-names>J. T.</given-names></name><name><surname>Lerin</surname><given-names>C.</given-names></name><name><surname>Haas</surname><given-names>W.</given-names></name><name><surname>Gygi</surname><given-names>S. P.</given-names></name><name><surname>Spiegelman</surname><given-names>B. M.</given-names></name><name><surname>Puigserver</surname><given-names>P.</given-names></name></person-group> (<year>2005</year>). <article-title>Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1.</article-title>
<source/><italic>Nature</italic>
<volume>434</volume>
<fpage>113</fpage>–<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1038/nature03354</pub-id>
<pub-id pub-id-type="pmid">15744310</pub-id></mixed-citation>
</ref>
<ref id="B401">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>N. M.</given-names></name><name><surname>Seeger</surname><given-names>F.</given-names></name><name><surname>Garcin</surname><given-names>E. D.</given-names></name><name><surname>Roberts</surname><given-names>D. D.</given-names></name><name><surname>Isenberg</surname><given-names>J. S.</given-names></name></person-group> (<year>2014</year>). <article-title>Regulation of soluble guanylate cyclase by matricellular thrombospondins: implications for blood flow.</article-title>
<source/><italic>Front. Physiol.</italic>
<volume>5</volume>:<issue>134</issue>. <pub-id pub-id-type="doi">10.3389/fphys.2014.00134</pub-id>
<pub-id pub-id-type="pmid">24772092</pub-id></mixed-citation>
</ref>
<ref id="B402">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojas</surname><given-names>F.</given-names></name><name><surname>González</surname><given-names>D.</given-names></name><name><surname>Cortes</surname><given-names>N.</given-names></name><name><surname>Ampuero</surname><given-names>E.</given-names></name><name><surname>Hernández</surname><given-names>D. E.</given-names></name><name><surname>Fritz</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Reactive oxygen species trigger motoneuron death in non-cell-autonmous models of ALS through activation of c-Abl signaling.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>9</volume>:<issue>203</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2015.00203</pub-id>
<pub-id pub-id-type="pmid">26106294</pub-id></mixed-citation>
</ref>
<ref id="B403">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romano</surname><given-names>A. D.</given-names></name><name><surname>Serviddio</surname><given-names>G.</given-names></name><name><surname>de Matthaeis</surname><given-names>A.</given-names></name><name><surname>Bellanti</surname><given-names>F.</given-names></name><name><surname>Vendemiale</surname><given-names>G.</given-names></name></person-group> (<year>2010</year>). <article-title>Oxidative stress and aging.</article-title>
<source/><italic>J. Nephrol.</italic>
<volume>23</volume>(<issue>Suppl. 15</issue>):36. <pub-id pub-id-type="pmid">20872368</pub-id></mixed-citation>
</ref>
<ref id="B404">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronnett</surname><given-names>G. B.</given-names></name><name><surname>Ramamurthy</surname><given-names>S.</given-names></name><name><surname>Kleman</surname><given-names>A. M.</given-names></name><name><surname>Landree</surname><given-names>L. E.</given-names></name><name><surname>Aja</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>AMPK in the brain: its roles in energy balance and neuroprotection.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>109</volume>
<fpage>17</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.05916.x</pub-id>
<pub-id pub-id-type="pmid">19393004</pub-id></mixed-citation>
</ref>
<ref id="B405">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>M.</given-names></name><name><surname>Caruso</surname><given-names>F.</given-names></name><name><surname>Antonioletti</surname><given-names>R.</given-names></name><name><surname>Viglianti</surname><given-names>A.</given-names></name><name><surname>Traversi</surname><given-names>G.</given-names></name><name><surname>Leone</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Scavenging of hydroxyl radical by resveratrol and related natural stilbenes after hydrogen peroxide attack on DNA.</article-title>
<source/><italic>Chem. Biol. Interact.</italic>
<volume>206</volume>
<fpage>175</fpage>–<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbi.2013.09.013</pub-id>
<pub-id pub-id-type="pmid">24075811</pub-id></mixed-citation>
</ref>
<ref id="B406">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothstein</surname><given-names>J. D.</given-names></name></person-group> (<year>2017</year>). <article-title>Edaravone: a new drug approved for ALS.</article-title>
<source/><italic>Cell</italic>
<volume>171</volume>:<issue>725</issue>. <pub-id pub-id-type="doi">10.1016/j.cell.2017.10.011</pub-id>
<pub-id pub-id-type="pmid">29100067</pub-id></mixed-citation>
</ref>
<ref id="B407">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rüb</surname><given-names>U.</given-names></name><name><surname>Stratmann</surname><given-names>K.</given-names></name><name><surname>Heinsen</surname><given-names>H.</given-names></name><name><surname>Seidel</surname><given-names>K.</given-names></name><name><surname>Bouzrou</surname><given-names>M.</given-names></name><name><surname>Korf</surname><given-names>H. W.</given-names></name></person-group> (<year>2017</year>). <article-title>Alzheimer’s disease: characterization of the brain sites of the initial tau cytoskeletal pathology will improve the success of novel immunological anti-tau treatment approaches.</article-title>
<source/><italic>J. Alzheimers Dis.</italic>
<volume>57</volume>
<fpage>683</fpage>–<lpage>696</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-161102</pub-id>
<pub-id pub-id-type="pmid">28269779</pub-id></mixed-citation>
</ref>
<ref id="B408">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz</surname><given-names>M. J.</given-names></name><name><surname>Fernández</surname><given-names>M.</given-names></name><name><surname>Picó</surname><given-names>Y.</given-names></name><name><surname>Mañes</surname><given-names>J.</given-names></name><name><surname>Asensi</surname><given-names>M.</given-names></name><name><surname>Carda</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Dietary administration of high doses of pterostilbene and quercetin to mice is not toxic.</article-title>
<source/><italic>J. Agric. Food Chem.</italic>
<volume>57</volume>
<fpage>3180</fpage>–<lpage>3186</lpage>. <pub-id pub-id-type="doi">10.1021/jf803579e</pub-id>
<pub-id pub-id-type="pmid">19292443</pub-id></mixed-citation>
</ref>
<ref id="B409">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rusconi</surname><given-names>M.</given-names></name><name><surname>Conti</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title><italic>Theobroma cacao</italic> L., the food of the gods: a scientific approach beyond myths and claims.</article-title>
<source/><italic>Pharmacol. Res.</italic>
<volume>61</volume>
<fpage>5</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2009.08.008</pub-id>
<pub-id pub-id-type="pmid">19735732</pub-id></mixed-citation>
</ref>
<ref id="B410">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Ropelle</surname><given-names>E. R.</given-names></name><name><surname>Sorrentino</surname><given-names>V.</given-names></name><name><surname>Mázala</surname><given-names>D. A.</given-names></name><name><surname>Mouchiroud</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>NAD+ repletion improves muscle function in muscular dystrophy and counters global PARylation.</article-title>
<source/><italic>Sci. Transl. Med.</italic>
<volume>8</volume>:<issue>361ra139</issue>. <pub-id pub-id-type="doi">10.1126/scitranslmed.aaf5504</pub-id>
<pub-id pub-id-type="pmid">27798264</pub-id></mixed-citation>
</ref>
<ref id="B411">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rzheshevsky</surname><given-names>A. V.</given-names></name></person-group> (<year>2014</year>). <article-title>Decrease in ATP biosynthesis and dysfunction of biological membranes. Two possible key mechanisms of phenoptosis.</article-title>
<source/><italic>Biochemistry</italic>
<volume>79</volume>
<fpage>1056</fpage>–<lpage>1068</lpage>. <pub-id pub-id-type="doi">10.1134/S0006297914100071</pub-id>
<pub-id pub-id-type="pmid">25519064</pub-id></mixed-citation>
</ref>
<ref id="B412">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saccon</surname><given-names>R. A.</given-names></name><name><surname>Bunton-Stasyshyn</surname><given-names>R. K.</given-names></name><name><surname>Fisher</surname><given-names>E. M.</given-names></name><name><surname>Fratta</surname><given-names>P.</given-names></name></person-group> (<year>2013</year>). <article-title>Is SOD1 loss of function involved in amyotrophic lateral sclerosis?</article-title>
<source/><italic>Brain</italic>
<volume>136</volume>(<issue>Pt 8</issue>), <fpage>2342</fpage>–<lpage>2358</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awt097</pub-id>
<pub-id pub-id-type="pmid">23687121</pub-id></mixed-citation>
</ref>
<ref id="B413">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salisbury</surname><given-names>D.</given-names></name><name><surname>Bronas</surname><given-names>U.</given-names></name></person-group> (<year>2015</year>). <article-title>Reactive oxygen and nitrogen species: impact on endothelial dysfunction.</article-title>
<source/><italic>Nurs. Res.</italic>
<volume>64</volume>
<fpage>53</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1097/NNR.0000000000000068</pub-id>
<pub-id pub-id-type="pmid">25502061</pub-id></mixed-citation>
</ref>
<ref id="B414">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salvatori</surname><given-names>I.</given-names></name><name><surname>Valle</surname><given-names>C.</given-names></name><name><surname>Ferri</surname><given-names>A.</given-names></name><name><surname>Carrì</surname><given-names>M. T.</given-names></name></person-group> (<year>2017</year>). <article-title>SIRT3 and mitochondrial metabolism in neurodegenerative diseases.</article-title>
<source/><italic>Neurochem. Int.</italic>
<volume>109</volume>
<fpage>184</fpage>–<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2017.04.012</pub-id>
<pub-id pub-id-type="pmid">28449871</pub-id></mixed-citation>
</ref>
<ref id="B415">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santa-Cruz</surname><given-names>L. D.</given-names></name><name><surname>Tapia</surname><given-names>R.</given-names></name></person-group> (<year>2014</year>). <article-title>Role of energy metabolic déficits and oxidative stress in extcitotoxic spinal motor neuron degeneration <italic>in vivo</italic>.</article-title>
<source/><italic>ANS Neuro</italic>
<volume>6</volume>:<issue>e00138</issue>. <pub-id pub-id-type="doi">10.1042/AN20130046</pub-id>
<pub-id pub-id-type="pmid">24524836</pub-id></mixed-citation>
</ref>
<ref id="B416">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarasija</surname><given-names>S.</given-names></name><name><surname>Norman</surname><given-names>K. R.</given-names></name></person-group> (<year>2018</year>). <article-title>Role of presenilin in mitochondrial oxidative stress and neurodegeneration in <italic>Caenorhabditis elegans</italic>.</article-title>
<source/><italic>Antioxidants</italic>
<volume>7</volume>:<issue>111</issue>. <pub-id pub-id-type="doi">10.3390/antiox7090111</pub-id>
<pub-id pub-id-type="pmid">30149498</pub-id></mixed-citation>
</ref>
<ref id="B417">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>S.</given-names></name><name><surname>Shibata</surname><given-names>N.</given-names></name><name><surname>Komori</surname><given-names>T.</given-names></name><name><surname>Iwata</surname><given-names>T.</given-names></name></person-group> (<year>2000</year>). <article-title>iNOS and nitrotyrosine immunoreactivity in amyotrophic lateral sclerosis.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>291</volume>
<fpage>44</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="pmid">10962150</pub-id></mixed-citation>
</ref>
<ref id="B418">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>Y.</given-names></name><name><surname>Araki</surname><given-names>T.</given-names></name><name><surname>Mildbrandt</surname><given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>26</volume>
<fpage>8484</fpage>–<lpage>8491</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2320-06.2006</pub-id>
<pub-id pub-id-type="pmid">16914673</pub-id></mixed-citation>
</ref>
<ref id="B419">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saw</surname><given-names>C. L.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>A. Y.</given-names></name><name><surname>Paredes-Gonzalez</surname><given-names>X.</given-names></name><name><surname>Ramirez</surname><given-names>C.</given-names></name><name><surname>Pung</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>The berry constituents quercetin, kaempferol and pterostilbene synergistically attenuate reactive oxygen species: involvement of the Nrf2-ARE signaling pathway.</article-title>
<source/><italic>Food Chem. Toxicol.</italic>
<volume>72</volume>
<fpage>303</fpage>–<lpage>311</lpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2014.07.038</pub-id>
<pub-id pub-id-type="pmid">25111660</pub-id></mixed-citation>
</ref>
<ref id="B420">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawada</surname><given-names>H.</given-names></name></person-group> (<year>2017</year>). <article-title>Clinical efficacy of edaravone for the treatment of amyotrophic lateral sclerosis.</article-title>
<source/><italic>Expert Opin. Pharmacother.</italic>
<volume>18</volume>
<fpage>735</fpage>–<lpage>738</lpage>. <pub-id pub-id-type="doi">10.1080/14656566.2017.1319937</pub-id>
<pub-id pub-id-type="pmid">28406335</pub-id></mixed-citation>
</ref>
<ref id="B421">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schetters</surname><given-names>S. T. T.</given-names></name><name><surname>Gómez-Nicola</surname><given-names>D.</given-names></name><name><surname>García-Vallejo</surname><given-names>J. J.</given-names></name><name><surname>Van Kooyk</surname><given-names>Y.</given-names></name></person-group> (<year>2018</year>). <article-title>Neuroinflammation: microglia and T Cells Get ready to tango.</article-title>
<source/><italic>Front. Immunol.</italic>
<volume>8</volume>:<issue>1905</issue>. <pub-id pub-id-type="doi">10.3389/fimmu.2017.01905</pub-id>
<pub-id pub-id-type="pmid">29422891</pub-id></mixed-citation>
</ref>
<ref id="B422">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schieber</surname><given-names>M.</given-names></name><name><surname>Chandel</surname><given-names>N. S.</given-names></name></person-group> (<year>2014</year>). <article-title>ROS function in redox signaling and oxidative stress.</article-title>
<source/><italic>Curr. Biol.</italic>
<volume>24</volume>
<fpage>R453</fpage>–<lpage>R462</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2014.03.034</pub-id>
<pub-id pub-id-type="pmid">24845678</pub-id></mixed-citation>
</ref>
<ref id="B423">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>M.</given-names></name><name><surname>Brenner</surname><given-names>C.</given-names></name></person-group> (<year>2019</year>). <article-title>Absence of evidence that Slc12a8 encodes a nicotinamide mononucleotide transporter.</article-title>
<source/><italic>Nat. Metab.</italic>
<volume>1</volume>
<fpage>660</fpage>–<lpage>661</lpage>. <pub-id pub-id-type="doi">10.1038/s42255-018-0009-4</pub-id>
<pub-id pub-id-type="pmid">31131364</pub-id></mixed-citation>
</ref>
<ref id="B424">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schon</surname><given-names>E. A.</given-names></name><name><surname>Manfredi</surname><given-names>G.</given-names></name></person-group> (<year>2003</year>). <article-title>Neuronal degeneration and mitochondrial dysfunction.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>111</volume>
<fpage>303</fpage>–<lpage>312</lpage>. <pub-id pub-id-type="doi">10.1172/JCI200317741</pub-id><pub-id pub-id-type="pmid">12569152</pub-id></mixed-citation>
</ref>
<ref id="B425">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schöndorf</surname><given-names>D. C.</given-names></name><name><surname>Ivanyuk</surname><given-names>D.</given-names></name><name><surname>Baden</surname><given-names>P.</given-names></name><name><surname>Sánchez-Martínez</surname><given-names>A.</given-names></name><name><surname>De Circo</surname><given-names>S.</given-names></name><name><surname>Yu</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>The NAD+ precursor nicotinamide riboside rescues mitochondrial defects and neuronal loss in iPSC and fly models of Parkinson’s disease.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>23</volume>
<fpage>2976</fpage>–<lpage>2988</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2018.05.009</pub-id>
<pub-id pub-id-type="pmid">29874584</pub-id></mixed-citation>
</ref>
<ref id="B426">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scialò</surname><given-names>F.</given-names></name><name><surname>Fernández-Ayala</surname><given-names>D. J.</given-names></name><name><surname>Sanz</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Role of mitochondrial reverse electron transport in ROS signaling: potential roles in health and disease.</article-title>
<source/><italic>Front. Physiol.</italic>
<volume>27</volume>:<issue>428</issue>. <pub-id pub-id-type="doi">10.3389/fphys.2017.00428</pub-id>
<pub-id pub-id-type="pmid">28701960</pub-id></mixed-citation>
</ref>
<ref id="B427">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selvaraji</surname><given-names>S.</given-names></name><name><surname>Poh</surname><given-names>L.</given-names></name><name><surname>Natarajan</surname><given-names>V.</given-names></name><name><surname>Mallilankaraman</surname><given-names>K.</given-names></name><name><surname>Arumugan</surname><given-names>T. V.</given-names></name></person-group> (<year>2019</year>). <article-title>Negative conditioning of mitochondrial dysfunction in age-related neurodegenerative diseases.</article-title>
<source/><italic>Cond. Med.</italic>
<volume>2</volume>
<fpage>30</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="pmid">31058265</pub-id></mixed-citation>
</ref>
<ref id="B428">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>E. J.</given-names></name><name><surname>Fischer</surname><given-names>N.</given-names></name><name><surname>Efferth</surname><given-names>T.</given-names></name></person-group> (<year>2018</year>). <article-title>Phytochemicals as inhibitors of NF-kB for treatment of Alzheimer’s disease.</article-title>
<source/><italic>Pharmacol. Res.</italic>
<volume>129</volume>
<fpage>262</fpage>–<lpage>273</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2017.11.030</pub-id>
<pub-id pub-id-type="pmid">29179999</pub-id></mixed-citation>
</ref>
<ref id="B429">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sferrazza-Papa</surname><given-names>G. F.</given-names></name><name><surname>Pellegrino</surname><given-names>G. M.</given-names></name><name><surname>Shaikh</surname><given-names>H.</given-names></name><name><surname>Lax</surname><given-names>A.</given-names></name><name><surname>Lorini</surname><given-names>L.</given-names></name><name><surname>Corbo</surname><given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>Respiratory muscle testing in amyotrophic lateral sclerosis: a practical approach.</article-title>
<source/><italic>Minerva Med.</italic>
<volume>109</volume>(<issue>6 Suppl. 1</issue>), <fpage>11</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.23736/S0026-4806.18.05920-7</pub-id>
<pub-id pub-id-type="pmid">30642145</pub-id></mixed-citation>
</ref>
<ref id="B430">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharina</surname><given-names>I. G.</given-names></name><name><surname>Martin</surname><given-names>E.</given-names></name></person-group> (<year>2017</year>). <article-title>The role of reactive oxygen and nitrogen species in the expression and splicing of nitric oxide receptor.</article-title>
<source/><italic>Antioxid. Redox Signal.</italic>
<volume>26</volume>
<fpage>122</fpage>–<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2016.6687</pub-id>
<pub-id pub-id-type="pmid">26972233</pub-id></mixed-citation>
</ref>
<ref id="B431">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>D. R.</given-names></name><name><surname>Wani</surname><given-names>W. Y.</given-names></name><name><surname>Sunkaria</surname><given-names>A.</given-names></name><name><surname>Kandimalla</surname><given-names>R. J.</given-names></name><name><surname>Sharma</surname><given-names>R. K.</given-names></name><name><surname>Verma</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Quercetin attenuates neuronal death against aluminium-induced neurodegeneration in the rat hippocampus.</article-title>
<source/><italic>Neuroscience</italic>
<volume>324</volume>
<fpage>163</fpage>–<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2016.02.055</pub-id>
<pub-id pub-id-type="pmid">26944603</pub-id></mixed-citation>
</ref>
<ref id="B432">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Aoyagi-Scharber</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name></person-group> (<year>2015</year>). <article-title>Trapping poly(ADP-Ribose) polymerase.</article-title>
<source/><italic>J. Pharmacol. Exp. Ther.</italic>
<volume>353</volume>
<fpage>446</fpage>–<lpage>457</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.114.222448</pub-id>
<pub-id pub-id-type="pmid">25758918</pub-id></mixed-citation>
</ref>
<ref id="B433">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shibata</surname><given-names>N.</given-names></name><name><surname>Hirano</surname><given-names>A.</given-names></name><name><surname>Hedley-Whyte</surname><given-names>E. T.</given-names></name><name><surname>Dal Canto</surname><given-names>M. C.</given-names></name><name><surname>Nagai</surname><given-names>R.</given-names></name><name><surname>Uchida</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Selective formation of certain advanced glycation end products in spinal cord astrocytes of humans and mice with superoxide dismutase-1 mutation.</article-title>
<source/><italic>Acta Neuropathol.</italic>
<volume>104</volume>
<fpage>171</fpage>–<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-002-0537-5</pub-id>
<pub-id pub-id-type="pmid">12111360</pub-id></mixed-citation>
</ref>
<ref id="B434">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>J. A.</given-names></name><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Lim</surname><given-names>Y. K.</given-names></name><name><surname>Koh</surname><given-names>Y.</given-names></name><name><surname>Choi</surname><given-names>J. H.</given-names></name><name><surname>Park</surname><given-names>E. M.</given-names></name></person-group> (<year>2010</year>). <article-title>Therapeutic effects of resveratrol during acute periods following experimental ischemic stroke.</article-title>
<source/><italic>J. Neuroimmunol.</italic>
<volume>227</volume>
<fpage>93</fpage>–<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneuroim.2010.06.017</pub-id>
<pub-id pub-id-type="pmid">20655115</pub-id></mixed-citation>
</ref>
<ref id="B435">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sidransky</surname><given-names>E.</given-names></name><name><surname>Nalls</surname><given-names>M. A.</given-names></name><name><surname>Aasly</surname><given-names>J. O.</given-names></name><name><surname>Aharon-Peretz</surname><given-names>J.</given-names></name><name><surname>Annesi</surname><given-names>G.</given-names></name><name><surname>Barbosa</surname><given-names>E. R.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Multicenter analysis of glucocerebroside mutations in Parkison’s disease.</article-title>
<source/><italic>N. Engl. J. Med.</italic>
<volume>361</volume>
<fpage>1651</fpage>–<lpage>1661</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa0901281</pub-id>
<pub-id pub-id-type="pmid">19846850</pub-id></mixed-citation>
</ref>
<ref id="B436">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sies</surname><given-names>H.</given-names></name></person-group> (<year>1986</year>). <article-title>Biochemistry of oxidative stress.</article-title>
<source/><italic>Angew. Chem. Int. Ed. Engl.</italic>
<volume>25</volume>
<fpage>1058</fpage>–<lpage>1071</lpage>. <pub-id pub-id-type="doi">10.1002/anie.198610581</pub-id></mixed-citation>
</ref>
<ref id="B437">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpkins</surname><given-names>J. W.</given-names></name><name><surname>Dykens</surname><given-names>J. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Mitochondrial mechanisms of estrogen neuroprotection.</article-title>
<source/><italic>Brain Res. Rev.</italic>
<volume>57</volume>
<fpage>421</fpage>–<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresrev.2007.04.007</pub-id>
<pub-id pub-id-type="pmid">17512984</pub-id></mixed-citation>
</ref>
<ref id="B438">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>E. P.</given-names></name><name><surname>Henry</surname><given-names>Y. K.</given-names></name><name><surname>Henkel</surname><given-names>J. S.</given-names></name><name><surname>Smith</surname><given-names>R. G.</given-names></name><name><surname>Appel</surname><given-names>S. H.</given-names></name></person-group> (<year>2004</year>). <article-title>Increased lipid peroxidation in será of ALS patients: a potential biomarker of disease burden.</article-title>
<source/><italic>Neurology</italic>
<volume>62</volume>
<fpage>1758</fpage>–<lpage>1765</lpage>.<pub-id pub-id-type="pmid">15159474</pub-id></mixed-citation>
</ref>
<ref id="B439">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>S. P.</given-names></name><name><surname>Schragenheim</surname><given-names>J.</given-names></name><name><surname>Cao</surname><given-names>J.</given-names></name><name><surname>Falck</surname><given-names>J. R.</given-names></name><name><surname>Abraham</surname><given-names>N. G.</given-names></name><name><surname>Bellner</surname><given-names>L.</given-names></name></person-group> (<year>2016</year>). <article-title>PGC-1 alpha regulates HO-1 expression, mitochondrial dynamics and biogenesis: role of epoxyeicosatrienoic acid.</article-title>
<source/><italic>Prostaglandins Other Lipid Mediat.</italic>
<volume>125</volume>
<fpage>8</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1016/j.prostaglandins.2016.07.004</pub-id>
<pub-id pub-id-type="pmid">27418542</pub-id></mixed-citation>
</ref>
<ref id="B440">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sirerol</surname><given-names>J. A.</given-names></name><name><surname>Rodríguez</surname><given-names>M. L.</given-names></name><name><surname>Mena</surname><given-names>S.</given-names></name><name><surname>Asensi</surname><given-names>M. A.</given-names></name><name><surname>Estrela</surname><given-names>J. M.</given-names></name><name><surname>Ortega</surname><given-names>A. L.</given-names></name></person-group> (<year>2016</year>). <article-title>Role of natural stilbenes in the prevention of cancer.</article-title>
<source/><italic>Oxid. Med. Cell. Longev.</italic>
<volume>2016</volume>:<issue>3128951</issue>. <pub-id pub-id-type="doi">10.1155/2016/3128951</pub-id>
<pub-id pub-id-type="pmid">26798416</pub-id></mixed-citation>
</ref>
<ref id="B441">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>E. F.</given-names></name><name><surname>Shaw</surname><given-names>P. J.</given-names></name><name><surname>De Vos</surname><given-names>K. J.</given-names></name></person-group> (<year>2017</year>). <article-title>The role of mitochondria in Amyotrophic Lateral Sclerosis.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>710</volume>:<issue>132933</issue>. <pub-id pub-id-type="doi">10.1016/j.neulet.2017.06.052</pub-id>
<pub-id pub-id-type="pmid">28669745</pub-id></mixed-citation>
</ref>
<ref id="B442">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sohmiya</surname><given-names>M.</given-names></name><name><surname>Tanaka</surname><given-names>M.</given-names></name><name><surname>Susuki</surname><given-names>Y.</given-names></name><name><surname>Tanino</surname><given-names>Y.</given-names></name><name><surname>Okamoto</surname><given-names>K.</given-names></name><name><surname>Yamamoto</surname><given-names>Y.</given-names></name></person-group> (<year>2005</year>). <article-title>An increase of oxidized coenzyme Q-10 occurs in the plasma of sporadic ALS patients.</article-title>
<source/><italic>J. Neurol. Sci.</italic>
<volume>228</volume>
<fpage>49</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2004.09.030</pub-id>
<pub-id pub-id-type="pmid">15607210</pub-id></mixed-citation>
</ref>
<ref id="B443">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solanki</surname><given-names>I.</given-names></name><name><surname>Parihar</surname><given-names>P.</given-names></name><name><surname>Mansuri</surname><given-names>M. L.</given-names></name><name><surname>Parihar</surname><given-names>M. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Flavonoid-based therapies in the early management of neurodegenerative diseases.</article-title>
<source/><italic>Adv. Nutr.</italic>
<volume>6</volume>
<fpage>64</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.3945/an.114.007500</pub-id>
<pub-id pub-id-type="pmid">25593144</pub-id></mixed-citation>
</ref>
<ref id="B444">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solleiro-Villavicencio</surname><given-names>H.</given-names></name><name><surname>Rivas-Arancibia</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>Effect of chronic oxidative stress on neuroinflammatory response mediated by CD4+T cells in neurodegenerative diseases.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>12</volume>:<issue>114</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2018.00114</pub-id>
<pub-id pub-id-type="pmid">29755324</pub-id></mixed-citation>
</ref>
<ref id="B445">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Le</surname><given-names>W.</given-names></name></person-group> (<year>2014</year>). <article-title>Resveratrol ameliorates motor neuron degeneration and improves survival in SOD1(G93A) mouse model of amyotrophic lateral sclerosis.</article-title>
<source/><italic>Biomed. Res. Int.</italic>
<volume>2014</volume>:<issue>483501</issue>. <pub-id pub-id-type="doi">10.1155/2014/483501</pub-id>
<pub-id pub-id-type="pmid">25057490</pub-id></mixed-citation>
</ref>
<ref id="B446">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>Z.</given-names></name><name><surname>Han</surname><given-names>S.</given-names></name><name><surname>Pan</surname><given-names>X.</given-names></name><name><surname>Gong</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Pterostilbene mediates neuroprotection against oxidative toxicity via oestrogen receptor α signalling pathways.</article-title>
<source/><italic>J. Pharm. Pharmacol.</italic>
<volume>67</volume>
<fpage>720</fpage>–<lpage>730</lpage>. <pub-id pub-id-type="doi">10.1111/jphp.12360</pub-id>
<pub-id pub-id-type="pmid">25644078</pub-id></mixed-citation>
</ref>
<ref id="B447">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srinivasan</surname><given-names>E.</given-names></name><name><surname>Rajasekaran</surname><given-names>R.</given-names></name></person-group> (<year>2018</year>). <article-title>Quantum chemical and molecular mechanisms studies on the assessment of interactions between resveratrol and mutant SOD1 (G93A) protein.</article-title>
<source/><italic>J. Comput. Aided Mol. Des.</italic>
<volume>32</volume>
<fpage>1347</fpage>–<lpage>1361</lpage>. <pub-id pub-id-type="doi">10.1007/s10822-018-0175-1</pub-id>
<pub-id pub-id-type="pmid">30368622</pub-id></mixed-citation>
</ref>
<ref id="B448">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>Emerging therapeutic roles for NAD(+) metabolism in mitochondrial and age-related disorders.</article-title>
<source/><italic>Clin. Transl. Med.</italic>
<volume>5</volume>:<issue>25</issue>. <pub-id pub-id-type="doi">10.1186/s40169-016-0104-7</pub-id>
<pub-id pub-id-type="pmid">27465020</pub-id></mixed-citation>
</ref>
<ref id="B449">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staiculescu</surname><given-names>M. C.</given-names></name><name><surname>Foote</surname><given-names>C.</given-names></name><name><surname>Meininger</surname><given-names>G. A.</given-names></name><name><surname>Martínez-Lemus</surname><given-names>L. A.</given-names></name></person-group> (<year>2014</year>). <article-title>The role of reactive oxygen species in microvascular remodeling.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>15</volume>
<fpage>23792</fpage>–<lpage>23835</lpage>. <pub-id pub-id-type="doi">10.3390/ijms151223792</pub-id>
<pub-id pub-id-type="pmid">25535075</pub-id></mixed-citation>
</ref>
<ref id="B450">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>St-Pierre</surname><given-names>J.</given-names></name><name><surname>Drori</surname><given-names>S.</given-names></name><name><surname>Uldry</surname><given-names>M.</given-names></name><name><surname>Silvaggi</surname><given-names>J. M.</given-names></name><name><surname>Rhee</surname><given-names>J.</given-names></name><name><surname>Jäger</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional activators.</article-title>
<source/><italic>Cell</italic>
<volume>127</volume>
<fpage>397</fpage>–<lpage>408</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2006.09.024</pub-id>
<pub-id pub-id-type="pmid">17055439</pub-id></mixed-citation>
</ref>
<ref id="B451">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strong</surname><given-names>M. J.</given-names></name><name><surname>Pattee</surname><given-names>G. L.</given-names></name></person-group> (<year>2000</year>). <article-title>Creatine and coenzyme Q10 in the treatment of ALS.</article-title>
<source/><italic>Amyotroph. Lateral Scler. Other Motor Neuron Disord.</italic>
<volume>4</volume>
<fpage>17</fpage>–<lpage>20</lpage>.</mixed-citation>
</ref>
<ref id="B452">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swinnen</surname><given-names>B.</given-names></name><name><surname>Robberecht</surname><given-names>W.</given-names></name></person-group> (<year>2014</year>). <article-title>The phenotypic variability of amyotrophic lateral sclerosis.</article-title>
<source/><italic>Nat. Rev. Neurol.</italic>
<volume>10</volume>
<fpage>661</fpage>–<lpage>670</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2014.184</pub-id>
<pub-id pub-id-type="pmid">25311585</pub-id></mixed-citation>
</ref>
<ref id="B453">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szkudelski</surname><given-names>T.</given-names></name><name><surname>Szkudelska</surname><given-names>K.</given-names></name></person-group> (<year>2015</year>). <article-title>Resveratrol and diabetes: from animal to human studies.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1852</volume>
<fpage>1145</fpage>–<lpage>1154</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2014.10.013</pub-id>
<pub-id pub-id-type="pmid">25445538</pub-id></mixed-citation>
</ref>
<ref id="B454">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szwajgier</surname><given-names>D.</given-names></name><name><surname>Borowiec</surname><given-names>K.</given-names></name><name><surname>Pustelniak</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>The neuroprotective effects of phenolic acids: molecular mechanism of action.</article-title>
<source/><italic>Nutrients</italic>
<volume>9</volume>:<issue>E477</issue>. <pub-id pub-id-type="doi">10.3390/nu9050477</pub-id>
<pub-id pub-id-type="pmid">28489058</pub-id></mixed-citation>
</ref>
<ref id="B455">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talbot</surname><given-names>K.</given-names></name></person-group> (<year>2016</year>). <article-title>Clinical tool for predicting survival in ALS: do we need one?</article-title>
<source/><italic>J. Neurol. Neurosurg. Psychiatry</italic>
<volume>87</volume>:<issue>1275</issue>. <pub-id pub-id-type="doi">10.1136/jnnp-2016-313683</pub-id>
<pub-id pub-id-type="pmid">27378084</pub-id></mixed-citation>
</ref>
<ref id="B456">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talhaoui</surname><given-names>N.</given-names></name><name><surname>Gómez-Caravaca</surname><given-names>A. M.</given-names></name><name><surname>León</surname><given-names>L.</given-names></name><name><surname>De la Rosa</surname><given-names>R.</given-names></name><name><surname>Fernández-Gutiérrez</surname><given-names>A.</given-names></name><name><surname>Segura-Carretero</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>From olive fruits to olive oil: phenolic compound transfer in six different olive cultivars grown under the same agronomical conditions.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>17</volume>:<issue>337</issue>. <pub-id pub-id-type="doi">10.3390/ijms17030337</pub-id>
<pub-id pub-id-type="pmid">26959010</pub-id></mixed-citation>
</ref>
<ref id="B457">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>B. L.</given-names></name><name><surname>Norhaizan</surname><given-names>M. E.</given-names></name><name><surname>Liew</surname><given-names>W. P.</given-names></name><name><surname>Sulaiman-Rahman</surname><given-names>H.</given-names></name></person-group> (<year>2018</year>). <article-title>Antioxidant and oxidative stress: a mutual interplay in age-related diseases.</article-title>
<source/><italic>Front. Pharmacol.</italic>
<volume>9</volume>:<issue>1162</issue>. <pub-id pub-id-type="doi">10.3389/fphar.2018.01162</pub-id>
<pub-id pub-id-type="pmid">30405405</pub-id></mixed-citation>
</ref>
<ref id="B458">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>W.</given-names></name><name><surname>Pasinelli</surname><given-names>P.</given-names></name><name><surname>Trotti</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>Role of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosis.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1842</volume>
<fpage>1295</fpage>–<lpage>1301</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2014.02.009</pub-id>
<pub-id pub-id-type="pmid">24568860</pub-id></mixed-citation>
</ref>
<ref id="B459">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>B. L.</given-names></name></person-group> (<year>2016</year>). <article-title>Sirt1 and the mitochondria.</article-title>
<source/><italic>Mol. Cells</italic>
<volume>39</volume>
<fpage>87</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.14348/molcells.2016.2318</pub-id>
<pub-id pub-id-type="pmid">26831453</pub-id></mixed-citation>
</ref>
<ref id="B460">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>B. L.</given-names></name></person-group> (<year>2017</year>). <article-title>Could sirtuins activities modify ALS onset and progression?</article-title>
<source/><italic>Cell. Mol. Neurobiol.</italic>
<volume>37</volume>
<fpage>1147</fpage>–<lpage>1160</lpage>. <pub-id pub-id-type="doi">10.1007/s10571-016-0452-2</pub-id>
<pub-id pub-id-type="pmid">27942908</pub-id></mixed-citation>
</ref>
<ref id="B461">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarique</surname><given-names>H.</given-names></name><name><surname>Tan</surname><given-names>B.</given-names></name><name><surname>Yulong</surname><given-names>Y.</given-names></name><name><surname>Blachier</surname><given-names>F.</given-names></name><name><surname>Myrlene</surname><given-names>C. B.</given-names></name><name><surname>Najma</surname><given-names>R.</given-names></name></person-group> (<year>2016</year>). <article-title>Oxidative stress and inflammation: what polyphenols can do for us?</article-title>
<source/><italic>Oxid. Med. Cell. Longev.</italic>
<volume>2016</volume>:<issue>7432797</issue>. <pub-id pub-id-type="doi">10.1155/2016/7432797</pub-id>
<pub-id pub-id-type="pmid">27738491</pub-id></mixed-citation>
</ref>
<ref id="B462">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Temsamani</surname><given-names>H. K. S.</given-names></name><name><surname>Merillon</surname><given-names>J. M.</given-names></name><name><surname>Richard</surname><given-names>T.</given-names></name></person-group> (<year>2015</year>). <article-title>Promising neuroprotective effects of oligostilbenes.</article-title>
<source/><italic>Nutr. Aging</italic>
<volume>3</volume>
<fpage>49</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.3233/NUA-150050</pub-id></mixed-citation>
</ref>
<ref id="B463">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tennen</surname><given-names>R. I.</given-names></name><name><surname>Chua</surname><given-names>K. F.</given-names></name></person-group> (<year>2011</year>). <article-title>Chromatin regulation and genome maintenance by mammalian SIRT6.</article-title>
<source/><italic>Trends Biochem. Sci.</italic>
<volume>36</volume>
<fpage>39</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibs.2010.07.009</pub-id>
<pub-id pub-id-type="pmid">20729089</pub-id></mixed-citation>
</ref>
<ref id="B464">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terao</surname><given-names>J.</given-names></name><name><surname>Piskula</surname><given-names>M.</given-names></name><name><surname>Yao</surname><given-names>Q.</given-names></name></person-group> (<year>1994</year>). <article-title>Protective effect of epicatechin, epicatechin gallate, and quercetin on lipid peroxidation in phospholipid bilayers.</article-title>
<source/><italic>Arch. Biochem. Biophys.</italic>
<volume>308</volume>
<fpage>278</fpage>–<lpage>284</lpage>. <pub-id pub-id-type="doi">10.1006/abbi.1994.1039</pub-id>
<pub-id pub-id-type="pmid">8311465</pub-id></mixed-citation>
</ref>
<ref id="B465">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thandapilly</surname><given-names>S. J.</given-names></name><name><surname>Louis</surname><given-names>X. L.</given-names></name><name><surname>Yang</surname><given-names>T.</given-names></name><name><surname>Stringer</surname><given-names>D. M.</given-names></name><name><surname>Yu</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Resveratrol prevents norepinephrine induced hypertrophy in adult rat cardiomyocytes, by activating no-ampk pathway.</article-title>
<source/><italic>Eur. J. Pharmacol.</italic>
<volume>668</volume>
<fpage>217</fpage>–<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2011.06.042</pub-id>
<pub-id pub-id-type="pmid">21756902</pub-id></mixed-citation>
</ref>
<ref id="B466">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thibault</surname><given-names>O.</given-names></name><name><surname>Gant</surname><given-names>J. C.</given-names></name><name><surname>Landfield</surname><given-names>P. W.</given-names></name></person-group> (<year>2007</year>). <article-title>Expansion of the calcium hypothesis of braing aging and Alzheimer’s disease: minding the store.</article-title>
<source/><italic>Aging Cell</italic>
<volume>6</volume>
<fpage>307</fpage>–<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1111/j.1474-9726.2007.00295.x</pub-id>
<pub-id pub-id-type="pmid">17465978</pub-id></mixed-citation>
</ref>
<ref id="B467">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thirupathi</surname><given-names>A.</given-names></name><name><surname>de Souza</surname><given-names>C. T.</given-names></name></person-group> (<year>2017</year>). <article-title>Multi-regulatory network of ROS: the interconnection of ROS, PGC-1 alpha, and AMPK-SIRT1 during exercise.</article-title>
<source/><italic>J. Physiol. Biochem.</italic>
<volume>73</volume>
<fpage>487</fpage>–<lpage>494</lpage>. <pub-id pub-id-type="doi">10.1007/s13105-017-0576-y</pub-id>
<pub-id pub-id-type="pmid">28707280</pub-id></mixed-citation>
</ref>
<ref id="B468">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trammell</surname><given-names>S. A.</given-names></name><name><surname>Schmidt</surname><given-names>M. S.</given-names></name><name><surname>Weidemann</surname><given-names>B. J.</given-names></name><name><surname>Redpath</surname><given-names>P.</given-names></name><name><surname>Jaksch</surname><given-names>F.</given-names></name><name><surname>Delinger</surname><given-names>R. W.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Nicotinamide riboside is uniquely and orally bioavaliable in mice and humans.</article-title>
<source/><italic>Nat. Commun.</italic>
<volume>7</volume>:<issue>12948</issue>. <pub-id pub-id-type="doi">10.1038/ncomms12948</pub-id>
<pub-id pub-id-type="pmid">27721479</pub-id></mixed-citation>
</ref>
<ref id="B469">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traversi</surname><given-names>G.</given-names></name><name><surname>Fiore</surname><given-names>M.</given-names></name><name><surname>Leone</surname><given-names>S.</given-names></name><name><surname>Basso</surname><given-names>E.</given-names></name><name><surname>Di Muzio</surname><given-names>E.</given-names></name><name><surname>Polticelli</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Resveratrol and its methoxy-derivatives as modulators of DNA damage induced by ionizing radiation.</article-title>
<source/><italic>Mutagenesis</italic>
<volume>31</volume>
<fpage>433</fpage>–<lpage>441</lpage>. <pub-id pub-id-type="doi">10.1093/mutage/gew002</pub-id>
<pub-id pub-id-type="pmid">26819346</pub-id></mixed-citation>
</ref>
<ref id="B470">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tressera-Rimbau</surname><given-names>A.</given-names></name><name><surname>Arranz</surname><given-names>S.</given-names></name><name><surname>Eder</surname><given-names>M.</given-names></name><name><surname>Vallverdú-Queralt</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Dietary polyphenols in the prevention of stroke.</article-title>
<source/><italic>Oxid. Med. Cell. Longev.</italic>
<volume>2017</volume>:<issue>7467962</issue>. <pub-id pub-id-type="doi">10.1155/2017/7467962</pub-id>
<pub-id pub-id-type="pmid">29204249</pub-id></mixed-citation>
</ref>
<ref id="B471">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripodo</surname><given-names>G.</given-names></name><name><surname>Chlapanidas</surname><given-names>T.</given-names></name><name><surname>Perteghella</surname><given-names>S.</given-names></name><name><surname>Vigani</surname><given-names>B.</given-names></name><name><surname>Mandracchia</surname><given-names>D.</given-names></name><name><surname>Trapani</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Mesenchymal stromal cells loading curcumin-INVITE-micelles: a drug delivery system for neurodegenerative diseases.</article-title>
<source/><italic>Colloids Surf. B Biointerfaces</italic>
<volume>125</volume>
<fpage>300</fpage>–<lpage>308</lpage>. <pub-id pub-id-type="doi">10.1016/j.colsurfb.2014.11.034</pub-id>
<pub-id pub-id-type="pmid">25524221</pub-id></mixed-citation>
</ref>
<ref id="B472">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>M. R.</given-names></name><name><surname>Bowser</surname><given-names>R.</given-names></name><name><surname>Bruijin</surname><given-names>L.</given-names></name><name><surname>Dupuis</surname><given-names>L.</given-names></name><name><surname>Ludolph</surname><given-names>A.</given-names></name><name><surname>Mcgrath</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Mechanisms, models and biomarkers in amyotrophic lateral sclerosis.</article-title>
<source/><italic>Amyotroph. Lateral Scler. Frontotemporal. Degener.</italic>
<volume>14</volume>(<issue>Suppl. 1</issue>), <fpage>19</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.3109/21678421.2013.778554</pub-id>
<pub-id pub-id-type="pmid">23678877</pub-id></mixed-citation>
</ref>
<ref id="B473">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turrens</surname><given-names>J. F.</given-names></name></person-group> (<year>2003</year>). <article-title>Mitochondrial formation of reactive oxygen species.</article-title>
<source/><italic>J. Physiol.</italic>
<volume>552</volume>(<issue>Pt 2</issue>), <fpage>335</fpage>–<lpage>344</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2003.049478</pub-id><pub-id pub-id-type="pmid">14561818</pub-id></mixed-citation>
</ref>
<ref id="B474">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ullah</surname><given-names>F.</given-names></name><name><surname>Liang</surname><given-names>A.</given-names></name><name><surname>Rangel</surname><given-names>A.</given-names></name><name><surname>Gyengesi</surname><given-names>E.</given-names></name><name><surname>Niedermayer</surname><given-names>G.</given-names></name><name><surname>Münch</surname><given-names>G.</given-names></name></person-group> (<year>2017</year>). <article-title>High bioavailability curcumin: an anti-inflammatory and neurosupportive bioactive nutrient for neurodegenerative diseases characterized by chronic neuroinflammation.</article-title>
<source/><italic>Arch. Toxicol.</italic>
<volume>91</volume>
<fpage>1623</fpage>–<lpage>1634</lpage>. <pub-id pub-id-type="doi">10.1007/s00204-017-1939-4</pub-id>
<pub-id pub-id-type="pmid">28204864</pub-id></mixed-citation>
</ref>
<ref id="B475">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valko</surname><given-names>K.</given-names></name><name><surname>Ciesla</surname><given-names>L.</given-names></name></person-group> (<year>2019</year>). <article-title>Amyotrophic lateral sclerosis.</article-title>
<source/><italic>Prog. Med. Chem.</italic>
<volume>58</volume>
<fpage>63</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/bs.pmch.2018.12.001</pub-id>
<pub-id pub-id-type="pmid">30879475</pub-id></mixed-citation>
</ref>
<ref id="B476">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valko</surname><given-names>M.</given-names></name><name><surname>Leibfritz</surname><given-names>D.</given-names></name><name><surname>Moncol</surname><given-names>J.</given-names></name><name><surname>Cronin</surname><given-names>M. T.</given-names></name><name><surname>Mazur</surname><given-names>M.</given-names></name><name><surname>Telser</surname><given-names>J.</given-names></name></person-group> (<year>2007</year>). <article-title>Free radicals and antioxidants in normal physiological functions and human disease.</article-title>
<source/><italic>Int. J. Biochem. Cell Biol.</italic>
<volume>39</volume>
<fpage>44</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2006.07.001</pub-id>
<pub-id pub-id-type="pmid">16978905</pub-id></mixed-citation>
</ref>
<ref id="B477">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valle</surname><given-names>C.</given-names></name><name><surname>Carrì</surname><given-names>M. T.</given-names></name></person-group> (<year>2017</year>). <article-title>Cysteine modifications in the pathogenesis of ALS.</article-title>
<source/><italic>Front. Mol. Neurosci.</italic>
<volume>10</volume>:<issue>5</issue>. <pub-id pub-id-type="doi">10.3389/fnmol.2017.00005</pub-id>
<pub-id pub-id-type="pmid">28167899</pub-id></mixed-citation>
</ref>
<ref id="B478">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallverdú-Queralt</surname><given-names>A.</given-names></name><name><surname>Boix</surname><given-names>N.</given-names></name><name><surname>Piqué</surname><given-names>E.</given-names></name><name><surname>Gómez-Catalán</surname><given-names>J.</given-names></name><name><surname>Medina-Remon</surname><given-names>A.</given-names></name><name><surname>Sasot</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Identification of phenolic compounds in red wine extract samples and zebrafisch embryos by HPLC-ESI-LTQ-Orbitrap-MS.</article-title>
<source/><italic>Food Chem.</italic>
<volume>181</volume>
<fpage>146</fpage>–<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2015.02.098</pub-id>
<pub-id pub-id-type="pmid">25794733</pub-id></mixed-citation>
</ref>
<ref id="B479">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallverdú-Queralt</surname><given-names>A.</given-names></name><name><surname>Regueiro</surname><given-names>J.</given-names></name><name><surname>Martínez-Huélamo</surname><given-names>M.</given-names></name><name><surname>Rinaldi-Alvarenga</surname><given-names>J. F.</given-names></name><name><surname>Leal</surname><given-names>L. N.</given-names></name><name><surname>Lamuela-Raventos</surname><given-names>R. M.</given-names></name></person-group> (<year>2014</year>). <article-title>A comprehensive study on the phenolic profile of widely used culinary herbs and spices: rosemary, thyme, oregano, cinnamon, cumin and bay.</article-title>
<source/><italic>Food Chem.</italic>
<volume>154</volume>
<fpage>299</fpage>–<lpage>307</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2013.12.106</pub-id>
<pub-id pub-id-type="pmid">24518346</pub-id></mixed-citation>
</ref>
<ref id="B480">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Damme</surname><given-names>P.</given-names></name><name><surname>Robberecht</surname><given-names>W.</given-names></name><name><surname>Van Den Bosch</surname><given-names>L.</given-names></name></person-group> (<year>2017</year>). <article-title>Modelling amyotrophic lateral sclerosis: progress and possibilities.</article-title>
<source/><italic>Dis. Model. Mech.</italic>
<volume>10</volume>
<fpage>537</fpage>–<lpage>549</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.029058</pub-id>
<pub-id pub-id-type="pmid">28468939</pub-id></mixed-citation>
</ref>
<ref id="B481">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Es</surname><given-names>M. A.</given-names></name><name><surname>Hardiman</surname><given-names>O.</given-names></name><name><surname>Chio</surname><given-names>A.</given-names></name><name><surname>Al-Chalabi</surname><given-names>A.</given-names></name><name><surname>Pasterkamp</surname><given-names>R. J.</given-names></name><name><surname>Veldink</surname><given-names>J. H.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Amyotrophic lateral sclerosis.</article-title>
<source/><italic>Lancet</italic>
<volume>390</volume>
<fpage>2084</fpage>–<lpage>2098</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(17)31287-4</pub-id>
<pub-id pub-id-type="pmid">28552366</pub-id></mixed-citation>
</ref>
<ref id="B482">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Giau</surname><given-names>V.</given-names></name><name><surname>An</surname><given-names>S. S. A.</given-names></name><name><surname>Hulme</surname><given-names>S. P.</given-names></name></person-group> (<year>2018</year>). <article-title>Mitochondrial therapeutic interventions in Alzheimer’s disease.</article-title>
<source/><italic>J. Neurol. Sci.</italic>
<volume>395</volume>
<fpage>62</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2018.09.033</pub-id>
<pub-id pub-id-type="pmid">30292965</pub-id></mixed-citation>
</ref>
<ref id="B483">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Horssen</surname><given-names>J.</given-names></name><name><surname>Van Schaik</surname><given-names>P.</given-names></name><name><surname>Witte</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Inflammation and mitochondrial dysfunction: a vicious circle in neurodegenerative disorders?</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>710</volume>:<issue>132931</issue>. <pub-id pub-id-type="doi">10.1016/j.neulet.2017.06.050</pub-id>
<pub-id pub-id-type="pmid">28668382</pub-id></mixed-citation>
</ref>
<ref id="B484">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Horssen</surname><given-names>J.</given-names></name><name><surname>Witte</surname><given-names>M. E.</given-names></name><name><surname>Schreibelt</surname><given-names>G.</given-names></name><name><surname>De Vries</surname><given-names>H. E.</given-names></name></person-group> (<year>2011</year>). <article-title>Radical changes in multiple sclerosis pathogenesis.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1812</volume>
<fpage>141</fpage>–<lpage>150</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2010.06.011</pub-id>
<pub-id pub-id-type="pmid">20600869</pub-id></mixed-citation>
</ref>
<ref id="B485">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Houten</surname><given-names>B.</given-names></name><name><surname>Woshner</surname><given-names>V.</given-names></name><name><surname>Santos</surname><given-names>J. H.</given-names></name></person-group> (<year>2006</year>). <article-title>Role of mitochondrial DNA in toxic responses to oxidative stress.</article-title>
<source/><italic>DNA Repair</italic>
<volume>5</volume>
<fpage>145</fpage>–<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1016/j.dnarep.2005.03.002</pub-id>
<pub-id pub-id-type="pmid">15878696</pub-id></mixed-citation>
</ref>
<ref id="B486">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van’t Erve</surname><given-names>T. J.</given-names></name><name><surname>Kadiiska</surname><given-names>M. B.</given-names></name><name><surname>London</surname><given-names>S. J.</given-names></name><name><surname>Mason</surname><given-names>R. P.</given-names></name></person-group> (<year>2017</year>). <article-title>Classifying oxidative stress by F2-isoprostane levels across human diseases: a meta-analysis.</article-title>
<source/><italic>Redox Biol.</italic>
<volume>12</volume>
<fpage>582</fpage>–<lpage>599</lpage>. <pub-id pub-id-type="doi">10.1016/j.redox.2017.03.024</pub-id>
<pub-id pub-id-type="pmid">28391180</pub-id></mixed-citation>
</ref>
<ref id="B487">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaur</surname><given-names>P.</given-names></name><name><surname>Brugg</surname><given-names>B.</given-names></name><name><surname>Mericskay</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Schmidt</surname><given-names>M. S.</given-names></name><name><surname>Vivien</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Nicotinamide riboside, a form of vitamin B3, protects againts excitotoxicity-induced axonal degeneration.</article-title>
<source/><italic>FASEB J.</italic>
<volume>31</volume>
<fpage>5440</fpage>–<lpage>5452</lpage>. <pub-id pub-id-type="doi">10.1096/fj.201700221RR</pub-id>
<pub-id pub-id-type="pmid">28842432</pub-id></mixed-citation>
</ref>
<ref id="B488">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vauzour</surname><given-names>D.</given-names></name><name><surname>Vafeiadou</surname><given-names>K.</given-names></name><name><surname>Rodriguez-Mateos</surname><given-names>A.</given-names></name><name><surname>Rendeiro</surname><given-names>C.</given-names></name><name><surname>Spencer</surname><given-names>J. P. E.</given-names></name></person-group> (<year>2008</year>). <article-title>The neuroprotective potential of flavonoids: a multiplicity of effects.</article-title>
<source/><italic>Genes Nutr.</italic>
<volume>3</volume>
<fpage>115</fpage>–<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1007/s12263-008-0091-4</pub-id>
<pub-id pub-id-type="pmid">18937002</pub-id></mixed-citation>
</ref>
<ref id="B489">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veldink</surname><given-names>J. H.</given-names></name><name><surname>Kalmijn</surname><given-names>S.</given-names></name><name><surname>Groeneveld</surname><given-names>G. J.</given-names></name><name><surname>Wunderink</surname><given-names>W.</given-names></name><name><surname>Koster</surname><given-names>A.</given-names></name><name><surname>de Vries</surname><given-names>J. H. M.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis.</article-title>
<source/><italic>J. Neurol. Neurosurg. Psychiatr.</italic>
<volume>78</volume>
<fpage>367</fpage>–<lpage>371</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp.2005.083378</pub-id>
<pub-id pub-id-type="pmid">16648143</pub-id></mixed-citation>
</ref>
<ref id="B490">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venditti</surname><given-names>P.</given-names></name><name><surname>Di Stefano</surname><given-names>L.</given-names></name><name><surname>Di Meo</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Mitochondrial metabolism of reactive oxygen species.</article-title>
<source/><italic>Mitochondrion</italic>
<volume>13</volume>
<fpage>71</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.mito.2013.01.008</pub-id>
<pub-id pub-id-type="pmid">23376030</pub-id></mixed-citation>
</ref>
<ref id="B491">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdin</surname><given-names>E.</given-names></name></person-group> (<year>2015</year>). <article-title>NAD+ in aging, metabolism, and neurodegeneration.</article-title>
<source/><italic>Science</italic>
<volume>350</volume>
<fpage>1208</fpage>–<lpage>1213</lpage>. <pub-id pub-id-type="doi">10.1126/science.aac4854</pub-id>
<pub-id pub-id-type="pmid">26785480</pub-id></mixed-citation>
</ref>
<ref id="B492">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vijayvergiya</surname><given-names>C.</given-names></name><name><surname>Beal</surname><given-names>M. F.</given-names></name><name><surname>Buck</surname><given-names>J.</given-names></name><name><surname>Manfredi</surname><given-names>G.</given-names></name></person-group> (<year>2005</year>). <article-title>Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>25</volume>
<fpage>2463</fpage>–<lpage>2470</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4385-04.2005</pub-id>
<pub-id pub-id-type="pmid">15758154</pub-id></mixed-citation>
</ref>
<ref id="B493">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voloshyna</surname><given-names>I.</given-names></name><name><surname>Hai</surname><given-names>O.</given-names></name><name><surname>Littlefield</surname><given-names>M. J.</given-names></name><name><surname>Carsons</surname><given-names>S.</given-names></name><name><surname>Reiss</surname><given-names>A. B.</given-names></name></person-group> (<year>2013</year>). <article-title>Resveratrol mediates anti-atherogenic effects on cholesterol flux in human macrophages and endothelium via pparγ and adenosine.</article-title>
<source/><italic>Eur. J. Pharmacol.</italic>
<volume>698</volume>
<fpage>299</fpage>–<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2012.08.024</pub-id>
<pub-id pub-id-type="pmid">23041272</pub-id></mixed-citation>
</ref>
<ref id="B494">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Yue</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Neuroprotective effects of pterostilbene against oxidative stress injury: involvement of nuclear factor erythroid 2-related factor 2 pathway.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1643</volume>
<fpage>70</fpage>–<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2016.04.048</pub-id>
<pub-id pub-id-type="pmid">27107941</pub-id></mixed-citation>
</ref>
<ref id="B495">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>O’reilly</surname><given-names>E. J.</given-names></name><name><surname>Weisskopf</surname><given-names>M. G.</given-names></name><name><surname>Logroscino</surname><given-names>G.</given-names></name><name><surname>McCullough</surname><given-names>M. L.</given-names></name><name><surname>Schatzkin</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Vitamin E intake and risk of amyotrophic lateral sclerosis: a pooled analysis of data from 5 prospective cohort studies.</article-title>
<source/><italic>Am. J. Epidemiol.</italic>
<volume>173</volume>
<fpage>595</fpage>–<lpage>602</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwq416</pub-id>
<pub-id pub-id-type="pmid">21335424</pub-id></mixed-citation>
</ref>
<ref id="B496">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Zhai</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Lin</surname><given-names>E.</given-names></name><name><surname>Gu</surname><given-names>W.</given-names></name><name><surname>McBurney</surname><given-names>M. W.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>A local mechanism mediates NAD-dependent protection of axon degeneration.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>170</volume>
<fpage>349</fpage>–<lpage>355</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200504028</pub-id>
<pub-id pub-id-type="pmid">16043516</pub-id></mixed-citation>
</ref>
<ref id="B497">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Tang</surname><given-names>L.</given-names></name><name><surname>Zhan</surname><given-names>N.</given-names></name><name><surname>Fan</surname><given-names>D.</given-names></name></person-group> (<year>2011</year>). <article-title>Protective effects of resveratrol through the up-regulation of SIRT1 expression in the mutant hSOD1-G93A-bearing motor neuron-like cell culture model of amyotrophic lateral sclerosis.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>503</volume>
<fpage>250</fpage>–<lpage>255</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2011.08.047</pub-id>
<pub-id pub-id-type="pmid">21896316</pub-id></mixed-citation>
</ref>
<ref id="B498">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>C. Y.</given-names></name><name><surname>Pei</surname><given-names>Z.</given-names></name><name><surname>Zhou</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name></person-group> (<year>2015</year>). <article-title>SIRT3 protects cells from hypoxia via PGC-1α- and MnSOD-dependent pathways.</article-title>
<source/><italic>Neuroscience</italic>
<volume>12</volume>
<fpage>109</fpage>–<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2014.11.045</pub-id>
<pub-id pub-id-type="pmid">25433241</pub-id></mixed-citation>
</ref>
<ref id="B499">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T. H.</given-names></name><name><surname>Wang</surname><given-names>S. Y.</given-names></name><name><surname>Wang</surname><given-names>X. D.</given-names></name><name><surname>Jiang</surname><given-names>H. Q.</given-names></name><name><surname>Yang</surname><given-names>Y. Q.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Fisetin exerts antioxidant and neuroprotective effects in multiple mutant hSOD1 models of amyotrophic lateral sclerosis by activating ERK.</article-title>
<source/><italic>Neuroscience</italic>
<volume>379</volume>
<fpage>152</fpage>–<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2018.03.008</pub-id>
<pub-id pub-id-type="pmid">29559385</pub-id></mixed-citation>
</ref>
<ref id="B500">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>E.</given-names></name><name><surname>Musich</surname><given-names>P. R.</given-names></name><name><surname>Lin</surname><given-names>F.</given-names></name></person-group> (<year>2019</year>). <article-title>Mitochondrial dysfunction in neurodegenerative diseases and the potential countermeasure.</article-title>
<source/><italic>CNS Neurosci. Ther.</italic>
<volume>25</volume>
<fpage>816</fpage>–<lpage>824</lpage>. <pub-id pub-id-type="doi">10.1111/cns.13116</pub-id>
<pub-id pub-id-type="pmid">30889315</pub-id></mixed-citation>
</ref>
<ref id="B501">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>K.</given-names></name><name><surname>Tanaka</surname><given-names>M.</given-names></name><name><surname>Yuki</surname><given-names>S.</given-names></name><name><surname>Hiraj</surname><given-names>M.</given-names></name><name><surname>Yamamoto</surname><given-names>Y.</given-names></name></person-group> (<year>2018</year>). <article-title>How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis?</article-title>
<source/><italic>J. Clin. Biochem. Nutr.</italic>
<volume>62</volume>
<fpage>20</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.3164/jcbn.17-62</pub-id>
<pub-id pub-id-type="pmid">29371752</pub-id></mixed-citation>
</ref>
<ref id="B502">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Ou</surname><given-names>R.</given-names></name><name><surname>Cao</surname><given-names>B.</given-names></name><name><surname>Hou</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Unique characteristics of the genetics epidemiology of amyotrophic lateral sclerosis in China.</article-title>
<source/><italic>Sci. China Life Sci.</italic>
<volume>62</volume>
<fpage>517</fpage>–<lpage>525</lpage>. <pub-id pub-id-type="doi">10.1007/s11427-018-9453-x</pub-id>
<pub-id pub-id-type="pmid">30863961</pub-id></mixed-citation>
</ref>
<ref id="B503">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiduschat</surname><given-names>N.</given-names></name><name><surname>Mao</surname><given-names>X.</given-names></name><name><surname>Hupf</surname><given-names>J.</given-names></name><name><surname>Armstrong</surname><given-names>N.</given-names></name><name><surname>Kang</surname><given-names>G.</given-names></name><name><surname>Lange</surname><given-names>D. J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Motor cortex glutathione déficit in ALS measured <italic>in vivo</italic> with the J-editing technique.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>570</volume>
<fpage>102</fpage>–<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2014.04.020</pub-id>
<pub-id pub-id-type="pmid">24769125</pub-id></mixed-citation>
</ref>
<ref id="B504">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weishaupt</surname><given-names>J. H.</given-names></name><name><surname>Bartels</surname><given-names>C.</given-names></name><name><surname>Pölking</surname><given-names>E.</given-names></name><name><surname>Dietrich</surname><given-names>J.</given-names></name><name><surname>Rohde</surname><given-names>G.</given-names></name><name><surname>Poeggeler</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Reduced oxidative damage in ALS by high-dose enteral melatonin treatment.</article-title>
<source/><italic>J. Pineal. Res.</italic>
<volume>41</volume>
<fpage>313</fpage>–<lpage>323</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-079X.2006.00377.x</pub-id>
<pub-id pub-id-type="pmid">17014688</pub-id></mixed-citation>
</ref>
<ref id="B505">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wier</surname><given-names>C. G.</given-names></name><name><surname>Crum</surname><given-names>A. E.</given-names></name><name><surname>Reynolds</surname><given-names>A. B.</given-names></name><name><surname>Iyer</surname><given-names>C. C.</given-names></name><name><surname>Chugh</surname><given-names>D.</given-names></name><name><surname>Palettas</surname><given-names>M. S.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Muscle contractility dysfunction precedes loss of motor unit connectivity in SOD1(G93A) mide.</article-title>
<source/><italic>Muscle Nerve</italic>
<volume>59</volume>
<fpage>254</fpage>–<lpage>262</lpage>. <pub-id pub-id-type="doi">10.1002/mus.26365</pub-id>
<pub-id pub-id-type="pmid">30370671</pub-id></mixed-citation>
</ref>
<ref id="B506">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witte</surname><given-names>M. E.</given-names></name><name><surname>Geurts</surname><given-names>J. J.</given-names></name><name><surname>de Vries</surname><given-names>H. E.</given-names></name><name><surname>Van der Valk</surname><given-names>P.</given-names></name><name><surname>Van Horssen</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>Mitochondrial dysfunction: a pontential link between neuroinflammation and neurodegeneration?</article-title>
<source/><italic>Mitochondrion</italic>
<volume>10</volume>
<fpage>411</fpage>–<lpage>418</lpage>. <pub-id pub-id-type="doi">10.1016/j.mito.2010.05.014</pub-id>
<pub-id pub-id-type="pmid">20573557</pub-id></mixed-citation>
</ref>
<ref id="B507">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Feng</surname><given-names>Y.</given-names></name><name><surname>Handschin</surname><given-names>C.</given-names></name><name><surname>Feng</surname><given-names>Y.</given-names></name><name><surname>Gullicksen</surname><given-names>P. S.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Transducer of regulated CREB-binding proteins (TORCs) induce PGC-1alpha transcription and mitochondrial biogénesis in muscle cells.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>103</volume>
<fpage>14379</fpage>–<lpage>14384</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0606714103</pub-id>
<pub-id pub-id-type="pmid">16980408</pub-id></mixed-citation>
</ref>
<ref id="B508">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>Y.</given-names></name><name><surname>Karam</surname><given-names>C.</given-names></name><name><surname>Yi</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Yoon</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>ROS-related mitochondrial dysfunction in skeletal muscle of an ALS mouse model during the disease progression.</article-title>
<source/><italic>Pharmacol. Res.</italic>
<volume>138</volume>
<fpage>25</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2018.09.008</pub-id>
<pub-id pub-id-type="pmid">30236524</pub-id></mixed-citation>
</ref>
<ref id="B509">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Xiao</surname><given-names>A.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name></person-group> (<year>2017</year>). <article-title>Antibacterial activity of polyphenols: structure-activity relationship and influence of hyperglycemic condition.</article-title>
<source/><italic>Molecules</italic>
<volume>22</volume>:<issue>1913</issue>. <pub-id pub-id-type="doi">10.3390/molecules22111913</pub-id>
<pub-id pub-id-type="pmid">29113147</pub-id></mixed-citation>
</ref>
<ref id="B510">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Luo</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Le</surname><given-names>W.</given-names></name></person-group> (<year>2006</year>). <article-title>Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis.</article-title>
<source/><italic>Neurochem. Res.</italic>
<volume>31</volume>
<fpage>1263</fpage>–<lpage>1269</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-006-9166-z</pub-id>
<pub-id pub-id-type="pmid">17021948</pub-id></mixed-citation>
</ref>
<ref id="B511">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>E. X.</given-names></name><name><surname>Lin</surname><given-names>J. P.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Sheng</surname><given-names>S. R.</given-names></name><name><surname>Liu</surname><given-names>H. X.</given-names></name><name><surname>Zhou</surname><given-names>Y. L.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Pterostilbene inhibits inflammation and ROS production in chondrocytes by activating Nrf2 pathway.</article-title>
<source/><italic>Oncotarget</italic>
<volume>8</volume>
<fpage>41988</fpage>–<lpage>42000</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.16716</pub-id>
<pub-id pub-id-type="pmid">28410217</pub-id></mixed-citation>
</ref>
<ref id="B512">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yaku</surname><given-names>K.</given-names></name><name><surname>Okabe</surname><given-names>K.</given-names></name><name><surname>Nakagawa</surname><given-names>T.</given-names></name></person-group> (<year>2018</year>). <article-title>NAD metabolism: implications in aging and longevity.</article-title>
<source/><italic>Ageing Res. Rev.</italic>
<volume>47</volume>
<fpage>1</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/j.arr.2018.05.006</pub-id>
<pub-id pub-id-type="pmid">29883761</pub-id></mixed-citation>
</ref>
<ref id="B513">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>Y.</given-names></name></person-group> (<year>2016</year>). <article-title>Coenzyme Q10 redox balance and a free radical scavenger drug.</article-title>
<source/><italic>Arch. Biochem. Biophys.</italic>
<volume>595</volume>
<fpage>132</fpage>–<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1016/j.abb.2015.11.026</pub-id>
<pub-id pub-id-type="pmid">27095229</pub-id></mixed-citation>
</ref>
<ref id="B514">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>T.</given-names></name><name><surname>Baur</surname><given-names>J. A.</given-names></name><name><surname>Pérez</surname><given-names>E.</given-names></name><name><surname>Matsui</surname><given-names>T.</given-names></name><name><surname>Carmona</surname><given-names>J. J.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival.</article-title>
<source/><italic>Cell</italic>
<volume>130</volume>
<fpage>1095</fpage>–<lpage>1107</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2007.07.035</pub-id>
<pub-id pub-id-type="pmid">17889652</pub-id></mixed-citation>
</ref>
<ref id="B515">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>T.</given-names></name><name><surname>Chan</surname><given-names>N. Y.</given-names></name><name><surname>Sauve</surname><given-names>A. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Synthesis of nicotinamide riboside and derivatives: effective agents for increasing nicotinamide adenine dinucleotide concentrations in mammalian cells.</article-title>
<source/><italic>J. Med. Chem.</italic>
<volume>50</volume>
<fpage>6458</fpage>–<lpage>6461</lpage>. <pub-id pub-id-type="doi">10.1021/jm701001c</pub-id>
<pub-id pub-id-type="pmid">18052316</pub-id></mixed-citation>
</ref>
<ref id="B516">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Fan</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Ma</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Gong</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Pterostilbene attenuates high glucose-induced oxidative injury in hippocampal neuronal cells by activating nuclear factor erythroid 2-related factor 2.</article-title>
<source/><italic>Biochim. Biophys. Acta. Mol. Basis Dis.</italic>
<volume>1863</volume>
<fpage>827</fpage>–<lpage>837</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2017.01.005</pub-id>
<pub-id pub-id-type="pmid">28089584</pub-id></mixed-citation>
</ref>
<ref id="B517">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Sauve</surname><given-names>A. A.</given-names></name></person-group> (<year>2016</year>). <article-title>NAD(+) metabolism: bioenergetics, signaling and manipulation for therapy.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1864</volume>
<fpage>1787</fpage>–<lpage>1800</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbapap.2016.06.014</pub-id>
<pub-id pub-id-type="pmid">27374990</pub-id></mixed-citation>
</ref>
<ref id="B518">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeo</surname><given-names>S. C.</given-names></name><name><surname>Ho</surname><given-names>P. C.</given-names></name><name><surname>Lin</surname><given-names>H. S.</given-names></name></person-group> (<year>2013</year>). <article-title>Pharmacokinetics of pterostilbene in Sprague-Dawley rats: the impacts of aqueous solubility, fasting, dose escalation, and dosing route on bioavailability.</article-title>
<source/><italic>Mol. Nutr. Food Res.</italic>
<volume>57</volume>
<fpage>1015</fpage>–<lpage>1025</lpage>. <pub-id pub-id-type="doi">10.1002/mnfr.201200651</pub-id>
<pub-id pub-id-type="pmid">23417986</pub-id></mixed-citation>
</ref>
<ref id="B519">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshino</surname><given-names>H.</given-names></name><name><surname>Kimura</surname><given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study).</article-title>
<source/><italic>Amyotroph. Lateral Scler.</italic>
<volume>7</volume>
<fpage>241</fpage>–<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1080/17482960600881870</pub-id>
<pub-id pub-id-type="pmid">17127563</pub-id></mixed-citation>
</ref>
<ref id="B520">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshino</surname><given-names>J.</given-names></name><name><surname>Baur</surname><given-names>J. A.</given-names></name><name><surname>Imai</surname><given-names>S. I.</given-names></name></person-group> (<year>2018</year>). <article-title>NAD+ intermediates: the biology and therapeutic potential of NMN and NR.</article-title>
<source/><italic>Cell Metab.</italic>
<volume>27</volume>
<fpage>513</fpage>–<lpage>528</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2017.11.002</pub-id>
<pub-id pub-id-type="pmid">29249689</pub-id></mixed-citation>
</ref>
<ref id="B521">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Y.</given-names></name><name><surname>Sy</surname><given-names>F. C.</given-names></name><name><surname>Callaghan</surname><given-names>B. C.</given-names></name><name><surname>Goutman</surname><given-names>S. A.</given-names></name><name><surname>Batterman</surname><given-names>S. A.</given-names></name><name><surname>Feldman</surname><given-names>E. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Environmental risk factors and amyotrophic lateral sclerosis (ALS): a case-control sutdy of ALS in Michingan.</article-title>
<source/><italic>PLoS One</italic>
<volume>9</volume>:<issue>e101186</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0101186</pub-id>
<pub-id pub-id-type="pmid">24979055</pub-id></mixed-citation>
</ref>
<ref id="B522">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yun</surname><given-names>Y. C.</given-names></name><name><surname>Jeong</surname><given-names>S. G.</given-names></name><name><surname>Kim</surname><given-names>S. H.</given-names></name><name><surname>Cho</surname><given-names>G. W.</given-names></name></person-group> (<year>2019</year>). <article-title>Reduced sirtuin 1/adenosine monophosphate-activated protein kinase in amyotrophic lateral sclerosis patient-derived mesenchymal stem cells can be restored by resveratrol.</article-title>
<source/><italic>J. Tissue Eng. Regen. Med.</italic>
<volume>13</volume>
<fpage>110</fpage>–<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1002/term.2776</pub-id>
<pub-id pub-id-type="pmid">30479062</pub-id></mixed-citation>
</ref>
<ref id="B523">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yusuf</surname><given-names>M.</given-names></name><name><surname>Khan</surname><given-names>M.</given-names></name><name><surname>Robaian</surname><given-names>M. A.</given-names></name><name><surname>Khan</surname><given-names>R. A.</given-names></name></person-group> (<year>2018</year>). <article-title>Biomechanistic insights into the roles of oxidative stress in generating complex neurological disorders.</article-title>
<source/><italic>Biol. Chem.</italic>
<volume>399</volume>
<fpage>305</fpage>–<lpage>319</lpage>. <pub-id pub-id-type="doi">10.1515/hsz-2017-0250</pub-id>
<pub-id pub-id-type="pmid">29261511</pub-id></mixed-citation>
</ref>
<ref id="B524">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zewen</surname><given-names>L.</given-names></name><name><surname>Zhangpin</surname><given-names>R.</given-names></name><name><surname>Jun</surname><given-names>Z.</given-names></name><name><surname>Chia-Chen</surname><given-names>C.</given-names></name><name><surname>Eswar</surname><given-names>K.</given-names></name><name><surname>Tingyang</surname><given-names>Z.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Role of ROS and nutritional antioxidants in human diseases.</article-title>
<source/><italic>Front. Physiol.</italic>
<volume>9</volume>:<issue>477</issue>. <pub-id pub-id-type="doi">10.3389/fphys.2018.00477</pub-id>
<pub-id pub-id-type="pmid">29867535</pub-id></mixed-citation>
</ref>
<ref id="B525">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>X. Q.</given-names></name><name><surname>Chen</surname><given-names>H. Y.</given-names></name><name><surname>Liu</surname><given-names>B. H.</given-names></name></person-group> (<year>2014</year>). <article-title>Involvement of the Nrf2 pathway in the regulation of pterostilbene-induced apoptosis in HeLa cells via ER stress.</article-title>
<source/><italic>J. Pharmacol. Sci.</italic>
<volume>126</volume>
<fpage>216</fpage>–<lpage>229</lpage>. <pub-id pub-id-type="pmid">25341683</pub-id></mixed-citation>
</ref>
<ref id="B526">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Ryu</surname><given-names>D.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Gariani</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Luan</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>NAD+ repletion improves mitochondial and stem cell function and enhaces life span in mice.</article-title>
<source/><italic>Science</italic>
<volume>352</volume>
<fpage>1436</fpage>–<lpage>1443</lpage>. <pub-id pub-id-type="doi">10.1126/science.aaf2693</pub-id>
<pub-id pub-id-type="pmid">27127236</pub-id></mixed-citation>
</ref>
<ref id="B527">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>G.</given-names></name><name><surname>Song</surname><given-names>W.</given-names></name><name><surname>Tan</surname><given-names>X.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Pterostilbene protects vascular endotelial cells against oxidized low-density lipoprotein-induced apoptosis <italic>in vitro</italic> and <italic>in vivo</italic>.</article-title>
<source/><italic>Apoptosis</italic>
<volume>17</volume>
<fpage>25</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1007/s10495-011-0653-6</pub-id>
<pub-id pub-id-type="pmid">21928089</pub-id></mixed-citation>
</ref>
<ref id="B528">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>N.</given-names></name><name><surname>Sauve</surname><given-names>A. A.</given-names></name></person-group> (<year>2018</year>). <article-title>Regulatory effects of NAD+ metabolic pathways on sirtuin activity.</article-title>
<source/><italic>Prog. Mol. Biol. Transl. Sci.</italic>
<volume>154</volume>
<fpage>71</fpage>–<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1016/bs.pmbts.2017.11.012</pub-id>
<pub-id pub-id-type="pmid">29413178</pub-id></mixed-citation>
</ref>
<ref id="B529">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Cook</surname><given-names>A.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Baranov</surname><given-names>S. V.</given-names></name><name><surname>Jiang</surname><given-names>J.</given-names></name><name><surname>Smith</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits mt1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>55</volume>
<fpage>26</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2013.03.008</pub-id>
<pub-id pub-id-type="pmid">23537713</pub-id></mixed-citation>
</ref>
<ref id="B530">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>N.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Synergistic activation of the human MnSOD promoter by DJ-1 and PGC-1alpha: regulation by SUMOylation and oxidation.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>17</volume>
<fpage>3357</fpage>–<lpage>3367</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddn230</pub-id>
<pub-id pub-id-type="pmid">18689799</pub-id></mixed-citation>
</ref>
<ref id="B531">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Zheng</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>D. P.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>Y. M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Natural polyphenols for prevention and treatment of cancer.</article-title>
<source/><italic>Nutrients</italic>
<volume>8</volume>:<issue>E515</issue>. <pub-id pub-id-type="doi">10.3390/nu8080515</pub-id>
<pub-id pub-id-type="pmid">27556486</pub-id></mixed-citation>
</ref>
<ref id="B532">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>X. H.</given-names></name><name><surname>Lu</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>B. Y.</given-names></name><name><surname>Ugurbil</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name></person-group> (<year>2015</year>). <article-title><italic>In vivo</italic> NAD assay reveals the intracelular NAD contents and redox state in healthy human brain and their age dependences.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>112</volume>
<fpage>2876</fpage>–<lpage>2881</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1417921112</pub-id>
<pub-id pub-id-type="pmid">25730862</pub-id></mixed-citation>
</ref>
<ref id="B533">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zordoky</surname><given-names>B. N.</given-names></name><name><surname>Robertson</surname><given-names>I. M.</given-names></name><name><surname>Dyck</surname><given-names>J. R.</given-names></name></person-group> (<year>2015</year>). <article-title>Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases.</article-title>
<source/><italic>Biochim. Biophys. Acta</italic>
<volume>1852</volume>
<fpage>1155</fpage>–<lpage>1177</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2014.10.016</pub-id>
<pub-id pub-id-type="pmid">25451966</pub-id></mixed-citation>
</ref>
<ref id="B534">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zufiría</surname><given-names>M.</given-names></name><name><surname>Gil-Bea</surname><given-names>F. J.</given-names></name><name><surname>Fernández-Torrón</surname><given-names>R.</given-names></name><name><surname>Poza</surname><given-names>J. J.</given-names></name><name><surname>Muñoz-Blanco</surname><given-names>J. L.</given-names></name><name><surname>Rojas-García</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>ALS: a bucket of genes, environment, metabolism and unknow ingredients.</article-title>
<source/><italic>Prog. Neurobiol.</italic>
<volume>142</volume>
<fpage>104</fpage>–<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2016.05.004</pub-id>
<pub-id pub-id-type="pmid">27236050</pub-id></mixed-citation>
</ref>
<ref id="B535">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuo</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>T.</given-names></name><name><surname>Pannell</surname><given-names>B. K.</given-names></name><name><surname>Ziegler</surname><given-names>A. C.</given-names></name><name><surname>Best</surname><given-names>T. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Biological and physiological role of reactive oxygen species –the good, the bad and the ugly.</article-title>
<source/><italic>Acta Physiol.</italic>
<volume>214</volume>
<fpage>329</fpage>–<lpage>348</lpage>. <pub-id pub-id-type="doi">10.1111/apha.12515</pub-id>
<pub-id pub-id-type="pmid">25912260</pub-id></mixed-citation>
</ref>
</ref-list>
<glossary>
<title>Abbreviations</title>
<def-list id="DL1">
<def-item>
<term>3-NT</term>
<def>
<p>3-nitrotyrosine</p>
</def>
</def-item>
<def-item>
<term>5-LOX</term>
<def>
<p>5-lipoxygenase</p>
</def>
</def-item>
<def-item>
<term>7,8-DHF</term>
<def>
<p>7,8-dihydroxyflavone</p>
</def>
</def-item>
<def-item>
<term>8-OHdG</term>
<def>
<p>8-oxo-deoxyguanosine</p>
</def>
</def-item>
<def-item>
<term>AD</term>
<def>
<p>Alzheimer’s disease</p>
</def>
</def-item>
<def-item>
<term>ALS</term>
<def>
<p>amyotrophic lateral sclerosis</p>
</def>
</def-item>
<def-item>
<term>CAT</term>
<def>
<p>catalase</p>
</def>
</def-item>
<def-item>
<term>CNS</term>
<def>
<p>central nervous system</p>
</def>
</def-item>
<def-item>
<term>CoQ10</term>
<def>
<p>Co-enzyme Q10</p>
</def>
</def-item>
<def-item>
<term>COX</term>
<def>
<p>cyclooxygenase</p>
</def>
</def-item>
<def-item>
<term>CSF</term>
<def>
<p>cerebrospinal fluid</p>
</def>
</def-item>
<def-item>
<term>DMC</term>
<def>
<p>dimethoxy curcumin</p>
</def>
</def-item>
<def-item>
<term>EGCG</term>
<def>
<p>epigallocatechin gallate</p>
</def>
</def-item>
<def-item>
<term>ETC</term>
<def>
<p>electron transport chain</p>
</def>
</def-item>
<def-item>
<term>F2-IsoPS</term>
<def>
<p>F2-isoprostane</p>
</def>
</def-item>
<def-item>
<term>fALS</term>
<def>
<p>familial amyotrophic lateral sclerosis</p>
</def>
</def-item>
<def-item>
<term>GPx</term>
<def>
<p>Glutathione peroxidase</p>
</def>
</def-item>
<def-item>
<term>GR</term>
<def>
<p>Glutathione reductase</p>
</def>
</def-item>
<def-item>
<term>GSH</term>
<def>
<p>Reduced glutathione</p>
</def>
</def-item>
<def-item>
<term>GSK-3ß</term>
<def>
<p>Glycogen synthase kinase 3 beta</p>
</def>
</def-item>
<def-item>
<term>GSSG</term>
<def>
<p>Glutathione disulfide</p>
</def>
</def-item>
<def-item>
<term>H<sub>2</sub>O<sub>2</sub></term>
<def>
<p>Hydrogen peroxide</p>
</def>
</def-item>
<def-item>
<term>HD</term>
<def>
<p>Huntington’s disease</p>
</def>
</def-item>
<def-item>
<term>HNE</term>
<def>
<p>4-hydroxy-2-nonenal</p>
</def>
</def-item>
<def-item>
<term>IDH2</term>
<def>
<p>Isocitrate dehydrogenase</p>
</def>
</def-item>
<def-item>
<term>IL-18</term>
<def>
<p>Interleukin-18</p>
</def>
</def-item>
<def-item>
<term>IL-1ß</term>
<def>
<p>Interleukin 1ß</p>
</def>
</def-item>
<def-item>
<term>IL-6</term>
<def>
<p>Interleukin-6</p>
</def>
</def-item>
<def-item>
<term>IL-8</term>
<def>
<p>Interleukin-8</p>
</def>
</def-item>
<def-item>
<term>iNOS</term>
<def>
<p>nitric oxide synthase</p>
</def>
</def-item>
<def-item>
<term>LDL</term>
<def>
<p>low-density lipoprotein</p>
</def>
</def-item>
<def-item>
<term>LMN</term>
<def>
<p>lower motor neurons</p>
</def>
</def-item>
<def-item>
<term>LOX</term>
<def>
<p>lipoxygenase</p>
</def>
</def-item>
<def-item>
<term>LPS</term>
<def>
<p>lipopolysaccharide</p>
</def>
</def-item>
<def-item>
<term>MDA</term>
<def>
<p>malondialdehyde</p>
</def>
</def-item>
<def-item>
<term>MPO</term>
<def>
<p>myeloperoxidase</p>
</def>
</def-item>
<def-item>
<term>MS</term>
<def>
<p>multiple sclerosis</p>
</def>
</def-item>
<def-item>
<term>mtDNA</term>
<def>
<p>mitochondrial DNA</p>
</def>
</def-item>
<def-item>
<term>mtROS</term>
<def>
<p>mitochondrial reactive oxygen species</p>
</def>
</def-item>
<def-item>
<term>NA</term>
<def>
<p>nicotinic acid</p>
</def>
</def-item>
<def-item>
<term>NAD<sup>+</sup></term>
<def>
<p>nicotinamide adenine dinucleotide</p>
</def>
</def-item>
<def-item>
<term>NADPH</term>
<def>
<p>nicotinamide adenine dinucleotide phosphate</p>
</def>
</def-item>
<def-item>
<term>NAM</term>
<def>
<p>nicotinamide</p>
</def>
</def-item>
<def-item>
<term>NAMPT</term>
<def>
<p>nicotinamide phosphoribosyltransferase</p>
</def>
</def-item>
<def-item>
<term>NF-kB</term>
<def>
<p>nuclear factor kappa-light-chain-enhancer of activated B cells</p>
</def>
</def-item>
<def-item>
<term>NMN</term>
<def>
<p>nicotinamide mononucleotide</p>
</def>
</def-item>
<def-item>
<term>NO</term>
<def>
<p>nitric oxide</p>
</def>
</def-item>
<def-item>
<term>NO<sup>–</sup></term>
<def>
<p>nitroxyl anion</p>
</def>
</def-item>
<def-item>
<term>NO<sup>+</sup></term>
<def>
<p>nitrosonium cation</p>
</def>
</def-item>
<def-item>
<term>NO <sup>∙</sup></term>
<def>
<p>nitric oxide radical</p>
</def>
</def-item>
<def-item>
<term>NOS</term>
<def>
<p>nitric oxide synthase</p>
</def>
</def-item>
<def-item>
<term>NR</term>
<def>
<p>nicotinamide riboside</p>
</def>
</def-item>
<def-item>
<term>Nrf2</term>
<def>
<p>nuclear factor erythroid 2-related factor</p>
</def>
</def-item>
<def-item>
<term>NRK1</term>
<def>
<p>nicotinamide riboside kinase 1</p>
</def>
</def-item>
<def-item>
<term>NRK2</term>
<def>
<p>nicotinamide riboside kinase 2</p>
</def>
</def-item>
<def-item>
<term>NRKs</term>
<def>
<p>nicotinamide riboside kinases</p>
</def>
</def-item>
<def-item>
<term>O<sub>2</sub></term>
<def>
<p>singlet oxygen</p>
</def>
</def-item>
<def-item>
<term>O<inline-formula><mml:math id="INEQ20"><mml:msubsup><mml:mi></mml:mi><mml:mn>2</mml:mn><mml:mrow><mml:mi></mml:mi><mml:mo>∙</mml:mo><mml:mo>-</mml:mo></mml:mrow></mml:msubsup></mml:math></inline-formula></term>
<def>
<p>superoxide anion radical</p>
</def>
</def-item>
<def-item>
<term>OH</term>
<def>
<p>hydroxyl group</p>
</def>
</def-item>
<def-item>
<term>OH <sup>∙</sup></term>
<def>
<p>hydroxyl radical</p>
</def>
</def-item>
<def-item>
<term>ONOO<sup>–</sup></term>
<def>
<p>peroxynitrite anion</p>
</def>
</def-item>
<def-item>
<term>OS</term>
<def>
<p>oxidative stress</p>
</def>
</def-item>
<def-item>
<term>PARPs</term>
<def>
<p>poly(ADP-ribose) polymerase</p>
</def>
</def-item>
<def-item>
<term>PD</term>
<def>
<p>Parkinson’s disease</p>
</def>
</def-item>
<def-item>
<term>PGC-1 α</term>
<def>
<p>Peroxisome proliferator-activated receptor gamma coactivator 1-alpha</p>
</def>
</def-item>
<def-item>
<term>PNP</term>
<def>
<p>purine nucleoside phosphorylase</p>
</def>
</def-item>
<def-item>
<term>PPAR- α</term>
<def>
<p>peroxisome proliferator activator receptor alpha</p>
</def>
</def-item>
<def-item>
<term>pTau</term>
<def>
<p>Tau protein</p>
</def>
</def-item>
<def-item>
<term>PTER</term>
<def>
<p>Pterostilbene (trans-3,5-dimethoxy-4 hydroxystilbene)</p>
</def>
</def-item>
<def-item>
<term>PUFAs</term>
<def>
<p>polyunsaturated fatty acids</p>
</def>
</def-item>
<def-item>
<term>Q3BDG</term>
<def>
<p>Quercetin 3-ß-<sc>D</sc>-glucoside</p>
</def>
</def-item>
<def-item>
<term>RCS</term>
<def>
<p>reactive species of copper</p>
</def>
</def-item>
<def-item>
<term>RES</term>
<def>
<p>Resveratrol (3,5,4 ′ -trihydroxy-<italic>trans</italic>-stilbene)</p>
</def>
</def-item>
<def-item>
<term>RIS</term>
<def>
<p>reactive iron species</p>
</def>
</def-item>
<def-item>
<term>RNA</term>
<def>
<p>ribonucleic acid</p>
</def>
</def-item>
<def-item>
<term>RNS</term>
<def>
<p>reactive nitrogen species</p>
</def>
</def-item>
<def-item>
<term>RONS</term>
<def>
<p>reactive oxygen and nitrogen species</p>
</def>
</def-item>
<def-item>
<term>ROS</term>
<def>
<p>reactive oxygen species</p>
</def>
</def-item>
<def-item>
<term>SA</term>
<def>
<p>spinocerebellar ataxia</p>
</def>
</def-item>
<def-item>
<term>sALS</term>
<def>
<p>sporadic amyotrophic lateral sclerosis</p>
</def>
</def-item>
<def-item>
<term>SIRT</term>
<def>
<p>sirtuin</p>
</def>
</def-item>
<def-item>
<term>SIRT1</term>
<def>
<p>sirtuin 1</p>
</def>
</def-item>
<def-item>
<term>SIRT3</term>
<def>
<p>sirtuin 3</p>
</def>
</def-item>
<def-item>
<term>SOD</term>
<def>
<p>superoxide dismutase</p>
</def>
</def-item>
<def-item>
<term>SOD1</term>
<def>
<p>superoxide dismutase 1</p>
</def>
</def-item>
<def-item>
<term>SOD2</term>
<def>
<p>superoxide dismutase 2</p>
</def>
</def-item>
<def-item>
<term>TAS</term>
<def>
<p>total antioxidant status</p>
</def>
</def-item>
<def-item>
<term>TBARS</term>
<def>
<p>thiobarbituric acid reactive species</p>
</def>
</def-item>
<def-item>
<term>TNF- α</term>
<def>
<p>tumor necrosis factor alpha</p>
</def>
</def-item>
<def-item>
<term>UMN</term>
<def>
<p>upper motor neurons</p>
</def>
</def-item>
<def-item>
<term>XO</term>
<def>
<p>xanthine oxidase.</p>
</def>
</def-item>
</def-list>
</glossary>
</back>
</article>
</pmc-articleset>